This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| Code | Display |
| 13361-1 | Semen analysis panel |
| 15129-0 | Deprecated Fibrin D-dimer EIA |
| 24313-9 | Hepatitis 1996 panel - Serum |
| 24314-7 | TORCH 1996 panel - Serum |
| 24315-4 | Cytomegalovirus IgG and IgM panel - Serum |
| 24316-2 | Epstein Barr virus capsid IgG and IgM panel - Serum |
| 24317-0 | Hemogram and platelets WO differential panel - Blood |
| 24318-8 | Manual Differential panel - Blood |
| 24319-6 | Cardiolipin IgG and IgM panel - Serum |
| 24320-4 | Basic metabolic 1998 panel - Serum or Plasma |
| 24321-2 | Basic metabolic 2000 panel - Serum or Plasma |
| 24322-0 | Comprehensive metabolic 1998 panel - Serum or Plasma |
| 24323-8 | Comprehensive metabolic 2000 panel - Serum or Plasma |
| 24324-6 | Hepatic function 1996 panel - Serum or Plasma |
| 24325-3 | Hepatic function 2000 panel - Serum or Plasma |
| 24326-1 | Electrolytes 1998 panel - Serum or Plasma |
| 24327-9 | Electrolytes 3 panel - Body fluid |
| 24328-7 | Electrolytes 3 panel - Stool |
| 24329-5 | Electrolytes 3 panel - Urine |
| 24331-1 | Lipid 1996 panel - Serum or Plasma |
| 24332-9 | Alkaline phosphatase isoenz panel - Serum or Plasma |
| 24333-7 | Amylase isoenzyme 3 panel - Serum or Plasma |
| 24334-5 | Amylase isoenzyme 7 panel - Serum |
| 24335-2 | Creatine kinase panel - Serum or Plasma |
| 24336-0 | Gas panel - Arterial blood |
| 24337-8 | Gas panel - Capillary blood |
| 24338-6 | Gas panel - Blood |
| 24339-4 | Gas panel - Venous blood |
| 24340-2 | Gas panel - Body fluid |
| 24341-0 | Gas and Carbon monoxide panel - Arterial blood |
| 24342-8 | Gas and Carbon monoxide panel - Capillary blood |
| 24343-6 | Gas and Carbon monoxide panel - Blood |
| 24344-4 | Gas and Carbon monoxide panel - Venous blood |
| 24345-1 | Deprecated Gas & CO panel |
| 24346-9 | Parathyrin.intact and Calcium panel - Serum or Plasma |
| 24347-7 | Parathyrin.mid molecule and Calcium panel - Serum or Plasma |
| 24348-5 | Free T4 and TSH panel - Serum or Plasma |
| 24349-3 | Drugs of abuse 5 panel - Urine |
| 24350-1 | Volatiles panel - Urine |
| 24351-9 | Protein electrophoresis panel - Serum or Plasma |
| 24352-7 | Protein electrophoresis panel - Cerebral spinal fluid |
| 24353-5 | Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma |
| 24356-8 | Urinalysis complete panel - Urine |
| 24357-6 | Urinalysis macro (dipstick) panel - Urine |
| 24358-4 | Hemogram without Platelets panel - Blood |
| 24359-2 | Hemogram without Platelets and with Manual Differential panel - Blood |
| 24360-0 | Hemoglobin and Hematocrit panel - Blood |
| 24361-8 | Deprecated Hemogram, platelets & Differential panel in Blood |
| 24362-6 | Renal function 2000 panel - Serum or Plasma |
| 24363-4 | Acute hepatitis 2000 panel - Serum Qualitative |
| 24364-2 | Obstetric 1996 panel - Serum and Blood |
| 24365-9 | Urinalysis microscopic panel - Urine sediment |
| 29576-6 | Bacterial susceptibility panel |
| 29577-4 | Fungal susceptibility panel |
| 29578-2 | Viral susceptibility panel |
| 29579-0 | Mycobacterial susceptibility panel |
| 29580-8 | Differential panel - Body fluid |
| 29581-6 | Differential panel - Peritoneal fluid |
| 29582-4 | Differential panel - Synovial fluid |
| 29583-2 | Differential panel - Pleural fluid |
| 29584-0 | Differential panel - Cerebral spinal fluid |
| 29585-7 | Immunoelectrophoresis panel - Urine |
| 29586-5 | Immunoelectrophoresis panel - Serum |
| 29587-3 | Toxicology panel - Blood |
| 29588-1 | Heavy metals panel - Blood |
| 29589-9 | Heavy metals panel - Urine |
| 34527-2 | Deprecated Hemogram, Platelets, Differential & Reticulocyte panel in Blood |
| 34528-0 | PT panel - Platelet poor plasma by Coagulation assay |
| 34529-8 | PT and aPTT panel - Platelet poor plasma by Coagulation assay |
| 34530-6 | ABO and Rh group panel - Blood |
| 34531-4 | Blood type and Crossmatch panel - Blood |
| 34532-2 | Blood type and Indirect antibody screen panel - Blood |
| 34534-8 | EKG 12 channel panel |
| 34535-5 | Microalbumin/Creatinine panel in random Urine |
| 34536-3 | Fluid intake and output panel 24 hour |
| 34537-1 | Fluid intake and output panel 8 hour |
| 34539-7 | Protein electrophoresis panel - Urine |
| 34540-5 | Phenytoin free and total panel [Mass/volume] - Serum or Plasma |
| 34541-3 | ACTH stimulation test using IM corticosteroids in Serum or Plasma |
| 34542-1 | ACTH stimulation test using IV corticosteroids in Serum or Plasma |
| 34543-9 | Bilirubin direct and total panel [Mass/volume] - Serum or Plasma |
| 34544-7 | Complement C3 and C4 panel [Mass/volume] - Serum or Plasma |
| 34545-4 | Carbamazepine free and total panel [Mass/volume] - Serum or Plasma |
| 34546-2 | Protein and Glucose panel [Mass/volume] - Cerebral spinal fluid |
| 34547-0 | Complement profile panel [Mass/volume] - Serum or Plasma |
| 34548-8 | Sodium and Potassium panel [Moles/volume] - Serum or Plasma |
| 34549-6 | Follitropin and Lutropin panel [Units/volume] - Serum or Plasma |
| 34550-4 | Immunoglobulin panel [Mass/volume] - Serum |
| 34551-2 | Catecholamines 3 panel [Mass/volume] - Plasma |
| 34552-0 | 2D echocardiogram panel |
| 34553-8 | Orthostatic blood pressure panel |
| 34554-6 | Electrolytes 1998 and Venous pH panel - Serum or Plasma + Blood venous |
| 34555-3 | Creatinine 24H renal clearance panel |
| 34556-1 | Cell count panel - Body fluid |
| 34557-9 | Cell count and Differential panel - Body fluid |
| 34558-7 | Cell count panel - Peritoneal fluid |
| 34559-5 | Cell count panel - Synovial fluid |
| 34560-3 | Cell count and Differential panel - Synovial fluid |
| 34561-1 | Cell count panel - Pleural fluid |
| 34562-9 | Cell count and Differential panel - Pleural fluid |
| 34563-7 | Cell count panel - Cerebral spinal fluid |
| 34564-5 | Cell count and Differential panel - Cerebral spinal fluid |
| 34565-2 | Vital signs, weight and height panel |
| 34566-0 | Vital signs with method details panel |
| 34567-8 | Cell count and Differential panel - Peritoneal fluid |
| 34665-0 | TORCH panel - Cerebral spinal fluid |
| 34667-6 | Heavy metals panel - Hair |
| 34672-6 | Immunoelectrophoresis panel - 24 hour Urine |
| 34940-7 | Babesia microti IgG and IgM panel - Serum |
| 34941-5 | Bordetella pertussis IgG and IgM panel - Serum |
| 34942-3 | Borrelia burgdorferi IgG and IgM panel - Serum |
| 34943-1 | Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid |
| 34944-9 | Cytomegalovirus IgG and IgM panel - Cerebral spinal fluid |
| 34945-6 | Herpes virus 6 IgG and IgM panel - Serum |
| 34946-4 | Herpes virus 6 IgG and IgM panel - Cerebral spinal fluid |
| 34947-2 | Herpes virus 7 IgG and IgM panel - Serum |
| 34948-0 | Measles virus IgG and IgM panel - Serum |
| 34949-8 | Measles virus IgG and IgM panel - Cerebral spinal fluid |
| 34950-6 | Parvovirus B19 IgG and IgM panel - Serum |
| 34951-4 | Phosphatidylserine IgG and IgM panel - Serum |
| 34952-2 | Rubella virus IgG and IgM panel - Serum |
| 34953-0 | Rubella virus IgG and IgM panel - Cerebral spinal fluid |
| 34954-8 | Treponema pallidum IgG and IgM panel - Serum |
| 34955-5 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid |
| 34994-4 | Smear morphology panel - Blood |
| 35083-5 | Amino acids panel [Moles/volume] - Serum or Plasma |
| 35084-3 | Fetal lung maturity in Amniotic fluid |
| 35085-0 | Deprecated Newborn screening panel American College of Medical Genetics (ACMG) |
| 35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
| 35087-6 | Amino acids panel - Urine |
| 35088-4 | Glasgow coma scale |
| 35089-2 | History and physical panel |
| 35090-0 | Patient history |
| 35091-8 | Patient physical |
| 35092-6 | Urology testicular ultrasound |
| 35093-4 | Urology urinary tract ultrasound |
| 35094-2 | Blood pressure panel |
| 35095-9 | Body temperature panel |
| 35096-7 | OB ultrasound panel |
| 35499-3 | Pesticide and Insecticide panel [Mass/volume] - Serum or Plasma |
| 35500-8 | Pesticide and Insecticide panel [Mass/volume] - Urine |
| 35501-6 | Pesticide and Insecticide panel [Mass/volume] - Urine and Serum or Plasma |
| 35502-4 | Mitochondrial myopathy enzyme panel [Enzymatic activity/mass] - Tissue |
| 35507-3 | Amino acids panel [Moles/volume] - Cerebral spinal fluid |
| 35508-1 | Amino acids panel [Moles/volume] - Amniotic fluid |
| 35509-9 | Amino acids panel [Moles/time] - 24 hour Urine |
| 35558-6 | Cholinesterase panel [Enzymatic activity/volume] - Blood |
| 35563-6 | Rickettsia rickettsii IgG and IgM panel - Serum |
| 35575-0 | Pigeon antibody panel - Serum |
| 35576-8 | Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma |
| 35577-6 | Hypersensitivity pneumonitis panel - Serum |
| 35650-1 | Lymphocytic choriomeningitis virus IgG and IgM panel - Cerebral spinal fluid |
| 35666-7 | Lymphocytic choriomeningitis virus IgG and IgM panel - Serum |
| 35679-0 | Varicella zoster virus IgG and IgM panel - Cerebral spinal fluid |
| 35680-8 | Hepatitis E virus IgG and IgM panel - Serum |
| 35681-6 | Tissue transglutaminase Ab panel - Serum |
| 35682-4 | Trypanosoma cruzi IgG and IgM panel - Serum |
| 35683-2 | Burkholderia pseudomallei IgG and IgM panel - Serum |
| 35684-0 | Colorado tick fever virus IgG and IgM panel - Serum |
| 35739-2 | Brucella sp IgG and IgM panel - Serum |
| 35740-0 | Rickettsia sp IgG and IgM panel - Serum |
| 35743-4 | Eastern equine encephalitis virus IgG and IgM panel - Unspecified specimen |
| 35752-5 | Escherichia coli O157:H7 IgG and IgM panel - Serum |
| 35866-3 | Organic acids panel - Serum or Plasma |
| 38212-7 | Pain assessment panel |
| 38213-5 | FLACC pain assessment panel |
| 38228-3 | Braden scale skin assessment panel |
| 38269-7 | Study report Skeletal system DXA |
| 38351-3 | Herpes virus 6 DNA panel - Unspecified specimen by Probe and target amplification method |
| 39135-9 | Wound assessment panel |
| 39136-7 | Deprecated Skin assessment panel |
| 39137-5 | Oral assessment panel |
| 41359-1 | Active range of motion panel Quantitative |
| 41360-9 | Passive range of motion panel Quantitative |
| 41478-9 | Bartonella henselae IgG and IgM panel - Serum |
| 41482-1 | Chlamydia sp IgG and IgM panel [Titer] - Serum |
| 41484-7 | Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation |
| 41485-4 | Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation |
| 41486-2 | Coxsackievirus B Ab panel [Titer] - Serum by Neutralization test |
| 41493-8 | Febrile agglutinin Ab panel [Titer] - Serum |
| 41505-9 | Parainfluenza virus Ag panel - Unspecified specimen by Immunofluorescence |
| 41506-7 | Polio virus Ab panel [Titer] - Serum by Neutralization test |
| 41839-2 | Burkholderia pseudomallei IgG and IgM panel - Serum by Immunofluorescence |
| 41840-0 | Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum |
| 41841-8 | Coxiella burnetii phase 1 and 2 IgM panel [Titer] - Serum |
| 41842-6 | Herpes virus 7 IgG and IgM panel [Titer] - Serum by Immunofluorescence |
| 41843-4 | Lymphocytic choriomeningitis virus IgG and IgM panel [Titer] - Cerebral spinal fluid by Immunofluorescence |
| 41875-6 | Bordetella pertussis and Bordetella parapertussis DNA panel - Unspecified specimen by Probe and target amplification method |
| 41876-4 | Rickettsia typhi and Rickettsia spotted fever group IgG and IgM panel - Serum |
| 41877-2 | Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay |
| 41878-0 | Dengue virus IgG and IgM panel [Units/volume] - Serum by Immunoassay |
| 42191-7 | Hepatitis A and B and C 7a panel - Serum |
| 42218-8 | Sulfatide IgG and IgM panel - Serum |
| 42342-6 | Rickettsia (Proteus) Ab panel - Serum |
| 42359-0 | Streptococcus pneumoniae 14b IgG panel [Mass/volume] - Serum |
| 42360-8 | Streptococcus pneumoniae 14a IgG panel [Mass/volume] - Serum |
| 42361-6 | Streptococcus pneumoniae 12 IgG panel [Mass/volume] - Serum |
| 42362-4 | Streptococcus pneumoniae 7b IgG panel [Mass/volume] - Serum |
| 42363-2 | Streptococcus pneumoniae 7a IgG panel [Mass/volume] - Serum |
| 42364-0 | Streptococcus pneumoniae 6 IgG panel [Mass/volume] - Serum |
| 42365-7 | Streptococcus pneumoniae 4 IgG panel [Mass/volume] - Serum |
| 42366-5 | Streptococcus pneumoniae 23 IgG panel [Mass/volume] - Serum |
| 42760-9 | Inflammatory bowel disease Ab panel - Serum |
| 42770-8 | Human papilloma virus high and Low risk DNA panel - Cervix |
| 42929-0 | Lactate dehydrogenase panel - Serum or Plasma |
| 43098-3 | Yersinia sp Ab panel - Serum |
| 43099-1 | Vanillylmandelate and Creatinine panel - 24 hour Urine |
| 43100-7 | Sjogrens syndrome-A and B extractable nuclear Ab panel - Serum |
| 43101-5 | Phosphatidylserine IgA and IgG and IgM panel - Serum |
| 43104-9 | Paraneoplastic Ab panel - Serum |
| 43105-6 | Acetaldehyde and Paraldehyde panel [Mass/volume] - Serum or Plasma |
| 43106-4 | Amitriptyline and Nortriptyline panel [Mass/volume] - Serum or Plasma |
| 43107-2 | Mycoplasma sp and Ureaplasma sp panel - Unspecified specimen by Organism specific culture |
| 43108-0 | Metanephrine and Normetanephrine panel [Mass/volume] - Serum or Plasma |
| 43109-8 | Leishmania sp IgG and IgM panel - Serum |
| 43110-6 | Immunoglobulin light chains panel - 24 hour Urine |
| 43112-2 | Herpes simplex virus Ab panel - Serum |
| 43113-0 | Hemoglobin electrophoresis panel in Blood |
| 43116-3 | Porphyrin fractions panel - 24 hour Urine |
| 43117-1 | Fluoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma |
| 43118-9 | Fat panel - Stool |
| 43119-7 | Extractable nuclear Ab panel - Serum |
| 43120-5 | Echovirus Ab panel - Serum |
| 43122-1 | Doxepin and Nordoxepin panel [Mass/volume] - Serum or Plasma |
| 43123-9 | Imipramine and Desipramine panel [Mass/volume] - Serum or Plasma |
| 43124-7 | Cystine panel - Urine |
| 43125-4 | Nicotine and Metabolites panel [Mass/volume] - Urine |
| 43126-2 | Cortisol.free panel - 24 hour Urine |
| 43127-0 | Clomipramine and Norclomipramine panel [Mass/volume] - Serum or Plasma |
| 43128-8 | Chloride panel - 24 hour Urine |
| 43129-6 | Brucella abortus IgG and IgM panel - Serum |
| 43130-4 | Bile acid fractions panel [Moles/volume] - Serum |
| 43131-2 | Bacterial Ag panel - Cerebral spinal fluid |
| 43133-8 | Allopurinol and Oxipurinol panel [Mass/volume] - Serum or Plasma |
| 43134-6 | Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma |
| 43135-3 | 17-Ketosteroids and 17-Ketogenic steroids panel - 24 hour Urine |
| 43141-1 | Synthetic glucocorticoid panel [Mass/volume] - Serum or Plasma |
| 43142-9 | Height measurement device panel |
| 43143-7 | Weighing device panel |
| 43144-5 | Pedometer device panel |
| 43145-2 | Peak flow meter device panel |
| 43146-0 | Oxygen saturation device panel |
| 43147-8 | Metabolism measurement device panel |
| 43148-6 | Insulin delivery device panel |
| 43149-4 | Heart rate device panel |
| 43150-2 | Hemoglobin A1c measurement device panel |
| 43151-0 | Glucose meter device panel |
| 43152-8 | Blood pressure device panel |
| 43153-6 | Blood coagulation device panel |
| 43309-4 | Desmoglein 1 and Desmoglein 3 Ab panel [Units/volume] - Serum |
| 43433-2 | Acylcarnitine panel - Serum or Plasma |
| 43434-0 | Bacterial Ag panel - Serum |
| 43435-7 | Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid |
| 43436-5 | Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid |
| 43437-3 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid |
| 43438-1 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum |
| 43439-9 | Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum |
| 43440-7 | Bartonella henselae and Bartonella quintana IgM panel [Titer] - Serum |
| 43443-1 | Bacterial Ag panel - Urine |
| 43674-1 | Fatty acid comprehensive (C8-C26) panel - Serum or Plasma |
| 43675-8 | Fatty acid mitochondrial (C8-C18) panel - Serum or Plasma |
| 43676-6 | Fatty acid essential (C12-C22) panel - Serum or Plasma |
| 43677-4 | Fatty acid very long chain (C22-C26) panel - Serum or Plasma |
| 44249-1 | PHQ-9 quick depression assessment panel [Reported.PHQ] |
| 44616-1 | Deprecated Pulse oximetry panel |
| 4463-6 | Spermatozoa motility and count panel |
| 44789-6 | Amylase and Creatinine clearance panel - Urine and Serum or Plasma |
| 44791-2 | Menorrhagia coagulation panel - Platelet poor plasma |
| 44792-0 | Immunoglobulin light chains panel - Urine |
| 44793-8 | Immunoglobulin light chains panel [Mass/volume] - Serum |
| 44906-6 | Homovanillate panel - 24 hour Urine |
| 44907-4 | 5-Hydroxyindoleacetate panel - 24 hour Urine |
| 45023-9 | HLA typing for celiac disease panel - Blood |
| 45024-7 | HLA typing for narcolepsy panel - Blood |
| 45027-0 | HLA-A2 panel - Blood |
| 45033-8 | Cardiovascular physiologic and EKG assessment panel |
| 45057-7 | Cardiolipin IgA and IgG and IgM panel - Serum |
| 45058-5 | Cyclosporine Monoclonal and Polyclonal panel [Mass/volume] - Blood |
| 45059-3 | Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence |
| 45060-1 | Protein and Glucose panel - Urine by Test strip |
| 45061-9 | Spermatozoa IgA and IgG and IgM panel - Serum |
| 45063-5 | Varicella zoster virus IgG and IgM panel - Serum |
| 45064-3 | Deprecated Basic metabolic panel & Glomerular filtration rate.predicted |
| 45065-0 | Deprecated Comprehensive metabolic panel & Glomerular filtration rate.predicted |
| 45066-8 | Creatinine and Glomerular filtration rate.predicted panel - Serum or Plasma |
| 45174-0 | Herpes gestationis Ab panel - Serum |
| 45268-0 | Immunodeficiency panel - Blood by Flow cytometry (FC) |
| 45269-8 | Chronic leukemia panel - Unspecified specimen by Flow cytometry (FC) |
| 45270-6 | Acute leukemia panel - Unspecified specimen by Flow cytometry (FC) |
| 45350-6 | Tick identification panel |
| 45962-8 | Minimum data set for nursing home resident assessment and care screen |
| 45963-6 | MDS basic assessment tracking form - version 2.0 |
| 45964-4 | Identification information section |
| 45965-1 | Name Set |
| 45966-9 | Social security and medicare numbers Set |
| 45967-7 | Facility provider numbers Set |
| 45968-5 | Reasons for assessment (basic) Set |
| 45969-3 | MDS background information at admission form - version 2.0 |
| 45970-1 | Demographic information section |
| 45971-9 | Residential history 5 years prior to entry Set |
| 45972-7 | Language Set |
| 45973-5 | Conditions related to mental retardation and developmental disabilities status Set |
| 45974-3 | Mental retardation and developmental disabilities with organic condition Set |
| 45975-0 | Customary routine section |
| 45976-8 | Customary routine in year prior to date of entry Set |
| 45977-6 | Cycle of daily events Set |
| 45978-4 | Eating patterns Set |
| 45979-2 | ADL patterns Set |
| 45980-0 | Involvement patterns Set |
| 45981-8 | MDS full assessment form - version 2.0 |
| 45982-6 | Identification and background information section |
| 45983-4 | Assessment reference date Set |
| 45984-2 | Current payment sources for nursing home stay Set |
| 45985-9 | Responsibility/legal guardian Set |
| 45986-7 | Advance directives Set |
| 45987-5 | Cognitive patterns section |
| 45988-3 | Memory Set |
| 45989-1 | Memory recall/ability Set |
| 45990-9 | Indicators of delirium - periodic disorded thinking or awareness Set |
| 45991-7 | Communication and hearing patterns section |
| 45992-5 | Communication devices and techniques Set |
| 45993-3 | Modes of expression Set |
| 45994-1 | Vision patterns section |
| 45995-8 | Visual limitations and dificulties Set |
| 45996-6 | Mood and behavior patterns section |
| 45997-4 | Indicators of depression, anxiety, sad mood Set |
| 45998-2 | Verbal expressions of distress Set |
| 45999-0 | Sleep-cycle issues Set |
| 46000-6 | Sad, apethetic, anxious appearance Set |
| 46001-4 | Behavioral symptoms Set |
| 46002-2 | Psychosocial well-being section |
| 46003-0 | Sense of initiative/involvement Set |
| 46004-8 | Unsettled releationships Set |
| 46005-5 | Past roles Set |
| 46006-3 | Physical functioning and stuctural problems section Set |
| 46007-1 | ADL self performance or support Set |
| 46008-9 | Bathing |
| 46009-7 | Test for balance Set |
| 46010-5 | Functional limitation in range of motion Set |
| 46011-3 | Modes of locomotion Set |
| 46012-1 | Modes of transfer Set |
| 46013-9 | ADL functional rehabilitation potential Set |
| 46014-7 | Continence in last 14 days section Set |
| 46015-4 | Continence self-control categories Set |
| 46016-2 | Bowel elimination pattern Set |
| 46017-0 | Continence appliances and programs Set |
| 46018-8 | Disease or condition diagnoses section |
| 46019-6 | Diseases or conditions Set |
| 46020-4 | Endocrine, metabolic or nutritional diseases or conditions Set |
| 46021-2 | Heart or circulation diseases or conditions Set |
| 46022-0 | Musculoskeletal diseases or conditions Set |
| 46023-8 | Neurological diseases or conditions Set |
| 46024-6 | Psychiatric or mood diseases or conditions Set |
| 46025-3 | Pulmonary diseases or conditions Set |
| 46026-1 | Sensory diseases or conditions Set |
| 46027-9 | Other diseases or conditions Set |
| 46028-7 | Infections Set |
| 46029-5 | Other current or more detailed diagnoses and ICD9 codes Set |
| 46030-3 | Health conditions section |
| 46031-1 | Indicators of fluid status Set |
| 46032-9 | Other indicators Set |
| 46033-7 | Pain symptoms Set |
| 46034-5 | Pain site Set |
| 46035-2 | Accidents Set |
| 46036-0 | Stability of conditions Set |
| 46037-8 | Oral and nutritional status section |
| 46038-6 | Oral problems Set |
| 46039-4 | Height and weight Set |
| 46040-2 | Weight change Set |
| 46041-0 | Nutritional problems Set |
| 46042-8 | Nutritional approaches Set |
| 46043-6 | Parenteral or enteral intake Set |
| 46044-4 | Oral or dental status section |
| 46045-1 | Oral status and disease prevention Set |
| 46046-9 | Skin condition section |
| 46047-7 | Ulcers Set |
| 46048-5 | Type of ulcer Set |
| 46049-3 | Other skin problems or lesions present Set |
| 46050-1 | Skin treatments Set |
| 46051-9 | Foot problems and care Set |
| 46052-7 | Activity pursuit patterns section |
| 46053-5 | Time awake Set |
| 46054-3 | Preferred activity settings Set |
| 46055-0 | General activity preferences Set |
| 46056-8 | Prefers change in daily routine Set |
| 46057-6 | Medications section |
| 46058-4 | Days received the following medication Set |
| 46059-2 | Special treatments and procedures section |
| 46060-0 | Special treatments, procedures and programs Set |
| 46061-8 | Special care Set |
| 46062-6 | Treatments Set |
| 46063-4 | Programs Set |
| 46064-2 | Therapies Set |
| 46065-9 | Intervention programs for mood, behavior and cognitive loss Set |
| 46066-7 | Nursing rehabilitation and restorative care Set |
| 46067-5 | Devices and restraints Set |
| 46068-3 | Discharge potential and overall status section |
| 46069-1 | Discharge potential Set |
| 46070-9 | Assessment information section |
| 46071-7 | Participation in assessment Set |
| 46072-5 | Therapy supplement for Medicare PPS section |
| 46073-3 | Special treatments and procedures Set |
| 46074-1 | Recreational therapy Set |
| 46075-8 | Walking when most self sufficient Set |
| 46076-6 | Minimum Data Set (MDS) supplemental items section - version 2.0 |
| 46077-4 | Influenza vaccine Set |
| 46078-2 | Pneumococcal vaccine Set |
| 46079-0 | Resident assessment protocol summary section |
| 46101-2 | Ordered therapies Set |
| 46102-0 | MDS quarterly assessment form - version 2.0 |
| 46103-8 | MDS quarterly assessment form - version 2.0 - optional version for RUG-III |
| 46104-6 | MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update |
| 46105-3 | Problem conditions Set |
| 46107-9 | Loss of interest Set |
| 46437-0 | Rheumatoid Factor and Cyclic Citrullinated Peptide IgG panel [Units/volume] - Serum |
| 46611-0 | Mental residual functional capacity (RFC) assessment form |
| 46612-8 | Summary conclusions Set |
| 46637-5 | Residual physical functional capacity (RFC) assessment form [RFC] |
| 46959-3 | Synthetic glucocorticoid panel [Mass/volume] - Urine |
| 46993-2 | HLA Ab panel - Serum |
| 46999-9 | Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by DNA probe |
| 47245-6 | HIV treatment form Document |
| 47246-4 | HIV Antiretroviral therapy Demographic information section |
| 47248-0 | HIV Antiretroviral therapy Antiretroviral therapy status section |
| 47249-8 | HIV Antiretroviral therapy HIV care and family status section |
| 47286-0 | Differential panel - Bone marrow |
| 47287-8 | Deprecated Hemogram without Platelets panel in Cord blood |
| 47288-6 | CBC WO Differential panel - Cord blood |
| 47289-4 | IgG and IgG subclass panel [Mass/volume] - Serum |
| 47290-2 | IgG subclass panel [Mass/volume] - Serum |
| 47531-9 | Wet mount panel - Vaginal fluid |
| 48073-1 | Thyroxine binding globulin panel [Mass/volume] - Serum or Plasma by Electrophoresis |
| 48593-8 | von Willebrand panel - Platelet poor plasma |
| 48596-1 | Activated protein C resistance panel - Platelet poor plasma |
| 48615-9 | Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma |
| 48644-9 | Vanillylmandelate, Homovanillate and Creatinine panel - 24 hour Urine |
| 48760-3 | 3-Hydroxy fatty acid panel - Serum or Plasma |
| 48770-2 | Fetal Biophysical profile panel US |
| 48796-7 | Hepatitis C virus FibroSURE panel - Serum or Plasma |
| 48797-5 | Organic acids panel - Urine |
| 48798-3 | First trimester maternal screen panel - Serum or Plasma |
| 48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
| 48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
| 48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
| 48805-6 | Platelet aggregation panel - Platelet rich plasma |
| 48808-0 | Leukogram panel - Blood |
| 48809-8 | Erythrogram panel - Blood |
| 48811-4 | Protein fractions 3 panel - Serum or Plasma |
| 48812-2 | Spermatozoa morphology panel |
| 48824-7 | Respiratory allergen panel, US - North Atlantic states a - Serum |
| 48825-4 | Respiratory allergen panel, US - Mid Atlantic states - Serum |
| 48826-2 | Respiratory allergen panel, US - South Atlantic states a - Serum |
| 48827-0 | Respiratory allergen panel, US - Subtropical Florida - Serum |
| 48828-8 | Respiratory allergen panel, US - Greater Ohio valley a - Serum |
| 48829-6 | Respiratory allergen panel, US - South central states - Serum |
| 48830-4 | Respiratory allergen panel, US - Northern midwest states a - Serum |
| 48831-2 | Respiratory allergen panel, US - Central midwest a - Serum |
| 48832-0 | Respiratory allergen panel, US - Great plains states a - Serum |
| 48833-8 | Respiratory allergen panel, US - Southwestern grassland states - Serum |
| 48834-6 | Respiratory allergen panel, US - Rocky mountain states a - Serum |
| 48835-3 | Respiratory allergen panel, US - Arid southwest - Serum |
| 48836-1 | Respiratory allergen panel, US - Southern coastal California - Serum |
| 48837-9 | Respiratory allergen panel, US - California central valley - Serum |
| 48838-7 | Respiratory allergen panel, US - Intermountain west a - Serum |
| 48839-5 | Respiratory allergen panel, US - Inland northwest a - Serum |
| 48840-3 | Respiratory allergen panel, US - Cascade Pacific northwest a - Serum |
| 48841-1 | Respiratory allergen panel, US - Alaska a - Serum |
| 48916-1 | Respiratory allergen panel, US - North Atlantic states b - Serum |
| 48917-9 | Respiratory allergen panel, US - South Atlantic states b - Serum |
| 48918-7 | Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum |
| 48919-5 | Respiratory allergen panel, US - Central Florida - Serum |
| 48920-3 | Respiratory allergen panel, US - Southern Florida - Serum |
| 48921-1 | Respiratory allergen panel, US - Southeast coast - Serum |
| 48922-9 | Respiratory allergen panel, US - West south central states - Serum |
| 48923-7 | Respiratory allergen panel, US - Greater Ohio valley b - Serum |
| 48924-5 | Respiratory allergen panel, US - Northern midwest states b - Serum |
| 48925-2 | Respiratory allergen panel, US - Central midwest b - Serum |
| 48926-0 | Respiratory allergen panel, US - Great plains states b - Serum |
| 48927-8 | Respiratory allergen panel, US - Rocky mountain states b - Serum |
| 48928-6 | Respiratory allergen panel, US - Inland northwest b - Serum |
| 48929-4 | Respiratory allergen panel, US - Cascade Pacific northwest b - Serum |
| 48930-2 | Respiratory allergen panel, US - Intermountain west b - Serum |
| 48931-0 | Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum |
| 48932-8 | Respiratory allergen panel, US - Alaska b - Serum |
| 48933-6 | Respiratory allergen panel, US - Hawaii - Serum |
| 49017-7 | Respiratory allergen panel, US - North Atlantic states c - Serum |
| 49018-5 | Respiratory allergen panel, US - Intermountain west c - Serum |
| 49019-3 | Respiratory allergen panel, US - Puerto Rico - Serum |
| 49020-1 | Respiratory allergen panel, US - Coastal California - Serum |
| 49021-9 | Respiratory allergen panel, US - Greater Ohio valley c - Serum |
| 49022-7 | Respiratory allergen panel, US - Northern midwest states c - Serum |
| 49037-5 | Respiratory syncytial virus IgG and IgM panel [Units/volume] - Serum |
| 49044-1 | Diazepam and Nordiazepam panel [Mass/volume] - Serum or Plasma |
| 49045-8 | PT and aPTT and Fibrinogen panel - Platelet poor plasma by Coagulation assay |
| 49085-4 | First and Second trimester integrated maternal screen panel |
| 49086-2 | First trimester maternal screen with nuchal translucency panel |
| 49087-0 | Maternal screen clinical predictors panel |
| 49093-8 | Arbovirus IgG and IgM panel - Serum by Immunofluorescence |
| 49094-6 | Arbovirus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 49120-9 | Immunodeficiency follow-up panel - Unspecified specimen by Flow cytometry (FC) |
| 49143-1 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
| 49222-3 | Food allergen panel - Serum |
| 49589-5 | Bacterial susceptibility panel by Gradient strip (E-test) |
| 49660-4 | HIV susceptibility panel by Genotype method |
| 49665-3 | HIV susceptibility panel by Phenotype method |
| 49883-2 | Hepatitis B virus resistance panel by Genotype method |
| 49885-7 | Lymphocyte proliferation.beryllium stimulation panel - Blood |
| 50009-0 | Fetal lung maturity panel - Amniotic fluid |
| 50023-1 | Hepatitis C virus RNA panel (viral load) in Serum or Plasma by Probe and target amplification method |
| 50025-6 | Volatiles panel - Serum or Plasma |
| 50179-1 | Calcitonin Calcium and Pentagastrin challenge panel - Serum or Plasma |
| 50189-0 | Neonatal bilirubin panel [Mass/volume] - Serum or Plasma |
| 50190-8 | Iron and Iron binding capacity panel - Serum or Plasma |
| 50191-6 | Occult blood panel - Gastric fluid |
| 50196-5 | Occult blood panel - Stool |
| 50197-3 | aPTT panel - Platelet poor plasma |
| 50219-5 | Respiratory DNA virus and RNA viruses 12a panel - Unspecified specimen by Probe and target amplification method |
| 50261-7 | Deprecated Renal function panel & Glomerular filtration rate.predicted |
| 50262-5 | Reticulocytes panel - Blood |
| 50334-2 | Acylglycines panel [Mass Ratio] - Urine |
| 50337-5 | Carbamazepine free and total and 10,11-Epoxide panel [Mass/volume] - Serum or Plasma |
| 50399-5 | Deprecated Clinical genetic report summary panel in Blood or Tissue by Molecular genetics method |
| 50545-3 | Bacterial susceptibility panel by Minimum inhibitory concentration (MIC) |
| 50546-1 | Bacterial susceptibility panel by Disk diffusion (KB) |
| 50554-5 | Urinalysis microscopic panel [#/volume] - Urine by Automated count |
| 50556-0 | Urinalysis dipstick panel - Urine by Automated test strip |
| 50564-4 | Urinalysis panel - Urine by Auto |
| 50579-2 | Gastric analysis panel - Gastric fluid |
| 50580-0 | Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel - Serum or Plasma |
| 50581-8 | Adenosine monophosphate.cyclic stimulation panel - Urine |
| 50582-6 | Glucose tolerance gestational panel - Urine and Serum or Plasma |
| 50583-4 | Glucose screen gestational panel - Urine and Serum or Plasma |
| 50584-2 | Lactose challenge (hydrogen breath test) panel - Exhaled gas |
| 50585-9 | Triple bolus stimulation panel - Serum or Plasma |
| 50586-7 | Glucose tolerance 3 hours panel - Serum or Plasma |
| 50587-5 | Glucose tolerance 4 hours panel - Serum or Plasma |
| 50588-3 | Glucose tolerance 5 hours panel - Serum or Plasma |
| 50589-1 | Glucose tolerance 6 hours panel - Serum or Plasma |
| 50604-8 | HPA panel [Type] in Blood |
| 50607-1 | Neisseria meningitidis Ag panel - Unspecified specimen by Latex agglutination |
| 50608-9 | Glucose tolerance 3 hours gestational panel - Serum or Plasma |
| 50624-6 | HIV 1 RNA panel (viral load) in Cerebral spinal fluid by Probe and target amplification method |
| 50673-3 | Insulin XXX challenge panel - Serum |
| 50676-6 | Calcium-phosphorus product panel - Serum or Plasma |
| 50677-4 | Semen analysis post vasectomy panel |
| 50710-3 | Influenza virus susceptibility panel |
| 50736-8 | Serotonin release.heparin.unfractionated panel - Serum |
| 50737-6 | Serotonin release.heparin.porcine panel - Serum |
| 50738-4 | Serotonin release.heparin.low molecular weight panel - Serum |
| 50739-2 | Serotonin release.heparin.porcine and low molecular weight panel - Serum |
| 50943-0 | Reasons for assessment (full) Set |
| 51410-9 | Environmental stressors panel - Water |
| 51411-7 | Environmental stressors panel - Air |
| 51662-5 | Core respiratory allergens panel - Serum |
| 51782-1 | Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method |
| 51956-1 | DNA region analysis test coverage panel - Blood or Tissue by Molecular genetics method |
| 51960-3 | DNA marker results panel - Blood or Tissue by Molecular genetics method |
| 51962-9 | Pharmacogenetic DNA analysis panel - Blood or Tissue by Molecular genetics method |
| 51966-0 | Genetic disease DNA analysis panel - Blood or Tissue by Molecular genetics method |
| 51972-8 | Gas panel - Venous cord blood |
| 51973-6 | Gas panel - Mixed venous blood |
| 51974-4 | Gas panel - Arterial cord blood |
| 51990-0 | Basic metabolic panel - Blood |
| 51991-8 | Reference lab test panel |
| 51992-6 | Heavy metals panel - Serum or Plasma |
| 51993-4 | Metanephrine and Normetanephrine panel [Mass/volume] - Urine |
| 52135-1 | t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method |
| 52762-2 | Intrinsic coagulation system thromboelastography panel - Blood |
| 52763-0 | Extrinsic coagulation system thromboelastography panel - Blood |
| 52764-8 | Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel - Blood |
| 52765-5 | Thromboelastography without activation panel - Blood |
| 52777-0 | Intrinsic coagulation system with heparin inhibition thromboelastography panel - Blood |
| 53041-0 | DNA region of interest panel - Blood or Tissue by Molecular genetics method |
| 53042-8 | DNA marker assessed panel - Blood or Tissue by Molecular genetics method |
| 53043-6 | DNA marker analysis test coverage panel - Blood or Tissue by Molecular genetics method |
| 53044-4 | DNA marker identified panel - Blood or Tissue by Molecular genetics method |
| 53261-4 | Amino acid newborn screen panel |
| 53262-2 | Carnitine newborn screen panel |
| 53263-0 | Urinalysis yeast variants panel - Urine by Computer assisted method |
| 53264-8 | Urinalysis yeast variants panel [#/volume] - Urine by Computer assisted method |
| 53267-1 | Urinalysis yeast variants panel [#/area] - Urine by Computer assisted method |
| 53270-5 | Urinalysis type of non-squamous epithelial cells panel - Urine by Computer assisted method |
| 53273-9 | Urinalysis type of non-squamous epithelial cells panel [#/volume] - Urine by Computer assisted method |
| 53276-2 | Urinalysis type of non-squamous epithelial cells panel [#/area] - Urine by Computer assisted method |
| 53277-0 | Urinalysis type of cast panel - Urine by Computer assisted method |
| 53281-2 | Urinalysis type of cast panel [#/volume] - Urine by Computer assisted method |
| 53293-7 | Urinalysis microscopic panel [#/area] - Urine sediment by Automated count |
| 53295-2 | Urinalysis type of crystal panel [#/volume] - Urine by Computer assisted method |
| 53305-9 | Urinalysis type of crystal panel [#/area] - Urine by Computer assisted method |
| 53325-7 | Urinalysis type of crystal panel - Urine by Computer assisted method |
| 53330-7 | Urinalysis type of cast panel [#/area] - Urine by Computer assisted method |
| 53333-1 | Urinalysis other formed elements panel - Urine by Computer assisted method |
| 53351-3 | Urinalysis other formed elements panel [#/volume] - Urine by Computer assisted method |
| 53575-7 | VAP cholesterol panel - Serum or Plasma |
| 53598-9 | Irritable bowel disease prognostic panel - Serum or Plasma by Immunoassay |
| 53703-5 | Mycobacterium bovis tuberculin stimulated gamma interferon panel - Blood |
| 53705-0 | Myasthenia gravis evaluation pediatric panel - Serum |
| 53706-8 | Myasthenia grav eval adult rflx panel - Serum |
| 53745-6 | Benzodiazepines panel - Urine |
| 53746-4 | Barbiturates panel - Urine |
| 53747-2 | Cocaine panel - Urine |
| 53759-7 | Natural killer cell panel - Blood by Flow cytometry (FC) |
| 53764-7 | Prostate specific Ag panel - Serum or Plasma |
| 53766-2 | Estrogen fraction panel - Serum or Plasma |
| 53775-3 | Hepatitis A virus Ab panel - Serum |
| 53780-3 | Chromium panel - Urine |
| 53781-1 | Acetaminophen and Propoxyphene panel [Mass/volume] - Urine |
| 53783-7 | HTT gene mutation panel - Blood or Tissue by Molecular genetics method |
| 53800-9 | Platelets panel - Blood by Automated count |
| 53803-3 | Transferrin.carbohydrate deficient panel - Serum or Plasma |
| 53804-1 | Arbovirus IgG panel - Serum by Immunofluorescence |
| 53932-0 | Streptococcus pneumoniae 14a and Corynebacterium diphtheriae toxin and Clostridium tetani toxin Ab.IgG panel - Serum |
| 54075-7 | Endocrine newborn screening panel (SI units) |
| 54076-5 | Endocrine newborn screening panel |
| 54077-3 | Thyroid newborn screening panel (SI units) |
| 54078-1 | Cystic fibrosis newborn screening panel |
| 54079-9 | Galactosemia newborn screening panel |
| 54080-7 | Galactosemia newborn screening panel (SI units) |
| 54081-5 | Hemoglobinopathies newborn screening panel |
| 54082-3 | Infectious diseases newborn screening panel |
| 54089-8 | Newborn screening panel American Health Information Community (AHIC) |
| 54090-6 | Thyroid newborn screening panel |
| 54097-1 | Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine |
| 54111-0 | Newborn hearing screening panel |
| 54145-8 | Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe and signal amplification method |
| 54225-8 | Immune response panel - Unspecified specimen by Flow cytometry (FC) |
| 54226-6 | Lymphoma panel - Unspecified specimen by Flow cytometry (FC) |
| 54227-4 | Lymphoma - acute screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54228-2 | Lymphoma - CLL screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54229-0 | Lymphoma - T-cell screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54230-8 | Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid |
| 54231-6 | Semen analysis fertility panel |
| 54232-4 | Metabolic panel.large animal - Serum or Plasma |
| 54233-2 | Metabolic panel.small animal - Serum or Plasma |
| 54234-0 | Cell count and Diff panel with Gluc and Prot - Body fluid |
| 54235-7 | Cortisol challenge panel - Saliva (oral fluid) |
| 54246-4 | Protein and Glucose panel [Mass/volume] - Body fluid |
| 54450-2 | CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
| 54932-9 | Centers for Environmental Health abrine and ricinine panel [Mass/volume] - Urine |
| 55101-0 | Respiratory virus panel - Unspecified specimen by Organism specific culture |
| 55116-8 | Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma |
| 55117-6 | Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine |
| 55118-4 | Centers for Environmental Health trace metals panel [Mass/volume] - Urine |
| 55119-2 | Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine |
| 55120-0 | Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine |
| 55121-8 | Multiple sclerosis panel - Serum and CSF |
| 55150-7 | Anaplasma phagocytophilum IgG and IgM panel - Serum Qualitative |
| 55151-5 | Aldosterone and renin activity panel - Plasma |
| 55152-3 | Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma |
| 55153-1 | Biotinidase panel - Serum or Plasma |
| 55155-6 | Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine |
| 55157-2 | Risperidone and 9-Hydroxyrisperidone panel - Serum or Plasma |
| 55160-6 | Adenovirus IgG and IgM panel - Serum |
| 55161-4 | Bordetella pertussis IgA and IgG panel - Serum by Immunoassay |
| 55162-2 | HTLV I+II Ab panel - Serum Qualitative |
| 55163-0 | Streptococcus pyogenes enzyme Ab panel - Serum Qualitative |
| 55164-8 | Paroxysmal nocturnal panel - Blood |
| 55207-5 | Genetic analysis discrete result panel - Blood or Tissue by Molecular genetics method |
| 55208-3 | DNA analysis discrete sequence variation panel - Blood or Tissue by Molecular genetics method |
| 55231-5 | Electrolytes panel - Blood |
| 55232-3 | Genetic analysis summary panel - Blood or Tissue by Molecular genetics method |
| 55233-1 | Genetic analysis master panel - Blood or Tissue by Molecular genetics method |
| 55234-9 | Alpha thalassemia gene deletion panel [Presence] - Blood by Molecular genetics method |
| 55235-6 | Abnormal hemoglobin gene panel - Blood by Molecular genetics method |
| 55255-4 | Pyridinoline panel - Urine |
| 55295-0 | Protein electrophoresis and Immunoglobulins panel - Serum |
| 55394-1 | Protein and Glucose panel - Cerebral spinal fluid |
| 55395-8 | Phospholipid IgA and IgG and IgM panel - Serum |
| 55396-6 | Beta 2 glycoprotein 1 IgA and IgG panel - Serum |
| 55397-4 | Short myasthenia gravis panel - Serum |
| 55398-2 | Short Fibrin D-dimer FEU and DDU panel - Platelet poor plasma |
| 55399-0 | Diabetes tracking panel |
| 55401-4 | Warfarin tracking panel - Platelet poor plasma |
| 55402-2 | West Nile virus IgG and IgM panel - Serum |
| 55403-0 | Asthma tracking panel |
| 55405-5 | Heart failure tracking panel |
| 55409-7 | Exercise tracking panel |
| 55413-9 | Pedometer tracking panel |
| 55415-4 | Oxygen therapy tracking panel |
| 55417-0 | Short blood pressure panel |
| 55418-8 | Weight and Height tracking panel |
| 55419-6 | Home drug screening panel - Urine |
| 55427-9 | Seizure disorder tracking panel |
| 55429-5 | Short blood count panel - Blood |
| 55441-0 | Antithrombin Ag in Platelet poor plasma |
| 55442-8 | Antithrombin in Platelet poor plasma |
| 55443-6 | Cardiolipin Ab in Serum |
| 55444-4 | Cardiolipin IgA Ab in Serum |
| 55445-1 | Cardiolipin IgM Ab in Serum |
| 55446-9 | Cardiolipin IgG Ab in Serum |
| 55447-7 | Coagulation factor VIII Ag in Platelet poor plasma |
| 55448-5 | Complement total hemolytic CH50 in Serum or Plasma |
| 55449-3 | Fibrin D-dimer in Platelet poor plasma |
| 55450-1 | Fibrin+Fibrinogen fragments in Serum |
| 55451-9 | Fibrin+Fibrinogen fragments in Platelet poor plasma |
| 55452-7 | Fibrinogen in Platelet poor plasma |
| 55453-5 | Haptoglobin in Serum or Plasma |
| 55454-3 | Hemoglobin A1c in Blood |
| 55455-0 | Hemoglobin F in Unspecified specimen |
| 55456-8 | Hemoglobin S in Blood |
| 55457-6 | Free Hemoglobin in Plasma |
| 55458-4 | Interferon alpha in Serum or Plasma |
| 55459-2 | Prekallikrein (Fletcher Factor) in Platelet poor plasma |
| 55460-0 | Protein C Ag in Platelet poor plasma |
| 55461-8 | Protein C in Platelet poor plasma |
| 55462-6 | Thyrotropin in Serum or Plasma |
| 55466-7 | Influenza virus A H1 2009 pandemic RNA panel - Unspecified specimen by Probe and target amplification method |
| 55728-0 | Yersinia sp IgG and IgM panel - Serum |
| 55744-7 | howRU |
| 56146-4 | Fungal Ab panel - Serum |
| 56148-0 | Smith extractable nuclear Ab and Ribonucleoprotein extractable nuclear Ab panel - Serum |
| 56149-8 | Beta 2 glycoprotein and Cardiolipin Ab and Phosphatidylserine panel - Serum |
| 56152-2 | Beta 2 glycoprotein 1 Ab IgA and IgG and IgM panel - Serum |
| 56156-3 | Candida albicans IgA and IgG and IgM Ab panel - Serum |
| 57019-2 | Urinalysis dipstick W Reflex Culture panel - Urine |
| 57020-0 | Urinalysis dipstick W Reflex Microscopic panel - Urine |
| 57021-8 | CBC W Auto Differential panel - Blood |
| 57022-6 | CBC W Reflex Manual Differential panel - Blood |
| 57023-4 | Auto Differential panel - Blood |
| 57031-7 | Herpesviruses 6 DNA panel - Unspecified specimen by Probe and target amplification method |
| 57084-6 | Fatty acid oxidation newborn screen panel |
| 57085-3 | Organic acid newborn screen panel |
| 57086-1 | Congenital adrenal hyperplasia newborn screening panel |
| 57087-9 | Biotinidase newborn screening panel |
| 57128-1 | Newborn Screening Report summary panel |
| 57698-3 | Lipid panel with direct LDL - Serum or Plasma |
| 57717-1 | Newborn screen card data panel |
| 57765-0 | Disaccharidases panel - Small intestine Tissue |
| 57767-6 | Trimipramine and Nortrimipramine panel - Serum or Plasma |
| 57770-0 | Toxoplasma gondii IgG and IgM panel - Serum |
| 57772-6 | Metanephrine.free and Normetanephrine.free panel [Moles/volume] - Serum or Plasma |
| 57774-2 | Colorado tick fever virus IgG and IgM panel [Titer] - Serum |
| 57775-9 | Valproate.free and Valproate panel - Serum or Plasma |
| 57776-7 | Gliadin peptide IgA and IgG panel - Serum |
| 57777-5 | Myeloperoxidase Ab and Proteinase 3 panel - Serum |
| 57778-3 | Immunoglobulin light chains.free panel - Serum |
| 57780-9 | Thyroglobulin and Thyrogobulin Ab panel - Serum or Plasma |
| 57782-5 | CBC with Ordered Manual Differential panel - Blood |
| 57794-0 | Newborn screening test results panel - Dried blood spot |
| 57795-7 | Fecal hydrolysis panel - Stool |
| 57803-9 | Occult blood panel - Stool by Immunologic method |
| 58077-9 | Urinalysis complete W Reflex Culture panel - Urine |
| 58091-0 | Glucose-6-Phosphate dehydrogenase newborn screen panel |
| 58092-8 | Acylcarnitine newborn screen panel |
| 58406-0 | Platelet morphology panel - Blood |
| 58407-8 | Leukocyte morphology panel - Blood |
| 58408-6 | Erythrocyte morphology panel - Blood |
| 58410-2 | Complete blood count (hemogram) panel - Blood by Automated count |
| 58431-8 | Microalbumin panel - 24 hour Urine |
| 58446-6 | Creatinine 24H renal clearance adjusted for body surface area panel |
| 58447-4 | Microalbumin/Creatinine panel in 24H Urine |
| 58713-9 | Streptococcal DNAse B and ASO antibodies panel - Serum |
| 58715-4 | Adulterants panel - Urine |
| 58716-2 | Testosterone.free+weakly bound and total panel - Serum or Plasma |
| 58732-9 | Porphyrin fractions panel [Mass/volume] - Serum or Plasma |
| 58733-7 | Mycoplasma pneumoniae IgG and IgM panel - Serum |
| 58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
| 58736-0 | Manganese panel - Urine |
| 58953-1 | Meperidine and Normeperidine panel - Urine |
| 59049-7 | Coccidioides sp IgG and IgM panel - Unspecified specimen |
| 59059-6 | Inflammatory bowel disease Ab 7 panel - Serum |
| 59062-0 | Lipoprofile panel - Serum or Plasma |
| 59063-8 | Lymphocyte proliferation panel - Blood |
| 59257-6 | Cell count and Differential panel - Pericardial fluid |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 60342-3 | Borrelia burgdorferi IgG panel - Serum by Immunoblot (IB) |
| 60343-1 | Borrelia burgdorferi IgM panel - Serum by Immunoblot (IB) |
| 60566-7 | Respiratory DNA virus and RNA viruses 12b panel - Unspecified specimen by Probe and target amplification method |
| 60587-3 | Cell count and Differential panel - Peritoneal dialysis fluid |
| 62300-9 | Lysosomal storage disorders newborn screening panel |
| 62304-1 | Fabry disease newborn screening panel |
| 62307-4 | Krabbe disease newborn screening panel |
| 62311-6 | Gaucher disease newborn screening panel |
| 62315-7 | Niemann Pick disease A/B newborn screening panel |
| 62333-0 | Severe combined immunodeficiency (SCID) newborn screening panel |
| 62341-3 | Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum |
| 62426-2 | Bordetella sp DNA panel - Unspecified specimen by Probe and target amplification method |
| 63414-7 | Pompe disease newborn screening panel |
| 63430-3 | Human coronavirus RNA panel - Unspecified specimen by Probe and target amplification method |
| 63486-5 | Nut allergen panel - Serum |
| 64017-7 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Unspecified specimen by Probe and target amplification method |
| 64116-7 | Hemoglobin observations newborn screening panel |
| 64418-7 | KIR genotyping panel - Blood or Tissue |
| 64433-6 | Fragile X protein (FMRP) panel - Blood |
| 65632-2 | Clozapine and Norclozapine panel - Serum or Plasma |
| 65634-8 | Creatinine 24 hour urine panel - 24 hour Urine |
| 65750-2 | Drugs of abuse 5 panel - Urine by Screen method |
| 65758-5 | CD4 T-cell absolute panel - Blood |
| 65759-3 | T-cell subsets CD4 and CD8 panel - Blood |
| 65833-6 | Address Facility |
| 67767-4 | HEDIS 2012 panel |
| 67790-6 | Thromboelastography panel - Blood |
| 67795-5 | Vital signs, weight, height, head circumference and oximetry panel HITSP |
| 67822-7 | Fentanyl and Norfentanyl panel - Urine |
| 67866-4 | Babesia identification panel - Unspecified specimen |
| 68314-4 | Meperidine and Normeperidine panel - Serum or Plasma |
| 68315-1 | Transcortin and Cortisol.free panel - Serum or Plasma |
| 68317-7 | Metanephrine, Normetanephrine and Creatinine panel - Urine |
| 68318-5 | Hypoglycemics panel - Serum or Plasma |
| 68320-1 | Polio virus Ab panel [Titer] - Serum |
| 68501-6 | Serotonin release.heparin.unfractionated and low molecular weight panel - Serum |
| 68982-8 | PFGE panel - Isolate |
| 68991-9 | Epidemiologically important information for public health reporting panel |
| 68992-7 | Specimen-related information panel |
| 69008-1 | Cocaine panel - Meconium by Confirmatory method |
| 69018-0 | Lymphocyte proliferation mitogen panel - Blood by Flow cytometry (FC) |
| 69021-4 | Amphetamines panel - Meconium by Confirmatory method |
| 69026-3 | Opiates panel - Meconium by Confirmatory method |
| 69034-7 | Eastern equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 69035-4 | Eastern equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 69036-2 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 69039-6 | Enterocyte Ab panel - Serum |
| 69040-4 | Chronic urticaria index panel - Serum or Plasma |
| 69041-2 | Western equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 69042-0 | Lymphocyte proliferation antigen panel - Blood by Flow cytometry (FC) |
| 69459-6 | Care record summary panel |
| 69552-8 | Thromboelastography after addtion of heparinase panel - Blood |
| 69554-4 | Lactose tolerance panel [Moles/volume] in Serum or Plasma |
| 69555-1 | Lactose tolerance panel [Mass/volume] in Serum or Plasma |
| 69571-8 | Bacterial vaginosis DNA and score panel - Vaginal fluid by Probe and target amplification method |
| 69581-7 | National (USA) PFGE cluster code or CDC cluster [Identifier] in Isolate |
| 69726-8 | Tissue transglutaminase IgA + Gliadin peptides Ab.IgA and IgG panel - Serum |
| 69738-3 | Differential panel, method unspecified - Blood |
| 69739-1 | Drugs of abuse panel - Urine |
| 69740-9 | Cell count panel - Pericardial fluid |
| 69741-7 | Differential panel - Pericardial fluid |
| 69742-5 | CBC W Differential panel, method unspecified - Blood |
| 69999-1 | Positive airway pressure panel |
| 70130-0 | Rickettsia typhus group and Rickettsia spotted fever group acute and convalescent IgG and IgM panel - Serum by Immunofluorescence |
| 70161-5 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urine by Probe and target amplification method |
| 70162-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urethra by Probe and target amplification method |
| 70163-1 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by Probe and target amplification method |
| 70164-9 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by Probe and target amplification method |
| 70219-1 | Basic metabolic 2008 panel with ionized calcium - Serum or Plasma |
| 71432-9 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix |
| 71775-1 | Mycobacterium tuberculosis stimulated gamma interferon panel - Blood |
| 72103-5 | Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method |
| 72104-3 | Acute and chronic leukemia fusion transcript per control transcript panel - Blood or Tissue by Molecular genetics method |
| 72105-0 | Vital signs and oximetry - admission, home health, interim, discharge [CARE] |
| 72171-2 | Glucose tolerance 2 hours panel - Serum or Plasma |
| 72199-3 | HEDIS 2013 panel |
| 72203-3 | Parathyrin.intact intraoperative panel - Serum or Plasma |
| 72257-9 | Platelet function.collagen + Adenosine diphosphate induced and Epinephrine induced panel - Blood |
| 72264-5 | Bilirubin excess and oxyhemoglobin and methemoglobin and xanthochromia and albumin quotient panel - Serum and CSF |
| 72272-8 | Amylase and triacylglycerol lipase panel - Serum or Plasma |
| 72283-5 | Nail assessment panel |
| 72284-3 | Skin assessment panel |
| 72286-8 | Wound dressing panel |
| 72287-6 | Wound size panel |
| 72292-6 | Wound exudate panel |
| 72299-1 | Wound tunneling and undermining panel |
| 72369-2 | Body site identification panel |
| 72372-6 | Wound bed and edge panel |
| 72393-2 | Cell count and Differential panel - Vitreous fluid by Manual count |
| 72394-0 | Cell count panel - Vitreous fluid by Manual count |
| 72395-7 | Differential panel - Vitreous fluid |
| 72476-5 | Methadone panel - Saliva (oral fluid) by Confirmatory method |
| 72478-1 | Synthetic cannabinoids panel - Urine by Confirmatory method |
| 72479-9 | Drugs of abuse panel - Blood by Screen method |
| 72480-7 | Barbiturates panel - Blood by Confirmatory method |
| 72481-5 | Candida sp 6 panel - Vaginal fluid by Probe and target amplification method |
| 72488-0 | Beta 2 glycoprotein 1 IgG and IgM panel - Serum |
| 72661-2 | Intrinsic coagulation factor activity 4 panel - Platelet poor plasma by Coagulation assay |
| 72662-0 | Extrinsic coagulation factor activity 4 panel - Platelet poor plasma |
| 72670-3 | Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - Urine |
| 72694-3 | Cholinesterase activity panel - Serum or Plasma |
| 72695-0 | Erythrocyte enzyme panel - Red Blood Cells |
| 72718-0 | Borderline symptom list - behavior supplement |
| 72719-8 | Borderline symptom list - 23 item [BSL-23] |
| 72727-1 | Del(13)(q14) and del(17)(p13) in Blood or Tissue |
| 72828-7 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Unspecified specimen |
| 72852-7 | Cytomegalovirus resistance panel by Genotype method |
| 72862-6 | Hepatitis C virus resistance panel by Genotype method |
| 72886-5 | CYP2D6 gene and CYP2C19 gene mutation analysis panel - Blood, Tissue or Saliva by Molecular genetics method |
| 72892-3 | Staphylococcus aureus and Methicillin (mecA) genes panel - Nose by Probe and target amplification method |
| 72905-3 | Neutrophil Ab and HLA Ab screen panel - Serum or Plasma |
| 72906-1 | HNA Ab panel - Serum or Plasma |
| 72907-9 | HNA genotype panel - Serum or Plasma |
| 72908-7 | Drug induced platelet Ab panel - Serum or Plasma |
| 72909-5 | Drug induced neutrophil Ab panel - Serum or Plasma |
| 73660-3 | Propoxyphene panel - Saliva (oral fluid) |
| 73661-1 | Methadone panel - Saliva (oral fluid) by Screen method |
| 73662-9 | Benzodiazepines panel - Saliva (oral fluid) by Screen method |
| 73663-7 | Barbiturates panel - Saliva (oral fluid) by Confirmatory method |
| 73724-7 | Bile acid dihydroxy and trihydroxy panel - Serum or Plasma |
| 73725-4 | Bile acid panel - 24 hour Stool |
| 73738-7 | Newborn screening test results panel - Point of Care |
| 73741-1 | Newborn hearing screen panel of Ear - left |
| 73744-5 | Newborn hearing screen panel of Ear - right |
| 73790-8 | Neonatal skin risk assessment scale panel [NSRAS] |
| 73805-4 | CCHD newborn screening panel |
| 73852-6 | 7-Dehydrocholesterol and 8-Dehydrocholesterol panel - Serum or Plasma |
| 73865-8 | Catecholamines 3 panel [Moles/volume] - Plasma |
| 73866-6 | Catecholamines 3 and creatinine panel [Molar ratio] - Urine |
| 73879-9 | Catecholamine metabolites and creatinine panel - Urine |
| 73885-6 | Steroid fractions panel - 24 hour Urine |
| 73886-4 | Steroid fractions panel - Urine |
| 73897-1 | Chronic lyme disease panel - Blood by Flow cytometry (FC) |
| 73967-2 | Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA |
| 73979-7 | Keyhole limpet hemocyanin Ab panel - Serum or Plasma |
| 74028-2 | Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDS |
| 74029-0 | Periodontal attachment - recommended CDA set |
| 74032-4 | Arbovirus IgM panel - Serum |
| 74080-3 | Patient safety event report - hospital - medication or other substance - version 1.2 [AHRQ] |
| 74219-7 | Weight difference pre dialysis and post dialysis panel |
| 74281-7 | Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood |
| 74352-6 | Cryoglobulin and cryofibrinogen panel - Serum and Plasma |
| 74353-4 | Sodium and Potassium panel [Moles/volume] - Blood |
| 74408-6 | Middle east respiratory syndrome coronavirus (MERS-CoV) RNA panel - Unspecified specimen |
| 74409-4 | MICA IgG panel - Serum |
| 74410-2 | Polychlorinated biphenyl (PCB) panel - Serum or Plasma by Confirmatory method |
| 74412-8 | CBC W Differential panel - Cord blood |
| 74413-6 | Differential panel - Cord blood |
| 74439-1 | Gamma aminobutyrate free and total panel - Cerebral spinal fluid |
| 74445-8 | Porphyrin fractions panel [Moles/mass] - Stool |
| 74446-6 | Stone analysis panel |
| 74447-4 | Sugars and polyols panel [Molar ratio] - Urine |
| 74514-1 | Amino acids panel [Moles/volume] - Urine |
| 74519-0 | Complement activity panel - Serum |
| 74526-5 | Delta aminolevulinate, porphobilinogen and creatinine panel - 24 hour Urine |
| 74527-3 | Delta aminolevulinate, porphobilinogen and creatinine panel - Urine |
| 74533-1 | Fatty acid oxidation panel - Fibroblast |
| 74545-5 | Tryptophan-related indole profiling panel - Platelet rich plasma |
| 74633-9 | Dimethylacetal (DMA) panel - Fibroblast |
| 74634-7 | Dimethylacetal (DMA) panel - Red Blood Cells |
| 74635-4 | Bacterial vaginosis DNA panel - Vaginal fluid by Probe and target amplification method |
| 74728-7 | Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.CCDAr1.1 |
| 74749-3 | Gram positive blood culture panel by Nucleic acid capture and probe detection in Positive blood culture |
| 74760-0 | Hydrocodone and hydromorphone panel - Urine by Confirmatory method |
| 74764-2 | Soluble fms-like tyrosine kinase-1 and placental growth factor panel - Serum or Plasma |
| 74773-3 | Immunoglobulin light chains and heavy chains panel - Serum or Plasma |
| 74787-3 | Influenza virus B Victoria and Yamagata lineage RNA panel - Unspecified specimen |
| 74788-1 | Lactulose challenge (hydrogen breath test) panel - Exhaled gas |
| 74789-9 | Fructose challenge (hydrogen breath test) panel - Exhaled gas |
| 74790-7 | Glucose challenge (hydrogen breath test) panel - Exhaled gas |
| 74831-9 | Metanephrine and Normetanephrine panel [Moles/volume] - Urine |
| 74835-0 | Porphyrin fractions panel - Stool |
| 74874-9 | Metabolic disorder therapy monitoring panel - Dried blood spot |
| 74885-5 | HER2 panel - Tissue by Fluorescent in situ hybridization (FISH) |
| 74888-9 | Sterols panel [Moles/volume] - Serum or Plasma |
| 74910-1 | Porphyrin fractions and creatinine panel [Molar ratio] - 24 hour Urine |
| 74914-3 | Acylglycines panel [Molar ratio] - Urine |
| 74978-8 | Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
| 74991-1 | Amino acids panel [Molar ratio] - Urine |
| 74993-7 | Chloride and sodium panel [Moles/volume] - Sweat |
| 75021-6 | Olanzapine panel - Serum or Plasma |
| 75199-0 | Congenital syphilis case investigation and report panel [CDC.CS] |
| 75243-6 | Norton scale panel |
| 75256-8 | Disability information and assistance needed panel [HHS.ACA Section 4302.ONC] |
| 75258-4 | PROMIS short form - sleep disturbance 4a - version 1.0 |
| 75259-2 | PROMIS short form - pain intensity 3a - version 1.0 |
| 75282-4 | Nutrition assessment panel |
| 75283-2 | Food and nutrition history panel |
| 75284-0 | Food and nutrient intake panel |
| 75285-7 | Comparative nutrition assessment standards panel |
| 75286-5 | Nutrition related anthropometric measurements panel |
| 75287-3 | Food and beverage intake panel |
| 75304-6 | Nutrition status observation panel |
| 75418-4 | PCORI patient-reported outcomes common measures - core and recommended [PROMIS] |
| 75419-2 | PCORI patient-reported outcomes recommended measures [PROMIS] |
| 75420-0 | PCORI patient-reported outcomes core pediatric measures [PROMIS] |
| 75421-8 | PCORI patient-reported outcomes core adult measures [PROMIS] |
| 75515-7 | Lupus anticoagulant aPTT and dRVVT screening panel W Reflex |
| 75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
| 75619-7 | National Health Care Surveys (NHCS) panel |
| 75620-5 | TNM clinical staging before treatment panel Cancer |
| 75621-3 | TNM pathologic staging after surgery panel Cancer |
| 75622-1 | HIV 1 and 2 tests - Meaningful Use set |
| 75635-3 | Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA |
| 75641-1 | Electrolytes 3 panel - Cerebral spinal fluid |
| 75667-6 | Electrolytes 3 panel - 24 hour Urine |
| 75673-4 | Gram negative blood culture panel by Nucleic acid capture and probe detection in Positive blood culture |
| 75689-0 | Iron panel - Serum or Plasma |
| 75697-3 | Bilirubin fractions panel [Moles/volume] - Serum or Plasma |
| 75742-7 | Dartmouth COOP Functional Assessment Charts - 2 weeks |
| 75743-5 | Dartmouth COOP Functional Assessment Charts - 4 weeks |
| 75772-4 | Advance directives panel [ADVault] |
| 75814-4 | Antihistamines panel - Serum or Plasma or Urine by Screen method |
| 75815-1 | Antipsychotics drug panel - Blood or Urine by Screen method |
| 75842-5 | Clinical disease activity index [CDAI] |
| 75843-3 | Simplified disease activity index [SDAI] |
| 75858-1 | Sterols panel [Mass/volume] - Serum or Plasma |
| 75860-7 | Hepatitis A virus RNA and Parvovirus B19 DNA panel - Plasma from donor by Probe and target amplification method |
| 75881-3 | Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex |
| 76067-8 | Abbreviated Injury Scale panel AAAM |
| 76091-8 | Respiratory DNA virus and RNA viruses 4 panel - Nasopharynx by Probe and target amplification method |
| 76133-8 | Sugar absorption test panel [Molar ratio] - 5 hour Urine |
| 76478-7 | Acetylcholinesterase panel - Amniotic fluid |
| 76499-3 | Humiliation, Afraid, Rape, and Kick questionnaire [HARK] |
| 76506-5 | Social connection and isolation panel |
| 76546-1 | Breast cancer 10-year risk of distant recurrence panel by Prosigna |
| 76585-9 | Wound microorganism gene identification panel by Probe and target amplification method |
| 76586-7 | ENT microorganism gene identification panel by Probe and target amplification method |
| 76621-2 | Lysosomal acid lipase panel - Fibroblast |
| 76623-8 | Mitochondrial respiratory chain enzyme analysis panel - Fibroblast |
| 76659-2 | Antipsychotics drug panel - Urine by Screen method |
| 76700-4 | PROMIS short form - physical function 4a - version 1.0 |
| 76701-2 | PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 |
| 76702-0 | PROMIS short form - physical function 20a - version 1.0 |
| 76703-8 | PROMIS short form - sleep disturbance 6a - version 1.0 |
| 76704-6 | PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 |
| 76731-9 | PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 |
| 76732-7 | PROMIS short form - companionship 4a - version 2.0 |
| 76733-5 | PROMIS short form - companionship 6a - version 2.0 |
| 76734-3 | PROMIS short form - emotional support 6a - version 2.0 |
| 76735-0 | PROMIS short form - emotional support 4a - version 2.0 |
| 76736-8 | PROMIS short form - emotional support 8a - version 2.0 |
| 76770-7 | Trace elements panel - Hair |
| 76771-5 | Respiratory RNA viruses 8 panel - Unspecified specimen by Probe and target amplification method |
| 76792-1 | PROMIS short form - informational support 4a - version 2.0 |
| 76793-9 | PROMIS short form - informational support 6a - version 2.0 |
| 76794-7 | PROMIS short form - informational support 8a - version 2.0 |
| 76798-8 | PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 |
| 76799-6 | PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 |
| 76800-2 | PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 |
| 76801-0 | PROMIS short form - social isolation 4a - version 2.0 |
| 76802-8 | PROMIS short form - social isolation 6a - version 2.0 |
| 76803-6 | PROMIS short form - social isolation 8a - version 2.0 |
| 76804-4 | PROMIS short form - physical function 6b - version 1.2 |
| 76805-1 | PROMIS short form - physical function 8b - version 1.2 |
| 77003-2 | PROMIS short form - alcohol - alcohol use 7a - version 1.0 |
| 77004-0 | PROMIS short form - alcohol - negative consequences 7a - version 1.0 |
| 77005-7 | PROMIS short form - alcohol - negative expectancies 7a - version 1.0 |
| 77006-5 | PROMIS short form - alcohol - positive expectancies 7a - version 1.0 |
| 77007-3 | PROMIS short form - alcohol - positive consequences 7a - version 1.0 |
| 77009-9 | Porphyrin fractions panel [Moles/volume] - Serum or Plasma |
| 77018-0 | Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
| 77019-8 | Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing |
| 77029-7 | Respiratory DNA viruses and RNA viruses 14 panel - Nasopharynx by Probe and target amplification method |
| 77151-9 | Energy content panel - 24 hour Stool |
| 77165-9 | Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG panel [Titer] - Serum |
| 77166-7 | Chlamydia sp IgG and IgM panel [Titer] - Serum by Immunofluorescence |
| 77175-8 | Coxiella burnetii phase 1 and 2 IgG and IgM panel - Serum |
| 77176-6 | Hepatitis B virus little e Ag and Ab panel - Serum |
| 77190-7 | Hepatitis B virus core and surface Ab and surface Ag panel - Serum |
| 77197-2 | Noninvasive arteriosclerosis studies panel |
| 77217-8 | Salivary gland protein 1 and Carbonic anhydrase 6 and Parotid secretory protein IgA and IgG and IgM panel - Serum by Immunoassay |
| 77249-1 | Weight management summary - recommended IHE set |
| 77250-9 | Mumps virus IgG and IgM panel - Serum |
| 77310-1 | Measles virus Ab.IgG associated observations panel - Serum |
| 77347-3 | Beta-2 transferrin panel - Serum or Plasma and CSF |
| 77364-8 | Tryptophan, kynurenin and 3-hydroxykynurenin panel - Serum or Plasma |
| 77365-5 | Nitrogen panel - 24 hour Stool |
| 77366-3 | Metanephrine.free and Normetanephrine.free and 3-Methoxytyramine.free panel [Moles/volume] - Serum or Plasma |
| 77374-7 | Clomipramine trough, Clomipramine+Norclomipramine trough and Norclomipramine panel - Serum or Plasma |
| 77376-2 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Anorectal |
| 77378-8 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Unspecified specimen |
| 77381-2 | Protein electrophoresis panel in Urine collected for unspecified duration |
| 77398-6 | Mumps virus IgG and IgM index panel - Serum |
| 77547-8 | American National Adult Reading Test (AmNART) panel |
| 77548-6 | Client accessibility panel [NMMDS] |
| 77564-3 | Brief Pain Inventory Short Form - pain interference panel |
| 77574-2 | Global level of function panel APTA |
| 77575-9 | Health condition-specific level of function panel APTA |
| 77576-7 | Self-care and mobility panel APTA |
| 77577-5 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Urethra by Probe and target amplification method |
| 77637-7 | HLA-A and B and C (class I) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
| 77638-5 | HLA-DP and DQ and DR (class II) IgG panel [Identifier] - Serum or Plasma by Immunoassay |
| 77639-3 | HLA class I and II IgG panel - Serum or Plasma by Immunoassay |
| 77717-7 | Unified Parkinson's Disease Rating Scale (UPDRS) panel |
| 77737-5 | Mycobacterium abscessus complex clarithromycin resistance (erm(41)) gene panel - Isolate by Probe and target amplification method |
| 77742-5 | HTLV I and II panel - Serum or Plasma by Immunoblot (IB) |
| 77875-3 | PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1 |
| 78000-7 | Case notification panel [CDC.PHIN] |
| 78013-0 | HLA-A and B and DRB and DQB1 panel [Type] - Blood or Tissue by Low resolution |
| 78161-7 | PROMIS pediatric item bank - physical function - upper extremity - version 2.0 |
| 78344-9 | Fatty acid comprehensive (C8-C26) panel - Red Blood Cells |
| 78361-3 | Fatty acid and triglyceride panel - 24 hour Stool |
| 78365-4 | Imipramine trough, Imipramine+desimipramine trough and Desipramine panell - Serum or Plasma |
| 78434-8 | Carbamazepine free and total trough and 10,11-Epoxide panel - Serum or Plasma |
| 78435-5 | Mirtazapine trough and Normirtazapine panel - Serum or Plasma |
| 78436-3 | Primidone and phenobarbital trough panel - Serum or Plasma |
| 78437-1 | Fluoxetine trough, Fluoxetine+norfluoxetine trough and Norfluoxetine panel - Serum or Plasma |
| 78438-9 | Sertraline trough and Norsertraline panel - Serum or Plasma |
| 78439-7 | Phenytoin free and total trough panel - Serum or Plasma |
| 78440-5 | Risperidone trough and 9-Hydroxyrisperidone panel - Serum or Plasma |
| 78698-8 | Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore |
| 78699-6 | Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter |
| 78747-3 | Peritoneal equilibration test panel - Peritoneal dialysis fluid |
| 78895-0 | Coronary angiography panel |
| 78914-9 | Percutaneous coronary intervention panel |
| 78921-4 | Bordetella pertussis and Bordetella parapertussis DNA and culture panel - Nasopharynx |
| 78922-2 | Respiratory bacteria and viruses DNA and RNA panel - Nasopharynx by Probe and target amplification method |
| 78923-0 | Comorbid condition panel |
| 78933-9 | Assisted circulation procedures performed panel |
| 78939-6 | Percutaneous coronary intervention device panel |
| 78942-0 | Catheterization and angiography device panel |
| 78950-3 | Left ventricle Segmental wall motion panel by Angiogram |
| 78960-2 | Aldosterone and renin concentration panel - Plasma |
| 78993-3 | Prolactin isoforms panel - Serum or Plasma |
| 79062-6 | PROMIS item bank - physical function w mobility aids - version 1.0 |
| 79063-4 | PROMIS short form - physical function w mobility aids - version 1.0 |
| 79115-2 | General Practitioner Assessment of Cognition [GPCOG] |
| 79160-8 | Cold agglutinin panel - Serum |
| 79161-6 | Nortriptyline and E-10-hydroxynortriptyline and Z-10-hydroxynortriptyline panel - Serum or Plasma |
| 79162-4 | Chlordiazepoxide and Norchlordiazepoxide panel - Serum or Plasma |
| 79165-7 | Oxcarbazepine trough and 10-hydroxycarbazepine panel - Serum or Plasma |
| 79191-3 | Patient demographics panel |
| 79221-8 | Steroid fractions panel - Serum or Plasma |
| 79284-6 | Carnitine biosynthesis intermediates panel - Dried blood spot |
| 79285-3 | Carnitine biosynthesis intermediates panel - Serum or Plasma |
| 79286-1 | Carnitine biosynthesis intermediates panel - Cerebral spinal fluid |
| 79287-9 | Carnitine biosynthesis intermediates panel - Urine |
| 79288-7 | Creatine and guanidinoacetate panel - Cerebral spinal fluid |
| 79289-5 | Creatine and guanidinoacetate panel - Serum or Plasma |
| 79290-3 | Creatine, guanidinoacetate and creatinine panel - Urine |
| 79294-5 | D- and L-2-hydroxyglutarate panel - Cerebral spinal fluid |
| 79295-2 | D- and L-2-hydroxyglutarate panel - Serum or Plasma |
| 79296-0 | D- and L-2-hydroxyglutarate panel - Amniotic fluid |
| 79297-8 | D- and L-2-hydroxyglutarate panel - Urine |
| 79298-6 | D- and L-2-hydroxyglutarate panel - Dried blood spot |
| 79381-0 | Enteric pathogens panel - Stool by Probe and target amplification method |
| 79391-9 | Catecholamine metabolites panel - Cerebral spinal fluid |
| 79399-2 | Synovial fluid analysis panel - Synovial fluid |
| 79408-1 | Clobazam and norclobazam panel - Serum or Plasma |
| 79409-9 | Dothiepin+nordothiepin trough and dothiepin sulfoxide panel - Serum or Plasma |
| 79412-3 | Mianserin trough and Normianserin panel - Serum or Plasma |
| 79424-8 | Serial sputum smears for diagnosing pulmonary tuberculosis panel - by Acid fast stain - Ziehl-Neelsen |
| 79448-7 | Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus panel - Nose by Probe and target amplification method |
| 79499-0 | Catecholamine metabolites panel - Serum or Plasma |
| 79563-3 | Mucopolysaccharidosis type I newborn screening panel |
| 79572-4 | Folate and tryptophan and metabolites panel - Cerebral spinal fluid |
| 79573-2 | Riboflavin and flavin mononucleotide and flavin adenine dinucleotide panel - Serum or Plasma |
| 79575-7 | Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - 24 hour Urine |
| 79583-1 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Serum or Plasma |
| 79584-9 | Beta alanine and Beta aminoisobutyrate and Gamma aminobutyrate panel - Urine |
| 79586-4 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Cerebral spinal fluid |
| 79605-2 | R- and S-beta aminoisobutyrate and D- and L-serine panel - Urine |
| 79621-9 | Phenylalanine and Tyrosine panel - Dried blood spot |
| 79665-6 | Purine and Pyrimidine panel - Serum or Plasma |
| 79668-0 | Purine and Pyrimidine panel - Cerebral spinal fluid |
| 79673-0 | Purine and Pyrimidine panel - Urine |
| 79895-9 | Subjective refraction measurements panel |
| 79898-3 | Objective refraction measurements panel |
| 80163-9 | Bile alcohols panel - Urine |
| 80168-8 | Pterins panel - Cerebral spinal fluid |
| 80169-6 | Pterins panel - Serum or Plasma |
| 80170-4 | Pterins panel - Urine |
| 80178-7 | S-adenosylmethionine and S-adenosylhomocystine panel - Serum or Plasma |
| 80179-5 | S-adenosylmethionine and S-adenosylhomocystine panel - Cerebral spinal fluid |
| 80190-2 | Catheterization and angiography procedure details panel |
| 80191-0 | Spasm stress test panel |
| 80192-8 | Coronary segment additional details panel |
| 80354-4 | Herpes simplex virus 1 and 2 DNA panel - Anogenital specimen by Probe and target amplification method |
| 80381-7 | Influenza virus A and B Ag panel - Nasopharynx by Rapid immunoassay |
| 80439-3 | Alcohol intake panel |
| 80440-1 | Bioactive compound intake panel |
| 80441-9 | Breast milk andor formula intake panel |
| 80442-7 | Breast milk intake panel |
| 80443-5 | Calorie intake panel |
| 80444-3 | Fluid intake panel |
| 80445-0 | Food amounts panel |
| 80446-8 | Infant formula intake panel |
| 80447-6 | Meal andor snack pattern panel |
| 80453-4 | Food intake panel |
| 80454-2 | Enteral tube nutritional intake panel |
| 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 1015-7 | Ew Ag [Presence] on Red Blood Cells |
| 1021-5 | E Ag [Presence] on Red Blood Cells |
| 10226-9 | Oxygen content in Intravascular space |
| 10244-2 | Oxygen content in Left pulmonary artery |
| 10245-9 | Oxygen content in Main pulmonary artery |
| 10246-7 | Oxygen content in Right pulmonary artery |
| 10247-5 | Oxygen content in Pulmonary wedge |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
| 10331-7 | Rh [Type] in Blood |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
| 10337-4 | Procollagen type I [Mass/volume] in Serum |
| 10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
| 10339-0 | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
| 10340-8 | Molindone [Mass/volume] in Serum or Plasma |
| 10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
| 10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
| 10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
| 10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
| 10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
| 10347-3 | Babesia microti identified in Blood by Light microscopy |
| 10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
| 10349-9 | Brucella sp Ab [Units/volume] in Serum |
| 10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
| 10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
| 10353-1 | Bacteria identified in Nose by Aerobe culture |
| 10354-9 | Bacteria identified in Urethra by Culture |
| 10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
| 10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
| 10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
| 10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
| 10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
| 10362-2 | Endomysium IgA Ab [Presence] in Serum |
| 10363-0 | Barbiturates [Presence] in Unspecified specimen |
| 10364-8 | Cotinine [Mass/mass] in Hair |
| 10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
| 10366-3 | Cotinine [Mass/volume] in Urine |
| 10367-1 | Ethanol [Mass/volume] in Gastric fluid |
| 10368-9 | Lead [Mass/volume] in Capillary blood |
| 10369-7 | Opiates [Mass/mass] in Hair |
| 10370-5 | Phencyclidine [Mass/mass] in Hair |
| 10384-6 | A,B variant NOS Ag [Presence] on Red Blood Cells |
| 10400-0 | I Ag [Presence] on Red Blood Cells |
| 10408-3 | little i Ag [Presence] on Red Blood Cells |
| 1041-3 | G Ag [Presence] on Red Blood Cells |
| 10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
| 10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
| 10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
| 10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
| 10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
| 10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
| 10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
| 10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
| 10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
| 10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
| 10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
| 10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
| 10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
| 10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
| 10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
| 10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
| 10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
| 10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
| 10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
| 10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
| 10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
| 10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
| 10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
| 10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
| 10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
| 10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
| 10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
| 10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
| 10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
| 10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
| 10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
| 10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
| 10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
| 10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
| 10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
| 10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
| 10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
| 10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
| 10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
| 10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
| 10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
| 10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
| 10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
| 10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
| 10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
| 10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
| 10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
| 10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
| 10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
| 10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
| 10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
| 10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
| 10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
| 10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
| 10496-8 | Immunoglobulin light chains.kappa Ag [Presence] in Tissue by Immune stain |
| 10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
| 10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
| 10499-2 | Immunoglobulin light chains.lambda Ag [Presence] in Tissue by Immune stain |
| 1050-4 | H NOS Ag [Presence] on Red Blood Cells |
| 10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
| 10501-5 | Lutropin [Units/volume] in Serum or Plasma |
| 10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
| 10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
| 10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
| 10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
| 10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
| 10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
| 10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain |
| 10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
| 10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
| 10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
| 10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
| 10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
| 10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
| 10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
| 10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
| 10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
| 10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
| 10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
| 10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
| 10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
| 10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
| 10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
| 10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
| 10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
| 10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
| 10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
| 10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
| 10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
| 10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
| 10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
| 10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
| 10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
| 10539-5 | Glipizide [Mass/volume] in Serum or Plasma |
| 10540-3 | Glyburide [Mass/volume] in Serum or Plasma |
| 10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
| 10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
| 10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
| 10544-5 | Normeperidine [Presence] in Serum or Plasma |
| 10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
| 10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
| 10547-8 | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma |
| 10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
| 10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
| 10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
| 10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
| 10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
| 10558-5 | Albumin [Moles/volume] in Semen |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 10561-9 | Carnitine [Moles/volume] in Semen |
| 10565-0 | Choriogonadotropin [Units/volume] in Semen |
| 10567-6 | Citrate [Moles/volume] in Semen |
| 10573-4 | Ferning [Type] in Cervical mucus |
| 10574-2 | Fructose [Moles/volume] in Semen |
| 10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
| 10582-5 | pH of Cervical mucus |
| 10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
| 10596-5 | Deprecated Spermatozoa Ab in cervical mucosa |
| 10597-3 | Deprecated Spermatozoa Ab in semen |
| 10598-1 | Deprecated Spermatozoa Ab in serum |
| 10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
| 10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
| 10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
| 10630-2 | Spinnbarkeit [Length] in Cervical mucus |
| 10631-0 | Testosterone [Moles/volume] in Semen |
| 10633-6 | Zinc [Moles/volume] in Semen |
| 10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
| 10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
| 10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
| 10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
| 10639-3 | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
| 10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
| 10641-9 | Amoeba identified in Aspirate by Immune stain |
| 10642-7 | Amoeba identified in Aspirate by Wet preparation |
| 10643-5 | Amoeba identified in Stool by Organism specific culture |
| 10644-3 | Arthropod identified in Unspecified specimen |
| 10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
| 10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
| 10647-6 | Babesia sp identified in Blood by Thick film |
| 10648-4 | Babesia sp identified in Blood by Thin film |
| 10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
| 10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
| 10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
| 10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
| 10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
| 10656-7 | Coccidia identified in Stool by Acid fast stain |
| 10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |
| 10658-3 | Cyanobacterium identified in Water by Light microscopy |
| 10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
| 1066-0 | I NOS Ag [Presence] on Red Blood Cells |
| 10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
| 10661-7 | Dinoflagellate identified in Water by Light microscopy |
| 10662-5 | Filaria identified in Blood by Concentration |
| 10663-3 | Filaria identified in Blood by Thick film |
| 10664-1 | Filaria identified in Blood by Thin film |
| 10665-8 | Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
| 10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
| 10667-4 | Fungus identified in Unspecified specimen by Animal inoculation |
| 10668-2 | Fungus identified in Unspecified specimen by Environmental culture |
| 10669-0 | Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
| 10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
| 10671-6 | Helminth identified in Unspecified specimen |
| 10672-4 | Helminth+Arthropod identified in Unspecified specimen |
| 10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
| 10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
| 10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
| 10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
| 10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
| 10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
| 10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
| 10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
| 10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
| 10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
| 10684-9 | Hydatid cyst identified in Liver by Wet preparation |
| 10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
| 10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
| 10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
| 10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
| 10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
| 10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
| 10691-4 | Mushroom.toxic identified by Inspection |
| 10692-2 | Mushroom.toxic identified in Food by Light microscopy |
| 10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
| 10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
| 10695-5 | Naegleria sp identified in Tissue by Wet preparation |
| 10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
| 10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
| 10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
| 10701-1 | Ova and parasites identified in Stool by Concentration |
| 10702-9 | Ova and parasites identified in Stool by Immune stain |
| 10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
| 10704-5 | Ova and parasites identified in Stool by Light microscopy |
| 10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
| 10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
| 10707-8 | Toxic Plant identified in plant specimen by Inspection |
| 10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
| 10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
| 10710-2 | Plasmodium sp identified in Blood by Thin film |
| 10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
| 10712-8 | Pneumocystis sp identified in Lung tissue |
| 10713-6 | Prototheca identified in Unspecified specimen by Culture |
| 10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |
| 10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
| 10716-9 | Schistosoma sp identified in Unspecified specimen by Organism specific culture |
| 10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
| 10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
| 10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot (IB) |
| 1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
| 10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
| 10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
| 10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
| 10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
| 10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
| 10727-6 | Toxoplasma gondii identified in Tissue |
| 10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
| 10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
| 10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
| 10731-8 | Trypanosoma sp identified in Blood by Thick film |
| 10732-6 | Trypanosoma sp identified in Blood by Thin film |
| 10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
| 10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
| 10735-9 | Viral sequencing [Identifier] in Serum by Sequencing |
| 10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
| 10737-5 | Virus identified in Stool by Electron microscopy |
| 10738-3 | Virus identified in Tissue by Electron microscopy |
| 10739-1 | Virus identified in Unspecified specimen by Electron microscopy |
| 10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
| 10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
| 10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
| 10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
| 10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
| 10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
| 10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
| 10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
| 10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
| 1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells |
| 10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
| 10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
| 10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
| 10829-0 | Silicon [Mass/volume] in Serum or Plasma |
| 10834-0 | Globulin [Mass/volume] in Serum by calculation |
| 10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
| 10836-5 | Niacin [Mass/volume] in Blood |
| 10837-3 | Organic acids [Presence] in Serum or Plasma |
| 10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
| 1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells |
| 10840-7 | Atropine [Mass/volume] in Urine |
| 10841-5 | Methazolamide [Mass/volume] in Serum or Plasma |
| 10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
| 10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
| 10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
| 10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
| 10850-6 | Cyclospora cayetanensis [Presence] in Unspecified specimen |
| 10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
| 10853-0 | Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
| 10854-8 | Deprecated Midrofilaria identified in Blood by Concentration |
| 10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
| 10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain |
| 10857-1 | Microsporidia identified in Unspecified specimen by Light microscopy |
| 10858-9 | Teichoate Ab [Presence] in Serum |
| 10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
| 10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue |
| 10862-1 | Basement membrane Ab [Titer] in Serum |
| 10863-9 | Endomysium IgA Ab [Titer] in Serum |
| 10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
| 10865-4 | Intercellular substance Ab [Presence] in Serum |
| 10866-2 | Sulfatide IgG Ab [Titer] in Serum |
| 10867-0 | Sulfatide IgM Ab [Titer] in Serum |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
| 10874-6 | Bombesin [Mass/volume] in Plasma |
| 10875-3 | Carnitine esters [Mass/volume] in Urine |
| 10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma |
| 10877-9 | Carnitine free (C0) [Mass/volume] in Urine |
| 10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma |
| 10880-3 | Magnesium [Mass/mass] in Stool |
| 10883-7 | Phenolphthalein [Mass/mass] in Stool |
| 10884-5 | Phosphate [Mass/mass] in Stool |
| 10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
| 10887-8 | Pyridinoline [Mass/time] in 24 hour Urine |
| 10888-6 | Lipase [Enzymatic activity/volume] in Urine |
| 10889-4 | Bisacodyl [Mass/mass] in Stool |
| 10891-0 | Oxyphenisatin [Mass/mass] in Stool |
| 10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma |
| 10893-6 | Trenbolone [Mass/volume] in Urine |
| 10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
| 10895-1 | Clostridium difficile toxin B [Presence] in Stool |
| 10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells |
| 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
| 10903-3 | Hyaluronidase Ab [Titer] in Serum |
| 10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 10909-0 | Benzidine [Mass/volume] in Urine |
| 10910-8 | Borate [Mass/volume] in Urine |
| 10911-6 | Dichlorobenzidine [Mass/volume] in Urine |
| 10912-4 | Lead [Mass/volume] in Serum or Plasma |
| 10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
| 10914-0 | Methylenediamine [Mass/volume] in Urine |
| 10915-7 | Phencyclidine [Mass/volume] in Unspecified specimen |
| 10916-5 | Platinum [Mass/volume] in Blood |
| 10917-3 | Zinc [Mass/mass] in Stool |
| 10918-1 | Zinc [Mass/volume] in Unspecified specimen |
| 10919-9 | Anisakis IgE Ab [Units/volume] in Serum |
| 10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum |
| 10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum |
| 10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
| 10923-1 | Bromelin IgE Ab [Units/volume] in Serum |
| 10924-9 | Starfruit IgE Ab [Units/volume] in Serum |
| 10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum |
| 10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum |
| 10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum |
| 10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum |
| 10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum |
| 10930-6 | Fish Feed IgE Ab [Units/volume] in Serum |
| 10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
| 10932-2 | Tetramin IgE Ab [Units/volume] in Serum |
| 10933-0 | Guar gum IgE Ab [Units/volume] in Serum |
| 10934-8 | Guava IgE Ab [Units/volume] in Serum |
| 10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum |
| 10936-3 | Mare milk IgE Ab [Units/volume] in Serum |
| 10937-1 | Marjoram IgE Ab [Units/volume] in Serum |
| 10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum |
| 10939-7 | Whiff IgE Ab [Units/volume] in Serum |
| 10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum |
| 10941-3 | Milk powder IgE Ab [Units/volume] in Serum |
| 10942-1 | Cockspur IgE Ab [Units/volume] in Serum |
| 10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum |
| 10944-7 | Octopus IgE Ab [Units/volume] in Serum |
| 10945-4 | Papain IgE Ab [Units/volume] in Serum |
| 10946-2 | Passion fruit IgE Ab [Units/volume] in Serum |
| 10947-0 | Persimmon IgE Ab [Units/volume] in Serum |
| 10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum |
| 10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum |
| 10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum |
| 10951-2 | Sericin IgE Ab [Units/volume] in Serum |
| 10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum |
| 10953-8 | Timothy IgG Ab [Units/volume] in Serum |
| 10954-6 | Pine Nut IgE Ab [Units/volume] in Serum |
| 10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum |
| 10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum |
| 10957-9 | Slash Pine IgE Ab [Units/volume] in Serum |
| 10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
| 10959-5 | Plaice IgE Ab [Units/volume] in Serum |
| 1096-7 | K Ag [Presence] on Red Blood Cells |
| 10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum |
| 10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum |
| 10962-9 | Deprecated Sagebrush tridenda IgE Ab [Units/volume] in Serum |
| 10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
| 10969-4 | Cystine+Homocysteine [Presence] in Urine |
| 10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
| 10971-0 | Lysozyme [Mass/volume] in Urine |
| 10972-8 | Organic acids [Mass/volume] in Urine |
| 10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
| 10974-4 | 5-Fluorocytosine [Mass/volume] in Urine |
| 10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
| 10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
| 10977-7 | Alprazolam [Mass/volume] in Blood |
| 10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine |
| 10979-3 | Carisoprodol [Mass/volume] in Urine |
| 10980-1 | Cephapirin [Mass/volume] in Serum or Plasma |
| 10981-9 | Clonidine [Mass/volume] in Urine |
| 10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma |
| 10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma |
| 10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma |
| 10985-0 | Doxapram [Mass/volume] in Serum or Plasma |
| 10986-8 | Doxycycline [Mass/volume] in Serum or Plasma |
| 10987-6 | Fluconazole [Mass/volume] in Serum or Plasma |
| 10988-4 | Fluvoxamine [Mass/volume] in Serum or Plasma |
| 10989-2 | Itraconazole [Mass/volume] in Serum or Plasma |
| 10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma |
| 10991-8 | Metronidazole [Mass/volume] in Serum or Plasma |
| 10992-6 | Norclozapine [Mass/volume] in Serum or Plasma |
| 10993-4 | Nafcillin [Mass/volume] in Serum or Plasma |
| 10994-2 | Naltrexone [Mass/volume] in Serum or Plasma |
| 10995-9 | Neomycin [Mass/volume] in Serum or Plasma |
| 10996-7 | Normeperidine [Mass/volume] in Serum or Plasma |
| 10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma |
| 10998-3 | Oxycodone [Presence] in Urine |
| 10999-1 | Paramethadione [Mass/volume] in Serum or Plasma |
| 11000-7 | Promethazine [Presence] in Urine |
| 11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma |
| 11002-3 | Scopolamine [Presence] in Urine |
| 11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma |
| 11004-9 | Tricyclic antidepressants [Presence] in Urine |
| 11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma |
| 11006-4 | Borrelia burgdorferi Ab [Presence] in Serum |
| 11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine |
| 11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method |
| 11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation |
| 11013-0 | DNA double strand Ab [Titer] in Serum |
| 11014-8 | Somatotropin Ab [Titer] in Serum or Plasma |
| 11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma |
| 11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
| 11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
| 11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
| 1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells |
| 11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
| 11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
| 11022-1 | Barbiturates [Mass/volume] in Meconium |
| 11023-9 | Benzodiazepines [Mass/volume] in Meconium |
| 11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma |
| 11025-4 | Methadone [Mass/volume] in Meconium |
| 11026-2 | Methaqualone [Mass/volume] in Meconium |
| 11027-0 | Propoxyphene [Mass/volume] in Meconium |
| 11028-8 | Zinc [Mass/volume] in Body fluid |
| 11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
| 11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum |
| 11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
| 11039-5 | C reactive protein [Presence] in Serum or Plasma |
| 11040-3 | Cortisol Free [Mass/volume] in Urine |
| 11043-7 | Cryofibrinogen [Presence] in Plasma |
| 11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
| 11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells |
| 11046-0 | Epinephrine [Mass/volume] in Urine |
| 11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 11050-2 | Immunoglobulin light chains.kappa [Mass/volume] in Serum or Plasma |
| 11051-0 | Immunoglobulin light chains.lambda [Mass/volume] in Serum or Plasma |
| 11052-8 | Ketamine [Mass/volume] in Urine |
| 11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 11055-1 | Melatonin [Mass/volume] in Serum or Plasma |
| 11056-9 | Melatonin [Flow] in 24 hour Urine |
| 11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
| 11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
| 11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
| 11060-1 | Reducing substances [Presence] in Stool |
| 11061-9 | Thromboxane beta 2 [Mass/time] in 24 hour Urine |
| 11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
| 11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
| 11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
| 11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
| 11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
| 11067-6 | Bleeding time |
| 11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain |
| 11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
| 11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
| 11071-8 | Butalbital [Mass/volume] in Urine |
| 11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma |
| 11073-4 | Despropionylfentanyl [Mass/volume] in Urine |
| 11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma |
| 11075-9 | Norfentanyl [Mass/volume] in Urine |
| 11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot (IB) |
| 1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells |
| 11083-3 | Human papilloma virus identified in Cervix |
| 11084-1 | Reagin Ab [Titer] in Serum |
| 11085-8 | Schistosoma sp identified in Stool by Concentration |
| 11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum |
| 11087-4 | Insulin Ab [Titer] in Serum |
| 11088-2 | Neuronal nuclear Ab [Presence] in Serum |
| 11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
| 11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum |
| 11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma |
| 11092-4 | Barbiturates [Mass/mass] in Hair |
| 11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
| 11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
| 11095-7 | Dieldrin [Mass/volume] in Serum or Plasma |
| 11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma |
| 11097-3 | Lindane [Mass/volume] in Serum or Plasma |
| 11098-1 | Malaoxon [Mass/volume] in Serum or Plasma |
| 11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma |
| 11100-5 | Tetrachloroethylene [Mass/volume] in Blood |
| 11102-1 | Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain |
| 11133-6 | Catecholamines Free [Mass/volume] in Urine |
| 11139-3 | Metanephrine [Mass/volume] in Urine |
| 11140-1 | Metanephrine [Moles/time] in 24 hour Urine |
| 11144-3 | Homovanillate [Mass/volume] in Urine |
| 11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
| 11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine |
| 11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine |
| 11148-4 | Potassium/Creatinine [Mass Ratio] in Urine |
| 11149-2 | Sodium/Creatinine [Mass Ratio] in Urine |
| 1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells |
| 11151-8 | Hematocrit [Volume Fraction] of Cord blood |
| 11153-4 | Hematocrit [Volume Fraction] of Body fluid |
| 11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood |
| 11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine |
| 11159-1 | Alkalase IgE Ab [Units/volume] in Serum |
| 11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum |
| 11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum |
| 11162-5 | Deprecated Cocoa IgE Ab [Units/volume] in Serum |
| 11163-3 | Carageenan IgE Ab [Units/volume] in Serum |
| 11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum |
| 11165-8 | Chinchilla IgE Ab [Units/volume] in Serum |
| 11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
| 11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum |
| 11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum |
| 11169-0 | Deer hair IgE Ab [Units/volume] in Serum |
| 11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum |
| 11171-6 | Erythromycin IgE Ab [Units/volume] in Serum |
| 11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum |
| 11173-2 | Fig IgE Ab [Units/volume] in Serum |
| 11174-0 | Grain weevel IgE Ab [Units/volume] in Serum |
| 11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum |
| 11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum |
| 11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum |
| 11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum |
| 11179-9 | Linden IgE Ab [Units/volume] in Serum |
| 11180-7 | Lupin IgE Ab [Units/volume] in Serum |
| 11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum |
| 11182-3 | Lysozyme IgE Ab [Units/volume] in Serum |
| 11183-1 | Macadamia IgE Ab [Units/volume] in Serum |
| 11184-9 | Scad IgE Ab [Units/volume] in Serum |
| 11185-6 | Maxatase IgE Ab [Units/volume] in Serum |
| 11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum |
| 11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum |
| 11188-0 | Cayenne IgE Ab [Units/volume] in Serum |
| 11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum |
| 11190-6 | Mint IgE Ab [Units/volume] in Serum |
| 11191-4 | Pollock IgE Ab [Units/volume] in Serum |
| 11192-2 | Protamine IgE Ab [Units/volume] in Serum |
| 11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum |
| 11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum |
| 11195-5 | Rapeseed IgE Ab [Units/volume] in Serum |
| 11196-3 | Orange roughy IgE Ab [Units/volume] in Serum |
| 11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum |
| 11198-9 | Shark IgE Ab [Units/volume] in Serum |
| 11199-7 | Silver IgE Ab [Units/volume] in Serum |
| 11200-3 | Escargot IgE Ab [Units/volume] in Serum |
| 11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum |
| 11202-9 | Tarragon IgE Ab [Units/volume] in Serum |
| 11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum |
| 11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum |
| 11205-2 | Deprecated Paper Wasp IgE Ab [Units/volume] in Serum |
| 11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
| 11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
| 11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma |
| 11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
| 11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid |
| 11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 11214-4 | Deprecated Creatinine |
| 11215-1 | Delta aminolevulinate [Mass/volume] in Urine |
| 11216-9 | Deoxypyridinoline [Mass/volume] in Urine |
| 11218-5 | Microalbumin [Mass/volume] in Urine by Test strip |
| 11219-3 | Immunoglobulin light chains [Presence] in Serum |
| 11220-1 | Iodine Free [Mass/time] in 24 hour Urine |
| 11226-8 | Prorenin [Units/volume] in Plasma |
| 11227-6 | Pyruvate kinase [Presence] in Blood |
| 11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma |
| 11230-0 | Amobarbital [Mass/volume] in Urine |
| 11231-8 | Astemizole [Mass/volume] in Serum or Plasma |
| 11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma |
| 11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma |
| 11234-2 | Propoxyphene [Mass/mass] in Hair |
| 11235-9 | Fentanyl [Presence] in Urine |
| 11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma |
| 11237-5 | Hydralazine [Mass/volume] in Serum or Plasma |
| 11238-3 | Hydroxyalprazolam [Mass/volume] in Urine |
| 11240-9 | Hydroxyzine [Mass/volume] in Urine |
| 11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma |
| 11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma |
| 11243-3 | Methadone [Mass/mass] in Hair |
| 11244-1 | Morphine Free [Mass/volume] in Serum or Plasma |
| 11246-6 | Oxycodone [Mass/volume] in Urine |
| 11247-4 | Oxymorphone [Presence] in Urine |
| 11248-2 | Pergolide [Mass/volume] in Serum or Plasma |
| 11249-0 | Phenacemide [Mass/volume] in Serum or Plasma |
| 11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma |
| 11251-6 | Piroxicam [Mass/volume] in Serum or Plasma |
| 11252-4 | Scopolamine [Mass/volume] in Serum or Plasma |
| 11253-2 | Tacrolimus [Mass/volume] in Blood |
| 11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum |
| 11255-7 | Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture |
| 11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
| 11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
| 11258-1 | Hepatitis B virus DNA [Units/volume] in Serum |
| 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay |
| 11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture |
| 11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum |
| 11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum |
| 11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
| 11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
| 11266-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
| 11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
| 11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
| 11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
| 1132-0 | Le NOS Ag [Presence] on Red Blood Cells |
| 1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells |
| 11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot (IB) |
| 11468-6 | Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
| 11469-4 | Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
| 1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells |
| 11470-2 | Clostridium botulinum toxin [Units/volume] in Stool |
| 11471-0 | Deprecated Cryptococcus neoformans Ag [Titer] in Unspecified specimen |
| 11472-8 | Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen |
| 11473-6 | Cryptococcus sp Ag [Titer] in Unspecified specimen |
| 11474-4 | Hydatid cyst identified in Unspecified specimen by Wet preparation |
| 11475-1 | Microorganism identified in Unspecified specimen by Culture |
| 11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
| 11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain |
| 11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain |
| 11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain |
| 11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain |
| 11481-9 | Human papilloma virus identified in Unspecified specimen |
| 11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by Probe and target amplification method |
| 11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 11484-3 | Virus identified in Amniotic fluid by Culture |
| 11488-4 | Consult note |
| 11490-0 | Physician Discharge summary |
| 11492-6 | Provider-unspecifed, History and physical note |
| 11504-8 | Provider-unspecified Operation note |
| 11505-5 | Physician Procedure note |
| 11506-3 | Provider-unspecified Progress note |
| 11507-1 | Occupational therapy Progress note |
| 11508-9 | Physical therapy Progress note |
| 11509-7 | Podiatry Progress note |
| 11510-5 | Psychology Progress note |
| 11512-1 | Speech-language pathology Progress note |
| 11522-0 | Deprecated Cardiac echo study |
| 11523-8 | EEG study |
| 11524-6 | EKG Study |
| 11525-3 | US Pelvis and Fetus for pregnancy |
| 11526-1 | Pathology study |
| 11527-9 | Psychiatry study |
| 11529-5 | Surgical pathology study |
| 1153-6 | Lu NOS Ag [Presence] on Red Blood Cells |
| 11536-0 | Nurse Notes |
| 11541-0 | Deprecated MRI Brain study |
| 11545-1 | Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
| 11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain |
| 11550-1 | Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture |
| 11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
| 11556-8 | Oxygen [Partial pressure] in Blood |
| 11557-6 | Carbon dioxide [Partial pressure] in Blood |
| 11558-4 | pH of Blood |
| 11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum |
| 11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum |
| 11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum |
| 11564-2 | Intrinsic factor Ab [Units/volume] in Serum |
| 11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum |
| 11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum |
| 11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum |
| 11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum |
| 11570-9 | Platelet IgG Ab [Units/volume] in Serum |
| 11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
| 11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma |
| 11573-3 | Rheumatoid factor IgM [Units/volume] in Serum |
| 11574-1 | Deprecated Thyroperoxidase Ab [Units/volume] in Serum |
| 11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
| 11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
| 11581-6 | Ebola virus Ab [Units/volume] in Serum |
| 11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum |
| 11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum |
| 11584-0 | Aureobasidium pullulans Ab [Presence] in Serum |
| 11585-7 | Bordetella pertussis Ab [Units/volume] in Serum |
| 11586-5 | Brucella abortus Ab [Units/volume] in Serum |
| 11587-3 | Brucella canis Ab [Units/volume] in Serum |
| 11588-1 | Brucella melitensis Ab [Units/volume] in Serum |
| 11589-9 | Brucella suis Ab [Units/volume] in Serum |
| 1159-3 | little c Ag [Presence] on Red Blood Cells |
| 11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum |
| 11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum |
| 11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum |
| 11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum |
| 11594-9 | Echovirus 16 Ab [Units/volume] in Serum |
| 11595-6 | Echovirus 18 Ab [Units/volume] in Serum |
| 11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum |
| 11597-2 | Treponema pallidum Ab [Units/volume] in Serum |
| 11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum |
| 11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum |
| 11600-4 | Shigella flexneri Ab [Units/volume] in Serum |
| 11601-2 | Echovirus 7 Ab [Units/volume] in Serum |
| 11602-0 | Shigella boydii Ab [Units/volume] in Serum |
| 11603-8 | Salmonella sp Ab [Units/volume] in Serum |
| 11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum |
| 11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
| 11606-1 | Leptospira interrogans Ab [Units/volume] in Serum |
| 11607-9 | Junin virus Ab [Units/volume] in Serum |
| 11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum |
| 11609-5 | HTLV I Ab [Units/volume] in Serum |
| 11610-3 | Heterophile Ab [Units/volume] in Serum |
| 11611-1 | Shigella sonnei Ab [Units/volume] in Serum |
| 1165-0 | little e Ag [Presence] on Red Blood Cells |
| 1171-8 | little f Ag [Presence] on Red Blood Cells |
| 1189-0 | little i NOS Ag [Presence] on Red Blood Cells |
| 1195-7 | little k Ag [Presence] on Red Blood Cells |
| 1204-7 | pk Ag [Presence] on Red Blood Cells |
| 1207-0 | little p Ag [Presence] on Red Blood Cells |
| 1213-8 | little s Ag [Presence] on Red Blood Cells |
| 12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
| 12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 12176-4 | Amino acids [Moles/volume] in Serum or Plasma |
| 12177-2 | Amino acids/Creatinine [Ratio] in Urine |
| 12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation |
| 12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 12181-4 | Calcium [Moles/volume] in Body fluid |
| 12183-0 | Cholesterol [Mass/volume] in Body fluid |
| 12184-8 | Choriogonadotropin [Presence] in Body fluid |
| 12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma |
| 1219-5 | LW Ag [Presence] on Red Blood Cells |
| 12190-5 | Creatinine [Mass/volume] in Body fluid |
| 12191-3 | Creatinine [Mass/volume] in Peritoneal fluid |
| 12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
| 12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
| 12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
| 12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
| 12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count |
| 12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
| 12217-6 | Globulin [Mass/volume] in Body fluid |
| 12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
| 12222-6 | Human papilloma virus Ag [Presence] in Genital specimen |
| 12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
| 12228-3 | Triglyceride [Mass/volume] in Body fluid |
| 12232-5 | Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12237-4 | Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12239-0 | Oligosaccharides [Presence] in Urine |
| 12240-8 | Orotidine [Moles/volume] in Urine |
| 12242-4 | Phosphate [Mass/volume] in Body fluid |
| 12245-7 | Porphobilinogen [Presence] in 24 hour Urine |
| 12247-3 | Pyruvate [Mass/volume] in Serum or Plasma |
| 1225-2 | Mg Ag [Presence] on Red Blood Cells |
| 12251-5 | Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
| 12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
| 12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells |
| 12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
| 12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
| 12263-0 | Deprecated EBV [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 12264-8 | Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid |
| 12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid |
| 12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
| 12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
| 12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
| 12269-7 | Urobilinogen [Presence] in 24 hour Urine |
| 12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
| 12272-1 | Virus identified in Unspecified specimen by Immunofluorescence |
| 12274-7 | Xylose [Mass/time] in 5 hour Urine |
| 12275-4 | Yeast [Presence] in Genital specimen by Wet preparation |
| 12276-2 | Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture |
| 12277-0 | DNA double strand Ab [Presence] in Serum by Farr method |
| 12281-2 | Bacteria identified in Cervix by Anaerobe culture |
| 12282-0 | Warfarin [Presence] in Urine |
| 12283-8 | Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
| 12284-6 | Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
| 12286-1 | Drugs identified in Urine by Screen method |
| 12287-9 | Drugs identified in Gastric fluid by Screen method |
| 12288-7 | Diuretics [Identifier] in Urine |
| 12289-5 | Drugs identified in Vitreous fluid by Screen method |
| 12290-3 | Procyclidine [Presence] in Urine |
| 12291-1 | Mephentermine [Presence] in Urine |
| 12292-9 | Dimethyltryptamine [Presence] in Urine |
| 12293-7 | Cotinine [Presence] in Urine |
| 12294-5 | Nicotine [Presence] in Urine |
| 12295-2 | Hallucinogens [Identifier] in Urine |
| 12296-0 | Mescaline [Presence] in Urine |
| 12297-8 | Chlorate [Presence] in Blood |
| 12298-6 | Erythromycin [Presence] in Urine |
| 12299-4 | Ethinamate [Presence] in Urine |
| 12300-0 | Polythiazide [Presence] in Urine |
| 12301-8 | Procaine [Presence] in Urine |
| 12302-6 | Theobromine [Presence] in Serum or Plasma |
| 12303-4 | Theobromine [Presence] in Urine |
| 12304-2 | Benzyl alcohol [Presence] in Serum or Plasma |
| 12305-9 | Chlordecone [Presence] in Blood |
| 12306-7 | Cyclohexane [Mass/volume] in Blood |
| 12307-5 | Dichloroethane [Mass/volume] in Blood |
| 12308-3 | Hydrocodone [Presence] in Urine |
| 12309-1 | Naltrexone [Presence] in Urine |
| 1231-0 | M Ag [Presence] on Red Blood Cells |
| 12310-9 | Phenytoin [Presence] in Urine |
| 12311-7 | Prazepam [Mass/volume] in Urine |
| 12312-5 | Cyclopropane [Mass/volume] in Blood |
| 12313-3 | Aprobarbital [Presence] in Urine |
| 12314-1 | Clorazepate [Presence] in Urine |
| 12315-8 | Mephobarbital [Presence] in Urine |
| 12317-4 | Phenolphthalein [Presence] in Urine |
| 12318-2 | Spironolactone [Presence] in Urine |
| 12319-0 | Thioridazine [Presence] in Urine |
| 12320-8 | Thiothixene [Presence] in Urine |
| 12321-6 | Trifluoperazine [Presence] in Urine |
| 12322-4 | Triflupromazine [Presence] in Urine |
| 12323-2 | Trimeprazine [Presence] in Urine |
| 12324-0 | Hydroxyzine [Presence] in Urine |
| 12325-7 | Tetrahydrocortisone [Presence] in Urine |
| 12326-5 | Diamorphine [Presence] in Unknown substance |
| 12327-3 | Ketamine [Presence] in Urine |
| 12328-1 | Beta blockers [Identifier] in Urine |
| 12329-9 | Chlorpropamide [Presence] in Urine |
| 12330-7 | Hypoglycemics.oral [Identifier] in Urine |
| 12331-5 | Phenethylamine [Presence] in Urine |
| 12332-3 | Antihistamines [Identifier] in Urine |
| 12333-1 | Butorphanol [Presence] in Urine |
| 12334-9 | Para aminophenol [Mass/volume] in Urine |
| 12335-6 | Halothane [Presence] in Blood |
| 12336-4 | Hydralazine [Presence] in Serum or Plasma |
| 12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma |
| 12338-0 | Pentachlorophenol [Presence] in Serum or Plasma |
| 12339-8 | Diquat [Presence] in Urine |
| 1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells |
| 12340-6 | Ethylene [Presence] in Blood |
| 12341-4 | Mazindol [Presence] in Serum or Plasma |
| 12342-2 | Oxymorphone [Presence] in Serum or Plasma |
| 12343-0 | Thiazides [Identifier] in Urine |
| 12344-8 | Antipsychotics [Identifier] in Serum or Plasma |
| 12345-5 | Cyclothiazide [Presence] in Urine |
| 12346-3 | Methyclothiazide [Presence] in Urine |
| 12347-1 | Metolazone [Presence] in Urine |
| 12348-9 | Quinethazone [Presence] in Urine |
| 12349-7 | Trichlormethiazide [Presence] in Urine |
| 12350-5 | Amphetamines [Presence] in Stool |
| 12351-3 | Tetrahydrocannabinol [Presence] in Stool |
| 12352-1 | Benzoylecgonine [Presence] in Stool |
| 12353-9 | Methaqualone [Presence] in Stool |
| 12354-7 | Opiates [Presence] in Stool |
| 12355-4 | Phencyclidine [Presence] in Stool |
| 12356-2 | Methadone [Presence] in Stool |
| 12357-0 | Propoxyphene [Presence] in Stool |
| 12358-8 | Barbiturates [Presence] in Stool |
| 12359-6 | Benzodiazepines [Presence] in Stool |
| 12360-4 | Barbital [Presence] in Urine |
| 12361-2 | Oxazepam [Presence] in Urine |
| 12362-0 | Oxazepam [Presence] in Serum or Plasma |
| 12363-8 | Carbamazepine [Presence] in Urine |
| 12364-6 | Benzodiazepines [Presence] in Gastric fluid |
| 12365-3 | Dimenhydrinate [Presence] in Urine |
| 12366-1 | Disopyramide [Presence] in Urine |
| 12367-9 | Mesoridazine [Presence] in Urine |
| 12368-7 | Phenacetin [Presence] in Urine |
| 12369-5 | Sympathomimetics [Identifier] in Urine |
| 12370-3 | Thiopental [Mass/volume] in Urine |
| 12371-1 | Isopropyl ether [Mass/volume] in Blood |
| 12372-9 | Dimethylacetamide [Mass/volume] in Urine |
| 12374-5 | Clobazam [Mass/volume] in Urine |
| 12375-2 | Clozapine+Norclozapine [Mass/volume] in Serum or Plasma |
| 12377-8 | Demoxepam [Mass/volume] in Serum or Plasma |
| 12378-6 | Diazepam [Presence] in Stool |
| 12379-4 | Halazepam [Mass/volume] in Serum or Plasma |
| 12380-2 | Lorazepam [Presence] in Stool |
| 12381-0 | Oxazepam [Presence] in Stool |
| 12382-8 | Temazepam [Mass/volume] in Urine |
| 12383-6 | Hydroxytriazolam [Presence] in Stool |
| 12384-4 | Triazolam [Presence] in Stool |
| 12386-9 | Nordoxepin [Mass/volume] in Urine |
| 12387-7 | Primidone [Mass/volume] in Urine |
| 12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
| 12389-3 | Olanzapine [Mass/volume] in Serum or Plasma |
| 12390-1 | Sulfasalazine [Mass/volume] in Serum or Plasma |
| 12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma |
| 12394-3 | Butorphanol [Mass/volume] in Serum or Plasma |
| 12395-0 | Butorphanol [Mass/volume] in Urine |
| 12396-8 | Chlorpropamide [Mass/volume] in Urine |
| 12397-6 | Colchicine [Mass/volume] in Serum or Plasma |
| 12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma |
| 12399-2 | Emetine [Mass/volume] in Serum or Plasma |
| 12400-8 | Emetine [Mass/volume] in Urine |
| 12401-6 | Ethinamate [Mass/volume] in Serum or Plasma |
| 12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma |
| 12403-2 | Mephentermine [Mass/volume] in Blood |
| 12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma |
| 12405-7 | Nabumetone [Mass/volume] in Serum or Plasma |
| 12406-5 | Nadolol [Mass/volume] in Serum or Plasma |
| 12407-3 | 6-Beta naltrexone [Mass/volume] in Serum or Plasma |
| 12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma |
| 12410-7 | Pimozide [Mass/volume] in Serum or Plasma |
| 12411-5 | Promazine [Mass/volume] in Serum or Plasma |
| 12412-3 | Pyridine [Mass/volume] in Serum or Plasma |
| 12413-1 | Resperine [Mass/volume] in Serum or Plasma |
| 12414-9 | Resperine [Mass/volume] in Urine |
| 12415-6 | Selegiline [Mass/volume] in Serum or Plasma |
| 12416-4 | Sotalol [Mass/volume] in Serum or Plasma |
| 12417-2 | Sulindac [Mass/volume] in Serum or Plasma |
| 12418-0 | Terfenadine [Mass/volume] in Serum or Plasma |
| 12419-8 | Terfenadine [Mass/volume] in Urine |
| 12420-6 | Thiosulfate [Mass/volume] in Urine |
| 12421-4 | Thiosulfate/Creatinine [Mass Ratio] in Urine |
| 12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma |
| 12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma |
| 12424-8 | Triprolidine [Mass/volume] in Serum or Plasma |
| 12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma |
| 12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma |
| 12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma |
| 12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma |
| 12429-7 | Succinylcholine [Mass/volume] in Urine |
| 1243-5 | M NOS Ag [Presence] on Red Blood Cells |
| 12430-5 | Cumene [Mass/volume] in Serum or Plasma |
| 12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma |
| 12432-1 | Hydroxytriazolam [Mass/volume] in Urine |
| 12433-9 | Bufotenine [Mass/volume] in Serum or Plasma |
| 12434-7 | Prednisone [Mass/volume] in Serum or Plasma |
| 12435-4 | Naphthalene [Mass/volume] in Serum or Plasma |
| 12436-2 | Naphthol [Mass/volume] in Serum or Plasma |
| 12437-0 | Tramadol [Mass/volume] in Serum or Plasma |
| 12438-8 | Nortramadol [Mass/volume] in Serum or Plasma |
| 12439-6 | Fluoxetine [Mass/volume] in Urine |
| 12440-4 | Midazolam [Presence] in Stool |
| 12441-2 | Tolmetin [Mass/volume] in Serum or Plasma |
| 12442-0 | Acetaminophen [Mass/volume] in Unspecified specimen |
| 12443-8 | Trimipramine [Mass/volume] in Urine |
| 12444-6 | Nortrimipramine [Mass/volume] in Urine |
| 12445-3 | Norfluoxetine [Mass/volume] in Urine |
| 12446-1 | Halogenated organic molecules [Identifier] in Urine |
| 12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting |
| 12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
| 12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
| 12465-1 | Ethanol [Mass/volume] in Vitreous fluid |
| 12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephlometry |
| 12467-7 | Amino acids [Identifier] in Urine |
| 12468-5 | Amino acids [Identifier] in Serum or Plasma |
| 12470-1 | Homocysteine [Mass/volume] in Urine |
| 12471-9 | Amino beta guanidinopropionate [Mass/volume] in Urine |
| 12472-7 | Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine |
| 12475-0 | Delta aminolevulinate [Mass/time] in Urine |
| 12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
| 12477-6 | Dextromethamphetamine [Mass/volume] in Urine |
| 12478-4 | Levomethamphetamine [Mass/volume] in Urine |
| 12479-2 | Androsterone [Mass/time] in Urine |
| 12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
| 12481-8 | Arsenic.inorganic [Mass/volume] in Urine |
| 12482-6 | Ascorbate [Mass/volume] in Leukocytes |
| 12483-4 | Tungsten [Presence] in Serum or Plasma |
| 12484-2 | Phenobarbital [Presence] in Gastric fluid |
| 12485-9 | Amobarbital [Presence] in Gastric fluid |
| 12486-7 | Butabarbital [Presence] in Gastric fluid |
| 12487-5 | Butalbital [Presence] in Gastric fluid |
| 12488-3 | Pentobarbital [Presence] in Gastric fluid |
| 12489-1 | Secobarbital [Presence] in Gastric fluid |
| 1249-2 | M1 Ag [Presence] on Red Blood Cells |
| 12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
| 12491-7 | Methohexital [Presence] in Serum or Plasma |
| 12492-5 | Thiamylal [Presence] in Serum or Plasma |
| 12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma |
| 12494-1 | Amobarbital [Presence] in Stool |
| 12495-8 | Barbital [Presence] in Stool |
| 12496-6 | Butabarbital [Presence] in Stool |
| 12497-4 | Butalbital [Presence] in Stool |
| 12498-2 | Metharbital [Presence] in Stool |
| 12499-0 | Pentobarbital [Presence] in Stool |
| 12500-5 | Secobarbital [Presence] in Stool |
| 12501-3 | Phenobarbital [Presence] in Stool |
| 12502-1 | Allobarbital [Presence] in Stool |
| 12505-4 | Cadmium [Mass/volume] in Red Blood Cells |
| 12511-2 | Calcium [Mass/volume] in 4 hour Urine |
| 12513-8 | Bicarbonate [Moles/volume] in Water |
| 12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
| 12530-2 | Chloride [Moles/volume] in Water |
| 12532-8 | Meclizine [Presence] in Serum or Plasma |
| 12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
| 12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
| 12535-1 | Amyl nitrite [Presence] in Blood |
| 12536-9 | Butyl nitrate [Presence] in Blood |
| 12537-7 | Phenylglyoxylate [Mass/volume] in Urine |
| 12538-5 | Nitrate [Mass/volume] in Blood |
| 12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
| 12542-7 | N-methylacetamide [Mass/volume] in Urine |
| 12543-5 | Methyl formamide [Mass/volume] in Urine |
| 12544-3 | Nefazodone [Mass/volume] in Serum or Plasma |
| 12545-0 | Zomepirac [Mass/volume] in Serum or Plasma |
| 12546-8 | Quinethazone [Presence] in Serum or Plasma |
| 12547-6 | Phorate [Mass/volume] in Serum or Plasma |
| 12548-4 | Tybamate [Mass/volume] in Serum or Plasma |
| 12549-2 | Turpentine [Mass/volume] in Serum or Plasma |
| 12550-0 | Papaverine [Mass/volume] in Serum or Plasma |
| 12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma |
| 12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma |
| 12553-4 | Stimulants [Identifier] in Urine |
| 12554-2 | Narcotics and opioids [Identifier] in Urine |
| 12555-9 | Turpentine [Mass/volume] in Urine |
| 12556-7 | Copper [Mass/volume] in Blood |
| 12584-9 | Creatinine [Mass/volume] in Vitreous fluid |
| 12585-6 | Creatinine [Mass/time] in 2 hour Urine |
| 12586-4 | Creatinine [Mass/time] in 4 hour Urine |
| 12587-2 | Creatinine [Mass/time] in 6 hour Urine |
| 12588-0 | Creatinine [Mass/time] in 8 hour Urine |
| 12589-8 | Creatinine [Mass/time] in 12 hour Urine |
| 12595-5 | Estradiol (E2) [Mass/volume] in Urine |
| 12598-9 | Fat.neutral [Presence] in Stool |
| 12601-1 | Fluoride [Mass/volume] in Dialysis fluid |
| 12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine |
| 12603-7 | N-desalkylflurazepam [Presence] in Stool |
| 12604-5 | Hydroxyethylflurazepam [Presence] in Stool |
| 12605-2 | Flurazepam [Presence] in Stool |
| 1261-7 | N Ag [Presence] on Red Blood Cells |
| 12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
| 12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
| 12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid |
| 12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
| 12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
| 12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
| 1267-4 | N NOS Ag [Presence] on Red Blood Cells |
| 12702-7 | Antimony [Presence] in Serum or Plasma |
| 12703-5 | Gallium [Mass/volume] in Serum or Plasma |
| 12705-0 | Strontium [Mass/volume] in Urine |
| 12706-8 | Tellurium [Mass/volume] in Serum or Plasma |
| 12707-6 | Thorium [Mass/volume] in Serum or Plasma |
| 12708-4 | Tin [Mass/volume] in Urine |
| 12709-2 | Norastemizole [Mass/volume] in Serum or Plasma |
| 12714-2 | N-methylhistamine [Mass/volume] in Urine |
| 12715-9 | Homovanillate [Mass/time] in Urine |
| 12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine |
| 12721-7 | Melatonin [Units/volume] in Serum or Plasma |
| 12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
| 12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
| 12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
| 12725-8 | IgA.secretory [Units/volume] in Serum or Plasma |
| 12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma |
| 12727-4 | Prednisolone [Mass/volume] in Serum or Plasma |
| 12728-2 | Alpha subunit [Units/volume] in Serum or Plasma |
| 12729-0 | Interferon gamma [Units/volume] in Serum or Plasma |
| 12730-8 | Interferon beta [Units/volume] in Serum or Plasma |
| 12731-6 | Interferon alpha [Units/volume] in Serum or Plasma |
| 12732-4 | Interleukin 12 [Units/volume] in Serum or Plasma |
| 12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma |
| 12734-0 | Cytokeratin Ab [Units/volume] in Serum |
| 12735-7 | Collagen Ab [Units/volume] in Urine |
| 12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma |
| 12737-3 | Endothelin [Units/volume] in Serum or Plasma |
| 12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
| 12770-4 | Lead [Mass/mass] in Tissue |
| 12774-6 | Mercury [Mass/volume] in Red Blood Cells |
| 12775-3 | Mercury [Mass/volume] in Dentin |
| 12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
| 12777-9 | Immunoglobulin light chains.kappa.free [Units/volume] in Urine |
| 12778-7 | Immunoglobulin light chains.lambda.free [Units/volume] in Urine |
| 12779-5 | Nickel [Mass/time] in Urine |
| 12780-3 | Nickel [Mass/volume] in Red Blood Cells |
| 12784-5 | Codeine Free [Mass/volume] in Serum or Plasma |
| 12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
| 12786-0 | Hydrocodone Free [Mass/volume] in Serum or Plasma |
| 12787-8 | Hydromorphone Free [Mass/volume] in Serum or Plasma |
| 12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
| 12789-4 | Oxycodone Free [Mass/volume] in Serum or Plasma |
| 12799-3 | Parathyrin Ab [Units/volume] in Serum |
| 12801-7 | Methdilazine [Mass/volume] in Serum or Plasma |
| 12802-5 | Propiomazine [Mass/volume] in Serum or Plasma |
| 12803-3 | Phenylalanine [Presence] in Blood by Guthrie test |
| 12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid |
| 12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
| 12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
| 12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
| 12814-0 | Potassium [Moles/volume] in Vitreous fluid |
| 12820-7 | Progesterone [Mass/volume] in 24 hour Urine |
| 12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine |
| 12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine |
| 12838-9 | Prostaglandin D2 [Mass/volume] in Urine |
| 12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma |
| 12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine |
| 12842-1 | Protein [Mass/volume] in 12 hour Urine |
| 12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid |
| 1285-6 | P NOS Ag [Presence] on Red Blood Cells |
| 12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot (IB) |
| 12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot (IB) |
| 12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum |
| 12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 12898-3 | Chloride [Moles/volume] in Vitreous fluid |
| 12899-1 | Acetylene [Mass/volume] in Serum or Plasma |
| 12907-2 | Sodium [Moles/volume] in Red Blood Cells |
| 12908-0 | Sodium [Moles/volume] in Vitreous fluid |
| 1291-4 | P1 Ag [Presence] on Red Blood Cells |
| 12912-2 | Lipids [Mass/volume] in Body fluid |
| 12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
| 12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
| 12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
| 12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
| 12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
| 12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood |
| 12920-5 | Sulfate [Mass/volume] in 24 hour Urine |
| 12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
| 12960-1 | Alpha 1 antitrypsin fecal clearance |
| 12961-9 | Urea nitrogen [Mass/volume] in Arterial blood |
| 12962-7 | Urea nitrogen [Mass/volume] in Venous blood |
| 12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood |
| 12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine |
| 1297-1 | P2 Ag [Presence] on Red Blood Cells |
| 12983-3 | Volatiles and gases [Identifier] in Urine |
| 12987-4 | Acetonitrile [Mass/volume] in Urine |
| 12988-2 | Acrylamide [Mass/volume] in Blood |
| 12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma |
| 12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
| 12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
| 12992-4 | Isobutane [Mass/volume] in Blood |
| 12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood |
| 12994-0 | Oxychlordane [Mass/volume] in Blood |
| 12995-7 | Cyclohexanone [Mass/volume] in Blood |
| 12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood |
| 12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma |
| 12998-1 | Methylene chloride [Mass/volume] in Blood |
| 12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma |
| 13000-5 | Mandelate [Mass/volume] in Urine |
| 13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine |
| 13002-1 | Mesityl oxide [Mass/volume] in Blood |
| 13003-9 | Halogenated organic molecules [Identifier] in Blood |
| 13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood |
| 13007-0 | Ethane [Mass/volume] in Blood |
| 13008-8 | Methyl propyl ketone [Mass/volume] in Blood |
| 13009-6 | Methyl ethyl ketone [Mass/volume] in Urine |
| 13010-4 | Methyl amyl ketone [Mass/volume] in Blood |
| 13011-2 | Methyl ethyl ketone [Mass/volume] in Blood |
| 13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood |
| 13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood |
| 13014-6 | Methyl butyl ketone [Mass/volume] in Blood |
| 13015-3 | Diisobutylketone [Mass/volume] in Blood |
| 13016-1 | Nitrophenol [Units/volume] in Blood |
| 13018-7 | Pesticides [Identifier] in Urine |
| 13019-5 | Pesticides [Identifier] in Serum or Plasma |
| 13020-3 | Pesticides [Identifier] in Blood |
| 13021-1 | Pesticides [Identifier] in Gastric fluid |
| 13022-9 | Propane [Mass/volume] in Blood |
| 13023-7 | Trichlorofluoromethane [Mass/volume] in Blood |
| 13024-5 | Trichlorofluoroethane [Mass/volume] in Blood |
| 13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood |
| 13026-0 | Orthocresol [Mass/volume] in Urine |
| 13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma |
| 13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting |
| 13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
| 13051-8 | Deprecated Protein S [Units/volume] in Platelet poor plasma |
| 13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma |
| 13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine |
| 13055-9 | Heparin [Units/volume] in Platelet poor plasma |
| 13056-7 | Platelets [#/volume] in Plasma by Automated count |
| 13061-7 | Platelet IgM Ab [Units/volume] in Serum |
| 13062-5 | Platelet IgA Ab [Units/volume] in Serum |
| 13063-3 | Drug induced platelet Ab [Units/volume] in Serum |
| 13064-1 | Platelet associated IgA Ab [Units/volume] in Blood |
| 13065-8 | Deprecated Platelet Ab [Units/volume] in Serum |
| 13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
| 13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum |
| 13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum |
| 13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum |
| 13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum |
| 13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum |
| 13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum |
| 13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum |
| 13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
| 13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
| 13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
| 13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
| 13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
| 13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
| 13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum |
| 13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum |
| 13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum |
| 13085-6 | Complement C4 Nephritic [Mass/volume] in Serum or Plasma |
| 13086-4 | Complement C3 Nephritic [Mass/volume] in Serum or Plasma |
| 13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
| 13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
| 13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum |
| 13092-2 | Endomysium Ab [Units/volume] in Serum |
| 13096-3 | Deprecated Myelin associated glycoprotein Ab.IgM in serum |
| 13097-1 | Deprecated PM-SCL extractable nuclear Ab |
| 13098-9 | Deprecated Sulfatide Ab.IgG |
| 13099-7 | Deprecated Sulfatide Ab.IgM in serum |
| 131-3 | Cefsulodin [Mass/volume] in Serum or Plasma |
| 13100-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in serum |
| 13101-1 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in CSF |
| 13110-2 | Deprecated Beta tubulin Ab.IgM |
| 13111-0 | Deprecated Nuclear Ab by Immunofluorescence |
| 13112-8 | Deprecated Nuclear Ab Immunofluorescence (rat kidney substrate) |
| 13114-4 | Deprecated Neuronal nuclear type 2 Ab |
| 13115-1 | Deprecated Neuronal nuclear type 1 Ab |
| 13116-9 | Deprecated Reticulin Ab.IgG |
| 13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
| 13118-5 | Deprecated Myelin associated glycoprotein Ab |
| 13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot (IB) |
| 1312-8 | D NOS Ag [Presence] on Red Blood Cells |
| 13120-1 | Ovary Ab [Units/volume] in Serum |
| 13121-9 | Deprecated Ribosomal P protein Ab |
| 13123-5 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum |
| 13126-8 | Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB) |
| 13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
| 13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
| 13130-0 | Motilin [Units/volume] in Serum or Plasma |
| 1314-4 | Rh immune globulin screen [interpretation] |
| 13164-9 | Human antimouse Ab [Units/volume] in Serum |
| 13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
| 13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
| 13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum |
| 13175-5 | Liver cytosol Ab [Presence] in Serum |
| 13176-3 | Wasp venom IgE Ab [Units/volume] in Serum |
| 13177-1 | Russian olive IgE Ab [Units/volume] in Serum |
| 13178-9 | Wasp venom IgG Ab [Units/volume] in Serum |
| 13179-7 | English Walnut IgG Ab [Units/volume] in Serum |
| 13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum |
| 13181-3 | Bahia grass IgG Ab [Units/volume] in Serum |
| 13182-1 | Mesquite IgG Ab [Units/volume] in Serum |
| 13183-9 | White Elm IgG Ab [Units/volume] in Serum |
| 13184-7 | Cottonwood IgG Ab [Units/volume] in Serum |
| 13185-4 | Nettle IgG Ab [Units/volume] in Serum |
| 13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum |
| 13187-0 | False ragweed IgG Ab [Units/volume] in Serum |
| 13188-8 | Mugwort IgG Ab [Units/volume] in Serum |
| 13189-6 | English Plantain IgG Ab [Units/volume] in Serum |
| 13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
| 13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
| 13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
| 13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum |
| 13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum |
| 13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum |
| 13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum |
| 13198-7 | Thermoactinomyces Ab [Units/volume] in Serum |
| 13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum |
| 1320-1 | S Ag [Presence] on Red Blood Cells |
| 13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum |
| 13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
| 13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot (IB) |
| 13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot (IB) |
| 13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum |
| 13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum |
| 13210-0 | Brucella sp IgG Ab [Units/volume] in Serum |
| 13211-8 | Brucella sp IgA Ab [Units/volume] in Serum |
| 13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma |
| 13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum |
| 13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum |
| 13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
| 13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
| 13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
| 13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum --1st specimen |
| 13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
| 13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
| 13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
| 13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
| 13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
| 13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
| 13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
| 13238-1 | Epstein Barr virus Ab [Units/volume] in Serum |
| 13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum |
| 13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum |
| 13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum |
| 13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum |
| 13244-9 | Filaria IgG Ab [Units/volume] in Serum |
| 13245-6 | Filaria IgM Ab [Units/volume] in Serum |
| 13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum |
| 13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
| 13248-0 | Hepatitis D virus Ab [Presence] in Serum |
| 13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
| 13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13253-0 | Legionella non-pneumophila Ab [Presence] in Serum |
| 13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum |
| 13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum |
| 13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum |
| 13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum |
| 13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum |
| 13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum |
| 13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum |
| 13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum |
| 13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum |
| 13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum |
| 13264-7 | Leptospira sp IgG Ab [Titer] in Serum |
| 13265-4 | Leptospira sp IgM Ab [Titer] in Serum |
| 13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
| 13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
| 13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
| 13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum |
| 13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum |
| 13273-8 | Sporothrix schenckii Ab [Presence] in Serum |
| 13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
| 13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum |
| 13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum |
| 13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum |
| 13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum |
| 13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
| 1328-4 | U Ag [Presence] on Red Blood Cells |
| 13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
| 13284-5 | Salmonella typhi H D Ab [Presence] in Serum |
| 13285-2 | Salmonella typhi O D Ab [Presence] in Serum |
| 13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
| 13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
| 13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
| 13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum |
| 13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
| 13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
| 13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum |
| 13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum |
| 13294-4 | Hepatitis E virus Ab [Presence] in Serum |
| 13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
| 13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum |
| 13308-2 | Deprecated DNA |
| 13309-0 | Duffy group Ag [Type] on Red Blood Cells |
| 13310-8 | Kell group Ag [Type] on Red Blood Cells |
| 13311-6 | MNS group Ag [Type] on Red Blood Cells |
| 13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma |
| 13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma |
| 13314-0 | Bacteria identified in Semen |
| 13315-7 | Bacteria identified in 24 hour Urine by Culture |
| 13316-5 | Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture |
| 13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
| 13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
| 13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen |
| 13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen |
| 13321-5 | Human papilloma virus IgG Ab [Presence] in Serum |
| 13322-3 | Human papilloma virus IgM Ab [Presence] in Serum |
| 13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
| 13325-6 | Bartonella sp identified in Blood by Light microscopy |
| 13326-4 | Pneumocystis sp identified in Unspecified specimen by Light microscopy |
| 13327-2 | Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
| 13329-8 | Escherichia coli labile toxin [Presence] in Unspecified specimen |
| 1334-2 | V Ag [Presence] on Red Blood Cells |
| 13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum |
| 13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma |
| 13349-6 | Leukocytes [#/volume] in Stool by Manual count |
| 13356-1 | Fat [Presence] in Body fluid |
| 13364-5 | Amino beta guanidinopropionate [Mass/volume] in Plasma |
| 13365-2 | Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
| 13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
| 13382-7 | Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
| 13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid |
| 13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid |
| 1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells |
| 13441-1 | Creatinine renal clearance in 4 hour |
| 13442-9 | Creatinine renal clearance in 6 hour |
| 13443-7 | Creatinine renal clearance in 8 hour |
| 13451-0 | Creatinine dialysis fluid clearance |
| 13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF |
| 13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
| 13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine |
| 13464-3 | Chromium/Creatinine [Mass Ratio] in Urine |
| 13465-0 | Mercury/Creatinine [Mass Ratio] in Urine |
| 13466-8 | Lead/Creatinine [Mass Ratio] in Urine |
| 13467-6 | Selenium/Creatinine [Mass Ratio] in Urine |
| 13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine |
| 13469-2 | Thallium/Creatinine [Mass Ratio] in Urine |
| 1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells |
| 13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine |
| 13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine |
| 13472-6 | Nickel/Creatinine [Mass Ratio] in Urine |
| 13473-4 | Zinc/Creatinine [Mass Ratio] in Urine |
| 13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine |
| 13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine |
| 13476-7 | Silver/Creatinine [Mass Ratio] in Urine |
| 13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine |
| 13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
| 13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
| 13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine |
| 13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine |
| 13484-1 | Creatine/Creatinine [Mass Ratio] in Urine |
| 13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
| 13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine |
| 13487-4 | Phenol/Creatinine [Mass Ratio] in Urine |
| 13489-0 | Follitropin/Creatinine [Mass Ratio] in Urine |
| 13490-8 | Lutropin/Creatinine [Mass Ratio] in Urine |
| 13506-1 | Urea nitrogen renal clearance |
| 13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
| 13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain |
| 13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
| 13511-1 | Cyanide ascorbate screen [Presence] in Blood |
| 13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
| 13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
| 1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells |
| 13533-5 | Acid hemolysis [Presence] of Blood |
| 13534-3 | Sucrose hemolysis [Presence] of Blood |
| 13536-8 | Globulin [Mass/volume] in Plasma |
| 13538-4 | Carbon dioxide, total [Moles/volume] in Urine |
| 13539-2 | Phosphate [Moles/volume] in Urine |
| 13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
| 13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid |
| 13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma |
| 13545-9 | Alprazolam [Presence] in Serum or Plasma |
| 13546-7 | Amikacin [Mass/volume] in Body fluid |
| 13547-5 | Butriptyline [Presence] in Serum or Plasma |
| 13548-3 | Chlorpromazine [Presence] in Serum or Plasma |
| 13549-1 | Clomipramine [Presence] in Serum or Plasma |
| 13550-9 | Clonazepam [Presence] in Serum or Plasma |
| 13551-7 | Clorazepate [Presence] in Serum or Plasma |
| 13552-5 | Clozapine [Presence] in Serum or Plasma |
| 13553-3 | Cocaethylene [Presence] in Serum or Plasma |
| 13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma |
| 13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma |
| 13556-6 | Demoxepam [Presence] in Serum or Plasma |
| 13557-4 | Norsertraline [Presence] in Serum or Plasma |
| 13558-2 | Disopyramide [Presence] in Serum or Plasma |
| 13559-0 | Flecainide [Presence] in Serum or Plasma |
| 13560-8 | Fluvoxamine [Presence] in Serum or Plasma |
| 13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid |
| 13562-4 | Gentamicin [Mass/volume] in Body fluid |
| 13563-2 | Glutethimide [Presence] in Serum or Plasma |
| 13564-0 | Ibuprofen [Presence] in Serum or Plasma |
| 13565-7 | Lorazepam [Presence] in Serum or Plasma |
| 13566-5 | Mesoridazine [Presence] in Serum or Plasma |
| 13567-3 | Mexiletine [Presence] in Serum or Plasma |
| 13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma |
| 13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma |
| 13570-7 | Norclomipramine [Presence] in Serum or Plasma |
| 13571-5 | Norclozapine [Presence] in Serum or Plasma |
| 13572-3 | Nordiazepam [Presence] in Serum or Plasma |
| 13573-1 | Nordoxepin [Presence] in Serum or Plasma |
| 13574-9 | Norfluoxetine [Presence] in Serum or Plasma |
| 13575-6 | Normaprotiline [Presence] in Serum or Plasma |
| 13576-4 | Oxycodone [Presence] in Serum or Plasma |
| 13577-2 | Paroxetine [Presence] in Serum or Plasma |
| 13578-0 | Promazine [Presence] in Serum or Plasma |
| 13579-8 | Sertraline [Presence] in Serum or Plasma |
| 13580-6 | Temazepam [Presence] in Serum or Plasma |
| 13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid |
| 13582-2 | Theophylline [Mass/volume] in Body fluid |
| 13583-0 | Thioridazine [Presence] in Serum or Plasma |
| 13584-8 | Tobramycin [Mass/volume] in Body fluid |
| 13585-5 | Trifluoperazine [Presence] in Serum or Plasma |
| 13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid |
| 13587-1 | Vancomycin [Mass/volume] in Body fluid |
| 13588-9 | Venlafaxine [Presence] in Serum or Plasma |
| 13589-7 | Activated protein C resistance [Presence] in Blood by Probe and target amplification method |
| 13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
| 13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
| 13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
| 13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
| 13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
| 13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma |
| 13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
| 13622-6 | Acetaminophen [Mass/volume] in Urine |
| 13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma |
| 13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma |
| 13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma |
| 13626-7 | Mitotane [Mass/volume] in Serum or Plasma |
| 13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma |
| 13630-9 | Deprecated Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
| 13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
| 13632-5 | Insulin receptor Ab [Titer] in Serum |
| 13633-3 | Insulin receptor Ab [Presence] in Serum |
| 13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid |
| 13635-8 | Ribosomal Ab [Titer] in Serum |
| 13636-6 | Ribosomal P Ab [Units/volume] in Serum |
| 13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma |
| 13638-2 | Chlordecone [Mass/volume] in Blood |
| 13639-0 | Chlordecone [Mass/volume] in Serum or Plasma |
| 13640-8 | Vinyl chloride [Mass/volume] in Urine |
| 13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method |
| 13643-2 | Lindane [Mass/volume] in Urine |
| 13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood |
| 13646-5 | Methaqualone [Mass/mass] in Hair |
| 13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method |
| 13649-9 | Nickel [Mass/volume] in Water |
| 13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood |
| 13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood |
| 13652-3 | Zinc [Mass/mass] in Hair |
| 13655-6 | Leukocytes [Presence] in Stool by Light microscopy |
| 13658-0 | Urobilinogen [Presence] in Urine |
| 13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
| 13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
| 13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
| 13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
| 13676-2 | 2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
| 13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
| 13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
| 13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
| 13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine |
| 13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine |
| 13703-4 | Adipate/Creatinine [Mass Ratio] in Urine |
| 13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine |
| 1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma |
| 13712-5 | Azelate/Creatinine [Mass Ratio] in Urine |
| 13713-3 | Benzoate/Creatinine [Mass Ratio] in Urine |
| 13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
| 13716-6 | C peptide/Creatinine [Mass Ratio] in Urine |
| 13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13718-2 | Carnitine free (C0)/Creatinine [Mass Ratio] in Urine |
| 13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
| 13722-4 | Citrate/Creatinine [Mass Ratio] in Urine |
| 13725-7 | Cystine/Creatinine [Mass Ratio] in Urine |
| 13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
| 13729-9 | Deoxypyridinoline/Creatinine [Mass Ratio] in Urine |
| 13730-7 | Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
| 13731-5 | Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
| 13733-1 | Dopamine/Creatinine [Mass Ratio] in Urine |
| 13734-9 | Epinephrine/Creatinine [Mass Ratio] in Urine |
| 13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
| 13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
| 13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
| 13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine |
| 13742-2 | Formate/Creatinine [Mass Ratio] in Urine |
| 13743-0 | Fumarate/Creatinine [Mass Ratio] in Urine |
| 13744-8 | Galactose/Creatinine [Mass Ratio] in Urine |
| 13745-5 | Glutaconate/Creatinine [Mass Ratio] in Urine |
| 13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine |
| 13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine |
| 13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine |
| 13752-1 | Glyoxylate/Creatinine [Mass Ratio] in Urine |
| 13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
| 13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine |
| 13755-4 | Histamine/Creatinine [Mass Ratio] in Urine |
| 13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
| 13758-8 | Homocysteine/Creatinine [Mass Ratio] in Urine |
| 13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine |
| 13764-6 | Isocitrate/Creatinine [Mass Ratio] in Urine |
| 13767-9 | Lactate/Creatinine [Mass Ratio] in Urine |
| 13770-3 | Malate/Creatinine [Mass Ratio] in Urine |
| 13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine |
| 13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine |
| 13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine |
| 13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine |
| 13778-6 | Mevalonate/Creatinine [Mass Ratio] in Urine |
| 13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
| 13780-2 | N-acetyltyrosine/Creatinine [Mass Ratio] in Urine |
| 13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine |
| 13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine |
| 13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine |
| 13787-7 | Orotate/Creatinine [Mass Ratio] in Urine |
| 13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine |
| 13791-9 | Phenylacetate/Creatinine [Mass Ratio] in Urine |
| 13792-7 | Phenyllactate/Creatinine [Mass Ratio] in Urine |
| 13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
| 13794-3 | Phenylpyruvate/Creatinine [Mass Ratio] in Urine |
| 13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine |
| 13798-4 | Potassium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13800-8 | Propionylglycine/Creatinine [Mass Ratio] in Urine |
| 13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine |
| 13802-4 | Pyridinoline/Creatinine [Mass Ratio] in Urine |
| 13803-2 | Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
| 13804-0 | Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
| 13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine |
| 13809-9 | Sodium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13810-7 | Suberate/Creatinine [Mass Ratio] in Urine |
| 13812-3 | Succinate/Creatinine [Mass Ratio] in Urine |
| 13816-4 | Tiglylglycine/Creatinine [Mass Ratio] in Urine |
| 13819-8 | Uracil/Creatinine [Mass Ratio] in Urine |
| 13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine |
| 13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
| 13823-0 | Antimony/Creatinine [Mass Ratio] in Urine |
| 13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
| 13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
| 13826-3 | Barium/Creatinine [Mass Ratio] in Urine |
| 13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine |
| 13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
| 13829-7 | Copper/Creatinine [Mass Ratio] in Urine |
| 13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
| 13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine |
| 13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
| 13833-9 | Finch feather IgE Ab [Units/volume] in Serum |
| 13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
| 13840-4 | CD19 blasts/100 blasts in Blood |
| 13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine |
| 13876-8 | Beta-2 transferrin [Presence] in Body fluid |
| 13877-6 | Bilirubin.total [Presence] in Amniotic fluid |
| 13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum |
| 13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum |
| 13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum |
| 13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
| 13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
| 13891-7 | Motilin [Mass/volume] in Serum or Plasma |
| 13892-5 | Nitrosonaphthol [Presence] in Urine |
| 13894-1 | Pregnenolone [Mass/time] in 24 hour Urine |
| 13895-8 | Sodium [Moles/volume] in Milk |
| 13896-6 | Insulin-like growth factor-I [Units/volume] in Blood |
| 13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
| 13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma |
| 13900-6 | Deprecated Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
| 13902-2 | Urate [Mass/volume] in Cerebral spinal fluid |
| 13903-0 | Vasopressin [Mass/volume] in Urine |
| 13904-8 | Meclizine [Mass/volume] in Serum or Plasma |
| 13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma |
| 13907-1 | Norethindrone [Mass/volume] in Serum or Plasma |
| 13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma |
| 13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma |
| 13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence |
| 13914-7 | Adenovirus IgG Ab [Units/volume] in Serum |
| 13915-4 | Adenovirus IgM Ab [Titer] in Serum |
| 13916-2 | Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
| 13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
| 13921-2 | Mumps virus [Presence] in Unspecified specimen by Organism specific culture |
| 13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
| 13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
| 13924-6 | Calcitonin Ab [Presence] in Serum |
| 13925-3 | Cytokeratin Ab [Presence] in Serum |
| 13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
| 13927-9 | Pancreatic islet cell Ab [Titer] in Serum |
| 13928-7 | Parathyrin Ab [Presence] in Serum |
| 13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
| 13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
| 13931-1 | Striated muscle Ab [Presence] in Serum |
| 13932-9 | Testes IgG Ab [Titer] in Serum |
| 13933-7 | Benzodiazepines [Mass/mass] in Hair |
| 13934-5 | Butanol [Mass/volume] in Blood |
| 13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood |
| 13936-0 | Diethyl ether [Mass/volume] in Blood |
| 13937-8 | Ethyl acetate [Mass/volume] in Blood |
| 13938-6 | Trichloroethane [Mass/volume] in Blood |
| 13940-2 | Dimethylbenzene [Mass/volume] in Blood |
| 13943-6 | Fructose [Presence] in Semen |
| 13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells |
| 13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
| 13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
| 13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum by Immunoassay |
| 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
| 13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
| 13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
| 13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
| 13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
| 13956-8 | Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 13957-6 | Clostridium difficile toxin A [Presence] in Stool by Immunoassay |
| 13958-4 | Arsenic [Presence] in 24 hour Urine |
| 13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
| 13961-8 | Mercury [Presence] in 24 hour Urine |
| 13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
| 13963-4 | Orotate [Moles/volume] in Urine |
| 13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma |
| 13965-9 | Homocysteine [Moles/volume] in Serum or Plasma |
| 13966-7 | Cystine [Moles/time] in 24 hour Urine |
| 13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
| 13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
| 1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma |
| 13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
| 1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
| 13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum |
| 13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum |
| 13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
| 14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
| 14001-2 | IgE [Units/volume] in Cord blood |
| 14002-0 | IgM [Units/volume] in Cord blood |
| 14003-8 | Carbon dioxide [Partial pressure] in Cord blood |
| 14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine |
| 14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine |
| 14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine |
| 14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
| 14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
| 14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
| 14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
| 14011-1 | Deprecated Platelet associated IgA Ab [Units/volume] in Blood |
| 14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
| 14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
| 14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
| 14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
| 14028-5 | Deprecated HTLV I+II rgp46-I Ab [Presence] in Serum by Immunoblot (IB) |
| 14029-3 | Deprecated HTLV I+II rgp46-II Ab [Presence] in Serum by Immunoblot (IB) |
| 14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
| 14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
| 14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
| 14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
| 14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
| 14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum |
| 14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
| 14037-6 | Fox IgE Ab [Units/volume] in Serum |
| 14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum |
| 14040-0 | Carbon dioxide, total [Moles/volume] in Stool |
| 14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
| 14042-6 | Corticosterone [Mass/time] in 24 hour Urine |
| 14043-4 | Cortisol Free [Mass/time] in 12 hour Urine |
| 14044-2 | Cortisone [Mass/time] in 24 hour Urine |
| 14045-9 | D-Lactate [Moles/volume] in Serum or Plasma |
| 14046-7 | D-Lactate [Moles/volume] in Urine |
| 14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma |
| 14048-3 | Elastase.pancreatic [Mass/volume] in Serum |
| 14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma |
| 14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
| 14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma |
| 14052-5 | Formate [Mass/volume] in Urine |
| 14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine |
| 14055-8 | Sodium [Moles/mass] in Stool |
| 14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
| 14057-4 | Carbamazepine free [Mass/volume] in Saliva (oral fluid) |
| 14060-8 | Cyclobenzaprine [Presence] in Urine |
| 14061-6 | Cyclobenzaprine [Mass/volume] in Urine |
| 14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma |
| 14063-2 | Dezocine [Presence] in Urine |
| 14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma |
| 14065-7 | Diflunisal [Mass/volume] in Serum or Plasma |
| 14066-5 | Dihydrocodeine [Presence] in Urine |
| 14067-3 | Dihydrocodeine [Mass/volume] in Blood |
| 14068-1 | Triamterene+Hydrochlorothiazide [Mass/volume] in Serum or Plasma |
| 14069-9 | Estazolam [Mass/volume] in Serum or Plasma |
| 14070-7 | Fluphenazine [Presence] in Urine |
| 14071-5 | Ibuprofen [Presence] in Urine |
| 14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma |
| 14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) |
| 14074-9 | Spironolactone [Mass/volume] in Serum or Plasma |
| 14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma |
| 14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
| 14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
| 14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
| 14081-4 | Coliform bacteria [Presence] in Water |
| 14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot (IB) |
| 14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
| 14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
| 14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
| 14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14088-9 | Deprecated Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14091-3 | Deprecated Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence |
| 14093-9 | Bacteria identified in Water by Culture |
| 14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum |
| 14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum |
| 14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
| 14097-0 | Antimony [Mass/time] in 24 hour Urine |
| 14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
| 14099-6 | Nickel [Mass/volume] in Urine |
| 14100-2 | Strontium [Presence] in Urine |
| 14101-0 | Strychnine [Mass/volume] in Gastric fluid |
| 14102-8 | Strychnine [Mass/volume] in Blood |
| 14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
| 14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
| 14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
| 14118-4 | Lactate [Mass/volume] in Serum or Plasma |
| 14121-8 | Pyruvate [Moles/volume] in Blood |
| 14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid |
| 14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain |
| 14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
| 14128-3 | Rabies virus Ab [Titer] in Serum |
| 14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue |
| 14131-7 | PM-1 Ab [Presence] in Serum |
| 14133-3 | Silver Maple IgE Ab [Units/volume] in Serum |
| 14134-1 | Deprecated Free Hemoglobin [Mass/volume] in Serum |
| 1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine |
| 14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
| 14151-5 | Bicarbonate [Moles/volume] in Cord blood |
| 14152-3 | Bilirubin.direct [Mass/volume] in Body fluid |
| 14153-1 | Carnitine esters/Creatinine [Mass Ratio] in Urine |
| 14154-9 | Cholesterol sulfate [Mass/volume] in Serum |
| 14158-0 | Cortisol [Mass/time] in 24 hour Urine |
| 14159-8 | Cortisone [Mass/volume] in Serum or Plasma |
| 14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma |
| 14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
| 14165-5 | Lactate [Moles/volume] in Body fluid |
| 14166-3 | Methane [Mass/volume] in Blood |
| 14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
| 14168-9 | Palatinase [Enzymatic activity/mass] in Tissue |
| 14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma |
| 14170-5 | Pituitary glucoprotein hormone.alpha subunit [Mass/volume] in Serum |
| 14172-1 | Potassium [Moles/volume] in Synovial fluid |
| 14173-9 | Progesterone Free [Mass/time] in 24 hour Urine |
| 14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
| 14176-2 | Pyrroles [Mass/volume] in Urine |
| 14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
| 14178-8 | Sucrase [Enzymatic activity/mass] in Tissue |
| 14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
| 14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
| 14183-8 | Aprobarbital [Mass/volume] in Urine |
| 14184-6 | Atropine [Presence] in Urine |
| 14185-3 | Methimazole [Mass/volume] in Serum or Plasma |
| 14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma |
| 14187-9 | OKT3 [Mass/volume] in Serum or Plasma |
| 14188-7 | Omeprazole [Mass/volume] in Serum or Plasma |
| 14189-5 | Phenyltoloxamine [Mass/volume] in Urine |
| 14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
| 14191-1 | Prazosin [Mass/volume] in Serum or Plasma |
| 14192-9 | Triazolam [Presence] in Urine |
| 14193-7 | Tripelennamine [Presence] in Urine |
| 14195-2 | Complement C3b Inactive [Mass/volume] in Plasma |
| 14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
| 14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
| 14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
| 14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
| 14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
| 14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
| 14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
| 14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
| 14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
| 14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate |
| 14207-5 | Streptococcal DNAse B [Titer] in Serum |
| 14208-3 | Filaria IgG4 Ab [Units/volume] in Serum |
| 14209-1 | Francisella tularensis IgA Ab [Presence] in Serum |
| 14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
| 14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum |
| 14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum |
| 14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate |
| 14215-8 | HTLV I g46 Ab [Presence] in Serum |
| 14224-0 | HTLV I rgp21 Ab [Presence] in Serum |
| 14225-7 | HTLV II g46 Ab [Presence] in Serum |
| 14226-5 | Nocardia sp identified in Isolate by Organism specific culture |
| 14227-3 | Salmonella typhi H D Ab [Titer] in Serum |
| 14228-1 | Estrogen receptor/100 cells in Tissue by Immune stain |
| 14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain |
| 14230-7 | Progesterone receptor/100 cells in Tissue by Immune stain |
| 14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum |
| 14232-3 | Adrenal Ab [Presence] in Serum |
| 14233-1 | Beta tubulin IgG Ab [Titer] in Serum |
| 14234-9 | Beta tubulin IgM Ab [Titer] in Serum |
| 14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum |
| 14236-4 | Mitochondria Ab [Presence] in Serum |
| 14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum |
| 14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum |
| 14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum |
| 14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
| 14241-4 | Parietal cell Ab [Presence] in Serum |
| 14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum |
| 14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum |
| 14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum |
| 14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum |
| 14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum |
| 14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
| 14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum |
| 14252-1 | Smooth muscle Ab [Presence] in Serum |
| 14253-9 | Somatotropin Ab [Presence] in Serum or Plasma |
| 14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum |
| 14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue |
| 14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
| 14258-8 | 1,4-Dioxane [Mass/volume] in Blood |
| 14259-6 | 1-Pentanol [Mass/volume] in Blood |
| 14260-4 | Bromoform [Mass/volume] in Blood |
| 14261-2 | Codeine [Presence] in Gastric fluid |
| 14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
| 14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
| 14264-6 | Enflurane [Mass/volume] in Blood |
| 14265-3 | Isobutyl acetate [Mass/volume] in Blood |
| 14266-1 | Methoxyflurane [Mass/volume] in Blood |
| 14267-9 | Methylenedioxymethamphetamine [Presence] in Urine |
| 14268-7 | Butyl acetate [Mass/volume] in Blood |
| 14269-5 | Sec-butyl acetate [Mass/volume] in Blood |
| 14270-3 | Tert-butyl acetate [Mass/volume] in Blood |
| 14272-9 | Liver kidney microsomal Ab [Presence] in Serum |
| 14273-7 | Reticulin IgA Ab [Presence] in Serum |
| 14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
| 14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
| 14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
| 14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma |
| 14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma |
| 14285-1 | Carnitine free (C0) [Moles/volume] in Urine |
| 14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma |
| 14287-7 | Carnitine [Moles/volume] in Urine |
| 14288-5 | Carnitine [Moles/volume] in Serum or Plasma |
| 14292-7 | IgE [Moles/volume] in Serum |
| 14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine |
| 14295-0 | Organic acids/Creatinine [Molar ratio] in Urine |
| 14296-8 | Thyroperoxidase Ab [Moles/volume] in Serum or Plasma |
| 14297-6 | Thyrotropin [Moles/volume] in Serum or Plasma |
| 14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
| 14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
| 14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
| 14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
| 14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
| 14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 14314-9 | Benzoylecgonine [Presence] in Urine by Screen method |
| 14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method |
| 14316-4 | Benzodiazepines [Presence] in Urine by Screen method |
| 14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation |
| 14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation |
| 14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
| 14320-6 | Deprecated Bacteria identified in Urine by Culture @1:100 |
| 14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 14325-5 | Bacteria identified in Unspecified specimen by Environmental culture |
| 14333-9 | Lead [Presence] in 24 hour Urine |
| 14334-7 | Lithium [Moles/volume] in Serum or Plasma |
| 14335-4 | Optical density of Amniotic fluid by Spectrophotometry |
| 14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
| 14338-8 | Prealbumin [Mass/volume] in Serum or Plasma |
| 14345-3 | Specific gravity of Amniotic fluid by Refractometry |
| 14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry |
| 14347-9 | Specific gravity of Gastric fluid by Refractometry |
| 14348-7 | Specific gravity of Peritoneal fluid by Refractometry |
| 14349-5 | Specific gravity of Pleural fluid by Refractometry |
| 14350-3 | Specific gravity of Synovial fluid by Refractometry |
| 14351-1 | Specific gravity of Stool by Refractometry |
| 14352-9 | Specific gravity of Water by Refractometry |
| 14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
| 14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
| 14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation |
| 14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
| 14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
| 14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain |
| 14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
| 14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain |
| 14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
| 14362-8 | Microscopic observation [Identifier] in Throat by Gram stain |
| 14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain |
| 14364-4 | Microscopic observation [Identifier] in Eye by Gram stain |
| 14365-1 | Microscopic observation [Identifier] in Ear by Gram stain |
| 14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
| 14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
| 14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
| 14369-3 | Yeast [Presence] in Cervix by Wet preparation |
| 14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation |
| 14371-9 | Yeast [Presence] in Urethra by Wet preparation |
| 14386-7 | Glucose [Mass/volume] in Gastric fluid |
| 14387-5 | Protein [Mass/volume] in Gastric fluid |
| 14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid |
| 14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid |
| 14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid |
| 14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid |
| 14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid |
| 14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid |
| 14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid |
| 14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid |
| 14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid |
| 14399-0 | Creatinine [Mass/volume] in Pleural fluid |
| 14401-4 | Creatinine [Mass/volume] in Synovial fluid |
| 14402-2 | Creatinine [Mass/volume] in Gastric fluid |
| 14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
| 14404-8 | Phosphate [Mass/volume] in Pleural fluid |
| 14405-5 | Phosphate [Mass/volume] in Peritoneal fluid |
| 14406-3 | Phosphate [Mass/volume] in Synovial fluid |
| 14407-1 | Phosphate [Mass/volume] in Gastric fluid |
| 14408-9 | Phosphate [Mass/volume] in Amniotic fluid |
| 14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
| 14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
| 14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
| 14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
| 14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
| 14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
| 14415-4 | Calcium [Moles/volume] in Amniotic fluid |
| 14416-2 | Calcium [Moles/volume] in Pleural fluid |
| 14417-0 | Calcium [Moles/volume] in Peritoneal fluid |
| 14418-8 | Calcium [Moles/volume] in Synovial fluid |
| 14419-6 | Calcium [Moles/volume] in Gastric fluid |
| 14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid |
| 14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid |
| 14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid |
| 14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid |
| 14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid |
| 14425-3 | Globulin [Mass/volume] in Amniotic fluid |
| 14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid |
| 14427-9 | Globulin [Mass/volume] in Pleural fluid |
| 14428-7 | Globulin [Mass/volume] in Peritoneal fluid |
| 14429-5 | Globulin [Mass/volume] in Semen |
| 14430-3 | Globulin [Mass/volume] in Synovial fluid |
| 14431-1 | Globulin [Mass/volume] in Urine |
| 14438-6 | Cholesterol [Mass/volume] in Amniotic fluid |
| 14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid |
| 1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid |
| 14442-8 | Cholesterol [Mass/volume] in Semen |
| 14443-6 | Cholesterol [Mass/volume] in Synovial fluid |
| 14444-4 | Cholesterol [Mass/volume] in Urine |
| 14445-1 | Triglyceride [Mass/volume] in Amniotic fluid |
| 14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid |
| 14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid |
| 14448-5 | Triglyceride [Mass/volume] in Semen |
| 14449-3 | Triglyceride [Mass/volume] in Synovial fluid |
| 14450-1 | Triglyceride [Mass/volume] in Urine |
| 14451-9 | Virus identified in Eye by Culture |
| 14452-7 | Virus identified in Cervix by Culture |
| 14453-5 | Virus identified in Vaginal fluid by Culture |
| 14454-3 | Virus identified in Nose by Culture |
| 14455-0 | Virus identified in Pleural fluid by Culture |
| 14456-8 | Virus identified in Peritoneal fluid by Culture |
| 14457-6 | Virus identified in Urine by Culture |
| 14458-4 | Virus identified in Sputum by Culture |
| 14459-2 | Virus identified in Penis by Culture |
| 14460-0 | Virus identified in Urethra by Culture |
| 14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
| 14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
| 14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
| 14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
| 14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
| 14466-7 | Deprecated Chlamydia trachomatis [Presence] in Penis by Organism specific culture |
| 14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
| 14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
| 14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
| 14470-9 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay |
| 14471-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay |
| 14472-5 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay |
| 14473-3 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunoassay |
| 14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
| 14475-8 | Bacteria identified in Cervix by Aerobe culture |
| 14477-4 | Bacteria identified in Urethra by Aerobe culture |
| 14478-2 | Bacteria identified in Penis by Aerobe culture |
| 14479-0 | Diphtheria identified in Throat by Organism specific culture |
| 14480-8 | Diphtheria identified in Sputum by Organism specific culture |
| 14481-6 | Diphtheria identified in Nose by Organism specific culture |
| 14482-4 | Diphtheria identified in Skin by Organism specific culture |
| 14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture |
| 14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
| 14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
| 14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
| 14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
| 14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence |
| 14489-9 | Virus identified in Blood by Immunofluorescence |
| 14490-7 | Virus identified in Semen by Immunofluorescence |
| 14491-5 | Virus identified in Throat by Immunofluorescence |
| 14492-3 | Virus identified in Eye by Immunofluorescence |
| 14493-1 | Virus identified in Cervix by Immunofluorescence |
| 14494-9 | Virus identified in Vaginal fluid by Immunofluorescence |
| 14495-6 | Virus identified in Urine sediment by Immunofluorescence |
| 14496-4 | Virus identified in Sputum by Immunofluorescence |
| 14497-2 | Virus identified in Penis by Immunofluorescence |
| 14498-0 | Virus identified in Urethra by Immunofluorescence |
| 14499-8 | Human papilloma virus Ag [Presence] in Cervix |
| 14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid |
| 14501-1 | Human papilloma virus Ag [Presence] in Penis |
| 14502-9 | Human papilloma virus Ag [Presence] in Urethra |
| 14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix |
| 14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
| 14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis |
| 14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra |
| 14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
| 14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14509-4 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence |
| 14510-2 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14511-0 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence |
| 14512-8 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunofluorescence |
| 14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
| 14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
| 14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
| 14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
| 14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
| 14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
| 14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
| 14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
| 14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
| 14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence |
| 14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence |
| 14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence |
| 14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence |
| 14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
| 14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
| 14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence |
| 14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
| 14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence |
| 14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence |
| 14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence |
| 14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence |
| 14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence |
| 14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence |
| 14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence |
| 14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence |
| 14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence |
| 14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence |
| 14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence |
| 14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence |
| 14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
| 14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
| 14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
| 14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence |
| 14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
| 14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by Probe and target amplification method |
| 14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by Probe and target amplification method |
| 14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by Probe and target amplification method |
| 14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by Probe and target amplification method |
| 14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by Probe and target amplification method |
| 14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by Probe and target amplification method |
| 14566-4 | Calcitriol [Moles/volume] in Serum or Plasma |
| 14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma |
| 14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
| 14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
| 14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine |
| 14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
| 14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine |
| 14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
| 14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 14580-5 | ABO group [Type] in Blood from newborn |
| 14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma |
| 14582-1 | Acetone [Moles/volume] in Serum or Plasma |
| 14583-9 | Acidity.titratable [Mass/volume] in Gastric fluid |
| 14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
| 14585-4 | Albumin/Creatinine [Molar ratio] in Urine |
| 14586-2 | Aldosterone [Moles/volume] in Serum or Plasma |
| 14587-0 | Aldosterone [Moles/time] in 24 hour Urine |
| 14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma |
| 14591-2 | Alprazolam [Moles/volume] in Serum or Plasma |
| 14592-0 | Aluminum [Moles/volume] in 24 hour Urine |
| 14593-8 | Aluminum [Moles/volume] in Serum or Plasma |
| 14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
| 14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
| 14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine |
| 14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma |
| 14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
| 14599-5 | Ammonium [Presence] in Stone |
| 14600-1 | Amoxapine [Moles/volume] in Serum or Plasma |
| 14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
| 14603-5 | Androstenedione [Moles/volume] in Serum or Plasma |
| 14607-6 | Nuclear Ab [Presence] in Body fluid |
| 14608-4 | Nuclear Ab [Presence] in Pleural fluid |
| 14609-2 | Nuclear Ab [Presence] in Peritoneal fluid |
| 14610-0 | Nuclear Ab [Presence] in Synovial fluid |
| 14612-6 | Nuclear Ab [Titer] in Pericardial fluid |
| 14613-4 | Nuclear Ab [Titer] in Body fluid |
| 14614-2 | Nuclear Ab [Titer] in Pleural fluid |
| 14615-9 | Nuclear Ab [Titer] in Peritoneal fluid |
| 14616-7 | Nuclear Ab [Titer] in Synovial fluid |
| 14622-5 | Ascorbate [Moles/volume] in Serum or Plasma |
| 14623-3 | Barbital [Presence] in Serum or Plasma |
| 14624-1 | Barbiturates [Presence] in Gastric fluid |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
| 14627-4 | Bicarbonate [Moles/volume] in Venous blood |
| 14628-2 | Bile acid [Moles/volume] in Serum |
| 14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma |
| 14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma |
| 14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma |
| 14633-2 | C peptide [Moles/volume] in Serum or Plasma |
| 14634-0 | C reactive protein [Titer] in Serum or Plasma |
| 14635-7 | Calcidiol [Moles/volume] in Serum or Plasma |
| 14636-5 | Calcium [Presence] in Stone |
| 14637-3 | Calcium [Moles/time] in 24 hour Urine |
| 14639-9 | Carbamazepine [Moles/volume] in Serum or Plasma |
| 14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid |
| 14641-5 | Carbonate [Presence] in Stone |
| 14642-3 | Carotene [Moles/volume] in Serum |
| 14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine |
| 14644-9 | Chlorpromazine [Presence] in Gastric fluid |
| 14645-6 | Chlorpromazine [Moles/volume] in Serum or Plasma |
| 14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma |
| 14647-2 | Cholesterol [Moles/volume] in Serum or Plasma |
| 14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma |
| 14649-8 | Cimetidine [Presence] in Gastric fluid |
| 1465-4 | Epinephrine [Mass/volume] in Plasma --supine |
| 14650-6 | Citrate [Moles/time] in 24 hour Urine |
| 14651-4 | Clobazam [Moles/volume] in Serum or Plasma |
| 14652-2 | Clomipramine [Moles/volume] in Serum or Plasma |
| 14653-0 | Clomipramine [Moles/volume] in Urine |
| 14655-5 | Clonazepam [Moles/volume] in Serum or Plasma |
| 14656-3 | Clozapine [Moles/volume] in Serum or Plasma |
| 14657-1 | Clozapine+Norclozapine [Moles/volume] in Serum or Plasma |
| 14658-9 | Cold agglutinin [Titer] in Serum or Plasma |
| 14665-4 | Copper [Moles/volume] in Serum or Plasma |
| 14666-2 | Copper [Moles/time] in 24 hour Urine |
| 14674-6 | Corticotropin [Moles/volume] in Plasma |
| 14675-3 | Cortisol [Moles/volume] in Serum or Plasma |
| 14676-1 | Cortisol Free [Moles/time] in 24 hour Urine |
| 14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
| 14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
| 14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid |
| 14682-9 | Creatinine [Moles/volume] in Serum or Plasma |
| 14683-7 | Creatinine [Moles/volume] in Urine |
| 14684-5 | Creatinine [Moles/time] in 24 hour Urine |
| 14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
| 14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
| 14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine |
| 14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 14691-0 | Desipramine [Moles/volume] in Serum or Plasma |
| 14692-8 | Desipramine [Moles/volume] in Urine |
| 14693-6 | Norclobazam [Moles/volume] in Serum or Plasma |
| 14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma |
| 14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma |
| 14697-7 | Diazepam [Moles/volume] in Serum or Plasma |
| 14698-5 | Digoxin [Moles/volume] in Serum or Plasma |
| 14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid |
| 14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma |
| 14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine |
| 14702-5 | Disopyramide [Moles/volume] in Serum or Plasma |
| 14703-3 | Dopamine [Moles/volume] in Serum or Plasma |
| 14704-1 | Doxepin [Presence] in Gastric fluid |
| 14705-8 | Doxepin [Moles/volume] in Serum or Plasma |
| 14706-6 | Doxepin [Moles/volume] in Urine |
| 14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
| 14708-2 | Endomysium Ab [Titer] in Serum |
| 14710-8 | Ephedrine+Pseudoephedrine [Presence] in Gastric fluid |
| 14711-6 | Epinephrine [Moles/volume] in Plasma |
| 14712-4 | Epinephrine [Moles/time] in 24 hour Urine |
| 14714-0 | Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
| 14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma |
| 14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma |
| 14717-3 | Estriol (E3) [Moles/volume] in Urine |
| 14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine |
| 14719-9 | Ethanol [Moles/volume] in Serum or Plasma |
| 14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma |
| 14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma |
| 14722-3 | Extractable nuclear Ab [Presence] in Serum |
| 14723-1 | Ferritin [Moles/volume] in Serum or Plasma |
| 14726-4 | Fluoride [Moles/volume] in Serum or Plasma |
| 14727-2 | Fluoxetine [Presence] in Gastric fluid |
| 14728-0 | Fluoxetine [Moles/volume] in Serum or Plasma |
| 14729-8 | Flurazepam [Moles/volume] in Serum or Plasma |
| 14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
| 14731-4 | Folate [Moles/volume] in Red Blood Cells |
| 14732-2 | Folate [Moles/volume] in Serum or Plasma |
| 14734-8 | Follitropin [Moles/time] in 24 hour Urine |
| 14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer |
| 14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid |
| 14745-4 | Glucose [Moles/volume] in Body fluid |
| 14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid |
| 14747-0 | Glucose [Moles/volume] in Pleural fluid |
| 14748-8 | Glucose [Moles/volume] in Peritoneal fluid |
| 14749-6 | Glucose [Moles/volume] in Serum or Plasma |
| 14750-4 | Glucose [Moles/volume] in Synovial fluid |
| 14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
| 14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
| 14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal |
| 14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
| 14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
| 14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
| 14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma |
| 14772-8 | Gold [Moles/volume] in Serum or Plasma |
| 14774-4 | Haloperidol [Moles/volume] in Serum or Plasma |
| 14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
| 14776-9 | Heptacarboxylate [Moles/volume] in Plasma |
| 14777-7 | Heptacarboxylate [Moles/volume] in Stool |
| 14778-5 | Heptacarboxylate [Moles/volume] in Urine |
| 14779-3 | Hexacarboxylate [Moles/volume] in Plasma |
| 14780-1 | Hexacarboxylate [Moles/volume] in Stool |
| 14781-9 | Hexacarboxylate [Moles/volume] in Urine |
| 14782-7 | Homovanillate [Moles/volume] in Urine |
| 14783-5 | Homovanillate [Moles/time] in 24 hour Urine |
| 14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine |
| 14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine |
| 14787-6 | Arthropod identified in Unspecified specimen by Permanent mount |
| 14788-4 | Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture |
| 14789-2 | Helminth identified in Unspecified specimen by Macro/micro identification |
| 14790-0 | Helminth identified in Unspecified specimen by Permanent mount |
| 14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid |
| 14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma |
| 14793-4 | Imipramine+Desipramine [Presence] in Urine |
| 14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
| 14796-7 | Insulin [Moles/volume] in Serum or Plasma |
| 14798-3 | Iron [Moles/volume] in Serum or Plasma |
| 14799-1 | Iron [Moles/time] in 24 hour Urine |
| 14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma |
| 14801-5 | Iron saturation [Molar fraction] in Serum or Plasma |
| 14802-3 | Isopropanol [Moles/volume] in Serum or Plasma |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
| 14807-2 | Lead [Moles/volume] in Blood |
| 14808-0 | Lead [Moles/volume] in Urine |
| 14809-8 | Lead [Moles/time] in 24 hour Urine |
| 14812-2 | Lidocaine [Moles/volume] in Serum or Plasma |
| 14817-1 | Lorazepam [Moles/volume] in Serum or Plasma |
| 14825-4 | Maprotiline [Moles/volume] in Serum or Plasma |
| 14826-2 | Meperidine [Presence] in Gastric fluid |
| 14832-0 | Metanephrines [Moles/volume] in Urine |
| 14833-8 | Metanephrines [Moles/time] in 24 hour Urine |
| 14834-6 | Methamphetamine [Presence] in Gastric fluid |
| 14835-3 | Methanol [Moles/volume] in Serum or Plasma |
| 14836-1 | Methotrexate [Moles/volume] in Serum or Plasma |
| 14837-9 | Methsuximide [Moles/volume] in Serum or Plasma |
| 14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
| 14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy |
| 14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
| 14841-1 | Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain |
| 14842-9 | Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain |
| 14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
| 14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
| 14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma |
| 14850-2 | Nitrazepam [Moles/volume] in Urine |
| 14851-0 | Norclozapine [Moles/volume] in Serum or Plasma |
| 14852-8 | Norepinephrine [Moles/volume] in Plasma |
| 14853-6 | Norepinephrine [Moles/volume] in Urine |
| 14854-4 | Norepinephrine [Moles/time] in 24 hour Urine |
| 14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma |
| 14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma |
| 14862-7 | Oxalate [Moles/time] in 24 hour Urine |
| 14863-5 | Oxycodone [Presence] in Gastric fluid |
| 14864-3 | Oxygen [Partial pressure] in Cord blood |
| 14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma |
| 14867-6 | Paroxetine [Moles/volume] in Serum or Plasma |
| 14870-0 | Pentacarboxylate [Moles/volume] in Plasma |
| 14871-8 | Pentacarboxylate [Moles/volume] in Stool |
| 14872-6 | Pentacarboxylate [Moles/volume] in Urine |
| 14873-4 | pH of Cord blood |
| 14874-2 | Phenobarbital [Moles/volume] in Serum or Plasma |
| 14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma |
| 14876-7 | Phenylpropanolamine [Presence] in Gastric fluid |
| 14877-5 | Phenytoin [Moles/volume] in Serum or Plasma |
| 14878-3 | Phosphate [Presence] in Stone |
| 14879-1 | Phosphate [Moles/volume] in Serum or Plasma |
| 14881-7 | Phosphate [Moles/time] in 24 hour Urine |
| 14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine |
| 14885-8 | Pregnanediol [Moles/time] in 24 hour Urine |
| 14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine |
| 14887-4 | Primidone [Moles/volume] in Serum or Plasma |
| 14888-2 | Procainamide [Moles/volume] in Serum or Plasma |
| 14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
| 14890-8 | Progesterone [Moles/volume] in Serum or Plasma |
| 14891-6 | Propranolol [Moles/volume] in Serum or Plasma |
| 14892-4 | Propranolol [Moles/volume] in Urine |
| 14893-2 | Propranolol [Moles/time] in 24 hour Urine |
| 14894-0 | Propylene glycol [Presence] in Serum or Plasma |
| 14898-1 | Protriptyline [Moles/volume] in Serum or Plasma |
| 14899-9 | Quinidine [Moles/volume] in Serum or Plasma |
| 14900-5 | Ranitidine [Presence] in Gastric fluid |
| 14901-3 | Ranitidine [Presence] in Serum or Plasma |
| 14902-1 | Ranitidine [Presence] in Urine |
| 14904-7 | Reagin Ab [Presence] in Unspecified specimen by VDRL |
| 14905-4 | Retinol [Moles/volume] in Serum or Plasma |
| 14906-2 | Rh [Type] in Cord blood |
| 14908-8 | Rh [Type] in Blood from newborn |
| 14909-6 | Salicylates [Moles/volume] in Serum or Plasma |
| 14910-4 | Serotonin [Moles/volume] in Serum |
| 14911-2 | Sertraline [Moles/volume] in Serum or Plasma |
| 14913-8 | Testosterone [Moles/volume] in Serum or Plasma |
| 14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma |
| 14915-3 | Theophylline [Moles/volume] in Serum or Plasma |
| 14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma |
| 14917-9 | Thioridazine [Moles/volume] in Serum or Plasma |
| 14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma |
| 14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
| 14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
| 14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma |
| 14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
| 14923-7 | Toxoplasma gondii Ab [Units/volume] in Unspecified specimen |
| 14925-2 | Trazodone [Moles/volume] in Serum or Plasma |
| 14926-0 | Triazolam [Moles/volume] in Serum or Plasma |
| 14927-8 | Triglyceride [Moles/volume] in Serum or Plasma |
| 14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
| 14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
| 1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
| 14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
| 14931-0 | Trimipramine [Moles/volume] in Serum or Plasma |
| 14932-8 | Urate [Presence] in Stone |
| 14933-6 | Urate [Moles/volume] in Serum or Plasma |
| 14934-4 | Urate [Moles/volume] in Urine |
| 14935-1 | Urate [Moles/time] in 24 hour Urine |
| 14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
| 14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma |
| 14938-5 | Urea nitrogen [Moles/volume] in Urine |
| 14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine |
| 14946-8 | Valproate [Moles/volume] in Serum or Plasma |
| 14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine |
| 14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine |
| 14949-2 | Vasopressin [Moles/volume] in Plasma |
| 14950-0 | Viscosity of Synovial fluid Qualitative |
| 14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
| 14955-9 | Zinc [Moles/volume] in Serum or Plasma |
| 14956-7 | Microalbumin [Mass/time] in 24 hour Urine |
| 14957-5 | Microalbumin [Mass/volume] in Urine |
| 14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
| 14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine |
| 14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
| 14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 14973-2 | Mycobacterium sp DNA [Presence] in Sputum by Probe and target amplification method |
| 14974-0 | Mycobacterium sp DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 14975-7 | Human antimouse Ab [Mass/volume] in Serum |
| 14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
| 14977-3 | Immunoglobulin light chains.free [Type] in Urine |
| 14978-1 | Cyclosporine [Mass/volume] in Blood by Immunoassay |
| 14979-9 | aPTT in Platelet poor plasma by Coagulation assay |
| 1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
| 14994-8 | O group [Presence] on Red Blood Cells |
| 14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
| 15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
| 15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine |
| 15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
| 15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
| 15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
| 15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
| 1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
| 15010-2 | Aldosterone [Moles/volume] in Urine |
| 15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine |
| 15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright |
| 15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
| 15026-8 | Androstanediol [Moles/volume] in Serum or Plasma |
| 15027-6 | Androstenedione [Moles/volume] in Urine |
| 15028-4 | Androstenedione [Moles/time] in 24 hour Urine |
| 15029-2 | Androsterone [Moles/volume] in Serum or Plasma |
| 1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
| 15030-0 | Androsterone [Moles/time] in 24 hour Urine |
| 15031-8 | Angiotensin I [Moles/volume] in Plasma |
| 15032-6 | Angiotensin II [Moles/volume] in Plasma |
| 15033-4 | Ascorbate [Moles/time] in 24 hour Urine |
| 15034-2 | Bromide [Moles/volume] in Serum or Plasma |
| 15035-9 | Calcitonin [Moles/volume] in Serum or Plasma |
| 15036-7 | Catecholamines [Moles/time] in 24 hour Urine |
| 15037-5 | Chymotrypsin [Moles/mass] in Stool |
| 15038-3 | Citrate [Moles/volume] in Serum or Plasma |
| 1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
| 15042-5 | Corticotropin [Units/volume] in Serum |
| 15043-3 | Cortisol [Moles/volume] in Urine |
| 15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma |
| 15045-8 | Creatine [Moles/volume] in Serum or Plasma |
| 15046-6 | Creatine [Moles/volume] in Urine |
| 15047-4 | Creatine [Moles/time] in 24 hour Urine |
| 1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
| 15050-8 | Creatinine [Moles/volume] in Amniotic fluid |
| 15051-6 | Creatinine [Moles/volume] in Dialysis fluid |
| 15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
| 15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
| 15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
| 15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine |
| 15057-3 | Androstanolone [Moles/volume] in Serum or Plasma |
| 15058-1 | Dopamine [Moles/volume] in Urine |
| 15059-9 | Dopamine [Moles/time] in 24 hour Urine |
| 1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
| 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
| 15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
| 15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
| 15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
| 15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
| 15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine |
| 15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
| 15067-2 | Follitropin [Units/volume] in Serum or Plasma |
| 15068-0 | Follitropin [Units] in 24 hour Urine |
| 15069-8 | Fructosamine [Moles/volume] in Serum or Plasma |
| 1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
| 15070-6 | Fructose [Moles/time] in 24 hour Urine |
| 15071-4 | Galactose [Moles/time] in 24 hour Urine |
| 15072-2 | Gastrin [Moles/volume] in Serum or Plasma |
| 15073-0 | Glucagon [Moles/volume] in Serum or Plasma |
| 15074-8 | Glucose [Moles/volume] in Blood |
| 15075-5 | Glucose [Moles/volume] in Dialysis fluid |
| 15076-3 | Glucose [Moles/volume] in Urine |
| 15077-1 | Glucose [Moles/time] in 24 hour Urine |
| 15078-9 | Lactate [Moles/time] in 24 hour Urine |
| 15079-7 | Lutropin [Units/volume] in Urine |
| 15080-5 | Lutropin [Units] in 24 hour Urine |
| 15081-3 | Prolactin [Units/volume] in Serum or Plasma |
| 15082-1 | Methemoglobin [Mass/volume] in Blood |
| 15083-9 | Normetanephrine [Moles/time] in 24 hour Urine |
| 15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma |
| 15085-4 | Oxalate [Moles/volume] in Serum or Plasma |
| 15086-2 | Oxalate [Moles/volume] in Urine |
| 15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma |
| 15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
| 15089-6 | Phospholipid [Moles/volume] in Serum or Plasma |
| 1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
| 15091-2 | Pregnanediol [Moles/volume] in Urine |
| 15092-0 | Pregnanetriol [Moles/volume] in Urine |
| 15094-6 | Testosterone [Moles/volume] in Urine |
| 15095-3 | Testosterone [Moles/time] in 24 hour Urine |
| 15097-9 | Vanillylmandelate [Moles/volume] in Urine |
| 15098-7 | Amikacin [Moles/volume] in Serum or Plasma --random |
| 15099-5 | Amiodarone [Moles/volume] in Serum or Plasma |
| 1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
| 15100-1 | Barbiturates [Moles/volume] in Serum or Plasma |
| 15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma |
| 15102-7 | Codeine [Moles/volume] in Serum or Plasma |
| 15103-5 | Cyclosporine [Moles/volume] in Serum |
| 15104-3 | Digitoxin [Moles/volume] in Serum or Plasma |
| 15105-0 | Flecainide [Moles/volume] in Serum or Plasma |
| 15106-8 | Gentamicin [Moles/volume] in Serum or Plasma --random |
| 15107-6 | Imipramine [Moles/volume] in Serum or Plasma |
| 15108-4 | Methadone [Moles/volume] in Serum or Plasma |
| 15109-2 | Midazolam [Moles/volume] in Serum or Plasma |
| 15110-0 | Morphine [Moles/volume] in Serum or Plasma |
| 15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
| 15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes |
| 15113-4 | Aluminum [Moles/volume] in Dialysis fluid |
| 15114-2 | Arsenic [Moles/volume] in Blood |
| 15115-9 | Arsenic [Moles/volume] in Urine |
| 15117-5 | Cadmium [Moles/volume] in Blood |
| 15118-3 | Chromium [Moles/volume] in Blood |
| 15119-1 | Cobalt [Moles/volume] in Blood |
| 15120-9 | Ethanol [Moles/volume] in Blood |
| 15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma |
| 15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma |
| 15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
| 15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
| 15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
| 15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
| 15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma |
| 15138-1 | Isoleucine+Leucine [Presence] in Urine |
| 15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
| 1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
| 15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
| 15142-3 | Alanine+Ethanolamine [Presence] in Urine |
| 15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
| 15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine |
| 15145-6 | Methionine+Tryptophan [Presence] in Urine |
| 15146-4 | Acetone [Units/volume] in Body fluid |
| 15147-2 | Deprecated Acetone [Units] in 24 hour Urine Qualitative |
| 15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
| 15149-8 | Ammonia [Moles/volume] in Body fluid |
| 15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
| 15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
| 15155-5 | Calcium [Mass/volume] in Body fluid |
| 15158-9 | Chloride [Moles/volume] in Stool |
| 1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
| 15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
| 15162-1 | Complement C1q [Mass/volume] in Body fluid |
| 15163-9 | Complement C2 [Mass/volume] in Body fluid |
| 15164-7 | Complement C3 [Mass/volume] in Synovial fluid |
| 15165-4 | Complement C4 [Mass/volume] in Synovial fluid |
| 15166-2 | Complement C5 [Mass/volume] in Body fluid |
| 15167-0 | Complement C6 [Mass/volume] in Body fluid |
| 15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
| 15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
| 1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
| 15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
| 15171-2 | Cryoglobulin.IgA [Units/volume] in Serum |
| 15172-0 | Cryoglobulin.IgG [Units/volume] in Serum |
| 15173-8 | Cryoglobulin.IgM [Units/volume] in Serum |
| 15174-6 | Cryocrit of Serum by Spun Westergren |
| 15176-1 | Cryoproteins identified in Serum or Plasma |
| 15177-9 | DNA double strand Ab [Units/volume] in Body fluid |
| 15178-7 | Complement factor B [Mass/volume] in Body fluid |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma |
| 1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
| 15181-1 | IgA [Mass/volume] in Body fluid |
| 15183-7 | IgG [Mass/volume] in Body fluid |
| 15185-2 | IgM [Mass/volume] in Body fluid |
| 15187-8 | Immunoglobulin light chains.lambda [Mass/volume] in 24 hour Urine |
| 15188-6 | Immunoglobulin light chains.kappa [Mass/volume] in 24 hour Urine |
| 15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
| 1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
| 15200-9 | Osmolality of Body fluid |
| 15202-5 | Potassium [Moles/volume] in Stool |
| 15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephlometry |
| 15204-1 | Rheumatoid factor [Titer] in Serum by Nephlometry |
| 15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephlometry |
| 15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephlometry |
| 15207-4 | Sodium [Moles/volume] in Stool |
| 15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
| 1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
| 15210-8 | Thyroglobulin Ab [Presence] in Serum |
| 15212-4 | Lipase [Enzymatic activity/volume] in Body fluid |
| 15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
| 15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
| 15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
| 15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
| 15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
| 15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
| 15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
| 15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
| 15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
| 15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
| 15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
| 1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
| 15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
| 15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
| 15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
| 15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
| 15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
| 15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
| 15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
| 15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
| 15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
| 15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
| 15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
| 15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
| 15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
| 15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
| 15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
| 15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
| 15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
| 15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
| 15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
| 15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
| 15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
| 15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
| 15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
| 15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
| 15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
| 15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
| 15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
| 15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
| 15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
| 15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
| 15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
| 15277-7 | Deprecated Turkey feather IgE Ab [Units/volume] in Serum |
| 15278-5 | Lovage IgE Ab [Units/volume] in Serum |
| 15279-3 | Cardamon IgE Ab [Units/volume] in Serum |
| 15280-1 | Mace IgE Ab [Units/volume] in Serum |
| 15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum |
| 15282-7 | Deprecated Cultivated Rye IgE Ab [Units/volume] in Serum |
| 15283-5 | Silver Birch IgE Ab [Units/volume] in Serum |
| 15284-3 | Grey Alder IgE Ab [Units/volume] in Serum |
| 15285-0 | London Plane IgE Ab [Units/volume] in Serum |
| 15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum |
| 15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum |
| 15341-1 | Black Fly IgE Ab [Units/volume] in Serum |
| 15342-9 | European Hornet IgE Ab [Units/volume] in Serum |
| 15343-7 | Blood group antibody screen [Titer] in Serum or Plasma |
| 15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine |
| 15351-0 | Apolipoprotein E2 [Presence] in Blood |
| 15352-8 | Apolipoprotein E3 [Presence] in Blood |
| 15353-6 | Apolipoprotein E4 [Presence] in Blood |
| 15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain |
| 15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma |
| 15356-9 | Globulin [Mass/time] in 24 hour Urine |
| 15357-7 | Iron [Mass/mass] in Tissue |
| 15358-5 | Macroamylase [Presence] in Serum or Plasma |
| 15360-1 | dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay |
| 15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
| 15363-5 | Busulfan [Mass/volume] in Serum or Plasma |
| 15364-3 | Codeine [Mass/volume] in Meconium |
| 15366-8 | Dextroamphetamine [Mass/volume] in Urine |
| 15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma |
| 15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
| 15370-0 | Morphine [Mass/volume] in Meconium |
| 15372-6 | Nordiazepam [Mass/volume] in Urine |
| 15373-4 | Phenyltoloxamine [Mass/volume] in Blood |
| 15374-2 | Sulfonylurea [Presence] in Serum or Plasma |
| 15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) |
| 15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
| 15378-3 | Fungus identified in Isolate by Culture |
| 15379-1 | Haemophilus influenzae B Ag [Presence] in Urine |
| 15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum |
| 15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum |
| 15382-5 | Leishmania donovani IgG Ab [Titer] in Serum |
| 15383-3 | Leishmania donovani IgM Ab [Titer] in Serum |
| 15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum |
| 15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum |
| 15386-6 | Leishmania tropica IgG Ab [Titer] in Serum |
| 15387-4 | Leishmania tropica IgM Ab [Titer] in Serum |
| 15388-2 | Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
| 15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum |
| 15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum |
| 15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum |
| 15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum |
| 15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum |
| 15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum |
| 15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum |
| 15396-5 | Deprecated Toxoplasma gondii IgG Ab [Units/volume] in Serum |
| 15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum |
| 15398-1 | Neuronal nuclear Ab [Titer] in Serum |
| 15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 15400-5 | Platelet IgG Ab [Presence] in Serum |
| 15401-3 | Drugs identified in Blood by Screen method |
| 15402-1 | Ethanol [Presence] in Meconium |
| 15403-9 | Isopropanol [Presence] in Meconium |
| 15405-4 | Methamphetamine [Mass/volume] in Meconium |
| 15407-0 | Methanol [Presence] in Meconium |
| 15408-8 | Thallium [Mass/mass] in Hair |
| 15409-6 | Thallium [Mass/mass] in Nail |
| 15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
| 15411-2 | Ergosterol [Mass/volume] in Serum or Plasma |
| 15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination |
| 15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
| 15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
| 15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
| 15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
| 15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
| 15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
| 15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
| 15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
| 15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay |
| 15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
| 15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay |
| 15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination |
| 15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay |
| 15459-1 | Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
| 15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
| 15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15462-5 | Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test |
| 15463-3 | Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test |
| 15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
| 15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15467-4 | Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
| 15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15470-8 | Equine influenza virus A2 Ab [Presence] in Serum |
| 15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay |
| 15473-2 | Equine arteritis virus Ab [Titer] in Serum by Neutralization test |
| 15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
| 15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
| 15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
| 15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
| 15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
| 15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
| 15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
| 15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
| 15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
| 15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
| 15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
| 15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by DNA probe |
| 15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
| 15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
| 15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
| 15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
| 15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by DNA probe |
| 15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay |
| 15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
| 15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
| 15495-5 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunoassay |
| 15496-3 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunofluorescence |
| 15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
| 15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
| 15499-7 | Pseudorabies virus Ab [Titer] in Serum by Neutralization test |
| 1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
| 15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
| 15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
| 15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
| 15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination |
| 15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination |
| 15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
| 15507-7 | Provider-unspecified ED Progress note |
| 1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
| 1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting |
| 1556-0 | Fasting glucose [Mass/volume] in Capillary blood |
| 1557-8 | Fasting glucose [Mass/volume] in Venous blood |
| 1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma |
| 1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
| 1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
| 16101-8 | Cumin IgE Ab [Units/volume] in Serum |
| 16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum |
| 16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum |
| 16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum |
| 16105-9 | Pheasant IgE Ab [Units/volume] in Serum |
| 16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
| 16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
| 16114-1 | Amitriptyline [Mass/volume] in Urine |
| 16115-8 | Doxepin [Mass/mass] in Tissue |
| 16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine |
| 16117-4 | Babesia microti IgG Ab [Titer] in Serum |
| 16118-2 | Babesia microti IgM Ab [Titer] in Serum |
| 16119-0 | Brucella abortus IgG Ab [Titer] in Serum |
| 16120-8 | Brucella abortus IgM Ab [Titer] in Serum |
| 16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum |
| 16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum |
| 16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
| 16124-0 | Cryptococcus sp Ab [Titer] in Serum |
| 16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum |
| 16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum |
| 16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum |
| 16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum |
| 16130-7 | Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16131-5 | Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
| 16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture |
| 16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
| 16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
| 16137-2 | Centromere Ab [Presence] in Serum |
| 16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
| 16140-6 | Tellurium [Mass/volume] in Blood |
| 16141-4 | Nitrogen [Mass/time] in 24 hour Stool |
| 16142-2 | Fat [Mass/time] in 24 hour Stool |
| 16144-8 | Droperidol [Presence] in Serum or Plasma |
| 16145-5 | Mescaline [Mass/volume] in Serum or Plasma |
| 16146-3 | Psilocin [Mass/volume] in Serum or Plasma |
| 16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
| 16151-3 | Dechlorane [Presence] in Serum or Plasma |
| 16171-1 | Cocaethylene [Mass/mass] in Hair |
| 16172-9 | Magnesium [Mass/mass] in Hair |
| 16173-7 | Amyl ether [Mass/volume] in Blood |
| 16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
| 16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
| 16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16178-6 | Beryllium [Mass/mass] in Tissue |
| 16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
| 16180-2 | Zinc [Mass/mass] in Tissue |
| 16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
| 16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
| 16183-6 | Phenolphthalein [Mass/volume] in Stool |
| 16184-4 | Temazepam [Mass/volume] in Stool |
| 16185-1 | Chlordiazepoxide [Mass/volume] in Stool |
| 16186-9 | Hydroxyalprazolam [Mass/volume] in Stool |
| 16187-7 | Alprazolam [Mass/volume] in Stool |
| 16190-1 | Amobarbital [Presence] in Urine by Confirmatory method |
| 16191-9 | Butabarbital [Presence] in Urine by Confirmatory method |
| 16192-7 | Phenobarbital [Presence] in Urine by Confirmatory method |
| 16193-5 | Pentobarbital [Presence] in Urine by Confirmatory method |
| 16194-3 | Secobarbital [Presence] in Urine by Confirmatory method |
| 16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method |
| 16196-8 | Morphine [Presence] in Urine by Confirmatory method |
| 16197-6 | Codeine [Presence] in Urine by Confirmatory method |
| 16198-4 | Diamorphine [Presence] in Urine by Confirmatory method |
| 16199-2 | Methadone [Presence] in Urine by Confirmatory method |
| 16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method |
| 16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method |
| 16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method |
| 16203-2 | Alprazolam [Presence] in Urine by Confirmatory method |
| 16204-0 | Clonazepam [Presence] in Urine by Confirmatory method |
| 16205-7 | Lorazepam [Presence] in Urine by Confirmatory method |
| 16206-5 | Temazepam [Presence] in Urine by Confirmatory method |
| 16207-3 | Meperidine [Presence] in Urine by Confirmatory method |
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method |
| 16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method |
| 16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method |
| 16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method |
| 16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method |
| 16213-1 | Levorphanol [Presence] in Urine by Confirmatory method |
| 16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| 16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16216-4 | Methylephedrine [Presence] in Urine by Confirmatory method |
| 16217-2 | Methyprylon [Presence] in Urine by Confirmatory method |
| 16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method |
| 16219-8 | Pentazocine [Presence] in Urine by Confirmatory method |
| 16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method |
| 16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method |
| 16222-2 | Phentermine [Presence] in Urine by Confirmatory method |
| 16223-0 | Thiopental [Presence] in Urine by Confirmatory method |
| 16224-8 | Triazolam [Presence] in Urine by Confirmatory method |
| 16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method |
| 16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
| 16227-1 | Diazepam [Mass/volume] in Urine by Confirmatory method |
| 16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
| 16229-7 | Clonazepam [Mass/volume] in Urine by Confirmatory method |
| 16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method |
| 16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method |
| 16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method |
| 16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method |
| 16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method |
| 16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method |
| 16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method |
| 16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method |
| 16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method |
| 16240-4 | Pentobarbital [Mass/volume] in Urine by Confirmatory method |
| 16241-2 | Phenobarbital [Mass/volume] in Urine by Confirmatory method |
| 16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method |
| 16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method |
| 16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method |
| 16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method |
| 16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16249-5 | Oxycodone [Mass/volume] in Urine by Confirmatory method |
| 16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method |
| 16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method |
| 16252-9 | Hydrocodone [Mass/volume] in Urine by Confirmatory method |
| 16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method |
| 16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method |
| 16255-2 | Troponin I.cardiac [Units/volume] in Serum or Plasma |
| 16273-5 | Calcium [Mass/mass] in Red Blood Cells |
| 16275-0 | Bartonella sp DNA [Presence] in Blood by Probe and target amplification method |
| 16276-8 | Bartonella henselae DNA [Presence] in Blood by Probe and target amplification method |
| 16277-6 | Bartonella quintana DNA [Presence] in Blood by Probe and target amplification method |
| 16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by Probe and target amplification method |
| 16279-2 | Toxoplasma gondii DNA [Presence] in Blood by Probe and target amplification method |
| 16280-0 | Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification |
| 16281-8 | Trazodone [Units/volume] in Urine |
| 16282-6 | Acetaminophen [Units/volume] in Urine |
| 16283-4 | Escherichia coli verotoxin [Presence] in Unspecified specimen |
| 16284-2 | Polio virus Ab [Units/volume] in Serum |
| 16287-5 | Deprecated Sulfatide Ab |
| 16291-7 | Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture |
| 16292-5 | 1,4-Dioxane [Mass/volume] in Urine |
| 16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma |
| 16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
| 16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine |
| 16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine |
| 16305-5 | 2-Methoxyethanol [Mass/volume] in Blood |
| 16307-1 | Acetate [Mass/volume] in Dialysis fluid |
| 16308-9 | Acetazolamide [Units/volume] in Serum or Plasma |
| 16309-7 | Acetazolamide [Units/volume] in Urine |
| 16310-5 | Acetone [Presence] in Body fluid |
| 16311-3 | Acetone [Mass/volume] in Body fluid |
| 16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma |
| 16313-9 | Acetylene [Mass/volume] in Blood |
| 16314-7 | Acetylsalicylate [Presence] in Urine |
| 16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
| 16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
| 16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid |
| 16318-8 | Acrylamide [Mass/volume] in Urine |
| 16319-6 | Acrylamide [Mass/volume] in Serum or Plasma |
| 16322-0 | Biperiden [Mass/volume] in Serum or Plasma |
| 16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 16327-9 | Allyl alcohol [Mass/volume] in Blood |
| 16328-7 | Benzyl alcohol [Presence] in Blood |
| 16333-7 | Aldrin [Mass/volume] in Blood |
| 16334-5 | Alfentanil [Mass/volume] in Urine |
| 16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood |
| 16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine |
| 16346-9 | Alpha chlordane [Mass/volume] in Urine |
| 16347-7 | Alpha chlordane [Mass/volume] in Blood |
| 16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 16349-3 | Aluminum [Mass/volume] in Body fluid |
| 16351-9 | Amiloride [Units/volume] in Serum or Plasma |
| 16352-7 | Amiloride [Units/volume] in Urine |
| 16353-5 | Amino beta guanidinopropionate [Presence] in Urine |
| 16355-0 | Amino beta guanidinopropionate [Presence] in Plasma |
| 16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak |
| 16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough |
| 16362-6 | Ammonia [Moles/volume] in Plasma |
| 16363-4 | Ammonia [Moles/mass] in Tissue |
| 16364-2 | Amobarbital [Mass/volume] in Gastric fluid |
| 16365-9 | Amoxicillin+Clavulanate [Mass/volume] in Serum or Plasma |
| 16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma |
| 16367-5 | Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative |
| 16369-1 | Amphetamines [Presence] in Urine by Confirmatory method |
| 16370-9 | Amphotericin B [Mass/volume] in Urine |
| 16373-3 | Amyl ether [Presence] in Blood |
| 16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma |
| 16388-1 | Anticonvulsants [Identifier] in Urine |
| 16389-9 | Antidepressants [Identifier] in Serum or Plasma |
| 16390-7 | Antidiuretics [Identifier] in Urine |
| 16391-5 | Antimony [Presence] in Urine |
| 16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate |
| 16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate |
| 16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
| 16395-6 | Antipsychotics [Identifier] in Urine |
| 16402-0 | Aromatic solvents [Identifier] in Blood |
| 16403-8 | Arsenic [Presence] in Serum or Plasma |
| 16404-6 | Arsenic [Presence] in Urine |
| 16405-3 | Arylamidase [Presence] in Urine |
| 16406-1 | Arylamidase [Enzymatic activity/volume] in Urine |
| 16407-9 | Asbestos identified in Sputum by Light microscopy |
| 16408-7 | Ascorbate [Mass/volume] in Urine |
| 16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
| 16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum |
| 16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
| 16416-0 | Aspergillus terreus Ab [Units/volume] in Serum |
| 16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum |
| 16418-6 | Azatadine [Presence] in Urine |
| 16419-4 | Azathioprine [Mass/volume] in Serum or Plasma |
| 16420-2 | Azithromycin [Mass/volume] in Serum or Plasma |
| 16422-8 | Azlocillin [Mass/volume] in Urine |
| 16423-6 | Aztreonam [Mass/volume] in Urine |
| 16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 16426-9 | Babesia sp IgM Ab [Titer] in Serum |
| 16427-7 | Babesia microti Ab [Titer] in Serum |
| 16428-5 | Bacitracin [Mass/volume] in Serum or Plasma |
| 16429-3 | Barbiturates [Presence] in Urine by Confirmatory method |
| 16430-1 | Barbiturates [Units/volume] in Urine |
| 16431-9 | Barium [Presence] in Urine |
| 16432-7 | Barium [Mass/volume] in Blood |
| 16433-5 | Basement membrane Ab [Presence] in Serum |
| 16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
| 16435-0 | Deprecated White Bean IgE Ab [Units/volume] in Serum |
| 16436-8 | Deprecated Bean string IgE Ab [Units/volume] in Serum |
| 16437-6 | Bendroflumethiazide [Units/volume] in Urine |
| 16438-4 | Benzaldehyde [Presence] in Urine |
| 16439-2 | Benzene [Presence] in Blood |
| 1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
| 16440-0 | Benzene ring IgE Ab [Units/volume] in Serum |
| 16441-8 | Benzene ring IgG Ab [Units/volume] in Serum |
| 16442-6 | Benzene ring IgM Ab [Units/volume] in Serum |
| 16443-4 | Benzonatate [Mass/volume] in Serum |
| 16444-2 | Benzophenone [Mass/volume] in Serum or Plasma |
| 16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
| 16447-5 | Cocaine [Units/volume] in Serum or Plasma |
| 16448-3 | Cocaine [Units/volume] in Urine |
| 16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma |
| 16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma |
| 16451-7 | Beryllium [Presence] in Urine |
| 16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood |
| 16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
| 16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine |
| 16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
| 16458-2 | Bethanechol [Mass/volume] in Serum or Plasma |
| 16459-0 | Bicarbonate [Moles/volume] in Body fluid |
| 16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid |
| 16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells |
| 16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid |
| 16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum |
| 16464-0 | Bile acid [Units/volume] in Exhaled gas |
| 16465-7 | Bile acid [Mass/volume] in Urine |
| 16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum |
| 16467-3 | Bismuth [Presence] in Blood |
| 16468-1 | Bismuth [Presence] in Urine |
| 16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine |
| 16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
| 16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum |
| 16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by DNA probe |
| 16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum |
| 16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
| 16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
| 16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid |
| 16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
| 16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
| 16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoassay |
| 16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
| 16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
| 16483-0 | Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture |
| 16484-8 | Boysenberry IgE Ab [Units/volume] in Serum |
| 16485-5 | Bromodiphenhydramine [Mass/volume] in Urine |
| 16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
| 16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
| 16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
| 16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
| 1649-3 | Calcitriol [Mass/volume] in Serum or Plasma |
| 16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
| 16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence |
| 16492-1 | Bufotenine [Units/volume] in Urine |
| 16493-9 | Bufotenine [Units/volume] in Serum or Plasma |
| 16494-7 | Bumetanide [Units/volume] in Urine |
| 16495-4 | Buprenorphine [Units/volume] in Serum or Plasma |
| 16496-2 | Buprenorphine [Units/volume] in Urine |
| 16497-0 | Butabarbital [Mass/volume] in Gastric fluid |
| 16498-8 | Butalbital [Units/volume] in Gastric fluid |
| 16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method |
| 1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
| 16503-5 | C reactive protein [Mass/volume] in Body fluid |
| 16518-3 | Calcium [Mass/time] in 2 hour Urine |
| 16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by DNA probe |
| 16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by DNA probe |
| 16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by DNA probe |
| 16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by DNA probe |
| 16532-4 | Campylobacter lari rRNA [Presence] in Serum by DNA probe |
| 16533-2 | Helicobacter pylori Ab [Titer] in Serum |
| 16534-0 | Campylobacter sp rRNA [Presence] in Serum by DNA probe |
| 16535-7 | Canary droppings IgE Ab [Units/volume] in Serum |
| 16536-5 | Canary serum proteins Ab [Units/volume] in Serum |
| 16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
| 16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
| 16539-9 | Candida sp Ag [Presence] in Serum |
| 1654-3 | 1-Naphthalene [Mass/volume] in Urine |
| 16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
| 16544-9 | Canrenone [Units/volume] in Urine |
| 16545-6 | Capreomycin [Mass/volume] in Serum or Plasma |
| 16546-4 | Captopril [Mass/volume] in Serum or Plasma |
| 16547-2 | Carbamate pesticides [Type] in Urine |
| 16548-0 | Carbamazepine [Mass/volume] in Urine |
| 16549-8 | Carbinoxamine [Presence] in Urine |
| 16550-6 | Carbohydrates [Identifier] in Urine |
| 16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood |
| 16553-0 | Carnitine [Mass/mass] in Tissue |
| 16555-5 | Carnitine [Mass/volume] in Cerebral spinal fluid |
| 16556-3 | Carnitine [Mass/volume] in Amniotic fluid |
| 1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
| 16562-1 | Cathartic laxatives [Identifier] in Urine |
| 16564-7 | Cefaclor [Mass/volume] in Serum or Plasma |
| 16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma |
| 16566-2 | Cefazolin [Mass/volume] in Urine |
| 16567-0 | Cefixime [Mass/volume] in Serum or Plasma |
| 16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum |
| 16569-6 | Ceftriaxone IgE Ab [Mass/volume] in Serum |
| 1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma |
| 16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence |
| 16571-2 | Cephadrine [Mass/volume] in Serum or Plasma |
| 16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma |
| 1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
| 16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by DNA probe |
| 16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by DNA probe |
| 16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
| 1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine |
| 16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
| 16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16593-6 | Chlamydia sp Ag [Presence] in Urine |
| 16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
| 16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
| 16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by Probe and target amplification method |
| 1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum |
| 16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by DNA probe |
| 16601-7 | Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
| 16602-5 | Deprecated Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
| 16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
| 16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
| 16605-8 | Chlorocycline [Mass/volume] in Urine |
| 16606-6 | Chlorine [Mass/volume] in Dialysis fluid |
| 16608-2 | Chlorpheniramine [Units/volume] in Urine |
| 16609-0 | Chlorphentermine [Units/volume] in Blood |
| 1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum |
| 16610-8 | Chlorphentermine [Units/volume] in Urine |
| 16611-6 | Chlorpyrifos [Mass/volume] in Urine |
| 16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma |
| 16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen |
| 16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum |
| 16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma |
| 1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum |
| 16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak |
| 16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough |
| 16624-9 | Clomipramine [Units/volume] in Milk |
| 16625-6 | Clomipramine [Mass/volume] in Milk |
| 16626-4 | Clostridium tetani Ab [Units/volume] in Serum --1st specimen |
| 16627-2 | Clostridium tetani Ab [Units/volume] in Serum --2nd specimen |
| 16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma |
| 1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum |
| 16631-4 | aPTT in Blood by Coagulation 1:1 saline |
| 16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method |
| 16633-0 | Cocaine [Presence] in Blood |
| 16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
| 16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
| 16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
| 16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum |
| 16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
| 16641-3 | Cockatiel droppings Ab [Units/volume] in Serum |
| 16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum |
| 16643-9 | Cockatoo droppings Ab [Units/volume] in Serum |
| 16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 16645-4 | Colistin [Mass/volume] in Serum or Plasma |
| 16647-0 | Collagen Ab [Units/volume] in Serum |
| 16648-8 | Copper [Mass/volume] in Body fluid |
| 16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
| 1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma |
| 16650-4 | Cilantro IgE Ab [Units/volume] in Serum |
| 16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
| 16653-8 | Corticotropin Canine [Mass/volume] in Plasma |
| 1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine |
| 16667-8 | Cortisol Free [Mass/time] in 48 hour Urine |
| 16668-6 | Cortisol Free [Mass/time] in 72 hour Urine |
| 1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine |
| 16676-9 | Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture |
| 16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum |
| 16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum |
| 16679-3 | Coxsackievirus A Ab [Units/volume] in Serum |
| 1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
| 16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum |
| 16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum |
| 16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
| 16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
| 16684-3 | Coxsackievirus B Ab [Units/volume] in Serum |
| 16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
| 16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
| 16687-6 | Creatine [Mass/volume] in Vitreous fluid |
| 16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid |
| 16689-2 | Creatinine [Mass/time] in 48 hour Urine |
| 16690-0 | Creatinine [Mass/time] in 72 hour Urine |
| 16691-8 | Cresols [Identifier] in Unspecified specimen |
| 16692-6 | Cryptococcus sp Ag [Presence] in Body fluid |
| 16693-4 | Cryptococcus sp Ag [Presence] in Urine |
| 16694-2 | Cumene [Presence] in Blood |
| 16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood |
| 16697-5 | Cyclohexane [Presence] in Blood |
| 16698-3 | Cyclohexanol [Mass/volume] in Blood |
| 16699-1 | Cyclohexanol [Mass/volume] in Urine |
| 1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine |
| 16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine |
| 16701-5 | Cyclopropane [Presence] in Blood |
| 16702-3 | Cycloserine [Mass/volume] in Urine |
| 16703-1 | Cyclosporine [Mass/volume] in Plasma |
| 16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma |
| 16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
| 16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum |
| 16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
| 16709-8 | Cystine [Units/volume] in Urine |
| 1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood |
| 16711-4 | Cystine+Homocystine [Presence] in Urine |
| 16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid |
| 16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
| 16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
| 16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
| 16718-9 | Cytomegalovirus Ag [Presence] in Blood |
| 16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
| 16720-5 | Dechlorane [Presence] in Blood |
| 16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
| 1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine |
| 16731-2 | Deprecated Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma |
| 16736-1 | Dengue virus 1 Ab [Titer] in Serum |
| 16737-9 | Dengue virus 2 Ab [Titer] in Serum |
| 16738-7 | Dengue virus 3 Ab [Titer] in Serum |
| 16739-5 | Dengue virus 4 Ab [Titer] in Serum |
| 1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
| 16740-3 | Dengue virus Ab [Presence] in Serum |
| 16741-1 | American house dust mite IgG Ab [Presence] in Blood |
| 16742-9 | European house dust mite IgG Ab [Presence] in Blood |
| 16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma |
| 16747-8 | Dextromoramide [Presence] in Serum or Plasma |
| 16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
| 16749-4 | Propoxyphene + Norpropoxyphene [Units/volume] in Urine |
| 1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
| 16750-2 | Dezocine [Mass/volume] in Serum or Plasma |
| 16751-0 | Dezocine [Mass/volume] in Blood |
| 16752-8 | Deprecated Diacetate [Presence] in Urine |
| 16754-4 | Diamorphine [Mass/volume] in Unknown substance |
| 16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method |
| 16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma |
| 16758-5 | Dicamba [Mass/volume] in Serum or Plasma |
| 16759-3 | Dicamba [Mass/volume] in Urine |
| 1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum |
| 16762-7 | Dichlorobenzene [Mass/volume] in Blood |
| 16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
| 16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
| 16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
| 16766-8 | Dichloroethane [Presence] in Blood |
| 16767-6 | Deprecated 2,4-Dichlorophenoxyacetate [Mass/volume] in Urine |
| 16768-4 | Dichlorvos [Mass/volume] in Urine |
| 16769-2 | Dicloxacillin [Mass/volume] in Urine |
| 1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 16770-0 | Dicoumarol [Mass/volume] in Urine |
| 16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma |
| 16772-6 | Dieldrin [Mass/volume] in Urine |
| 16773-4 | Dieldrin [Mass/volume] in Blood |
| 16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
| 16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
| 16776-7 | Diltiazem [Mass/volume] in Urine |
| 16777-5 | Dimethylacetamide [Presence] in Urine |
| 16778-3 | Dinitrophenol [Presence] in Serum or Plasma |
| 16779-1 | Dinitrophenol [Mass/volume] in Urine |
| 1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum |
| 16780-9 | Disopyramide [Mass/volume] in Urine |
| 16781-7 | Disulfiram [Presence] in Urine |
| 1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
| 16791-6 | Doxylamine [Mass/volume] in Serum or Plasma |
| 16792-4 | Doxylamine [Mass/volume] in Urine |
| 16793-2 | Drugs identified in Unknown substance by Screen method |
| 16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum |
| 16795-7 | Echovirus Ab [Units/volume] in Serum |
| 16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation |
| 16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
| 16798-1 | Echovirus 14 Ab [Units/volume] in Serum |
| 16799-9 | Deprecated Echovirus 140 Ab by complement fixation |
| 1680-8 | 3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum |
| 16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
| 16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
| 16802-1 | Echovirus 30 Ab [Units/volume] in Serum |
| 16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
| 16804-7 | Echovirus 40 Ab [Units/volume] in Serum |
| 16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
| 16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum |
| 16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
| 16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
| 16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
| 1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
| 16812-0 | Emetine [Presence] in Serum or Plasma |
| 16813-8 | Emetine [Units/volume] in Serum or Plasma |
| 16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence |
| 16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
| 16816-1 | Enoxacin [Mass/volume] in Urine |
| 16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
| 16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
| 16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
| 1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
| 16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
| 16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
| 16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
| 16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
| 16829-4 | Erythromycin [Mass/volume] in Urine |
| 16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture |
| 16833-6 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay |
| 16834-4 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
| 16835-1 | Escherichia coli shiga-like identified in Stool by Organism specific culture |
| 16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture |
| 16838-5 | Estriol (E3) [Mass/volume] in Body fluid |
| 1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
| 16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma |
| 16842-7 | Ethanol [Mass/volume] in Unknown substance |
| 16843-5 | Ethanol [Mass/volume] in Body fluid |
| 16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
| 16845-0 | Ethionamide [Mass/volume] in Serum or Plasma |
| 16847-6 | Ethoheptazine [Presence] in Serum or Plasma |
| 16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma |
| 16849-2 | Ethyl benzene [Mass/volume] in Urine |
| 16850-0 | Ethylene oxide [Mass/volume] in Blood |
| 16851-8 | Ethylmorphine [Units/volume] in Urine |
| 16852-6 | Etodolac [Mass/volume] in Serum or Plasma |
| 16853-4 | Fat [Mass] in Stool |
| 16855-9 | Fat [Mass/time] in 48 hour Stool |
| 16857-5 | Fenclorvos [Presence] in Blood |
| 16858-3 | Fentanyl [Mass/volume] in Body fluid |
| 16859-1 | Fibrinogen [Presence] in Platelet poor plasma |
| 16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunologic method |
| 16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
| 16868-2 | Finch droppings IgE Ab [Presence] in Serum |
| 16870-8 | Fluconazole [Mass/volume] in Urine |
| 16871-6 | Fluoride [Units/volume] in Bone |
| 16872-4 | Fluorocarbons [Identifier] in Serum or Plasma |
| 16874-0 | Formate+Formaldehyde [Mass/volume] in Blood |
| 16875-7 | Francisella tularensis Ab [Titer] in Serum |
| 16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
| 16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
| 16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum |
| 16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
| 1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma |
| 16881-5 | Gallium [Mass/volume] in Blood |
| 16888-0 | Gamma chlordane [Mass/volume] in Urine |
| 1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
| 16898-9 | Giardia lamblia 65 Ag [Presence] in Stool |
| 16899-7 | Giardia lamblia Ag [Presence] in Unspecified specimen |
| 1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
| 16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) |
| 16901-1 | Gliadin IgA Ab [Presence] in Serum |
| 16902-9 | Gliadin IgG Ab [Presence] in Serum |
| 16903-7 | Glucose [Mass/volume] in Vitreous fluid |
| 1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
| 16913-6 | Fasting glucose [Presence] in Urine |
| 16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal |
| 16918-5 | Glutathione [Mass/volume] in Serum or Plasma |
| 1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
| 16920-1 | Glycoproteins [Presence] in Serum or Plasma |
| 16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum |
| 16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum |
| 16923-5 | Guaifenesin [Mass/volume] in Serum or Plasma |
| 16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum |
| 16925-0 | Haemophilus influenzae A Ag [Presence] in Urine |
| 16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
| 16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
| 16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
| 16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
| 1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum |
| 16930-0 | Helminth IgE Ab [Units/volume] in Serum |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum |
| 16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by Probe and target amplification method |
| 16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
| 16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum |
| 16937-5 | Hepatitis G virus RNA [Presence] in Serum by Probe and target amplification method |
| 16939-1 | Heptachlor [Mass/volume] in Urine |
| 1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine |
| 16940-9 | Heptachlorepoxide [Mass/volume] in Urine |
| 16941-7 | Herbicide [Identifier] in Unspecified specimen |
| 16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot (IB) |
| 16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum |
| 16945-8 | Herpes simplex virus Ag [Presence] in Unspecified specimen |
| 16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
| 1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
| 16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
| 16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum |
| 16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot (IB) |
| 16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
| 16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
| 16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
| 16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
| 16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
| 16965-6 | Lindane [Mass/volume] in Blood |
| 16966-4 | Hexachloroethane [Mass/volume] in Blood |
| 16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
| 16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
| 16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
| 1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
| 16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
| 16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
| 16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
| 16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid |
| 16975-5 | HIV 1 IgG Ab [Presence] in Serum |
| 16976-3 | HIV 1 Ag [Units/volume] in Serum |
| 16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid |
| 1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
| 16980-5 | HTLV II DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16981-3 | HTLV I DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot (IB) |
| 16983-9 | Hydralazine [Presence] in Urine |
| 16984-7 | Hydrastine [Presence] in Urine |
| 1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
| 16998-7 | Hydromorphone [Mass/volume] in Urine by Confirmatory method |
| 16999-5 | Hydroquinone [Mass/volume] in Urine |
| 1700-4 | Acetaldehyde [Mass/volume] in Blood |
| 17001-9 | Hydroxyproline [Presence] in Urine |
| 17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17003-5 | Serotonin [Mass/volume] in Urine |
| 17004-3 | Hypoxanthine [Mass/volume] in Urine |
| 17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
| 17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
| 17007-6 | IgG [Presence] in Serum |
| 17009-2 | IgM [Presence] in Serum |
| 1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma |
| 17010-0 | Imipenem [Mass/volume] in Serum or Plasma |
| 17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
| 17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
| 17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
| 17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum |
| 17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum |
| 1702-0 | Acetoacetate [Mass/volume] in Urine |
| 17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
| 17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
| 17022-5 | Interleukin 1+2 [Units/volume] in Serum or Plasma |
| 17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma |
| 17026-6 | Isocyanate IgE Ab [Units/volume] in Serum |
| 17027-4 | Isocyanate IgG Ab [Units/volume] in Serum |
| 17028-2 | Isocyanate IgM Ab [Units/volume] in Serum |
| 1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid |
| 17030-8 | Isopropyl ether [Presence] in Blood |
| 17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17033-2 | Ketamine [Presence] in Urine by Confirmatory method |
| 17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma |
| 17035-7 | Ketorolac [Mass/volume] in Serum or Plasma |
| 17036-5 | La Crosse virus Ab [Titer] in Serum |
| 17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid |
| 17038-1 | La Crosse virus IgG Ab [Titer] in Serum |
| 17039-9 | La Crosse virus IgM Ab [Titer] in Serum |
| 1704-6 | Acetoacetate [Presence] in Serum or Plasma |
| 17040-7 | Labetalol [Presence] in Serum or Plasma |
| 17041-5 | Lactate dehydrogenase [Presence] in Urine |
| 17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum |
| 17043-1 | Lactose [Mass/volume] in Urine |
| 17044-9 | Lamellar bodies [Presence] in Amniotic fluid |
| 17045-6 | Latex IgE Ab [Units/volume] in Blood |
| 17046-4 | Latex IgG Ab [Units/volume] in Serum |
| 17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum |
| 17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood |
| 17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
| 1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma |
| 17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood |
| 17051-4 | Laxatives [Identifier] in Urine |
| 17052-2 | Lead [Presence] in Blood |
| 17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum |
| 17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum |
| 17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum |
| 17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum |
| 17057-1 | Legionella pneumophila Ag [Presence] in Unspecified specimen |
| 17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
| 17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
| 1706-1 | Acetonitrile [Mass/volume] in Blood |
| 17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum |
| 17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
| 17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum |
| 17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
| 17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum |
| 17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
| 17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum |
| 17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
| 17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum |
| 17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
| 1707-9 | Acetylcholine [Mass/volume] in Serum |
| 17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum |
| 17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum |
| 17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum |
| 17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum |
| 17075-3 | Lidocaine [Mass/volume] in Urine |
| 17076-1 | Lidocaine [Mass/volume] in Body fluid |
| 1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
| 17086-0 | Lithium [Mass/volume] in Body fluid |
| 17087-8 | Loperamide [Mass/volume] in Serum or Plasma |
| 17088-6 | Lorazepam [Mass/volume] in Urine by Confirmatory method |
| 17089-4 | Lorcainide [Mass/volume] in Serum or Plasma |
| 1709-5 | Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
| 17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum |
| 17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
| 1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 17100-9 | CD103 cells/100 cells in Blood |
| 1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood |
| 1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
| 1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
| 1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
| 17148-8 | CD41 cells/100 cells in Blood |
| 1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
| 1716-0 | Acidity.titratable [Mass/volume] in Urine |
| 1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
| 1719-4 | Adenine [Mass/volume] in Serum |
| 1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 1721-0 | Adenosine triphosphate [Mass/volume] in Blood |
| 1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood |
| 17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
| 17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 1723-6 | Adenosine deaminase binding protein [Mass/volume] in Urine |
| 17231-2 | Lysosomal enzymes [Identifier] in Plasma |
| 17232-0 | Lysozyme [Enzymatic activity/volume] in Tear |
| 17235-3 | Magnesium [Moles/volume] in Leukocytes |
| 17236-1 | Magnesium [Moles/volume] in Stool |
| 17237-9 | Magnesium [Moles/mass] in Hair |
| 17238-7 | Malignin Ab [Units/volume] in Serum |
| 1724-4 | Adenosine diphosphate [Mass/volume] in Serum |
| 17244-5 | Manganese [Mass/mass] in Hair |
| 17246-0 | Mefenamate [Mass/volume] in Serum or Plasma |
| 17247-8 | Melanin [Units/volume] in Urine |
| 17248-6 | Melanin [Units/volume] in Serum or Plasma |
| 17249-4 | Menthol [Mass/volume] in Blood |
| 1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
| 17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method |
| 17251-0 | Mepivacaine [Presence] in Serum or Plasma |
| 17252-8 | Mercaptopurine [Presence] in Serum or Plasma |
| 17253-6 | Mercury [Mass/volume] in Milk |
| 17254-4 | Mercury [Mass/volume] in Food |
| 17255-1 | Mercury [Mass/volume] in Dialysis fluid |
| 17256-9 | Mesoridazine [Mass/volume] in Urine |
| 17258-5 | Metandienone [Mass/volume] in Serum or Plasma |
| 17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
| 1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
| 17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17261-9 | Methapyrilene [Mass/volume] in Urine |
| 17263-5 | Methemalbumin [Presence] in Serum or Plasma |
| 17265-0 | Methocarbamol [Units/volume] in Serum or Plasma |
| 17266-8 | Methotrexate [Mass/volume] in Urine |
| 17267-6 | Methoxychlor [Mass/volume] in Urine |
| 17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine |
| 1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
| 17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma |
| 17272-6 | Methylenedianiline [Mass/volume] in Blood |
| 17273-4 | Methylephedrine [Units/volume] in Urine |
| 17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma |
| 17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma |
| 17276-7 | 2-Methylpentane [Mass/volume] in Blood |
| 17277-5 | Metolazone [Mass/volume] in Serum or Plasma |
| 17278-3 | Miconazole [Mass/volume] in Serum or Plasma |
| 17279-1 | Bacteria identified in Pleural fluid by Aerobe culture |
| 1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
| 17280-9 | Microscopic observation [Identifier] in Tissue by Malaria thick smear |
| 17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation |
| 17282-5 | Minoxidil [Mass/volume] in Serum or Plasma |
| 17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma |
| 17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence |
| 17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
| 17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
| 1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
| 17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method |
| 17291-6 | Deprecated Mulberry tree IgE Ab [Units/volume] in Serum |
| 17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
| 17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum |
| 17294-0 | Mushroom toxins [Identifier] in Urine |
| 17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe |
| 17297-3 | Deprecated Mycobacterium tuberculosum rRNA [Presence] in Unspecified specimen by DNA probe |
| 17299-9 | Mycoplasma fermentans Ab [Presence] in Serum |
| 1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
| 17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
| 17301-3 | Mycoplasma hominis Ab [Presence] in Serum |
| 17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum |
| 17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
| 17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
| 17305-4 | Myelin IgA Ab [Presence] in Serum |
| 17306-2 | Myelin IgG Ab [Presence] in Serum |
| 17307-0 | Myelin IgM Ab [Presence] in Serum |
| 17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot (IB) |
| 1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum |
| 17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
| 17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
| 17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
| 17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
| 17315-3 | Myelin basic protein Ab [Mass/volume] in Serum |
| 17316-1 | Myeloperoxidase Ab [Presence] in Serum |
| 17317-9 | N-acetylprocainamide [Mass/volume] in Urine |
| 17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma |
| 17319-5 | Nalidixate [Mass/volume] in Serum or Plasma |
| 1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
| 17320-3 | Nefazodone [Mass/volume] in Urine |
| 17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine |
| 17322-9 | Neisseria meningitidis Ab [Presence] in Serum |
| 17323-7 | Neisseria meningitidis Ag [Presence] in Urine |
| 17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
| 17325-2 | Neisseria meningitidis C+w135 Ag [Presence] in Urine |
| 17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum |
| 17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination |
| 17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 1733-5 | Adipate [Mass/volume] in Urine |
| 17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid |
| 17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
| 17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
| 17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
| 17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine |
| 17335-1 | Neostigmine [Mass/volume] in Serum or Plasma |
| 17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence |
| 17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
| 17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 1734-3 | Aldosterone renal clearance in 24 hour |
| 17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
| 17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum |
| 17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
| 17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
| 17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence |
| 17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
| 17348-4 | Neutrophil IgA Ab [Units/volume] in Serum |
| 17349-2 | Neutrophil IgG Ab [Units/volume] in Serum |
| 17350-0 | Neutrophil IgM Ab [Units/volume] in Serum |
| 17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum |
| 17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
| 17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
| 17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
| 17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
| 17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
| 17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
| 17360-9 | Heptane [Mass/volume] in Blood |
| 17362-5 | Nicotinamide [Presence] in Urine |
| 17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
| 17364-1 | Nitrophenol [Presence] in Urine |
| 17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma |
| 17366-6 | Nizatidine [Mass/volume] in Serum or Plasma |
| 17367-4 | Nomifensine [Mass/volume] in Serum or Plasma |
| 17375-7 | Norflunitrazepam [Mass/volume] in Blood |
| 17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method |
| 17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
| 17378-1 | Novobiocin [Mass/volume] in Serum or Plasma |
| 17379-9 | Propanol [Mass/volume] in Blood |
| 17380-7 | Nuclear Ab.histone reactive [Presence] in Serum |
| 17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method |
| 17385-6 | Organic acids [Units/volume] in Urine |
| 17386-4 | Organic acids [Units/volume] in Blood |
| 17387-2 | Organic acids [Units/volume] in Serum or Plasma |
| 17388-0 | Organochlorine pesticides [Type] in Urine |
| 17390-6 | Orphenadrine [Mass/volume] in Urine |
| 17391-4 | Orthocresol [Mass/volume] in Blood |
| 17392-2 | Osmium [Mass/volume] in Urine |
| 17393-0 | Ovary Ab [Presence] in Serum |
| 17394-8 | Oxychlordane [Mass/volume] in Urine |
| 17395-5 | Oxymorphone [Mass/volume] in Urine by Confirmatory method |
| 17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma |
| 17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma |
| 17398-9 | Human papilloma virus 11 Ag [Presence] in Unspecified specimen |
| 17399-7 | Human papilloma virus 16 Ag [Presence] in Unspecified specimen |
| 1740-0 | Alanine aminopeptidase [Mass/volume] in Serum |
| 17400-3 | Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen |
| 17401-1 | Human papilloma virus 18 Ag [Presence] in Unspecified specimen |
| 17402-9 | Human papilloma virus 31 Ag [Presence] in Unspecified specimen |
| 17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen |
| 17404-5 | Human papilloma virus 33 Ag [Presence] in Unspecified specimen |
| 17405-2 | Human papilloma virus 42 Ag [Presence] in Unspecified specimen |
| 17406-0 | Human papilloma virus 43 Ag [Presence] in Unspecified specimen |
| 17407-8 | Human papilloma virus 44 Ag [Presence] in Unspecified specimen |
| 17408-6 | Human papilloma virus 45 Ag [Presence] in Unspecified specimen |
| 17409-4 | Human papilloma virus 5 Ag [Presence] in Unspecified specimen |
| 1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
| 17410-2 | Human papilloma virus 51 Ag [Presence] in Unspecified specimen |
| 17411-0 | Human papilloma virus 6 Ag [Presence] in Unspecified specimen |
| 17412-8 | Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen |
| 17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum |
| 17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen |
| 17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum |
| 17416-9 | Parakeet droppings Ab [Units/volume] in Serum |
| 17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum |
| 17418-5 | Parakeet serum Ab [Units/volume] in Serum |
| 17419-3 | Parathion [Mass/volume] in Urine |
| 1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 17420-1 | Parrot droppings Ab [Units/volume] in Serum |
| 17421-9 | Parrot serum Ab [Units/volume] in Serum |
| 17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
| 17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum |
| 17427-6 | Penicillium sp Ab [Units/volume] in Serum |
| 17429-2 | Pentachlorophenol [Mass/volume] in Blood |
| 1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
| 17430-0 | Pentane [Mass/volume] in Blood |
| 17431-8 | Pentobarbital [Mass/volume] in Gastric fluid |
| 17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma |
| 17433-4 | pH of Unspecified specimen |
| 17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma |
| 17435-9 | Pheniramine [Mass/volume] in Urine |
| 17436-7 | Phenobarbital [Mass/volume] in Gastric fluid |
| 17437-5 | Phenolphthalein [Mass/volume] in Urine |
| 17438-3 | Phenolphthalein [Mass/volume] in Blood |
| 17439-1 | Phenols [Mass/volume] in Blood |
| 1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by Without P-5'-P |
| 17440-9 | Phenothiazines [Units/volume] in Serum or Plasma |
| 17441-7 | Phenothiazines [Units/volume] in Urine |
| 17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma |
| 17443-3 | Phenylpropanolamine [Mass/volume] in Urine |
| 17444-1 | Phenytoin [Mass/volume] in Urine |
| 17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum |
| 17446-6 | Phoma sp IgE Ab [Units/volume] in Serum |
| 17447-4 | Phosphate [Presence] in Stool |
| 17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum |
| 17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum |
| 1745-9 | Albumin [Mass/volume] in Amniotic fluid |
| 17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum |
| 17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum |
| 17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum |
| 17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum |
| 17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum |
| 17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum |
| 17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum |
| 17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
| 1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid |
| 17462-3 | Picloram [Mass/volume] in Urine |
| 17463-1 | Pigeon droppings Ab [Units/volume] in Serum |
| 17464-9 | Pigeon feather IgE Ab [Presence] in Serum |
| 17465-6 | Pigeon serum IgE Ab [Presence] in Serum |
| 17466-4 | Deprecated Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunologic method |
| 17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
| 17468-0 | Plutonium [Mass/volume] in Urine |
| 17469-8 | PM-1 Ab [Units/volume] in Serum |
| 1747-5 | Albumin [Mass/volume] in Body fluid |
| 17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence |
| 17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
| 17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
| 17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma |
| 17476-3 | Porphyrins [Units/volume] in Red Blood Cells |
| 17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method |
| 1748-3 | Albumin [Mass/volume] in Pleural fluid |
| 17480-5 | Pregnenolone [Mass/volume] in Urine |
| 17481-3 | Probenecid [Units/volume] in Urine |
| 17482-1 | Procainamide [Mass/volume] in Urine |
| 17483-9 | Progesterone [Mass/volume] in Urine |
| 1749-1 | Albumin [Mass/volume] in Peritoneal fluid |
| 17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma |
| 17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine |
| 17495-3 | Prostaglandins [Mass/volume] in Urine |
| 1750-9 | Albumin [Mass/volume] in Semen |
| 17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum |
| 17504-2 | Psilocybin [Presence] in Urine |
| 17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
| 17506-7 | Quinacrine [Mass/volume] in Serum or Plasma |
| 17507-5 | Quinidine [Mass/volume] in Urine |
| 17508-3 | Quinine [Units/volume] in Urine |
| 17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum |
| 1751-7 | Albumin [Mass/volume] in Serum or Plasma |
| 17510-9 | Raisin IgE Ab [Units/volume] in Serum |
| 17511-7 | Red dye IgE Ab [Units/volume] in Serum |
| 17512-5 | Redfish IgE Ab [Units/volume] in Serum |
| 17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine |
| 17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
| 17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum |
| 17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
| 1752-5 | Albumin [Mass/volume] in Synovial fluid |
| 17520-8 | Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture |
| 17521-6 | Reticulin Ab [Presence] in Serum |
| 17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
| 17523-2 | Reticulin IgG Ab [Titer] in Serum |
| 17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
| 17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma |
| 17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma |
| 17527-3 | Retinol Free [Mass/volume] in Serum or Plasma |
| 1753-3 | Albumin [Presence] in Urine |
| 17530-7 | Retrovirus identified in Unspecified specimen by Organism specific culture |
| 17531-5 | Rh [Type] in Amniotic fluid |
| 17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum |
| 17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
| 17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe and target amplification method |
| 17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by DNA probe |
| 17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
| 1754-1 | Albumin [Mass/volume] in Urine |
| 17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
| 17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
| 17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
| 17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
| 17546-3 | Bartonella quintana rRNA [Presence] in Unspecified specimen by DNA probe |
| 17547-1 | Rotavirus Ag [Presence] in Stool |
| 17548-9 | Rotavirus RNA [Presence] in Unspecified specimen by DNA probe |
| 17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
| 17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
| 17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
| 17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid |
| 17554-7 | Measles virus IgA Ab [Units/volume] in Serum |
| 17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen |
| 17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen |
| 17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
| 17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
| 17559-6 | Salicylates [Presence] in Blood |
| 1756-6 | Albumin in CSF/Albumin in Serum or Plasma |
| 17560-4 | Salicylates [Presence] in Gastric fluid |
| 17561-2 | Salmon roe IgE Ab [Units/volume] in Serum |
| 17562-0 | Salmonella sp Ab [Presence] in Serum |
| 17563-8 | Salmonella sp identified in Unspecified specimen by Organism specific culture |
| 17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
| 17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
| 17566-1 | Salmonella typhi O Ab [Presence] in Serum |
| 17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma |
| 17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 1757-4 | Albumin renal clearance in 24 hour |
| 17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17571-1 | Scopolamine [Mass/volume] in Urine |
| 17573-7 | Secobarbital [Mass/volume] in Gastric fluid |
| 17574-5 | Selenium [Mass/volume] in Body fluid |
| 17576-0 | Shigella sp identified in Unspecified specimen by Organism specific culture |
| 1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma |
| 17582-8 | Silver [Mass/volume] in Dialysis fluid |
| 17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
| 17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
| 17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
| 17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
| 17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
| 17593-5 | Smooth muscle Ab [Presence] in Sweat |
| 17598-4 | Specific gravity of Synovial fluid |
| 1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
| 1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
| 17611-5 | Stimulants [Identifier] in Serum or Plasma |
| 1762-4 | Aldosterone [Mass/volume] in Blood |
| 1763-2 | Aldosterone [Mass/volume] in Serum or Plasma |
| 1764-0 | Aldosterone [Mass/volume] in Urine |
| 17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum |
| 17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
| 1765-7 | Aldosterone [Mass/time] in 24 hour Urine |
| 17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
| 17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
| 17652-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination |
| 17656-0 | Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture |
| 17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid |
| 17658-6 | Strontium/Creatinine [Mass Ratio] in Urine |
| 17659-4 | Strychnine [Units/volume] in Serum or Plasma |
| 1766-5 | Aldosterone receptors [#] in Leukocytes |
| 17660-2 | Strychnine [Units/volume] in Urine |
| 17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma |
| 17662-8 | Succinylpurines [Presence] in Urine |
| 17663-6 | Sulfadiazine IgE Ab [Units/volume] in Serum |
| 17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum |
| 17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum |
| 17666-9 | Sulfate [Mass/volume] in Dialysis fluid |
| 17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
| 1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine |
| 17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
| 17672-7 | Sulfide [Mass/volume] in Urine |
| 17673-5 | Sulfisoxazole IgE Ab [Units/volume] in Serum |
| 17674-3 | Sulfonamide [Units/volume] in Serum or Plasma |
| 17675-0 | Sulfonamide [Units/volume] in Urine |
| 17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
| 17677-6 | Deprecated Helianthus annuus Ab.IgE |
| 1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright |
| 17681-8 | Tellurium [Presence] in Urine |
| 17682-6 | Terpineol [Presence] in Blood |
| 17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood |
| 17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid |
| 17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
| 17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
| 1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
| 17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood |
| 17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine |
| 17697-4 | Tetrachloroethane [Mass/volume] in Blood |
| 17698-2 | Tetraethyl lead [Mass/volume] in Blood |
| 17699-0 | Thebaine [Mass/volume] in Serum or Plasma |
| 17700-6 | Theophylline [Mass/volume] in Urine |
| 17701-4 | Thiazides [Mass/volume] in Urine |
| 17703-0 | Thorium [Mass/volume] in Urine |
| 17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum |
| 17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
| 17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
| 17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum |
| 17709-7 | Ticlopidine [Presence] in Urine |
| 17710-5 | Tin/Creatinine [Mass Ratio] in Urine |
| 17712-1 | Toluene diisocyanate [Mass/volume] in Blood |
| 17713-9 | Topiramate [Mass/volume] in Serum or Plasma |
| 17714-7 | Toxaphene [Mass/volume] in Serum or Plasma |
| 17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
| 17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum |
| 17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
| 17718-8 | Tramadol [Presence] in Urine by Confirmatory method |
| 17719-6 | Tramadol [Mass/volume] in Urine |
| 17720-4 | Trans nonachlor [Mass/volume] in Urine |
| 17721-2 | Trans nonachlor [Mass/volume] in Blood |
| 17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization |
| 17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
| 17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
| 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
| 17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
| 17730-3 | Triamterene [Units/volume] in Urine |
| 17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
| 17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum |
| 17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum |
| 17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum |
| 17736-0 | Trichloroacetate [Mass/volume] in Blood |
| 17737-8 | Trichloroethane [Mass/volume] in Urine |
| 17738-6 | Chloral hydrate [Presence] in Urine |
| 17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method |
| 17740-2 | Trichlorophenoxyacetate [Presence] in Blood |
| 17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
| 17742-8 | Trichlorothiazide [Presence] in Urine |
| 17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
| 17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
| 17746-9 | Trimeprazine [Presence] in Serum or Plasma |
| 17747-7 | Trimethoprim [Mass/volume] in Urine |
| 17748-5 | Trimethylamine [Presence] in Urine |
| 17749-3 | Tromethamine [Mass/volume] in Serum or Plasma |
| 1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid |
| 17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
| 17751-9 | Tryptamine [Mass/volume] in Serum or Plasma |
| 17753-5 | Tungsten [Mass/volume] in Serum or Plasma |
| 17755-0 | Urate [Mass/time] in 2 hour Urine |
| 17756-8 | Urate [Mass/time] in 4 hour Urine |
| 17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
| 17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid |
| 17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
| 1776-4 | Alkaline phosphatase [Mass/volume] in Urine |
| 17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
| 17761-8 | Urobilinogen [Mass/time] in 48 hour Stool |
| 17762-6 | Valproate [Mass/volume] in Urine |
| 17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
| 17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
| 17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
| 17767-5 | Verapamil [Mass/volume] in Urine |
| 17768-3 | Vinyl chloride [Mass/volume] in Blood |
| 17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
| 17770-9 | Western equine encephalitis virus Ab [Titer] in Serum |
| 17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum |
| 17772-5 | Dimethylbenzene [Mass/volume] in Urine |
| 17774-1 | Yellow dye IgE Ab [Units/volume] in Serum |
| 17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum |
| 17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum |
| 17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum |
| 17778-2 | Zinc [Mass/volume] in Leukocytes |
| 17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
| 17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum |
| 17784-0 | Parasites in Blood by Light microscopy |
| 17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
| 17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
| 17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
| 17794-9 | Osmolality of Hyperal solution |
| 17795-6 | Potassium [Moles/volume] in Hyperal solution |
| 17796-4 | Sodium [Moles/volume] in Hyperal solution |
| 17797-2 | Thyroid colloidal Ab [Units/volume] in Serum |
| 17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid |
| 17805-3 | Procainamide [Mass/volume] in Body fluid |
| 17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid |
| 17807-9 | Cyclosporine [Mass/volume] in Body fluid |
| 17808-7 | Tobramycin [Mass/volume] in Urine |
| 17809-5 | Hematocrit [Volume Fraction] of Urine |
| 17824-4 | CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid |
| 17829-3 | CD19 cells/100 cells in Body fluid |
| 1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood |
| 17830-1 | Centromere Ab [Units/volume] in Body fluid |
| 17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
| 17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
| 17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood |
| 1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma |
| 17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
| 17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
| 17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
| 17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
| 17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count |
| 1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
| 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum |
| 17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum |
| 17852-5 | Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
| 17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
| 17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
| 17857-4 | Rheumatoid factor [Titer] in Serum |
| 17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
| 17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 17861-6 | Calcium [Mass/volume] in Serum or Plasma |
| 17862-4 | Calcium [Mass/volume] in Urine |
| 17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma |
| 17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
| 17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
| 17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine |
| 17869-9 | Orotate/Creatinine [Molar ratio] in Urine |
| 17870-7 | Orotidine/Creatinine [Molar ratio] in Urine |
| 17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation |
| 17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
| 17898-8 | Bacteria identified in Throat by Aerobe culture |
| 17909-3 | Bacteria identified in Wound deep by Aerobe culture |
| 17915-0 | Bacteria identified in Wound shallow by Aerobe culture |
| 17925-9 | Bacteria identified in Wound deep by Anaerobe culture |
| 17928-3 | Bacteria identified in Blood by Aerobe culture |
| 17934-1 | Bacteria identified in Blood by Anaerobe culture |
| 1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid |
| 1795-4 | Amylase [Enzymatic activity/volume] in Body fluid |
| 17950-7 | Deprecated Bacteria identified in Body fluid by Aerobe culture |
| 17956-4 | Bacteria identified in Body fluid by Anaerobe culture |
| 1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid |
| 17969-7 | Deprecated Bacteria identified in Urine by Aerobe culture |
| 1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid |
| 1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma |
| 1799-6 | Amylase [Enzymatic activity/volume] in Urine |
| 1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine |
| 1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue |
| 1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
| 1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
| 1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
| 1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
| 1817-6 | Alpha ketoglutarate [Mass/volume] in Serum or Plasma |
| 1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
| 18183-4 | Melatonin [Mass/time] in 24 hour Urine |
| 18184-2 | Erythrocyte sedimentation rate by 2H Westergren method |
| 18186-7 | Calcium [Mass/time] in 12 hour Urine |
| 18187-5 | Lorazepam [Presence] in Urine |
| 18188-3 | Acebutolol [Mass/volume] in Unspecified specimen |
| 18189-1 | Acetone [Mass/time] in 24 hour Urine |
| 1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue |
| 18190-9 | Acid phosphatase tartrate resistant [Presence] in Unspecified specimen |
| 18191-7 | Amino acids [Identifier] in 24 hour Urine |
| 18192-5 | Bacteria [Presence] in Nose by Light microscopy |
| 18194-1 | Barium [Mass/time] in 24 hour Urine |
| 18195-8 | Acid beta glucosidase [Presence] in Tissue |
| 18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
| 18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
| 18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum |
| 18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum |
| 1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum |
| 18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot (IB) |
| 18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot (IB) |
| 18204-8 | Caffeine renal clearance in 24 hour |
| 18205-5 | Carbon disulfide [Presence] in Urine |
| 18208-9 | Cocaine [Mass/volume] in Unspecified specimen |
| 18209-7 | Ubiquinone 10 [Units/volume] in Serum or Plasma |
| 1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
| 18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
| 18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
| 18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
| 18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
| 18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine |
| 18215-4 | Delta alanine [Mass/volume] in Urine |
| 18216-2 | Dezocine [Presence] in Urine by Confirmatory method |
| 18217-0 | Epidermis IgA Ab [Presence] in Tissue |
| 18218-8 | Epidermis IgM Ab [Presence] in Tissue |
| 1822-6 | Alpha thymosin [Mass/volume] in Serum |
| 18227-9 | Glucose [Mass/time] in 6 hour Urine |
| 18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
| 18229-5 | Heparan sulfate [Presence] in Serum or Plasma |
| 1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma |
| 18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum |
| 18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
| 18232-9 | Hydrocorticosterone [Presence] in Urine |
| 18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
| 18234-5 | Insulin [Presence] in Unknown substance |
| 18235-2 | Ketone solvents [Identifier] in Blood |
| 18236-0 | Lead [Presence] in Tissue |
| 18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum |
| 18238-6 | Lithium [Mass/mass] in Tissue |
| 18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
| 1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
| 18241-0 | Cefoxitin IgE Ab [Units/volume] in Serum |
| 18242-8 | Methyprylon [Mass/time] in 24 hour Urine |
| 18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
| 18244-4 | Niacin [Mass/volume] in Serum or Plasma |
| 18245-1 | Nickel [Mass/volume] in Unspecified specimen |
| 18246-9 | Nitrogen [Mass/volume] in Stool |
| 18247-7 | Nitrogen [Mass/volume] in Dialysis fluid |
| 18248-5 | Nordiazepam [Mass/volume] in Stool |
| 18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma |
| 1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
| 18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue |
| 18252-7 | Prednisone [Mass/time] in 24 hour Urine |
| 18253-5 | Serotonin [Mass/time] in 24 hour Urine |
| 18254-3 | Silicate [Mass/volume] in Body fluid |
| 18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma |
| 18256-8 | Sulfonylurea [Mass/volume] in Urine |
| 18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum |
| 18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
| 18260-0 | Zinc [Presence] in Tissue |
| 18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
| 18265-9 | Acetaminophen [Presence] in Body fluid |
| 18267-5 | CD16+CD56+ cells/100 cells in Blood |
| 18268-3 | CD16+CD56+ cells/100 cells in Body fluid |
| 18269-1 | Immune complex [Units/volume] in Body fluid |
| 18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
| 18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour |
| 18272-5 | RNA Ab [Units/volume] in Serum |
| 18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
| 18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from donor |
| 18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
| 18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method |
| 18279-0 | Deprecated Hemoglobin F [Presence] in Stool by Apt-Downey method |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method |
| 18286-5 | Donath Landsteiner Ab [Presence] in Blood |
| 18297-2 | Acid hemolysis [Mass/volume] of Red Blood Cells |
| 18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain |
| 18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
| 18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain |
| 18308-7 | Pneumocystis sp identified in Lung tissue by Immunohistochemical |
| 1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
| 18320-2 | Globulin [Mass/volume] in Urine by calculation |
| 18321-0 | Benzidine [Mass/volume] in Serum or Plasma |
| 18322-8 | Norketamine [Mass/volume] in Urine |
| 18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum |
| 18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum |
| 18325-1 | Oxymorphone [Presence] in Urine by Confirmatory method |
| 18326-9 | Microscopic observation [Identifier] in Cervix by Other stain |
| 18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain |
| 18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain |
| 18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
| 1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
| 18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
| 18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
| 18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
| 18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
| 18334-3 | Naltrexone [Presence] in Urine by Confirmatory method |
| 18335-0 | Antihistamines [Presence] in Urine by Confirmatory method |
| 18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood |
| 18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
| 18338-4 | Nortramadol [Mass/volume] in Urine |
| 18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
| 1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
| 18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
| 18341-8 | Propylene glycol [Mass/volume] in Urine |
| 18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
| 18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
| 18345-9 | Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
| 18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
| 18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
| 18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine |
| 18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
| 18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood |
| 18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood |
| 1836-6 | Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma |
| 18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine |
| 18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
| 18362-4 | Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine |
| 18363-2 | Carnitine free (C0) [Units/mass] in Tissue |
| 18364-0 | Chondroitin sulfate [Mass/volume] in Serum |
| 18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) |
| 18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
| 18367-3 | Iodine Free [Mass/volume] in Serum or Plasma |
| 18368-1 | Magnesium [Moles/time] in 2 hour Urine |
| 18369-9 | Magnesium [Moles/time] in 4 hour Urine |
| 1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
| 18371-5 | Methyl parathion [Mass/volume] in Urine |
| 18372-3 | Potassium [Moles/time] in 6 hour Urine |
| 18373-1 | Protein [Mass/time] in 6 hour Urine |
| 18374-9 | Riboflavin [Mass/volume] in 24 hour Urine |
| 18376-4 | Sodium [Moles/time] in 6 hour Urine |
| 18377-2 | Sodium [Moles/time] in 12 hour Urine |
| 18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid |
| 18379-8 | Urate [Mass/time] in 6 hour Urine |
| 1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
| 18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
| 18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
| 18383-0 | Alfentanil [Presence] in Urine |
| 18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
| 18385-5 | Butalbital [Presence] in Urine by Confirmatory method |
| 18386-3 | Chlorothiazide [Presence] in Serum or Plasma |
| 18387-1 | Diamorphine [Mass/volume] in Serum or Plasma |
| 18388-9 | Diazepam [Presence] in Urine by Confirmatory method |
| 18389-7 | Methaqualone [Presence] in Urine by Confirmatory method |
| 1839-0 | Ammonia [Moles/volume] in Blood |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method |
| 18391-3 | Paraldehyde [Mass/volume] in Urine |
| 18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method |
| 18393-9 | Quinidine+Quinine [Presence] in Urine |
| 18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
| 18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid |
| 18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
| 18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
| 18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen |
| 18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen |
| 18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen |
| 18405-1 | Arsenate [Mass/volume] in Urine |
| 18406-9 | Arsenic trioxide [Mass/volume] in Urine |
| 18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum |
| 1841-6 | Ammonia [Moles/volume] in Serum |
| 18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
| 18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum |
| 18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum |
| 18414-3 | Psilocin [Presence] in Urine |
| 18415-0 | Psilocin [Mass/volume] in Urine |
| 18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum |
| 18417-6 | Black Bean IgG Ab [Units/volume] in Serum |
| 18418-4 | Casein IgA Ab [Units/volume] in Serum |
| 18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum |
| 1842-4 | Ammonia [Moles/volume] in Urine |
| 18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum |
| 18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum |
| 18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum |
| 18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum |
| 18425-9 | Zucchini IgG Ab [Units/volume] in Serum |
| 18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
| 18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid |
| 18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
| 18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
| 1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine |
| 18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
| 18431-7 | Amphetamines [Presence] in Stool by Screen method |
| 18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method |
| 18435-8 | Sufentanil [Presence] in Urine |
| 18436-6 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
| 1844-0 | Ammonium ion [Moles/volume] in Arterial blood |
| 1845-7 | Ammonium ion [Moles/volume] in Plasma |
| 1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
| 18467-1 | Venlafaxine [Mass/volume] in Urine |
| 18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
| 18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma |
| 1847-3 | Amyloid associated protein [Mass/volume] in Serum |
| 18470-5 | Norclomipramine [Mass/volume] in Urine |
| 18471-3 | Metoclopramide [Mass/volume] in Urine |
| 18472-1 | Organophosphate pesticides [Identifier] in Urine |
| 18473-9 | Hydromorphone [Presence] in Urine by Confirmatory method |
| 18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
| 18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
| 18477-0 | Lithium [Moles/time] in 24 hour Urine |
| 18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by DNA probe |
| 18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by DNA probe |
| 1848-1 | Androstanolone [Mass/volume] in Serum or Plasma |
| 18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by DNA probe |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat |
| 18482-0 | Yeast [Presence] in Unspecified specimen by Organism specific culture |
| 18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture |
| 18484-6 | Ku Ab [Presence] in Serum |
| 18485-3 | Mi-2 Ab [Presence] in Serum |
| 18486-1 | Methylenediamine [Presence] in Urine |
| 18488-7 | Calcium [Mass/volume] in 24 hour Urine |
| 18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma |
| 1849-9 | Androstanolone [Mass/volume] in Semen |
| 18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
| 18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
| 18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
| 18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen |
| 18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen |
| 18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
| 18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
| 18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
| 18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
| 18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
| 1850-7 | Androstanediol [Mass/volume] in Urine |
| 18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
| 18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain |
| 18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
| 18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
| 1851-5 | Androstenedione [Mass/volume] in Amniotic fluid |
| 1852-3 | Androstenedione [Mass/volume] in Capillary blood |
| 1853-1 | Androstenedione [Mass/volume] in Semen |
| 1854-9 | Androstenedione [Mass/volume] in Serum or Plasma |
| 1855-6 | Androstenedione [Mass/volume] in Urine |
| 1856-4 | Androsterone [Mass/volume] in Serum or Plasma |
| 1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
| 1858-0 | Angiotensin I [Mass/volume] in Plasma |
| 1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid |
| 1860-6 | Angiotensin II [Mass/volume] in Plasma |
| 1861-4 | Angiotensinogen [Mass/volume] in Plasma |
| 1862-2 | Aniline [Mass/volume] in Serum or Plasma |
| 1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
| 1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
| 1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
| 1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
| 18733-6 | Physician attending Progress note |
| 18734-4 | Occupational therapy Initial evaluation note |
| 18735-1 | Physical therapy Initial evaluation note |
| 18736-9 | Physician Initial evaluation note |
| 18737-7 | Podiatry Initial evaluation note |
| 18738-5 | Psychology Initial evaluation note |
| 18739-3 | Social work Initial evaluation note |
| 18740-1 | Speech-language pathology Initial evaluation note |
| 18742-7 | Arthroscopy study |
| 18743-5 | Autopsy report |
| 18744-3 | Bronchoscopy study |
| 18745-0 | Cardiac catheterization study |
| 18746-8 | Colonoscopy Study |
| 18747-6 | Deprecated CT Unspecified system Study |
| 18748-4 | Diagnostic imaging study |
| 18749-2 | Electromyogram study |
| 1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
| 18750-0 | Electrophysiology study |
| 18751-8 | Endoscopy study |
| 18752-6 | Exercise stress test study |
| 18753-4 | Flexible sigmoidoscopy study |
| 18754-2 | Holter monitor study |
| 18755-9 | Deprecated MRI Unspecified site study |
| 18756-7 | MRI Spine study |
| 18757-5 | Deprecated Nuclear medicine study |
| 18758-3 | Deprecated PET scan Unspecified system Study |
| 18759-1 | Spirometry study |
| 1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
| 18760-9 | Deprecated US Unspecified system Study |
| 18761-7 | Provider-unspecified Transfer summary |
| 18762-5 | Deprecated Chiropractor Progress note |
| 18763-3 | Physician consulting Initial evaluation note |
| 18764-1 | Deprecated Nurse practitioner Progress note |
| 1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
| 1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
| 1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
| 1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
| 1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
| 1882-0 | Apolipoprotein LPQ [Mass/volume] in Serum or Plasma |
| 1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma |
| 18836-7 | Cardiac stress study Procedure |
| 1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma |
| 18841-7 | Hospital consultations Document |
| 18842-5 | Discharge summary |
| 1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma |
| 1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma |
| 1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma |
| 1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells |
| 1896-0 | Argininosuccinate [Mass/volume] in Serum or Plasma |
| 1897-8 | Argininosuccinate [Mass/volume] in Urine |
| 1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
| 1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
| 1900-0 | Arylamidase [Enzymatic activity/volume] in Serum |
| 1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 1902-6 | Ascorbate [Mass/volume] in Blood |
| 19022-3 | Neisseria meningitidis C+w135 Ag [Presence] in Cerebral spinal fluid |
| 1903-4 | Ascorbate [Mass/volume] in Serum or Plasma |
| 1904-2 | Ascorbate [Presence] in Urine |
| 19049-6 | Metanephrine [Mass/time] in 24 hour Urine |
| 1905-9 | Ascorbate [Mass/time] in 24 hour Urine |
| 19050-4 | Metanephrines [Mass/volume] in 24 hour Urine |
| 19051-2 | Saquinavir [Mass/volume] in Serum or Plasma |
| 19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
| 19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination |
| 19054-6 | Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
| 19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
| 19056-1 | Mercury [Presence] in Urine |
| 19057-9 | ABO and Rh group [Type] in Blood from newborn |
| 19058-7 | Allergens identified in Serum |
| 19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma |
| 19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma |
| 19090-0 | Colony count [#/volume] in Urine |
| 19091-8 | Colony count [#] in Urine by Visual count |
| 19101-5 | Fungus colony count [#/volume] in Unspecified specimen by Culture |
| 19102-3 | Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
| 19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum |
| 19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
| 19108-0 | Histoplasma capsulatum Ag [Presence] in Serum |
| 19109-8 | Histoplasma capsulatum Ag [Presence] in Unspecified specimen |
| 19113-0 | IgE [Units/volume] in Serum or Plasma |
| 19122-1 | CD42 cells/100 cells in Blood |
| 19123-9 | Magnesium [Mass/volume] in Serum or Plasma |
| 19124-7 | Magnesium [Mass/volume] in Urine |
| 19126-2 | Bacteria identified in Bone marrow by Aerobe culture |
| 19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
| 19128-8 | Bacteria identified in Catheter tip by Culture |
| 19129-6 | Microscopic observation [Identifier] in Tissue by Biopsy culture |
| 19133-8 | Neisseria meningitidis A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
| 19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) |
| 19140-3 | Phospholipid Ab [Presence] in Serum |
| 19141-1 | Propoxyphene [Presence] in Urine |
| 19161-9 | Urobilinogen [Units/volume] in Urine by Test strip |
| 19162-7 | Varicella zoster virus IgG Ab [Presence] in Serum |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid |
| 19164-3 | Cancer Ag 72-4 [Units/volume] in Pleural fluid |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
| 1917-4 | Aspartate aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
| 19171-8 | Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid |
| 19172-6 | Alpha-1-Fetoprotein [Units/volume] in Pleural fluid |
| 19173-4 | Alpha-1-Fetoprotein [Moles/volume] in Pleural fluid |
| 19174-2 | Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid |
| 19175-9 | Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid |
| 19176-7 | Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma |
| 19177-5 | Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma |
| 19178-3 | Choriogonadotropin.beta subunit free [Units/volume] in Amniotic fluid |
| 19179-1 | Choriogonadotropin.beta subunit free [Moles/volume] in Amniotic fluid |
| 1918-2 | Aspartate aminotransferase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 19180-9 | Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma |
| 19182-5 | Cytokeratin 19 [Units/volume] in Serum or Plasma |
| 19183-3 | Cytokeratin 19 [Units/volume] in Pleural fluid |
| 19184-1 | Tissue polypeptide specific Ag [Units/volume] in Serum or Plasma |
| 19185-8 | Tissue polypeptide specific Ag [Units/volume] in Pleural fluid |
| 19186-6 | Cancer Ag 15-3 [Units/volume] in Pleural fluid |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid |
| 19188-2 | Mucin-like carcinoma associated Ag [Units/volume] in Pleural fluid |
| 19189-0 | Cancer Ag 549 [Units/volume] in Serum or Plasma |
| 1919-0 | Aspartate aminotransferase [Enzymatic activity/volume] in Body fluid |
| 19190-8 | Cancer Ag 549 [Units/volume] in Pleural fluid |
| 19193-2 | Enolase.neuron specific [Units/volume] in Serum or Plasma |
| 19194-0 | Enolase.neuron specific [Units/volume] in Pleural fluid |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen |
| 1920-8 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen |
| 19201-3 | Prostate Specific Ag Free [Units/volume] in Serum or Plasma |
| 19203-9 | Prostate Specific Ag Free [Moles/volume] in Serum or Plasma |
| 19204-7 | Prostate Specific Ag Free [Units/volume] in Semen |
| 19205-4 | Prostate Specific Ag Free [Mass/volume] in Semen |
| 19206-2 | Prostate Specific Ag Free [Moles/volume] in Semen |
| 19207-0 | Squamous cell carcinoma Ag [Units/volume] in Serum or Plasma |
| 19208-8 | Squamous cell carcinoma Ag [Moles/volume] in Serum or Plasma |
| 19209-6 | Squamous cell carcinoma Ag [Units/volume] in Pleural fluid |
| 1921-6 | Atrial natriuretic factor [Mass/volume] in Arterial blood |
| 19210-4 | Squamous cell carcinoma Ag [Moles/volume] in Pleural fluid |
| 19211-2 | Oxygen [Partial pressure] in Mixed venous blood |
| 19212-0 | Carbon dioxide [Partial pressure] in Mixed venous blood |
| 19213-8 | pH of Mixed venous blood |
| 19223-7 | Carbon dioxide, total [Moles/volume] in Mixed venous blood |
| 19229-4 | Bicarbonate [Moles/volume] in Mixed venous blood |
| 19239-3 | Lactate [Moles/volume] in Capillary blood |
| 19240-1 | Lactate [Moles/volume] in Mixed venous blood |
| 19243-5 | Brucella abortus Ab [Units/volume] in Serum by Immunoassay |
| 19245-0 | Clonazepam [Presence] in Urine |
| 19247-6 | Doxepin+Metabolites [Mass/volume] in Urine |
| 19253-4 | Trichinella spiralis Ab [Presence] in Serum by Immunoassay |
| 19259-1 | Neisseria meningitidis A+C+w135+Y Ag [Presence] in Unspecified specimen by Latex agglutination |
| 19260-9 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
| 19261-7 | Amphetamines [Presence] in Urine by Screen method |
| 19270-8 | Barbiturates [Presence] in Urine by Screen method |
| 1928-1 | Immunoglobulin light chains [Presence] in Urine |
| 19289-8 | Cannabinoids [Presence] in Urine by Confirmatory method |
| 1929-9 | Immunoglobulin light chains [Mass/volume] in Urine |
| 19290-6 | Cannabinoids positive [Identifier] in Urine by Confirmatory method |
| 19295-5 | Opiates [Presence] in Urine by Screen method |
| 19298-9 | Opiates positive [Identifier] in Urine by Confirmatory method |
| 1930-7 | Benzoate [Mass/volume] in Serum or Plasma |
| 19303-7 | Thiazides [Presence] in Urine by Screen method |
| 19306-0 | Thiazides [Presence] in Urine by Confirmatory method |
| 19312-8 | Tricyclic antidepressants [Presence] in Urine by Screen method |
| 19315-1 | Tricyclic antidepressants [Presence] in Urine by Confirmatory method |
| 19321-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method |
| 19322-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method |
| 19325-0 | Alpha hydroxyalprazolam [Presence] in Urine by Screen method |
| 19326-8 | Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method |
| 19328-4 | Alpha hydroxyalprazolam [Mass/volume] in Urine |
| 19331-8 | Amitriptyline [Presence] in Urine by Screen method |
| 19335-9 | Amitriptyline+Nortriptyline [Presence] in Urine by Screen method |
| 19336-7 | Amitriptyline+Nortriptyline [Presence] in Urine by Confirmatory method |
| 19339-1 | Amobarbital [Presence] in Urine by Screen method |
| 19341-7 | Amobarbital cutoff [Mass/volume] in Urine for Screen method |
| 19343-3 | Amphetamine [Presence] in Urine by Screen method |
| 19344-1 | Amphetamine [Presence] in Urine by Confirmatory method |
| 19346-6 | Amphetamine [Mass/volume] in Urine |
| 19349-0 | Aprobarbital [Presence] in Urine by Screen method |
| 19350-8 | Aprobarbital [Presence] in Urine by Confirmatory method |
| 19353-2 | Barbital [Presence] in Urine by Screen method |
| 19354-0 | Barbital [Presence] in Urine by Confirmatory method |
| 19359-9 | Cocaine [Presence] in Urine by Screen method |
| 19360-7 | Cocaine [Presence] in Urine by Confirmatory method |
| 19364-9 | Bromazepam [Presence] in Urine by Screen method |
| 19365-6 | Bromazepam [Presence] in Urine by Confirmatory method |
| 19368-0 | Butabarbital [Presence] in Urine by Screen method |
| 1937-2 | Beta endorphin [Mass/volume] in Serum or Plasma |
| 19370-6 | Butabarbital [Mass/volume] in Urine |
| 19373-0 | Butalbital [Presence] in Urine by Screen method |
| 19377-1 | Butorphanol [Presence] in Urine by Screen method |
| 19378-9 | Butorphanol [Presence] in Urine by Confirmatory method |
| 1938-0 | Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells |
| 19381-3 | Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method |
| 19382-1 | Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
| 19385-4 | Chlordiazepoxide [Presence] in Urine by Screen method |
| 19386-2 | Chlordiazepoxide [Presence] in Urine by Confirmatory method |
| 19389-6 | Chlorpheniramine [Presence] in Urine by Screen method |
| 1939-8 | Beta fructofuranosidase [Enzymatic activity/volume] in Serum |
| 19391-2 | Chlorpheniramine [Mass/volume] in Urine by Confirmatory method |
| 19392-0 | Chlorpheniramine [Mass/volume] in Urine |
| 19395-3 | Chlorpromazine [Presence] in Urine by Screen method |
| 19396-1 | Chlorpromazine [Presence] in Urine by Confirmatory method |
| 19399-5 | Clonazepam [Presence] in Urine by Screen method |
| 1940-6 | Beta galactosidase [Enzymatic activity/volume] in Red Blood Cells |
| 19402-7 | Clonazepam [Mass/volume] in Urine |
| 19405-0 | Cocaethylene [Presence] in Urine by Screen method |
| 19406-8 | Cocaethylene [Presence] in Urine by Confirmatory method |
| 19408-4 | Cocaethylene [Mass/volume] in Urine |
| 1941-4 | Beta galactosidase [Enzymatic activity/volume] in Serum or Plasma |
| 19411-8 | Codeine [Presence] in Urine by Screen method |
| 19415-9 | Tetrahydrocannabinol [Presence] in Urine by Screen method |
| 19416-7 | Tetrahydrocannabinol [Presence] in Urine by Confirmatory method |
| 19419-1 | Dextroamphetamine [Presence] in Urine by Screen method |
| 1942-2 | Beta galactosidase [Enzymatic activity/mass] in Tissue |
| 19420-9 | Dextroamphetamine [Presence] in Urine by Confirmatory method |
| 19423-3 | Dextromethamphetamine [Presence] in Urine by Screen method |
| 19424-1 | Dextromethamphetamine [Presence] in Urine by Confirmatory method |
| 19425-8 | Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 19429-0 | Propoxyphene [Presence] in Urine by Screen method |
| 1943-0 | Acid beta glucosidase [Enzymatic activity/volume] in Leukocytes |
| 19433-2 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method |
| 19434-0 | Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method |
| 19435-7 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
| 19436-5 | Propoxyphene + Norpropoxyphene [Mass/volume] in Urine |
| 19439-9 | Diamorphine [Presence] in Urine by Screen method |
| 1944-8 | Beta glucuronidase [Enzymatic activity/mass] in Tissue |
| 19443-1 | Diazepam [Presence] in Urine by Screen method |
| 19446-4 | Dihydrocodeine [Presence] in Urine by Screen method |
| 19448-0 | Dihydrocodeine [Mass/volume] in Urine by Confirmatory method |
| 19449-8 | Dihydrocodeine [Mass/volume] in Urine |
| 1945-5 | Beta glucuronidase [Enzymatic activity/volume] in Urine |
| 19452-2 | Dimetamphetamine [Presence] in Urine by Screen method |
| 19453-0 | Dimetamphetamine [Presence] in Urine by Confirmatory method |
| 19456-3 | Ethylamphetamine [Presence] in Urine by Screen method |
| 19458-9 | Ethylamphetamine [Mass/volume] in Urine by Confirmatory method |
| 19459-7 | Ethylamphetamine [Mass/volume] in Urine |
| 1946-3 | Beta hydroxybutyrate [Mass/volume] in Cerebral spinal fluid |
| 19462-1 | Ethylmorphine [Presence] in Urine by Screen method |
| 19463-9 | Ethylmorphine [Presence] in Urine by Confirmatory method |
| 19466-2 | Flunitrazepam [Presence] in Urine by Screen method |
| 19467-0 | Flunitrazepam [Presence] in Urine by Confirmatory method |
| 1947-1 | Beta hydroxybutyrate [Mass/volume] in Urine |
| 19470-4 | Fluoxetine [Presence] in Urine by Screen method |
| 19471-2 | Fluoxetine [Presence] in Urine by Confirmatory method |
| 19474-6 | Flurazepam [Presence] in Urine by Screen method |
| 19475-3 | Flurazepam [Presence] in Urine by Confirmatory method |
| 19478-7 | Haloperidol [Presence] in Urine by Screen method |
| 19479-5 | Haloperidol [Presence] in Urine by Confirmatory method |
| 19482-9 | Hydrocodone [Presence] in Urine by Screen method |
| 19483-7 | Hydrocodone [Presence] in Urine by Confirmatory method |
| 19486-0 | Hydromorphone [Presence] in Urine by Screen method |
| 19489-4 | Hydroxyalprazolam [Presence] in Urine by Screen method |
| 1949-7 | Beta lipotropin [Mass/volume] in Serum or Plasma |
| 19490-2 | Hydroxyalprazolam [Presence] in Urine by Confirmatory method |
| 19493-6 | Hydroxyethylflurazepam [Presence] in Urine by Screen method |
| 19494-4 | Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method |
| 19497-7 | Hydroxytriazolam [Presence] in Urine by Screen method |
| 19499-3 | Ketamine [Mass/volume] in Urine by Screen method |
| 1950-5 | Beta melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
| 19502-4 | Methotrimeprazine [Presence] in Urine by Screen method |
| 19503-2 | Methotrimeprazine [Presence] in Urine by Confirmatory method |
| 19506-5 | Deprecated Levomepromazine [Presence] in Urine by Screen method |
| 19507-3 | Deprecated Levomepromazine [Presence] in Urine by Confirm method |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
| 19510-7 | Levomethamphetamine [Presence] in Urine by Screen method |
| 19511-5 | Levomethamphetamine [Presence] in Urine by Confirmatory method |
| 19512-3 | Levomethamphetamine [Mass/volume] in Urine by Confirmatory method |
| 19516-4 | Levorphanol [Presence] in Urine by Screen method |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
| 19520-6 | Lorazepam [Presence] in Urine by Screen method |
| 19524-8 | Lormetazepam [Presence] in Urine by Screen method |
| 19525-5 | Lormetazepam [Presence] in Urine by Confirmatory method |
| 19528-9 | Lysergate diethylamide [Presence] in Urine by Screen method |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine |
| 19532-1 | Meperidine [Presence] in Urine by Screen method |
| 19536-2 | Mephobarbital [Presence] in Urine by Screen method |
| 19537-0 | Mephobarbital [Presence] in Urine by Confirmatory method |
| 19539-6 | Mephobarbital [Mass/volume] in Urine |
| 1954-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Serum |
| 19542-0 | Mescaline [Presence] in Urine by Screen method |
| 19543-8 | Mescaline [Presence] in Urine by Confirmatory method |
| 19546-1 | Mesoridazine [Presence] in Urine by Screen method |
| 19547-9 | Mesoridazine [Presence] in Urine by Confirmatory method |
| 1955-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue |
| 19550-3 | Methadone [Presence] in Urine by Screen method |
| 19554-5 | Methamphetamine [Presence] in Urine by Screen method |
| 19555-2 | Methamphetamine [Presence] in Urine by Confirmatory method |
| 19558-6 | Methaqualone [Presence] in Urine by Screen method |
| 1956-2 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma |
| 19561-0 | Methylenediamine [Presence] in Urine by Screen method |
| 19562-8 | Methylenediamine [Presence] in Urine by Confirmatory method |
| 19565-1 | Methylenedioxyamphetamine [Presence] in Urine by Screen method |
| 19566-9 | Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method |
| 19568-5 | Methylenedioxymethamphetamine [Presence] in Urine by Screen method |
| 19569-3 | Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method |
| 1957-0 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum |
| 19570-1 | Methylenedioxymethamphetamine [Mass/volume] in Urine |
| 19573-5 | Methylephedrine [Presence] in Urine by Screen method |
| 19577-6 | Methylphenidate [Presence] in Urine by Screen method |
| 19578-4 | Methylphenidate [Presence] in Urine by Confirmatory method |
| 1958-8 | Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum |
| 19581-8 | Methyprylon [Presence] in Urine by Screen method |
| 19585-9 | Midazolam [Presence] in Urine by Screen method |
| 19586-7 | Midazolam [Presence] in Urine by Confirmatory method |
| 19588-3 | Midazolam [Mass/volume] in Urine |
| 1959-6 | Bicarbonate [Moles/volume] in Blood |
| 19593-3 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
| 19597-4 | Morphine [Presence] in Urine by Screen method |
| 1960-4 | Bicarbonate [Moles/volume] in Arterial blood |
| 19601-4 | Morphine Free [Presence] in Urine by Screen method |
| 19602-2 | Morphine Free [Presence] in Urine by Confirmatory method |
| 19605-5 | Nalbuphine [Presence] in Urine by Screen method |
| 19609-7 | Naltrexone [Presence] in Urine by Screen method |
| 1961-2 | Bicarbonate [Moles/volume] in Capillary blood |
| 19610-5 | Naltrexone [Mass/volume] in Urine by Confirmatory method |
| 19611-3 | Naltrexone [Mass/volume] in Urine |
| 19614-7 | N-desalkylflurazepam [Presence] in Urine by Screen method |
| 19615-4 | N-desalkylflurazepam [Presence] in Urine by Confirmatory method |
| 19617-0 | N-desalkylflurazepam [Mass/volume] in Urine |
| 1962-0 | Bicarbonate [Moles/volume] in Plasma |
| 19620-4 | Nitrazepam [Presence] in Urine by Screen method |
| 19621-2 | Nitrazepam [Presence] in Urine by Confirmatory method |
| 19624-6 | Nordiazepam [Presence] in Urine by Screen method |
| 19628-7 | Norfluoxetine [Presence] in Urine by Screen method |
| 19629-5 | Norfluoxetine [Presence] in Urine by Confirmatory method |
| 1963-8 | Bicarbonate [Moles/volume] in Serum |
| 19632-9 | Norpropoxyphene [Presence] in Urine by Screen method |
| 19635-2 | Norpropoxyphene [Mass/volume] in Urine |
| 19638-6 | Oxazepam [Presence] in Urine by Screen method |
| 19639-4 | Oxazepam [Presence] in Urine by Confirmatory method |
| 1964-6 | Bicarbonate [Moles/volume] in Urine |
| 19642-8 | Oxycodone [Presence] in Urine by Screen method |
| 19643-6 | Oxycodone [Presence] in Urine by Confirmatory method |
| 19646-9 | Oxymorphone [Presence] in Urine by Screen method |
| 19648-5 | Oxymorphone [Mass/volume] in Urine |
| 1965-3 | Bile [Presence] in Stool |
| 19651-9 | Para hydroxyamphetamine [Presence] in Urine by Screen method |
| 19652-7 | Para hydroxyamphetamine [Presence] in Urine by Confirmatory method |
| 19655-0 | Pentobarbital [Presence] in Urine by Screen method |
| 19659-2 | Phencyclidine [Presence] in Urine by Screen method |
| 1966-1 | Bile acid [Mass/volume] in Exhaled gas |
| 19662-6 | Phenmetrazine [Presence] in Urine by Screen method |
| 19666-7 | Phenobarbital [Presence] in Urine by Screen method |
| 1967-9 | Bile acid [Mass/volume] in Serum |
| 19670-9 | Phenothiazines [Presence] in Urine by Screen method |
| 19674-1 | Phentermine [Presence] in Urine by Screen method |
| 19678-2 | Prazepam [Presence] in Urine by Screen method |
| 19679-0 | Prazepam [Presence] in Urine by Confirmatory method |
| 1968-7 | Bilirubin.direct [Mass/volume] in Serum or Plasma |
| 19682-4 | Psilocin [Presence] in Urine by Screen method |
| 19683-2 | Psilocin [Presence] in Urine by Confirmatory method |
| 19686-5 | Psilocybin [Presence] in Urine by Screen method |
| 19687-3 | Psilocybin [Presence] in Urine by Confirmatory method |
| 19688-1 | Psilocybin [Mass/volume] in Urine by Confirmatory method |
| 1969-5 | Bilirubin.total renal clearance in 24 hour |
| 19692-3 | Secobarbital [Presence] in Urine by Screen method |
| 19695-6 | Secobarbital [Mass/volume] in Urine |
| 19698-0 | Temazepam [Presence] in Urine by Screen method |
| 1970-3 | Bilirubin.delta [Mass/volume] in Serum or Plasma |
| 19702-0 | Deprecated Tetrahydrocannabinol [Presence] in Urine by Screen method |
| 19703-8 | Deprecated Tetrahydrocannabinol [Presence] in Urine by Confirm method |
| 19706-1 | Thioridazine [Presence] in Urine by Screen method |
| 19707-9 | Thioridazine [Presence] in Urine by Confirmatory method |
| 1971-1 | Bilirubin.indirect [Mass/volume] in Serum or Plasma |
| 19710-3 | Tramadol [Presence] in Urine by Screen method |
| 19714-5 | Triazolam [Presence] in Urine by Screen method |
| 19718-6 | Trichlorothiazide [Presence] in Urine by Screen method |
| 19719-4 | Trichlorothiazide [Presence] in Urine by Confirmatory method |
| 1972-9 | Bilirubin.total [Mass/volume] in Amniotic fluid |
| 19720-2 | Trichlorothiazide [Mass/volume] in Urine by Confirmatory method |
| 19721-0 | Trichlorothiazide [Mass/volume] in Urine |
| 19724-4 | Abachi Wood Dust IgE Ab [Units/volume] in Serum |
| 19725-1 | Aspergillus flavus IgG Ab [Presence] in Serum |
| 19726-9 | Aspergillus fumigatus IgG Ab [Presence] in Serum |
| 19727-7 | Aspergillus niger IgG Ab [Presence] in Serum |
| 19728-5 | Beet IgE Ab [Units/volume] in Serum |
| 19729-3 | Blue vetch IgE Ab [Units/volume] in Serum |
| 1973-7 | Bilirubin.total [Mass/volume] in Cerebral spinal fluid |
| 19730-1 | Deprecated Budgerigar droppings IgE Ab [Units/volume] in Serum |
| 19731-9 | Deprecated Budgerigar serum proteins IgE Ab [Units/volume] in Serum |
| 19732-7 | Cat serum albumin IgE Ab [Units/volume] in Serum |
| 19733-5 | Cefaclor IgE Ab [Units/volume] in Serum |
| 19734-3 | Chicken droppings IgE Ab [Units/volume] in Serum |
| 19735-0 | Deprecated Cocksfoot IgE Ab [Units/volume] in Serum |
| 19736-8 | Coralbumin IgE Ab [Units/volume] in Serum |
| 19737-6 | Cotton fibers IgE Ab [Units/volume] in Serum |
| 19738-4 | Dog serum albumin IgE Ab [Units/volume] in Serum |
| 19739-2 | Fenugreek IgE Ab [Units/volume] in Serum |
| 1974-5 | Bilirubin.total [Mass/volume] in Body fluid |
| 19740-0 | Fox epithelium IgE Ab [Units/volume] in Serum |
| 19741-8 | Hake IgE Ab [Units/volume] in Serum |
| 19742-6 | Hexahydrophthalic anhydride (HHPA) IgE Ab [Units/volume] in Serum |
| 19743-4 | Horse meat IgE Ab [Units/volume] in Serum |
| 19744-2 | Jackfruit IgE Ab [Units/volume] in Serum |
| 19745-9 | Deprecated Flax IgE Ab [Units/volume] in Serum |
| 19746-7 | Maleic anhydride IgE Ab [Units/volume] in Serum |
| 19747-5 | Mealworm IgE Ab [Units/volume] in Serum |
| 19748-3 | Methyltetrahydrophthalic anhydride (MTHPA) IgE Ab [Units/volume] in Serum |
| 19749-1 | Saccharopolyspora rectivirgula IgG Ab [Presence] in Serum |
| 1975-2 | Bilirubin.total [Mass/volume] in Serum or Plasma |
| 19750-9 | Deprecated Mint IgE Ab [Units/volume] in Serum |
| 19751-7 | Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
| 19752-5 | Pigeon serum IgG Ab [Presence] in Serum |
| 19753-3 | Rat epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum |
| 19754-1 | Red Currant IgE Ab [Units/volume] in Serum |
| 19755-8 | Saffron IgE Ab [Units/volume] in Serum |
| 19756-6 | Sheep milk IgE Ab [Units/volume] in Serum |
| 19757-4 | Sheep whey IgE Ab [Units/volume] in Serum |
| 19758-2 | Silk waste IgE Ab [Units/volume] in Serum |
| 19759-0 | Swine serum albumin IgE Ab [Units/volume] in Serum |
| 1976-0 | Bilirubin.total [Presence] in Stool |
| 19760-8 | Clostridium tetani toxoid IgE Ab [Units/volume] in Serum |
| 19761-6 | Thermoactinomyces vulgaris IgG Ab [Presence] in Serum |
| 19765-7 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain |
| 19766-5 | Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative |
| 1977-8 | Bilirubin.total [Presence] in Urine |
| 1978-6 | Bilirubin.total [Mass/volume] in Urine |
| 1979-4 | Biopterin [Mass/volume] in 24 hour Urine |
| 1980-2 | Biotin [Mass/volume] in Serum or Plasma |
| 1981-0 | Biotinidase [Presence] in Blood |
| 1982-8 | Biotinidase [Enzymatic activity/volume] in Serum or Plasma |
| 1983-6 | Bradykinin [Mass/volume] in Serum or Plasma |
| 1984-4 | Bromide [Mass/volume] in Serum or Plasma |
| 1985-1 | Bromide [Mass/volume] in Urine |
| 1986-9 | C peptide [Mass/volume] in Serum or Plasma |
| 1987-7 | C peptide [Mass/volume] in Urine |
| 1988-5 | C reactive protein [Mass/volume] in Serum or Plasma |
| 1989-3 | Calcidiol [Mass/volume] in Serum or Plasma |
| 1990-1 | Cholecalciferol (Vit D3) [Mass/volume] in Serum or Plasma |
| 1991-9 | Calciferol binding proteins [Mass/volume] in Serum |
| 1992-7 | Calcitonin [Mass/volume] in Serum or Plasma |
| 1993-5 | Calcium renal clearance in 24 hour |
| 1994-3 | Calcium.ionized [Moles/volume] in Blood |
| 1995-0 | Calcium.ionized [Moles/volume] in Serum or Plasma |
| 1996-8 | Calcium [Moles/volume] in Blood |
| 1997-6 | Calcium [Moles/volume] in Cerebral spinal fluid |
| 1998-4 | Calcium [Moles/volume] in Dialysis fluid |
| 1999-2 | Calcium [Moles/volume] in Semen |
| 2000-8 | Calcium [Moles/volume] in Serum or Plasma |
| 2001-6 | Calcium [Moles/volume] in 24 hour Stool |
| 2002-4 | Calcium [Moles/volume] in Stool |
| 2004-0 | Calcium [Moles/volume] in Urine |
| 2005-7 | Calcium [Moles/time] in 2 hour Urine --12 hours fasting |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma |
| 2011-5 | Cancer Ag 242 [Presence] in Serum or Plasma |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma |
| 2013-1 | Cancer Ag 50 [Presence] in Serum or Plasma |
| 2014-9 | Cancer Ag 549 [Presence] in Serum or Plasma |
| 2015-6 | Cancer Ag 72-4 [Presence] in Serum or Plasma |
| 2016-4 | Carbamoyl phosphate synthetase [Enzymatic activity/volume] in Serum |
| 2017-2 | Carbamoyl phosphate synthetase (ammonia) [Enzymatic activity/mass] in Tissue |
| 2018-0 | Carbon dioxide [Partial pressure] in Amniotic fluid |
| 2019-8 | Carbon dioxide [Partial pressure] in Arterial blood |
| 2020-6 | Carbon dioxide [Partial pressure] in Capillary blood |
| 2021-4 | Carbon dioxide [Partial pressure] in Venous blood |
| 2022-2 | Carbon dioxide [Partial pressure] in Cerebral spinal fluid |
| 2023-0 | Carbon dioxide [Partial pressure] in Body fluid |
| 2024-8 | Carbon dioxide dissolved [Moles/volume] in Plasma |
| 2025-5 | Carbon dioxide dissolved [Moles/volume] in Red Blood Cells |
| 2026-3 | Carbon dioxide, total [Moles/volume] in Arterial blood |
| 2027-1 | Carbon dioxide, total [Moles/volume] in Venous blood |
| 2028-9 | Carbon dioxide, total [Moles/volume] in Serum or Plasma |
| 2033-9 | Carbonate [Mass/volume] in Arterial blood |
| 2034-7 | Carbonate [Mass/volume] in Venous blood |
| 2035-4 | Carbonate [Mass/volume] in Plasma |
| 2036-2 | Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
| 20398-4 | Nuclear Ab Pattern Homogenous [Titer] in Serum |
| 20399-2 | Nuclear Ab pattern.nucleolar [Titer] in Serum |
| 2040-4 | Cardiolipin [Mass/volume] in Serum |
| 20400-8 | Nuclear Ab pattern.rim [Titer] in Serum |
| 20401-6 | Nuclear Ab pattern.speckled [Titer] in Serum |
| 20402-4 | CD16+CD56+ cells [#/volume] in Blood |
| 20403-2 | Fibronectin.fetal [Mass/volume] in Vaginal fluid |
| 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid |
| 20405-7 | Urobilinogen [Mass/volume] in Urine by Test strip |
| 20406-5 | Deprecated Glucose [Mass/volume] in Urine by Test strip |
| 2041-2 | Carnitine acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
| 20410-7 | Amphetamines [Mass/volume] in Urine by Confirmatory method |
| 20411-5 | Barbiturates [Mass/volume] in Urine by Confirmatory method |
| 20412-3 | Benzodiazepines [Mass/volume] in Urine by Confirmatory method |
| 20413-1 | Cannabinoids [Mass/volume] in Urine by Confirmatory method |
| 20414-9 | Thiazides [Mass/volume] in Urine by Confirmatory method |
| 20415-6 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS |
| 20416-4 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method |
| 20417-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum |
| 20418-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum |
| 20419-8 | Lutropin [Units/volume] in Serum or Plasma by 1st IRP |
| 2042-0 | Carnitine free (C0) [Presence] in Serum or Plasma |
| 20420-6 | Prostatic acid phosphatase [Mass/volume] in Serum |
| 20421-4 | Barbiturates [Presence] in Serum or Plasma by Screen method |
| 20423-0 | Beta lactamase organism identified in Isolate |
| 20427-1 | Acetylcholine receptor Ab [Moles/volume] in Serum |
| 20428-9 | Phospholipid IgG Ab [Presence] in Serum |
| 20429-7 | Phospholipid IgM Ab [Presence] in Serum |
| 2043-8 | Carnitine free (C0) [Mass/volume] in Serum or Plasma |
| 20430-5 | Culture medium [Type] in Isolate |
| 20431-3 | Microscopic observation [Identifier] in Unspecified specimen by Smear |
| 20432-1 | Epstein Barr virus nuclear Ab [Presence] in Serum by Immunofluorescence |
| 20433-9 | Follitropin [Units/volume] in Serum or Plasma by 2nd IRP |
| 20434-7 | Prolactin [Units/volume] in Serum or Plasma by 3rd IS |
| 20435-4 | Unidentified extractable nuclear Ab [Presence] in Serum by Immune diffusion (ID) |
| 20436-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post dose glucose |
| 20438-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose glucose |
| 2044-6 | Carnitine [Mass/volume] in Semen |
| 20442-0 | Hepatitis B virus DNA [#/volume] (viral load) in Serum by Probe and signal amplification method |
| 20444-6 | Herpes simplex virus 1+2 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 20445-3 | Herpes virus identified in Unspecified specimen by Organism specific culture |
| 20447-9 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method |
| 20448-7 | Insulin [Units/volume] in Serum or Plasma |
| 20449-5 | Borrelia burgdorferi Ab [Presence] in Serum by Immunoassay |
| 2045-3 | Carnitine [Presence] in Serum or Plasma |
| 20451-1 | Thyroxine (T4) [Presence] in Blood |
| 20452-9 | Thyrotropin [Presence] in Blood |
| 20459-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen by Latex agglutination |
| 2046-1 | Carnitine [Mass/volume] in Serum or Plasma |
| 20463-6 | Mycobacterium avium complex rRNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 20468-5 | Thiamine [Moles/volume] in Serum or Plasma |
| 20469-3 | Acetone [Presence] in Serum or Plasma by Screen method |
| 2047-9 | Carnitine [Mass/volume] in Urine |
| 20470-1 | Ethanol [Presence] in Serum or Plasma by Screen method |
| 20471-9 | Isopropanol [Presence] in Serum or Plasma by Screen method |
| 20474-3 | Bacteria identified in Tissue by Biopsy culture |
| 20479-2 | Measles virus IgG Ab [Presence] in Serum |
| 20483-4 | Mitochondria Ab [Titer] in Serum |
| 20484-2 | Cardiolipin IgG Ab [Titer] in Serum |
| 20485-9 | Cardiolipin IgM Ab [Titer] in Serum |
| 20486-7 | Haemophilus influenzae B Ag [Units/volume] in Cerebral spinal fluid |
| 20487-5 | Neisseria meningitidis A+Y Ag [Presence] in Cerebral spinal fluid |
| 20488-3 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid |
| 20489-1 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid |
| 20490-9 | Epstein Barr virus capsid IgG Ab [Titer] in Serum |
| 20491-7 | Epstein Barr virus capsid IgM Ab [Titer] in Serum |
| 20495-8 | Gliadin IgA Ab [Units/volume] in Serum by Immunoassay |
| 20496-6 | Gliadin IgG Ab [Units/volume] in Serum by Immunoassay |
| 20497-4 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum by Complement fixation |
| 20498-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum by Complement fixation |
| 20500-5 | Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
| 20501-3 | Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method |
| 20502-1 | Clue cells [Presence] in Vaginal fluid by Wet preparation |
| 20507-0 | Reagin Ab [Presence] in Serum by RPR |
| 20508-8 | Reagin Ab [Units/volume] in Serum by RPR |
| 20514-6 | Deprecated 6-Monoacetylmorphine [Mass/volume] in Urine Confirm |
| 20515-3 | Amitriptyline [Mass/volume] in Urine by Confirmatory method |
| 20516-1 | Amitriptyline+Nortriptyline [Mass/volume] in Urine by Confirmatory method |
| 20517-9 | Aprobarbital [Mass/volume] in Urine by Confirmatory method |
| 20518-7 | Barbital [Mass/volume] in Urine by Confirmatory method |
| 20519-5 | Cocaine [Mass/volume] in Urine by Confirmatory method |
| 2052-9 | Carotene [Mass/volume] in Blood |
| 20520-3 | Bromazepam [Mass/volume] in Urine by Confirmatory method |
| 20521-1 | Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
| 20522-9 | Chlordiazepoxide [Mass/volume] in Urine by Confirmatory method |
| 20523-7 | Chlorpromazine [Mass/volume] in Urine by Confirmatory method |
| 20524-5 | Deprecated Tetrahydrocannabinol [Mass/volume] in Urine by Confirm method |
| 20525-2 | Dextroamphetamine [Mass/volume] in Urine by Confirmatory method |
| 20526-0 | Dimetamphetamine [Mass/volume] in Urine by Confirmatory method |
| 20527-8 | Ethylmorphine [Mass/volume] in Urine by Confirmatory method |
| 20528-6 | Flunitrazepam [Mass/volume] in Urine by Confirmatory method |
| 20529-4 | Fluoxetine [Mass/volume] in Urine by Confirmatory method |
| 2053-7 | Carotene [Mass/volume] in Serum |
| 20530-2 | Haloperidol [Mass/volume] in Urine by Confirmatory method |
| 20532-8 | Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
| 20533-6 | Hydroxytriazolam [Presence] in Urine by Confirmatory method |
| 20537-7 | Ketamine [Mass/volume] in Urine by Confirmatory method |
| 20538-5 | Methotrimeprazine [Mass/volume] in Urine by Confirmatory method |
| 20539-3 | Deprecated Levomepromazine [Mass/volume] in Urine by Confirm method |
| 2054-5 | Catalase [Enzymatic activity/volume] in Red Blood Cells |
| 20540-1 | Levorphanol [Mass/volume] in Urine by Confirmatory method |
| 20541-9 | Lormetazepam [Mass/volume] in Urine by Confirmatory method |
| 20542-7 | Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method |
| 20543-5 | Mescaline [Mass/volume] in Urine by Confirmatory method |
| 20544-3 | Mesoridazine [Mass/volume] in Urine by Confirmatory method |
| 20545-0 | Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method |
| 20547-6 | Methylephedrine [Mass/volume] in Urine by Confirmatory method |
| 20548-4 | Methylphenidate [Mass/volume] in Urine by Confirmatory method |
| 20549-2 | Methyprylon [Mass/volume] in Urine by Confirmatory method |
| 2055-2 | Catecholamines [Mass/volume] in Blood |
| 20550-0 | Morphine Free [Mass/volume] in Urine by Confirmatory method |
| 20551-8 | Nalbuphine [Mass/volume] in Urine by Confirmatory method |
| 20552-6 | Nitrazepam [Mass/volume] in Urine by Confirmatory method |
| 20553-4 | Norfluoxetine [Mass/volume] in Urine by Confirmatory method |
| 20554-2 | Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method |
| 20555-9 | Phenmetrazine [Mass/volume] in Urine by Confirmatory method |
| 20556-7 | Phenothiazines [Mass/volume] in Urine by Confirmatory method |
| 20557-5 | Phentermine [Mass/volume] in Urine by Confirmatory method |
| 20558-3 | Psilocin [Mass/volume] in Urine by Confirmatory method |
| 20559-1 | Temazepam [Mass/volume] in Urine by Confirmatory method |
| 2056-0 | Catecholamines [Mass/volume] in Plasma |
| 20560-9 | Thioridazine [Mass/volume] in Urine by Confirmatory method |
| 20561-7 | Tramadol [Mass/volume] in Urine by Confirmatory method |
| 20563-3 | Carboxyhemoglobin/Hemoglobin.total in Blood |
| 20565-8 | Carbon dioxide, total [Moles/volume] in Blood |
| 20566-6 | Colony count [#/volume] in Catheter tip by Culture |
| 20567-4 | Ferritin [Mass/volume] in Serum or Plasma by Immunoassay |
| 20568-2 | Prolactin [Mass/volume] in Serum or Plasma by Immunoassay |
| 2057-8 | Catecholamines [Mass/volume] in Urine |
| 20570-8 | Hematocrit [Volume Fraction] of Blood |
| 20571-6 | Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe and signal amplification method |
| 20573-2 | Histoplasma capsulatum mycelial phase Ab [Titer] in Serum by Complement fixation |
| 20574-0 | Histoplasma capsulatum yeast phase Ab [Titer] in Serum by Complement fixation |
| 20575-7 | Hepatitis A virus Ab [Presence] in Serum |
| 20576-5 | Galactose 1 phosphate uridyl transferase [Presence] in Blood |
| 20578-1 | Vancomycin [Mass/volume] in Serum or Plasma |
| 20579-9 | Methanol [Presence] in Serum or Plasma by Screen method |
| 2058-6 | Catecholamines [Mass/time] in 24 hour Urine |
| 2059-4 | Cerebroside sulfatase [Presence] in Serum or Plasma |
| 20592-2 | CD19 cells [#/volume] in Unspecified specimen |
| 20593-0 | CD19 cells/100 cells in Unspecified specimen |
| 20598-9 | CD3 cells [#/volume] in Unspecified specimen |
| 2060-2 | Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
| 20603-7 | CD38 cells/100 cells in Unspecified specimen |
| 20605-2 | Deprecated CD4 cells [#/volume] in Unspecified specimen |
| 20608-6 | CD41 cells/100 cells in Unspecified specimen |
| 20609-4 | CD42 cells/100 cells in Unspecified specimen |
| 2061-0 | Cerebroside sulfatase [Enzymatic activity/volume] in Urine |
| 20613-6 | Deprecated CD8 cells [#/volume] in Unspecified specimen |
| 20614-4 | Deprecated CD8 cells/100 cells in Unspecified specimen |
| 2062-8 | Cerebroside sulfatase [Presence] in Leukocytes |
| 20620-1 | CD16+CD56+ cells/100 cells in Unspecified specimen |
| 20621-9 | Albumin/Creatinine [Presence] in Urine by Test strip |
| 20622-7 | Cortisol [Mass/volume] in 24 hour Urine |
| 20624-3 | Creatinine [Mass/volume] in 24 hour Urine |
| 20625-0 | Lead [Mass/volume] in 24 hour Urine |
| 2063-6 | Cerebroside sulfatase [Enzymatic activity/volume] in Leukocytes |
| 2064-4 | Ceruloplasmin [Mass/volume] in Serum or Plasma |
| 20647-4 | Hydroxyproline [Moles/volume] in Serum or Plasma |
| 20660-7 | Tyrosine [Moles/volume] in Serum or Plasma |
| 20662-3 | Allergens tested for in Serum |
| 20663-1 | Tricyclic antidepressants [Mass/volume] in Urine by Screen method |
| 20664-9 | Barbiturates [Mass/volume] in Urine by Screen method |
| 20665-6 | Echovirus 14 Ab [Titer] in Serum by Neutralization test |
| 20669-8 | Cardiolipin IgA Ab [Titer] in Serum |
| 20672-2 | Actinobacillus pleuropneumoniae serotype [Identifier] in Isolate |
| 20673-0 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum |
| 20674-8 | Avian adenovirus 2 Ag [Presence] in Tissue by Immune diffusion (ID) |
| 20675-5 | Bovine adenovirus 3 Ag [Presence] in Tissue by Immunofluorescence |
| 20676-3 | Bovine adenovirus 5 Ag [Presence] in Tissue by Immunofluorescence |
| 20677-1 | Equine adenovirus Ag [Presence] in Lung by Immunofluorescence |
| 20678-9 | Alkaloid identified in Urine by Thin layer chromatography (TLC) |
| 20679-7 | Alkaloid identified in Plant by Thin layer chromatography (TLC) |
| 2068-5 | Chloride [Moles/volume] in Amniotic fluid |
| 20680-5 | Alkaloid identified in Ingesta by Thin layer chromatography (TLC) |
| 20681-3 | Alpha tocopherol [Mass/mass] in Tissue |
| 20682-1 | Ammonia [Mass/volume] in Urine |
| 20683-9 | Ammonia [Mass/volume] in Ingesta |
| 20684-7 | Ammonia [Mass/volume] in Serum |
| 20685-4 | Anaplasma marginale Ab [Presence] in Serum by Card agglutination |
| 20686-2 | Anaplasma marginale Ab [Presence] in Serum by Complement fixation |
| 20687-0 | Arsenic [Mass/volume] in Gastric fluid |
| 20688-8 | Aspergillus sp identified in Litter by Organism specific culture |
| 20689-6 | Babesia caballi Ab [Presence] in Serum by Complement fixation |
| 2069-3 | Chloride [Moles/volume] in Blood |
| 20690-4 | Theileria equi Ab [Presence] in Serum by Complement fixation |
| 20692-0 | Bacillus cereus [Presence] in Food by Culture FDA method |
| 20693-8 | Bacteria identified in Litter by Aerobe culture |
| 20694-6 | Bacteria identified in embryo by Aerobe culture |
| 20695-3 | Bacteria [#/volume] in Mother's milk |
| 20696-1 | Bifidobacterium sp [#/volume] in Milk by Organism specific culture |
| 20697-9 | Amines.biogenic [Mass/mass] in Feed |
| 20698-7 | Bluetongue virus serotype [Identifier] in Isolate |
| 20699-5 | Bluetongue virus Ab [Presence] in Serum by Complement fixation |
| 2070-1 | Chloride [Moles/volume] in Cerebral spinal fluid |
| 20700-1 | Bluetongue virus RNA [Presence] in Tissue by Probe and target amplification method |
| 20701-9 | Bluetongue virus Ag [Presence] in Tissue by Immunofluorescence |
| 20702-7 | Bluetongue virus [Presence] in Unspecified specimen by Organism specific culture |
| 20703-5 | Border disease virus Ag [Presence] in Tissue by Immunofluorescence |
| 20704-3 | Border disease virus Ag [Presence] in Blood by Immunofluorescence |
| 20705-0 | Clostridium botulinum toxin [Identifier] in Serum by Animal inoculation |
| 20706-8 | Clostridium botulinum toxin [Identifier] in Unspecified specimen by Animal inoculation |
| 20708-4 | Bovine papular stomatitis virus Ag [Presence] in Tissue by Immunofluorescence |
| 20709-2 | Bovine diarrhea virus RNA [Presence] in Tissue by Probe and target amplification method |
| 2071-9 | Chloride [Moles/volume] in Dialysis fluid |
| 20710-0 | Bovine diarrhea virus RNA [Presence] in Serum by Probe and target amplification method |
| 20711-8 | Bovine diarrhea virus Ag [Presence] in Nose by Immunofluorescence |
| 20712-6 | Bovine diarrhea virus Ag [Presence] in Tissue by Immunofluorescence |
| 20713-4 | Bovine diarrhea virus Ag [Presence] in Blood by Immunofluorescence |
| 20714-2 | Bovine diarrhea virus Ag [Presence] in Stool by Immunofluorescence |
| 20715-9 | Bovine diarrhea virus Ag [Presence] in Serum by Immune stain |
| 20716-7 | Bovine diarrhea virus [Presence] in Serum by Organism specific culture |
| 20717-5 | Bovine diarrhea virus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 20718-3 | Bromide [Mass/volume] in Ocular fluid |
| 20719-1 | Brucella abortus Ab [Titer] in Serum by Tube agglutination |
| 2072-7 | Chloride [Moles/volume] in Body fluid |
| 20720-9 | Brucella abortus Ab [Presence] in Milk by Serial ring agglutination |
| 20721-7 | Brucella abortus Ab [Presence] in Semen by Agglutination |
| 20722-5 | Brucella abortus Ab [Titer] in Serum by Rivanol agglutination |
| 20723-3 | Brucella abortus Ab [Presence] in Serum by Rapid agglutination |
| 20724-1 | Brucella abortus Ab [Presence] in Whey by Ring agglutination |
| 20725-8 | Brucella abortus Ab [Presence] in Milk by Ring agglutination |
| 20726-6 | Brucella abortus Ab [Presence] in Serum by Card agglutination |
| 20727-4 | Brucella abortus Ab [Presence] in Serum by Acidified buffered plate agglutination |
| 20728-2 | Brucella abortus Ab [Presence] in Serum by Complement fixation |
| 20729-0 | Brucella abortus Ab [Titer] in Serum by Plate agglutination |
| 2073-5 | Chloride [Moles/volume] in Red Blood Cells |
| 20730-8 | Brucella abortus Ab [Presence] in Serum by Immunoassay |
| 20731-6 | Brucella abortus Ab [Presence] in Serum by Immunoassay (EIA) RST |
| 20732-4 | Brucella ovis Ab [Presence] in Serum by Immunoassay |
| 20733-2 | Brucella ovis Ab [Presence] in Serum by Complement fixation |
| 20734-0 | Brucella sp identified in Tissue by Organism specific culture |
| 20735-7 | Brucella sp identified in Milk by Organism specific culture |
| 20736-5 | Cache valley virus Ab [Presence] in Serum by Neutralization test |
| 20737-3 | Cadmium [Mass/mass] in Tissue |
| 20738-1 | Campylobacter sp identified in Isolate by Organism specific culture |
| 20739-9 | Campylobacter sp identified in Body fluid by Organism specific culture |
| 2074-3 | Chloride [Moles/volume] in Saliva (oral fluid) |
| 20740-7 | Campylobacter sp identified in Tissue by Organism specific culture |
| 20741-5 | Canarypox virus Ag [Presence] in Serum by Immunofluorescence |
| 20742-3 | Canine distemper virus Ag [Presence] in Conjunctival specimen by Immunofluorescence |
| 20745-6 | Carbamates [Presence] in Gastric fluid by Screen method |
| 20746-4 | Carbamates [Presence] in Unspecified specimen by Screen method |
| 20747-2 | Carbamates [Presence] in Ingesta by Screen method |
| 20748-0 | Carbamates [Presence] in Tissue by Screen method |
| 20749-8 | Carbamates [Presence] in Feed by Screen method |
| 2075-0 | Chloride [Moles/volume] in Serum or Plasma |
| 20750-6 | Chicken anemia virus Ab [Presence] in Serum by Neutralization test |
| 20751-4 | Chicken anemia virus Ab [Presence] in Serum by Immunoassay |
| 20752-2 | Chlamydophila psittaci [Presence] in Unspecified specimen by Organism specific culture |
| 20753-0 | Chlamydophila psittaci Ag [Presence] in Tissue by Immunofluorescence |
| 20754-8 | Chlamydophila psittaci Ab [Presence] in Serum by Complement fixation |
| 20755-5 | Chlamydia sp Ag [Presence] in Body fluid by Immunoassay |
| 20756-3 | Chlamydia sp Ag [Presence] in Stool by Immunoassay |
| 20757-1 | Chlamydia sp Ag [Presence] in Tissue by Immunofluorescence |
| 20758-9 | Cholinesterase [Enzymatic activity/mass] in Brain |
| 20759-7 | Chromium [Mass/mass] in Tissue |
| 2076-8 | Chloride [Moles/mass] in Stool |
| 20760-5 | Clostridium chauvoei Ag [Presence] in Tissue by Immunofluorescence |
| 20761-3 | Clostridium difficile [Presence] in Stool by Agglutination |
| 20762-1 | Clostridium difficile [Presence] in Stool by Aerobe culture |
| 20763-9 | Clostridium novyii Ag [Presence] in Tissue by Immunofluorescence |
| 20764-7 | Clostridium perfringens genotype [Identifier] in Isolate |
| 20765-4 | Clostridium septicum Ag [Presence] in Tissue by Immunofluorescence |
| 20766-2 | Clostridium sordellii Ag [Presence] in Tissue by Immunofluorescence |
| 20767-0 | Coccidioides immitis [Presence] in Isolate |
| 20768-8 | Coccidioides immitis Ab [Presence] in Serum by Complement fixation |
| 20769-6 | Coliform bacteria [#/volume] in Water by Viability count |
| 2077-6 | Chloride [Moles/volume] in Sweat |
| 20770-4 | Coliform bacteria [#/volume] by Viability count |
| 20771-2 | Coliform bacteria [#/mass] in Egg by Viability count |
| 20772-0 | Coliform colony count [#/volume] in Milk |
| 20773-8 | Colony count [#/volume] in Milk by Culture Standard Plate Count |
| 20774-6 | Colony count [Units/volume] in Unspecified specimen by Visual count |
| 20775-3 | Colony count [Units/volume] in Unspecified specimen by Viability count FDA method |
| 20776-1 | Caprine parapoxvirus Ab [Presence] in Tissue by Immunofluorescence |
| 20777-9 | Caprine parapoxvirus Ab [Presence] in Serum by Complement fixation |
| 20778-7 | Copper [Mass/volume] in Unspecified specimen |
| 20779-5 | Bovine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
| 2078-4 | Chloride [Moles/volume] in Urine |
| 20780-3 | Cryptosporidium sp [Presence] in Large intestine or small intestine Tissue by Acid fast stain |
| 20781-1 | Cryptosporidium sp [Presence] in Stool by Acid fast stain |
| 20782-9 | Cyanide [Mass/mass] in Plant |
| 20783-7 | Cyanide [Units/mass] in Plant Qualitative |
| 20784-5 | Cyanide [Mass/volume] in Unspecified specimen |
| 20785-2 | Drugs identified in Serum or Plasma by Screen method |
| 20786-0 | Drugs identified in Tissue by Screen method |
| 20787-8 | Drugs identified in Unspecified specimen by Screen method |
| 20788-6 | Duck enteritis virus Ab [Presence] in Serum by Neutralization test |
| 20789-4 | Escherichia coli serotype [Identifier] in Isolate |
| 2079-2 | Chloride [Moles/time] in 24 hour Urine |
| 20790-2 | Eastern equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 20791-0 | Eastern equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
| 20792-8 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 20793-6 | Eastern equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 20794-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 20795-1 | Eastern equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
| 20796-9 | Endophyte identified in Plant |
| 20797-7 | Endotoxin identified in Unspecified specimen |
| 20798-5 | Clostridium perfringens enterotoxin [Presence] in Tissue |
| 20799-3 | Clostridium perfringens enterotoxin [Presence] in Body fluid |
| 2080-0 | Cholate [Mass/volume] in Serum |
| 20800-9 | Clostridium perfringens enterotoxin [Presence] in Small intestine Fixed |
| 20801-7 | Encephalitozoon cuniculi Ab [Presence] in Serum |
| 20802-5 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Neutralization test |
| 20803-3 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum |
| 20804-1 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood by Immunofluorescence |
| 20805-8 | Epizootic hemorrhagic disease virus Ag [Units/mass] in Lung Qualitative by Immunofluorescence |
| 20806-6 | Saint Louis encephalitis virus Ab [Presence] in Serum |
| 20807-4 | Equine arteritis virus [Presence] in Blood by Organism specific culture |
| 20808-2 | Ergot alkaloid [Mass/volume] in Unspecified specimen |
| 20809-0 | Ergot alkaloid [Mass/mass] in Feed |
| 2081-8 | Cholecystokinin [Mass/volume] in Plasma |
| 20811-6 | Escherichia coli [Presence] in Unspecified specimen by Culture FDA method |
| 20812-4 | Escherichia coli 987P [Presence] in Small intestine Tissue by Immunofluorescence |
| 20813-2 | Escherichia coli F41 [Presence] in Isolate by Agglutination |
| 20814-0 | Escherichia coli F41 [Presence] in Small intestine Tissue by Immunofluorescence |
| 20815-7 | Escherichia coli K88 [Presence] in Small intestine Tissue by Agglutination |
| 20816-5 | Escherichia coli K88 [Presence] in Isolate by Agglutination |
| 20817-3 | Escherichia coli K88 [Presence] in Small intestine Tissue by Immunofluorescence |
| 20818-1 | Escherichia coli K99 [Presence] in Small intestine Tissue by Agglutination |
| 20819-9 | Escherichia coli K99 [Presence] in Isolate by Agglutination |
| 2082-6 | Cholestanol [Mass/volume] in Serum or Plasma |
| 20821-5 | Escherichia coli K99 [Presence] in Stool by Agglutination |
| 20822-3 | Escherichia coli K99 [Presence] in Small intestine Tissue by Immunofluorescence |
| 20823-1 | Escherichia coli O157:H7 [Presence] in Raw milk by Organism specific culture |
| 20825-6 | Fumonisin [Mass/mass] in Feed |
| 20826-4 | Gallotannin [Mass/volume] in Serum or Plasma |
| 20827-2 | Gallotannin [Mass/mass] in Gastric fluid |
| 20828-0 | Gallotannin [Mass/mass] in Plant |
| 20829-8 | Glycol [Mass/mass] in Tissue |
| 2083-4 | Cholesterol esterase [Enzymatic activity/volume] in Serum |
| 20830-6 | Glycol [Mass/volume] in Urine |
| 20831-4 | Glycolate [Mass/mass] in Tissue |
| 20832-2 | Gossypol [Mass/mass] in Feed |
| 20833-0 | Haemophilus paragallinarum serotype [Identifier] in Isolate |
| 20834-8 | Deprecated Herbicide [Identifier] in Unspecified specimen |
| 20835-5 | Herbicide [Identifier] in Ingesta |
| 20836-3 | Herbicide [Identifier] in Tissue |
| 20837-1 | Herbicide [Identifier] in Feed |
| 20838-9 | Herbicide [Presence] in Gastric fluid by Screen method |
| 20839-7 | Herbicide [Presence] in Unspecified specimen by Screen method |
| 2084-2 | Cholesterol esters [Mass/volume] in Serum or Plasma |
| 20840-5 | Herbicide [Presence] in Ingesta by Screen method |
| 20841-3 | Herbicide [Presence] in Tissue by Screen method |
| 20842-1 | Herbicide [Presence] in Feed by Screen method |
| 20843-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence |
| 20844-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Lung tissue by Immunofluorescence |
| 20845-4 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunoassay |
| 20846-2 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 20847-0 | Bovine herpesvirus 2 Ag [Presence] in Exudate by Immunofluorescence |
| 20848-8 | Bovine herpesvirus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 20849-6 | Bovine herpesvirus 4 Ag [Presence] in Body fluid by Immunofluorescence |
| 2085-9 | Cholesterol in HDL [Mass/volume] in Serum or Plasma |
| 20850-4 | Bovine herpesvirus 4 Ag [Presence] in Tissue by Immunofluorescence |
| 20851-2 | Bovine herpesvirus 5 Ag [Presence] in Tissue by Immunofluorescence |
| 20852-0 | Duck enteritis virus Ag [Presence] in Tissue by Immunofluorescence |
| 20853-8 | Equine herpesvirus 1 Ag [Presence] in Tracheal swab by Immunofluorescence |
| 20854-6 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 20855-3 | IgG.bovine [Mass/volume] in Serum by Immune diffusion (ID) |
| 20856-1 | IgG.equine [Mass/volume] in Body fluid from Fetus by Immune diffusion (ID) |
| 20857-9 | IgG.equine [Mass/volume] in Colostrum by Immune diffusion (ID) |
| 20858-7 | Infectious bronchitis virus genotype [Identifier] in Isolate by Polyacrylamide gel electrophoresis (PAGE) |
| 20859-5 | Infectious bronchitis virus serotype [Identifier] in Isolate by Neutralization test |
| 20860-3 | Infectious bronchitis virus [Presence] in Tissue by Organism specific culture |
| 20861-1 | Infectious bronchitis virus genotype [Identifier] in Isolate by Probe and target amplification method |
| 20862-9 | Influenza virus A Ab [Presence] in Serum by Hemagglutination inhibition |
| 20864-5 | Iodine [Mass/volume] in Milk |
| 20865-2 | Iodine [Mass/mass] in Liver |
| 20866-0 | Lactobacillus acidophilus colony count [#/volume] in Milk by Organism specific culture |
| 20867-8 | Lead [Mass/mass] in Bone |
| 20868-6 | Leptospira sp [Presence] in Tissue by Immunofluorescence |
| 20869-4 | Leptospira sp [Presence] in Tissue by Organism specific culture |
| 20870-2 | Listeria sp [Presence] in Milk by Organism specific culture |
| 20871-0 | Listeria sp [Presence] in Cheese by Organism specific culture |
| 20872-8 | Magnesium [Mass/volume] in Ocular fluid |
| 20873-6 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
| 20874-4 | Manganese [Mass/mass] in Tissue |
| 20875-1 | Manganese [Mass/mass] in Feed |
| 20876-9 | Mercury [Mass/mass] in Feed |
| 20877-7 | Bacteria identified in Isolate by Animal inoculation |
| 20878-5 | Bacteria identified in Isolate by Anaerobe culture |
| 20879-3 | Bacteria identified in Milk by Aerobe culture |
| 20881-9 | Microscopic observation [Identifier] in Tissue by Electron microscopy thin sectiion |
| 20882-7 | Microscopic observation [Identifier] in Stool by Electron microscopy negative stain |
| 20883-5 | Microscopic observation [Identifier] in Urine by Dark field examination |
| 20884-3 | Microscopic observation [Identifier] in Stool by Dark field examination |
| 20885-0 | Microscopic observation [Identifier] in Gastric fluid by Dark field examination |
| 20886-8 | Molybdenum [Mass/volume] in Unspecified specimen |
| 20887-6 | Molybdenum [Mass/mass] in Tissue |
| 20888-4 | Molybdenum [Mass/mass] in Feed |
| 20889-2 | Monensin [Mass/mass] in Gastric fluid |
| 2089-1 | Cholesterol in LDL [Mass/volume] in Serum or Plasma |
| 20890-0 | Monensin [Mass/mass] in Feed |
| 20891-8 | Mushroom identified |
| 20892-6 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Organism specific culture |
| 20893-4 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Organism specific culture |
| 20894-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Complement fixation |
| 20895-9 | Mycoplasma gallisepticum Ag [Presence] in Tissue by Immune stain |
| 20896-7 | Mycoplasma sp [Presence] in Tissue by Culture NPIP (National Poultry Improvement Plan) |
| 20897-5 | Mycoplasma sp serotype [Identifier] in Isolate |
| 20898-3 | Mycoplasma sp [Presence] in Milk by Organism specific culture |
| 20899-1 | Mycoplasma sp [Presence] in Exudate by Organism specific culture |
| 20900-7 | Mycoplasma sp Ab [Presence] in Serum by Immunoassay |
| 20901-5 | Mycoplasma sp Ag [Presence] in Isolate by Immune stain |
| 20902-3 | Mycoplasma sp+Ureaplasma sp [Presence] in Tissue by Organism specific culture |
| 20903-1 | Mycotoxin identified in Feed |
| 20904-9 | Neospora caninum Ab [Presence] in Serum by Immunofluorescence |
| 20905-6 | Oleandrin [Mass/volume] in Urine |
| 20906-4 | Oleandrin [Mass/volume] in Ingesta |
| 20907-2 | Organochlorine pesticides [Identifier] in Blood |
| 20908-0 | Organochlorine pesticides [Identifier] in Unspecified specimen |
| 20909-8 | Organochlorine pesticides [Identifier] in Gastric fluid |
| 20910-6 | Organochlorine pesticides [Identifier] in Milk |
| 20911-4 | Organochlorine pesticides [Identifier] in Tissue |
| 20912-2 | Organochlorine pesticides [Presence] in Blood by Screen method |
| 20913-0 | Organochlorine pesticides [Presence] in Unspecified specimen by Screen method |
| 20914-8 | Organochlorine pesticides [Presence] in Gastric fluid by Screen method |
| 20915-5 | Organochlorine pesticides [Presence] in Milk by Screen method |
| 20916-3 | Organochlorine pesticides [Presence] in Tissue by Screen method |
| 20917-1 | Organophosphate pesticides [Presence] in Blood by Screen method |
| 20918-9 | Organophosphate pesticides [Presence] in Unspecified specimen by Screen method |
| 20919-7 | Organophosphate pesticides [Presence] in Gastric fluid by Screen method |
| 20920-5 | Organophosphate pesticides [Presence] in Tissue by Screen method |
| 20921-3 | Organophosphate pesticides [Identifier] in Unspecified specimen |
| 20922-1 | Organophosphate pesticides [Identifier] in Gastric fluid |
| 20923-9 | Organophosphate pesticides [Identifier] in Tissue |
| 20924-7 | Ova and parasites identified in Stool by Parasite sedimentation |
| 20925-4 | Ova and parasites identified in Stool by McMaster concentration |
| 20926-2 | Ova and parasites identified in Stool by Baerman concentration |
| 20927-0 | Oxalate [Mass/mass] in Tissue |
| 20928-8 | Oxalate [Mass/mass] in Plant |
| 20929-6 | Paraquat [Mass/volume] in Gastric fluid |
| 2093-3 | Cholesterol [Mass/volume] in Serum or Plasma |
| 20930-4 | Paraquat [Mass/mass] in Tissue |
| 20931-2 | Parasites [#/volume] in Gastric fluid |
| 20932-0 | Parasite identified in Unspecified specimen by Inspection |
| 20933-8 | Parasite identified in Serum by Light microscopy |
| 20934-6 | Bovine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 20935-3 | Pasteurella multocida serotype [Identifier] in Isolate by Immune diffusion (ID) |
| 20936-1 | Pentachlorophenol [Mass/mass] in Tissue |
| 20937-9 | Pentachlorophenol [Mass/mass] in Fat |
| 20938-7 | Phenols [Mass/volume] in Gastric fluid |
| 20939-5 | Phosphide [Mass/mass] in Gastrointestinal content |
| 2094-1 | Cholesterol.non-esterified [Mass/volume] in Serum or Plasma |
| 20940-3 | Phosphide [Mass/mass] in Feed |
| 20942-9 | Plant identified [Type] in Plant |
| 20943-7 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immune stain |
| 20944-5 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunoassay |
| 20945-2 | Bovine respiratory syncytial virus Ag [Presence] in Lung by Immunofluorescence |
| 20946-0 | Retinol [Mass/mass] in Liver |
| 20947-8 | Retinol [Mass/mass] in Feed |
| 20948-6 | Retinol [Mass/mass] in Tissue |
| 20949-4 | Rickettsia sp [Presence] in Blood by Light microscopy |
| 20950-2 | Bovine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
| 20951-0 | Salmonella sp serotype [Identifier] in Isolate by Agglutination |
| 20952-8 | Salmonella sp identified in Egg by Organism specific culture |
| 20953-6 | Salmonella sp identified in Tissue by Organism specific culture |
| 20955-1 | Salmonella sp identified in Stool by Organism specific culture |
| 20956-9 | Sarcocystis neurona Ab [Presence] in Body fluid by Immunoblot (IB) |
| 20957-7 | Sarcocystis neurona Ab [Presence] in Serum by Immunoblot (IB) |
| 20958-5 | Sarcocystis neurona Ab [Presence] in Blood by Immunoblot (IB) |
| 20959-3 | Sarcocystis neurona Ag [Presence] in Tissue by Immune stain |
| 20960-1 | Selenium [Mass/mass] in Gastric fluid |
| 20961-9 | Selenium [Mass/mass] in Feed |
| 20962-7 | Serpulina hyodysenteria [Presence] in Spiral colon by Organism specific culture |
| 20963-5 | Serpulina hyodysenteria [Presence] in Stool by Organism specific culture |
| 20964-3 | Shigella sp identified in Feed by Organism specific culture |
| 20965-0 | Somatic cells [#/volume] in Milk |
| 20966-8 | Staphylococcus sp identified in Unspecified specimen by Organism specific culture |
| 20967-6 | Staphylococcus sp identified in Milk by Organism specific culture |
| 20968-4 | Staphylococcus sp identified in Cheese by Organism specific culture |
| 20969-2 | Strychnine [Presence] in Gastric fluid |
| 2097-4 | Cholinesterase [Enzymatic activity/volume] in Amniotic fluid |
| 20970-0 | Strychnine [Presence] in Unspecified specimen |
| 20972-6 | Strychnine [Mass/mass] in Tissue |
| 20973-4 | Sulfate [Mass/volume] in Gastric fluid |
| 20974-2 | Sulfate [Mass/volume] in Serum or Plasma |
| 20975-9 | Thallium [Mass/mass] in Tissue |
| 20976-7 | Tritrichomonas foetus [Presence] in Preputial wash by Organism specific culture |
| 20977-5 | Urea [Mass/volume] in Blood |
| 20978-3 | Urea [Mass/volume] in Gastric fluid |
| 20979-1 | Urea [Mass/mass] in Feed |
| 2098-2 | Cholinesterase [Enzymatic activity/volume] in Serum or Plasma |
| 20980-9 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
| 20981-7 | Verotoxin identified in Isolate |
| 20982-5 | Western equine encephalitis virus Ab [Titer] in Serum by Neutralization test |
| 20983-3 | Western equine encephalitis virus Ab [Presence] in Serum by Immunofluorescence |
| 20984-1 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
| 20985-8 | Western equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 20986-6 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid by Complement fixation |
| 20987-4 | Yersinia sp identified in Dairy product by Organism specific culture |
| 20988-2 | Zinc phosphide [Mass/mass] in Gastrointestinal content |
| 20989-0 | Zinc phosphide [Mass/mass] in Unspecified specimen |
| 2099-0 | Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 20990-8 | APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 20992-4 | Bordetella pertussis Ab [Presence] in Unspecified specimen |
| 20993-2 | Deprecated Chlamydia trachomatis DNA [Presence] in Unspecified specimen by DNA probe |
| 2100-6 | Cholylglycine [Mass/volume] in Serum |
| 21003-9 | Fungus identified in Unspecified specimen by Fungus stain |
| 21005-4 | Hepatitis B virus core Ab [Units/volume] in Serum from donor by Immunoassay |
| 21006-2 | Hepatitis B virus surface Ab [Units/volume] in Serum from donor by Immunoassay |
| 21007-0 | HIV 1 Ab [Presence] in Serum from donor |
| 21008-8 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by DNA probe |
| 2101-4 | Cholylglycine.conjugated [Mass/volume] in Serum |
| 21016-1 | CD41 cells [#/volume] in Blood |
| 21019-5 | Metanephrine [Mass/volume] in 24 hour Urine |
| 2102-2 | Chondroitin sulfate [Mass/volume] in Urine |
| 21020-3 | Bacteria identified in Unspecified specimen by Anaerobe+Aerobe culture |
| 21021-1 | Microscopic observation [Identifier] in Bronchial specimen by Gram stain |
| 21022-9 | Microscopic observation [Identifier] in Dialysis fluid by Gram stain |
| 21023-7 | Neutrophil cytoplasmic Ab [Titer] in Serum |
| 2103-0 | Choriomammotropin [Mass/volume] in Amniotic fluid |
| 21030-2 | Reagin Ab [Presence] in Serum from donor by VDRL |
| 21034-4 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --evening specimen |
| 21035-1 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --morning specimen |
| 21036-9 | 17-Hydroxycorticosteroids [Mass/time] in 24 hour Urine |
| 21037-7 | 17-Hydroxypregnenolone [Mass/time] in 24 hour Urine |
| 21038-5 | 17-Ketosteroids [Mass/volume] in 24 hour Urine |
| 21039-3 | 18-Hydroxycortisol [Mass/volume] in 24 hour Urine |
| 2104-8 | Choriomammotropin [Mass/volume] in Serum |
| 21043-5 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in 24 hour Urine |
| 21044-3 | 5-Alpha tetrahydrocortisol [Mass/time] in 24 hour Urine |
| 21045-0 | 5-Hydroxytryptophan [Mass/time] in 24 hour Urine |
| 21046-8 | 7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma |
| 21047-6 | 8-Hydroxyloxapine [Mass/volume] in Urine |
| 21048-4 | Acetaldehyde [Mass/volume] in Urine |
| 21049-2 | Acetone [Mass/mass] in Tissue |
| 2105-5 | Choriogonadotropin [Moles/volume] in Semen |
| 21051-8 | Acrylaldehyde [Mass/volume] in Serum or Plasma |
| 21052-6 | Adenosine monophosphate.cyclic.nephrogenous [Moles/volume] in Urine and Serum or Plasma |
| 21053-4 | Adenovirus IgG Ab [Titer] in Serum |
| 21054-2 | Adenovirus IgM Ab [Presence] in Serum |
| 21055-9 | Adenovirus DNA [Presence] in Serum or Plasma by Probe and target amplification method |
| 21056-7 | Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine [Presence] in Urine |
| 21057-5 | Alanine+Histidine+Leucine+Phenylalanine+Tyrosine [Presence] in Serum or Plasma |
| 21059-1 | Albumin [Mass/volume] in 24 hour Urine |
| 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine |
| 21062-5 | Allobarbital [Mass/volume] in Serum or Plasma |
| 21064-1 | Acid alpha glucosidase [Enzymatic activity/volume] in Amniotic fluid |
| 21066-6 | Ampicillin [Mass/volume] in Unspecified specimen |
| 2107-1 | Choriogonadotropin [Moles/volume] in Urine |
| 21071-6 | Antimony [Mass/volume] in 24 hour Urine |
| 21074-0 | Arsenic [Mass/volume] in 24 hour Urine |
| 21075-7 | Ascaris lumbricoides IgE Ab [Units/volume] in Serum |
| 21077-3 | Black Ash IgE Ab [Units/volume] in Serum |
| 21078-1 | Green Ash IgE Ab [Units/volume] in Serum |
| 2108-9 | Choriogonadotropin.alpha subunit [Presence] in Serum or Plasma |
| 21081-5 | ASPA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21084-9 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21085-6 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21086-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21088-0 | Azinphos-methyl [Mass/volume] in Urine |
| 21089-8 | Babesia microti DNA [Presence] in Blood by Probe and target amplification method |
| 2109-7 | Choriogonadotropin.alpha subunit [Moles/volume] in Serum or Plasma |
| 21095-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21096-3 | Black Bean IgE Ab [Units/volume] in Serum |
| 2110-5 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma |
| 21107-8 | Bendiocarb [Mass/volume] in Urine |
| 21108-6 | Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum |
| 2111-3 | Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
| 21113-6 | Bismuth [Mass/volume] in 24 hour Urine |
| 21118-5 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoassay |
| 21119-3 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoassay |
| 2112-1 | Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine |
| 21120-1 | Borrelia burgdorferi DNA [Presence] in Urine by Probe and target amplification method |
| 21121-9 | Borrelia hermsii IgG Ab [Titer] in Serum by Immunofluorescence |
| 21122-7 | Borrelia hermsii IgM Ab [Titer] in Serum by Immunofluorescence |
| 21125-0 | Brush border Ab [Titer] in Serum by Immunofluorescence |
| 21128-4 | Cadmium [Mass/mass] in Nail |
| 21129-2 | Cadmium [Mass/volume] in Serum or Plasma |
| 2113-9 | Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine |
| 21130-0 | Cadmium [Mass/volume] in 24 hour Urine |
| 21135-9 | Canrenone [Mass/volume] in Serum or Plasma |
| 21139-1 | Carbofuran [Mass/volume] in Urine |
| 2114-7 | Choriogonadotropin.beta subunit [Moles/volume] in Urine |
| 21140-9 | Carbophenothion [Mass/volume] in Urine |
| 21142-5 | Carisoprodol [Presence] in Urine |
| 21143-3 | Carp IgE Ab [Units/volume] in Serum |
| 21148-2 | White Cedar IgE Ab [Units/volume] in Serum |
| 2115-4 | Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma |
| 21151-6 | Ceftazidime [Mass/volume] in Unspecified specimen |
| 2116-2 | Choriogonadotropin.intact [Presence] in Serum or Plasma |
| 2117-0 | Choriogonadotropin.intact [Moles/volume] in Serum or Plasma |
| 21173-0 | Cephaeline [Mass/volume] in Serum or Plasma |
| 21174-8 | Cephaeline [Mass/volume] in Urine |
| 21175-5 | Cephalexin [Mass/volume] in Unspecified specimen |
| 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma |
| 21184-7 | Chlamydophila pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
| 21185-4 | Chlamydia sp IgG Ab [Presence] in Serum |
| 21186-2 | Chlamydia sp IgM Ab [Presence] in Serum |
| 21187-0 | Chlamydia trachomatis DNA [Presence] in Conjunctival specimen by Probe and target amplification method |
| 21188-8 | Chlamydia trachomatis rRNA [Presence] in Conjunctival specimen by DNA probe |
| 21189-6 | Chlamydia trachomatis DNA [Presence] in Cervical mucus by Probe and target amplification method |
| 2119-6 | Choriogonadotropin [Moles/volume] in Serum or Plasma |
| 21190-4 | Chlamydia trachomatis DNA [Presence] in Cervix by Probe and target amplification method |
| 21191-2 | Chlamydia trachomatis DNA [Presence] in Urethra by Probe and target amplification method |
| 21192-0 | Chlamydia trachomatis rRNA [Presence] in Urethra by DNA probe |
| 21193-8 | Chlordiazepoxide+Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
| 21194-6 | Chloride [Moles/volume] in 24 hour Urine |
| 21195-3 | Chlorzoxazone [Mass/volume] in Urine |
| 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
| 21199-5 | Chromium [Mass/volume] in Body fluid |
| 2120-4 | Chylomicrons [Mass/volume] in Serum or Plasma |
| 21200-1 | Chromium [Mass/mass] in Nail |
| 21201-9 | Chromium [Mass/volume] in 24 hour Urine |
| 21203-5 | Citrate [Mass/volume] in 24 hour Urine |
| 21206-8 | Sweet Clover IgE Ab [Units/volume] in Serum |
| 21207-6 | CCR5 gene mutations found [Identifier] in Blood by Molecular genetics method Nominal |
| 21208-4 | Cobalt [Mass/volume] in 24 hour Urine |
| 21209-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 2121-2 | Chylomicrons [Presence] in Serum or Plasma |
| 21215-9 | Collagen crosslinked N-telopeptide [Moles/volume] in Serum |
| 21216-7 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in 24 hour Urine |
| 21217-5 | Complement C4d [Mass/volume] in Plasma |
| 21218-3 | Complement total hemolytic CH50 [Units/volume] in Cerebral spinal fluid |
| 21219-1 | Copper [Mass/volume] in 24 hour Urine |
| 2122-0 | Chymopapain [Mass/volume] in Serum |
| 21229-0 | Coumaphos [Mass/volume] in Urine |
| 2123-8 | Chymotrypsin [Enzymatic activity/volume] in Body fluid |
| 21232-4 | Creatinine [Mass/volume] in Arterial blood |
| 21233-2 | Cryptosporidium sp Ag [Presence] in Stool |
| 21236-5 | Cyclohexanone [Mass/volume] in Urine |
| 21237-3 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21239-9 | Desalkylhalazepam [Mass/volume] in Serum or Plasma |
| 2124-6 | Chymotrypsin [Mass/volume] in Serum or Plasma |
| 21240-7 | Dextromethorphan [Mass/volume] in Urine |
| 21241-5 | Diazepam+Nordiazepam [Mass/volume] in Urine |
| 21243-1 | Diethyl ether [Mass/volume] in Urine |
| 21245-6 | Diisobutylketone [Mass/volume] in Urine |
| 21246-4 | Dimethoate [Mass/volume] in Urine |
| 21247-2 | DMD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21248-0 | Dobutamine [Mass/volume] in Serum or Plasma |
| 2125-3 | Chymotrypsin [Mass/mass] in Stool |
| 21250-6 | Doxycycline [Mass/volume] in Unspecified specimen |
| 21252-2 | Echinococcus granulosus IgG Ab [Presence] in Serum by Immunoblot (IB) |
| 21259-7 | Entamoeba histolytica Ab [Titer] in Serum by Hemagglutination |
| 2126-1 | Citrate [Mass/volume] in Semen |
| 21260-5 | Epstein Barr virus nuclear Ab [Titer] in Serum by Immunofluorescence |
| 21262-1 | Escherichia coli shiga-like [Presence] in Stool by Immunoassay |
| 21263-9 | Estradiol (E2) [Mass/time] in 24 hour Urine |
| 21266-2 | Ethion [Mass/volume] in Urine |
| 21267-0 | Ethyl O-(P-nitrophenyl) phenylphosphonothionate [Mass/volume] in Urine |
| 21268-8 | Fenchlorphos [Mass/volume] in Urine |
| 21269-6 | Fenthion [Mass/volume] in Urine |
| 2127-9 | Citrate [Mass/volume] in Serum or Plasma |
| 21271-2 | Fireweed IgE Ab [Units/volume] in Serum |
| 2128-7 | Citrate [Mass/volume] in Urine |
| 21280-3 | Fonofos [Mass/volume] in Urine |
| 21284-5 | Gardnerella vaginalis [Presence] in Genital specimen by Organism specific culture |
| 21300-9 | Giardia lamblia IgA Ab [Titer] in Serum by Immunofluorescence |
| 21301-7 | Giardia lamblia IgM Ab [Titer] in Serum by Immunofluorescence |
| 21302-5 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --2nd specimen |
| 21303-3 | Giardia lamblia Ag [Presence] in Stool by Immunoassay --3rd specimen |
| 21305-8 | Glucose [Mass/volume] in 24 hour Urine |
| 21306-6 | Glucose [Mass/time] in 8 hour Urine |
| 21307-4 | Glucose [Mass/time] in 10 hour Urine |
| 21312-4 | Gold [Mass/volume] in Body fluid |
| 21317-3 | Deprecated Groundsel Tree IgE Ab [Units/volume] in Serum |
| 2132-9 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma |
| 21320-7 | Haemophilus influenzae B Ag [Presence] in Unspecified specimen by Latex agglutination |
| 21322-3 | Hantavirus puumala IgG Ab [Titer] in Serum by Immunofluorescence |
| 21323-1 | Hantavirus puumala IgM Ab [Titer] in Serum by Immunofluorescence |
| 21326-4 | Herpes simplex virus 1 IgM Ab [Titer] in Serum |
| 21327-2 | Herpes simplex virus 2 IgM Ab [Titer] in Serum |
| 2133-7 | Collagenase [Enzymatic activity/volume] in Serum |
| 21330-6 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid by Immune diffusion (ID) |
| 21333-0 | HIV 1 RNA [#/volume] in Serum |
| 21345-4 | HTLV I+II Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 21348-8 | HTLV I+II IgG Ab [Presence] in Serum by Immunoassay |
| 21361-1 | Laxatives present [Identifier] in Stool by Screen method |
| 21362-9 | Legionella pneumophila IgG Ab [Titer] in Serum by Immunofluorescence |
| 21363-7 | Legionella pneumophila DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 21365-2 | Leptin [Mass/volume] in Serum or Plasma |
| 21368-6 | Levofloxacin [Mass/volume] in Serum or Plasma |
| 21377-7 | Magnesium [Mass/volume] in Blood |
| 21378-5 | Malathion [Mass/volume] in Urine |
| 2138-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Serum |
| 21380-1 | Prolactin [Mass/time] in 24 hour Urine |
| 21382-7 | Manganese [Mass/volume] in 24 hour Urine |
| 21383-5 | Mercury [Mass/volume] in 24 hour Urine |
| 21385-0 | Metasystox [Mass/volume] in Urine |
| 21386-8 | Methamphetamine [Presence] in Urine by SAMHSA confirm method |
| 21387-6 | Methylhippurate [Mass/volume] in Urine |
| 21388-4 | Mevinphos [Mass/volume] in Urine |
| 21389-2 | Saccharopolyspora rectivirgula IgE Ab [Units/volume] in Serum |
| 2139-4 | Corticosterone [Mass/volume] in Serum or Plasma |
| 21391-8 | Microscopic observation [Identifier] in Bone by Acid phosphatase stain |
| 2140-2 | Corticotropin [Mass/volume] in Amniotic fluid |
| 21401-5 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21402-3 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21405-6 | Mycobacterium sp DNA [Presence] in Bronchial specimen by Probe and target amplification method |
| 21406-4 | Mycoplasma pneumoniae IgM Ab [Presence] in Serum |
| 21407-2 | Myelin IgA Ab [Titer] in Serum |
| 21408-0 | Myelin IgG Ab [Titer] in Serum |
| 21409-8 | Myelin IgM Ab [Titer] in Serum |
| 2141-0 | Corticotropin [Mass/volume] in Plasma |
| 21410-6 | Myelin associated glycoprotein IgM Ab [Titer] in Serum |
| 21411-4 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum |
| 21413-0 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/volume] in Urine |
| 21414-8 | Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by Probe and target amplification method |
| 21415-5 | Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe and target amplification method |
| 21416-3 | Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method |
| 21417-1 | Neurokinin A [Units/volume] in Serum or Plasma |
| 21418-9 | Neutrophil Ab [Presence] in Serum |
| 2142-8 | Cortisol [Mass/volume] in Saliva (oral fluid) |
| 21420-5 | Nitrate [Mass/volume] in Urine |
| 21421-3 | Norketamine [Mass/volume] in Serum or Plasma |
| 21422-1 | Normetanephrine [Mass/volume] in 24 hour Urine |
| 21423-9 | Nuclear Ab [Titer] in Serum by Immunofluorescence (IF) rat liver |
| 21424-7 | Nuclear IgG Ab [Presence] in Serum by Immunofluorescence |
| 21428-8 | Olive IgE Ab [Units/volume] in Serum |
| 2143-6 | Cortisol [Mass/volume] in Serum or Plasma |
| 21431-2 | Opiates [Presence] in Urine by Screen method >2000 ng/mL |
| 21435-3 | Osteocalcin.bovine [Mass/volume] in Serum or Plasma |
| 21436-1 | Ovary Ab [Presence] in Serum by Immunofluorescence |
| 21437-9 | Oxychlordane [Mass/volume] in Serum or Plasma |
| 2144-4 | Cortisol [Mass/volume] in Urine |
| 21440-3 | Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by DNA probe |
| 21441-1 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by DNA probe |
| 21442-9 | Parainfluenza virus identified in Nose by Organism specific culture |
| 21443-7 | Paraoxon [Mass/volume] in Urine |
| 2145-1 | Cortisol Free [Mass/volume] in Serum or Plasma |
| 21457-7 | Phorate [Mass/volume] in Urine |
| 21458-5 | Phosphate [Mass/volume] in 24 hour Urine |
| 21461-9 | Lodgepole Pine+Pondersosa Pine IgE Ab [Units/volume] in Serum |
| 21464-3 | Plasminogen activator urokinase type [Presence] in Tissue |
| 21465-0 | Plasmodium falciparum Ab [Titer] in Serum by Immunofluorescence |
| 21466-8 | Plasmodium malariae Ab [Titer] in Serum by Immunofluorescence |
| 21467-6 | Plasmodium ovale Ab [Titer] in Serum by Immunofluorescence |
| 21468-4 | Plasmodium vivax Ab [Titer] in Serum by Immunofluorescence |
| 2147-7 | Cortisol Free [Mass/time] in 24 hour Urine |
| 21471-8 | Pomegranate IgE Ab [Units/volume] in Serum |
| 21473-4 | White Poplar IgE Ab [Units/volume] in Serum |
| 21476-7 | Potassium [Moles/volume] in 24 hour Urine |
| 21477-5 | Deprecated Potato IgE Ab [Units/volume] in Serum |
| 2148-5 | Creatine [Mass/volume] in Serum or Plasma |
| 21480-9 | Propoxur [Mass/volume] in Urine |
| 21481-7 | Propranolol [Mass/volume] in Gastric fluid |
| 21482-5 | Protein [Mass/volume] in 24 hour Urine |
| 21483-3 | Quinidine [Mass/volume] in Serum or Plasma --peak |
| 21487-4 | Ribosomal P Ab [Units/volume] in Cerebral spinal fluid |
| 21489-0 | Rickettsia (Proteus OX19) Ab [Titer] in Serum by Latex agglutination |
| 2149-3 | Creatine [Mass/volume] in Urine |
| 21490-8 | Rickettsia (Proteus OX2) Ab [Titer] in Serum by Latex agglutination |
| 21491-6 | Rickettsia (Proteus OXK) Ab [Titer] in Serum by Latex agglutination |
| 21492-4 | Rickettsia conorii IgG Ab [Titer] in Serum |
| 21493-2 | Rickettsia conorii IgM Ab [Titer] in Serum |
| 21494-0 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21495-7 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21496-5 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21497-3 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21498-1 | Orientia tsutsugamushi IgG Ab [Titer] in Serum |
| 2150-1 | Creatine [Mass/time] in 24 hour Urine |
| 21500-4 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21501-2 | Measles virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 21502-0 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21503-8 | Measles virus IgM Ab [Presence] in Serum |
| 21509-5 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2151-9 | Creatine kinase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 21510-3 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21511-1 | Salmonella paratyphi A H Ab [Titer] in Serum by Agglutination |
| 21512-9 | Salmonella paratyphi A H Ab [Titer] in Serum by Immunofluorescence |
| 21513-7 | Salmonella paratyphi B H Ab [Titer] in Serum by Agglutination |
| 21514-5 | Salmonella paratyphi B H Ab [Titer] in Serum by Immunofluorescence |
| 21518-6 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum |
| 2152-7 | Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 21522-8 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum |
| 21523-6 | Smith extractable nuclear IgG Ab [Presence] in Serum |
| 21525-1 | Sodium [Moles/volume] in 24 hour Urine |
| 21526-9 | Sodium [Mass/volume] in 24 hour Urine |
| 21527-7 | Sodium [Mass/time] in 24 hour Urine |
| 2153-5 | Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma |
| 21536-8 | Acid sphingomyelinase [Enzymatic activity/volume] in Blood |
| 2154-3 | Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 21545-9 | Sulfatide IgG Ab [Titer] in Cerebral spinal fluid |
| 21546-7 | Sulfatide IgM Ab [Titer] in Cerebral spinal fluid |
| 2155-0 | Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis |
| 21554-1 | Terbufos [Mass/volume] in Urine |
| 21556-6 | Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL |
| 21557-4 | Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL |
| 21558-2 | Thallium [Mass/volume] in 24 hour Urine |
| 21559-0 | Theophylline [Mass/volume] in Gastric fluid |
| 2156-8 | Creatine kinase [Enzymatic activity/volume] in Amniotic fluid |
| 21560-8 | Thermoactinomyces candidus Ab [Presence] in Serum |
| 21561-6 | Thermoactinomyces sacchari Ab [Presence] in Serum |
| 21562-4 | Thiocyanate/Creatinine [Mass Ratio] in Urine |
| 21563-2 | Thiopurine methyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 21564-0 | Thiosulfate [Mass/volume] in Serum or Plasma |
| 21565-7 | Tiagabine [Mass/volume] in Serum or Plasma |
| 21566-5 | Tolazamide [Presence] in Serum or Plasma |
| 21567-3 | Tolbutamide [Presence] in Serum or Plasma |
| 21569-9 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2157-6 | Creatine kinase [Enzymatic activity/volume] in Serum or Plasma |
| 21570-7 | Toxoplasma gondii IgG Ab [Presence] in Serum by Sabin dye test |
| 21571-5 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21579-8 | Trichloroethylene [Mass/volume] in Blood |
| 21580-6 | Trimethobenzamide [Mass/volume] in Unspecified specimen |
| 21582-2 | Tryptase [Mass/volume] in Serum or Plasma |
| 21585-5 | Uranium [Mass/volume] in 24 hour Urine |
| 21586-3 | Uranium [Mass/time] in 24 hour Urine |
| 21587-1 | Urate [Mass/volume] in 24 hour Urine |
| 21588-9 | Urobilinogen [Mass/mass] in Stool |
| 2159-2 | Creatinine [Mass/volume] in Amniotic fluid |
| 21592-1 | Varicella zoster virus Ab [Titer] in Cerebral spinal fluid |
| 21594-7 | Varicella zoster virus Ab [Titer] in Serum |
| 21595-4 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21596-2 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 21597-0 | Varicella zoster virus IgM Ab [Presence] in Serum |
| 21598-8 | Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 2160-0 | Creatinine [Mass/volume] in Serum or Plasma |
| 21603-6 | Wheat dust IgE Ab [Units/volume] in Serum |
| 2161-8 | Creatinine [Mass/volume] in Urine |
| 21610-1 | Zinc [Mass/volume] in 24 hour Urine |
| 21613-5 | Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 21614-3 | CDKN2A gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 21615-0 | CDKN2B gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 21617-6 | APC gene p.I1307K [Presence] in Blood or Tissue by Molecular genetics method |
| 21619-2 | APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2162-6 | Creatinine [Mass/time] in 24 hour Urine |
| 21620-0 | STS gene deletion [Presence] in Blood or Tissue by Molecular genetics method |
| 21622-6 | ASPA gene p.E285A [Presence] in Blood or Tissue by Molecular genetics method |
| 21624-2 | ATM gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21626-7 | ATP7B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21627-5 | ATP7B gene c.2010_2016del [Presence] in Blood or Tissue by Molecular genetics method |
| 21628-3 | ATP7B gene c.2337delC [Presence] in Blood or Tissue by Molecular genetics method |
| 21629-1 | ATP7B gene c.2487insT [Presence] in Blood or Tissue by Molecular genetics method |
| 2163-4 | Creatinine renal clearance in 12 hour |
| 21630-9 | ATP7B gene c.1711G>C [Presence] in Blood or Tissue by Molecular genetics method |
| 21631-7 | ATP7B gene p.G1267R [Presence] in Blood or Tissue by Molecular genetics method |
| 21632-5 | ATP7B gene p.H1070Q [Presence] in Blood or Tissue by Molecular genetics method |
| 21633-3 | ATP7B gene p.H714Q [Presence] in Blood or Tissue by Molecular genetics method |
| 21634-1 | ATP7B gene p.N915S [Presence] in Blood or Tissue by Molecular genetics method |
| 21635-8 | ATP7B gene p.R778L [Presence] in Blood or Tissue by Molecular genetics method |
| 21636-6 | BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21637-4 | BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
| 21638-2 | BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
| 2164-2 | Creatinine renal clearance in 24 hour |
| 21640-8 | BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
| 21641-6 | CACNA1S gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21642-4 | CACNA1S gene p.R1239G [Presence] in Blood or Tissue by Molecular genetics method |
| 21643-2 | CACNA1S gene p.R1239H [Presence] in Blood or Tissue by Molecular genetics method |
| 21644-0 | CACNA1S gene p.R528H [Presence] in Blood or Tissue by Molecular genetics method |
| 21646-5 | CBS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21647-3 | Deprecated CBS gene p.G307S [Presence] in Blood or Tissue by Molecular genetics method |
| 21648-1 | Deprecated CBS gene p.I278T [Presence] in Blood or Tissue by Molecular genetics method |
| 2165-9 | Cryofibrinogen [Mass/volume] in Blood |
| 21652-3 | CDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21654-9 | CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21655-6 | CFTR gene p.F508del [Presence] in Blood or Tissue by Molecular genetics method |
| 21657-2 | COL2A1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21659-8 | CTNNB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2166-7 | Cryoglobulin [Mass/volume] in Blood |
| 21661-4 | CYP2D6 gene Del [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21662-2 | CYP2D6 gene c.2637delA [Presence] in Blood or Tissue by Molecular genetics method |
| 21663-0 | CYP2D6 gene G-A NT1 X4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21664-8 | CYP2D6 gene p.G169X [Presence] in Blood or Tissue by Molecular genetics method |
| 21665-5 | EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21667-1 | F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21668-9 | F5 gene p.R506Q [Presence] in Blood or Tissue by Molecular genetics method |
| 2167-5 | Cryoglobulin [Presence] in Serum or Plasma |
| 21670-5 | F7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21672-1 | F8 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21674-7 | FGFR2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21676-2 | FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21677-0 | FGFR3 gene p.G375C [Presence] in Blood or Tissue by Molecular genetics method |
| 21678-8 | FGFR3 gene p.G380R [Presence] in Blood or Tissue by Molecular genetics method |
| 21679-6 | FGFR3 gene p.K650E [Presence] in Blood or Tissue by Molecular genetics method |
| 2168-3 | Cryoglobulin [Mass/volume] in Serum or Plasma |
| 21680-4 | G6PD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21685-3 | HADHB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21687-9 | HBA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21689-5 | HBB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2169-1 | Cobalamin (Vitamin B12) renal clearance in 24 hour |
| 21690-3 | HBB gene p.E6V [Presence] in Blood or Tissue by Molecular genetics method |
| 21692-9 | PRSS1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21694-5 | HFE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21695-2 | HFE gene p.C282Y [Presence] in Blood or Tissue by Molecular genetics method |
| 21696-0 | HFE gene p.H63D [Presence] in Blood or Tissue by Molecular genetics method |
| 21698-6 | HRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21700-0 | Kallman syndrome gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21702-6 | KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21704-2 | MT-ATP6 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21705-9 | MT-ND4 gene m.11696G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 21706-7 | Deprecated MT-ND4 gene p.R304H [Presence] in Blood or Tissue by Molecular genetics method |
| 21707-5 | MT-ND4 gene p.T109A [Presence] in Blood or Tissue by Molecular genetics method |
| 21708-3 | Deprecated MT-ATP6 gene p.L156R [Presence] in Blood or Tissue by Molecular genetics method |
| 21709-1 | MTHFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2171-7 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Mass/volume] in Serum or Plasma |
| 21710-9 | MTHFR gene p.A677V [Presence] in Blood or Tissue by Molecular genetics method |
| 21711-7 | MTHFR gene p.C677E [Presence] in Blood or Tissue by Molecular genetics method |
| 21713-3 | MT-TK gene m.8344A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 21714-1 | MT-TL1 gene m.3243A>G [Presence] in Blood or Tissue by Molecular genetics method |
| 21715-8 | MXI1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21716-6 | NB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21717-4 | NF1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21719-0 | NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21721-6 | OTC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21723-2 | SERPINA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21724-0 | SERPINA1 gene p.E264V [Presence] in Blood or Tissue by Molecular genetics method |
| 21725-7 | SERPINA1 gene p.E342K [Presence] in Blood or Tissue by Molecular genetics method |
| 21727-3 | PMP22 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21729-9 | PSAP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21731-5 | RB1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21733-1 | RET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21735-6 | SNCA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21736-4 | SNCA gene p.A30P [Presence] in Blood or Tissue by Molecular genetics method |
| 21737-2 | SNCA gene p.A53T [Presence] in Blood or Tissue by Molecular genetics method |
| 21739-8 | TP53 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21740-6 | TRAF3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21742-2 | WT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21744-8 | CCND1 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21746-3 | BCL6 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21747-1 | HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21748-9 | Kappa LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21749-7 | Lambda LC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21750-5 | MYC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21751-3 | TCRB gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21752-1 | TCRD gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21753-9 | TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method |
| 21754-7 | AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21755-4 | CACNA1A gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21756-2 | ATN1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21757-0 | DMPK gene CTG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21759-6 | FMR1 gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21760-4 | FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21761-2 | Deprecated FRAXE gene CGG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21762-0 | FXN gene GAA repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21763-8 | HTT gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21764-6 | MJD gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21765-3 | SCA1 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21766-1 | SCA2 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21767-9 | SCA7 gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21769-5 | SCA genes CAG repeats [Presence] in Blood or Tissue by Molecular genetics method |
| 21770-3 | Chromosome 12 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 21771-1 | Chromosome 21 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 21772-9 | Chromosome 7 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 21773-7 | Chromosome 8 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 21774-5 | Chromosome 9 trisomy [Presence] in Blood or Tissue by Cytogenetics |
| 2178-2 | Cystine [Mass/volume] in Urine |
| 2179-0 | Cystine [Mass/time] in 24 hour Urine |
| 2180-8 | Cystine+Cysteine [Mass/volume] in Serum or Plasma |
| 21809-9 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Blood or Tissue by Molecular genetics method |
| 2181-6 | Cystinyl aminopeptidase [Enzymatic activity/volume] in Serum |
| 21810-7 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Blood or Tissue by Molecular genetics method |
| 21819-8 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 2182-4 | Cytochrome B reductase [Enzymatic activity/volume] in Amniotic fluid |
| 2183-2 | Cytochrome B5 reductase [Enzymatic activity/volume] in Serum |
| 2184-0 | Cytochrome C oxidase [Enzymatic activity/volume] in Plasma |
| 2185-7 | Cytochrome C oxidase [Enzymatic activity/volume] in Platelets |
| 2186-5 | Cytochrome C oxidase [Enzymatic activity/volume] in Leukocytes |
| 2187-3 | Cytosol aminopeptidase [Enzymatic activity/volume] in Serum or Plasma |
| 2188-1 | Cytosol aminopeptidase [Presence] in Urine |
| 2189-9 | Cytosol aminopeptidase [Enzymatic activity/volume] in Urine |
| 2190-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Amniotic fluid |
| 2191-5 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma |
| 2192-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/time] in 24 hour Urine |
| 2193-1 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma |
| 2194-9 | Dehydroepiandrosterone (DHEA) [Presence] in Urine |
| 2195-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Urine |
| 2196-4 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/volume] in Serum or Plasma |
| 2197-2 | Dehydroepiandrosterone (DHEA).unconjugated [Mass/time] in 24 hour Urine |
| 2198-0 | Delta aminolevulinate [Mass/volume] in Plasma |
| 2199-8 | Delta aminolevulinate [Mass/volume] in Serum |
| 2200-4 | Delta aminolevulinate [Mass/time] in 24 hour Urine |
| 2201-2 | Deoxycholate [Mass/volume] in Serum |
| 2202-0 | Deoxycholylglycine [Mass/volume] in Serum |
| 2203-8 | Dermatan sulfate [Mass/volume] in Serum or Plasma |
| 2204-6 | Dermatan sulfate [Mass/volume] in Urine |
| 2205-3 | Deprecated Diacetate [Mass/volume] in Serum |
| 2206-1 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Serum |
| 2207-9 | Dicarboxylate, C6-C8-C10 [Mass/volume] in Urine |
| 22070-7 | HP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22071-5 | Gaucher 3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22072-3 | Gaucher 2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22073-1 | Gaucher 1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 22077-2 | Acanthamoeba sp Ab [Presence] in Cornea |
| 22078-0 | Acanthamoeba sp Ab [Presence] in Cerebral spinal fluid |
| 22079-8 | Actinomyces sp Ab [Titer] in Serum |
| 2208-7 | Diethyl ether [Mass/volume] in Serum or Plasma |
| 22080-6 | Adenovirus Ab [Titer] in Serum |
| 22081-4 | Afipia felis IgG Ab [Titer] in Serum |
| 22082-2 | Afipia felis IgM Ab [Titer] in Serum |
| 22083-0 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum |
| 22084-8 | Anaplasma marginale Ab [Presence] in Serum |
| 22085-5 | Aspergillus fumigatus 3 Ab [Presence] in Serum |
| 22086-3 | Aspergillus niger Ab [Presence] in Serum |
| 22087-1 | Aspergillus sp Ab [Titer] in Serum |
| 22088-9 | Avian adenovirus 2 Ab [Presence] in Serum |
| 22089-7 | Avian adenovirus Ab [Presence] in Serum |
| 2209-5 | Dihydrofolate [Mass/volume] in Serum |
| 22090-5 | Avian encephalomyelitis virus Ab [Presence] in Serum |
| 22091-3 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum |
| 22092-1 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum |
| 22093-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum |
| 22094-7 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum |
| 22095-4 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum |
| 22096-2 | Influenza virus A Ab [Presence] in Serum |
| 22097-0 | Avian paramyxovirus 1 Ab [Presence] in Serum |
| 22098-8 | Avian paramyxovirus 1 Ab [Titer] in Serum |
| 22099-6 | Avian paramyxovirus 2 Ab [Titer] in Serum |
| 2210-3 | Dihydrolipoamide acetyl transferase [Enzymatic activity/mass] in Tissue |
| 22100-2 | Avian paramyxovirus 3 Ab [Titer] in Serum |
| 22101-0 | Avian pox virus Ab [Presence] in Serum |
| 22102-8 | Avian reovirus Ab [Presence] in Serum |
| 22103-6 | Reticuloendotheliosis virus Ab [Presence] in Serum |
| 22104-4 | Babesia caballi Ab [Presence] in Serum |
| 22105-1 | Theileria equi Ab [Presence] in Serum |
| 22106-9 | Babesia sp Ab [Titer] in Serum |
| 22107-7 | Babesia sp IgG Ab [Titer] in Serum |
| 22108-5 | Babesia sp IgM Ab [Units/volume] in Serum |
| 22109-3 | Bacillus anthracis Ab [Units/volume] in Unspecified specimen |
| 2211-1 | Dihydrolipoamide dehydrogenase [Enzymatic activity/mass] in Tissue |
| 22110-1 | Bartonella henselae IgG Ab [Titer] in Serum |
| 22111-9 | Bartonella henselae IgM Ab [Titer] in Serum |
| 22112-7 | Blastomyces dermatitidis Ab [Titer] in Serum |
| 22113-5 | Bluetongue virus Ab [Presence] in Serum |
| 22114-3 | Bordetella avium Ab [Presence] in Serum |
| 22115-0 | Bordetella avium Ab [Titer] in Serum |
| 22116-8 | Bordetella pertussis Ab [Titer] in Serum |
| 22117-6 | Bordetella pertussis Ab [Titer] in Unspecified specimen |
| 22118-4 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid |
| 22119-2 | Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid |
| 2212-9 | Dihydropteridine reductase [Enzymatic activity/volume] in Serum |
| 22120-0 | Borrelia burgdorferi Ab [Units/volume] in Body fluid |
| 22121-8 | Borrelia burgdorferi Ab [Units/volume] in Serum |
| 22122-6 | Borrelia burgdorferi Ab [Titer] in Serum |
| 22123-4 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid |
| 22124-2 | Borrelia burgdorferi IgA Ab [Presence] in Serum |
| 22125-9 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid |
| 22126-7 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22127-5 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid |
| 22128-3 | Borrelia burgdorferi IgG Ab [Presence] in Serum |
| 22129-1 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid |
| 2213-7 | Dimethadione [Mass/volume] in Serum or Plasma |
| 22130-9 | Borrelia burgdorferi IgG Ab [Titer] in Serum |
| 22131-7 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
| 22132-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid |
| 22133-3 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid |
| 22134-1 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid |
| 22135-8 | Borrelia burgdorferi IgM Ab [Presence] in Serum |
| 22136-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid |
| 22137-4 | Borrelia burgdorferi IgM Ab [Titer] in Serum |
| 22138-2 | Borrelia hermsii IgG Ab [Titer] in Serum |
| 22139-0 | Borrelia hermsii IgM Ab [Titer] in Serum |
| 2214-5 | Dinitrobenzene [Mass/volume] in Urine |
| 22140-8 | Bovine diarrhea virus 1 Ab [Titer] in Serum |
| 22141-6 | Bovine diarrhea virus 2 Ab [Titer] in Serum |
| 22142-4 | Bovine herpesvirus 1 Ab [Presence] in Serum |
| 22143-2 | Bovine herpesvirus 1 Ab [Titer] in Serum |
| 22144-0 | Bovine leukemia virus Ab [Presence] in Serum |
| 22146-5 | Brucella abortus Ab [Presence] in Milk |
| 22147-3 | Brucella abortus Ab [Presence] in Serum |
| 22148-1 | Brucella abortus Ab [Presence] in Semen |
| 22149-9 | Brucella abortus Ab [Presence] in Whey |
| 2215-2 | Dipalmitoylphosphatidylcholine [Mass/volume] in Serum |
| 22150-7 | Brucella abortus Ab [Titer] in Serum |
| 22151-5 | Brucella abortus IgM Ab [Units/volume] in Serum |
| 22152-3 | Brucella canis Ab [Titer] in Serum |
| 22153-1 | Brucella canis IgG Ab [Units/volume] in Serum |
| 22154-9 | Brucella canis IgG Ab [Titer] in Serum |
| 22155-6 | Brucella canis IgM Ab [Units/volume] in Serum |
| 22156-4 | Brucella canis IgM Ab [Titer] in Serum |
| 22157-2 | Brucella melitensis Ab [Titer] in Serum |
| 22158-0 | Brucella ovis Ab [Presence] in Serum |
| 22159-8 | Brucella sp Ab [Titer] in Serum |
| 2216-0 | Dopamine [Mass/volume] in Serum or Plasma |
| 22160-6 | Brucella suis Ab [Titer] in Serum |
| 22161-4 | Cache valley virus Ab [Presence] in Serum |
| 22162-2 | Candida albicans Ab [Presence] in Serum |
| 22163-0 | Candida albicans Ab [Units/volume] in Serum |
| 22164-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum |
| 22166-3 | Caprine parapoxvirus Ab [Presence] in Serum |
| 22167-1 | Caprine parapoxvirus Ab [Presence] in Tissue |
| 22168-9 | Chicken anemia virus Ab [Presence] in Serum |
| 22169-7 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid |
| 2217-8 | Dopamine [Mass/volume] in Urine |
| 22170-5 | Chlamydophila pneumoniae IgA Ab [Titer] in Serum |
| 22171-3 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid |
| 22172-1 | Chlamydophila pneumoniae IgG Ab [Titer] in Serum |
| 22173-9 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid |
| 22174-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Serum |
| 22175-4 | Chlamydophila psittaci Ab [Presence] in Serum |
| 22176-2 | Chlamydophila psittaci Ab [Titer] in Serum |
| 22177-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid |
| 22178-8 | Chlamydophila psittaci IgA Ab [Titer] in Serum |
| 22179-6 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid |
| 2218-6 | Dopamine [Mass/time] in 24 hour Urine |
| 22180-4 | Chlamydophila psittaci IgG Ab [Titer] in Serum |
| 22181-2 | Chlamydophila psittaci IgM Ab [Titer] in Serum |
| 22182-0 | Chlamydia sp Ab [Titer] in Serum |
| 22183-8 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22184-6 | Chlamydia sp IgG Ab [Titer] in Serum |
| 22185-3 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid |
| 22186-1 | Chlamydia sp IgM Ab [Titer] in Serum |
| 22187-9 | Chlamydia trachomatis Ab [Titer] in Serum |
| 22188-7 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid |
| 22189-5 | Chlamydia trachomatis IgA Ab [Titer] in Serum |
| 2219-4 | Dopamine beta-hydroxylase [Enzymatic activity/volume] in Serum or Plasma |
| 22190-3 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22191-1 | Chlamydia trachomatis IgG Ab [Titer] in Serum |
| 22192-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid |
| 22193-7 | Chlamydia trachomatis IgM Ab [Titer] in Serum |
| 22194-5 | Chlamydia trachomatis B IgA Ab [Titer] in Serum |
| 22195-2 | Chlamydia trachomatis B IgG Ab [Titer] in Serum |
| 22196-0 | Chlamydia trachomatis B IgM Ab [Titer] in Serum |
| 22197-8 | Chlamydia trachomatis C IgA Ab [Titer] in Serum |
| 22198-6 | Chlamydia trachomatis C IgG Ab [Titer] in Serum |
| 22199-4 | Chlamydia trachomatis C IgM Ab [Titer] in Serum |
| 2220-2 | Elastase.pancreatic Free [Enzymatic activity/volume] in Serum |
| 22200-0 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum |
| 22201-8 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum |
| 22202-6 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum |
| 22203-4 | Clostridium tetani IgG Ab [Units/volume] in Serum |
| 22204-2 | Coccidioides immitis Ab [Presence] in Cerebral spinal fluid |
| 22205-9 | Coccidioides immitis Ab [Presence] in Serum |
| 22206-7 | Coccidioides immitis Ab [Units/volume] in Serum |
| 22207-5 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid |
| 22208-3 | Coccidioides immitis Ab [Titer] in Serum |
| 22209-1 | Coccidioides immitis IgG Ab [Presence] in Serum |
| 2221-0 | Elastase.pancreatic [Enzymatic activity/volume] in Serum |
| 22210-9 | Coccidioides immitis IgM Ab [Presence] in Serum |
| 22211-7 | Coxiella burnetii Ab [Titer] in Serum |
| 22212-5 | Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid |
| 22213-3 | Coxsackievirus A10 Ab [Titer] in Serum |
| 22214-1 | Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid |
| 22215-8 | Coxsackievirus A16 Ab [Titer] in Serum |
| 22216-6 | Coxsackievirus A2 Ab [Titer] in Serum |
| 22217-4 | Coxsackievirus A21 Ab [Titer] in Serum |
| 22218-2 | Coxsackievirus A4 Ab [Titer] in Serum |
| 22219-0 | Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid |
| 2222-8 | Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum |
| 22220-8 | Coxsackievirus A7 Ab [Titer] in Serum |
| 22221-6 | Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid |
| 22222-4 | Coxsackievirus A9 Ab [Titer] in Serum |
| 22223-2 | Coxsackievirus B IgG Ab [Units/volume] in Serum |
| 22224-0 | Coxsackievirus B IgM Ab [Units/volume] in Serum |
| 22225-7 | Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid |
| 22226-5 | Coxsackievirus B1 Ab [Titer] in Serum |
| 22227-3 | Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid |
| 22228-1 | Coxsackievirus B2 Ab [Titer] in Serum |
| 22229-9 | Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid |
| 2223-6 | Elastase.leukocytary [Enzymatic activity/volume] in Plasma |
| 22230-7 | Coxsackievirus B3 Ab [Titer] in Serum |
| 22231-5 | Coxsackievirus B4 Ab [Titer] in Cerebral spinal fluid |
| 22232-3 | Coxsackievirus B4 Ab [Titer] in Serum |
| 22233-1 | Coxsackievirus B5 Ab [Titer] in Cerebral spinal fluid |
| 22234-9 | Coxsackievirus B5 Ab [Titer] in Serum |
| 22235-6 | Coxsackievirus B6 Ab [Titer] in Cerebral spinal fluid |
| 22236-4 | Coxsackievirus B6 Ab [Titer] in Serum |
| 22237-2 | Cryptococcus neoformans Ab [Titer] in Serum |
| 22238-0 | Taenia solium larva Ab [Presence] in Serum |
| 22239-8 | Cytomegalovirus Ab [Presence] in Serum |
| 2224-4 | Enolase [Enzymatic activity/volume] in Serum |
| 22240-6 | Cytomegalovirus Ab [Titer] in Cerebral spinal fluid |
| 22241-4 | Cytomegalovirus Ab [Titer] in Serum |
| 22243-0 | Cytomegalovirus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22244-8 | Cytomegalovirus IgG Ab [Presence] in Serum |
| 22245-5 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid |
| 22246-3 | Cytomegalovirus IgG Ab [Titer] in Serum |
| 22247-1 | Cytomegalovirus IgG Ab [Units/volume] in Serum --2nd specimen |
| 22248-9 | Cytomegalovirus IgM Ab [Titer] in Cerebral spinal fluid |
| 22249-7 | Cytomegalovirus IgM Ab [Titer] in Serum |
| 2225-1 | Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
| 22250-5 | Dengue virus 1 Ab [Presence] in Serum |
| 22251-3 | Dengue virus 2 Ab [Presence] in Serum |
| 22252-1 | Dengue virus 3 Ab [Presence] in Serum |
| 22253-9 | Dengue virus 4 Ab [Presence] in Serum |
| 22254-7 | Duck enteritis virus Ab [Presence] in Serum |
| 22255-4 | Eastern equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 22256-2 | Eastern equine encephalitis virus Ab [Presence] in Serum |
| 22257-0 | Eastern equine encephalitis virus Ab [Titer] in Serum |
| 22258-8 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22259-6 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum |
| 2226-9 | Enteroglucagon [Mass/volume] in Serum |
| 22260-4 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22261-2 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum |
| 22263-8 | Ebola virus Ab [Titer] in Serum |
| 22264-6 | Echinococcus granulosus IgG Ab [Presence] in Serum |
| 22265-3 | Echinococcus sp IgG Ab [Units/volume] in Serum |
| 22266-1 | Echovirus 1 Ab [Titer] in Serum |
| 22267-9 | Echovirus 11 Ab [Titer] in Cerebral spinal fluid |
| 22268-7 | Echovirus 11 Ab [Titer] in Serum |
| 22269-5 | Echovirus 14 Ab [Titer] in Serum |
| 2227-7 | Enteropeptidase [Enzymatic activity/volume] in Plasma |
| 22270-3 | Deprecated Echovirus 140 Ab |
| 22271-1 | Echovirus 16 Ab [Titer] in Serum |
| 22272-9 | Echovirus 18 Ab [Titer] in Serum |
| 22273-7 | Echovirus 19 Ab [Titer] in Serum |
| 22274-5 | Echovirus 3 Ab [Titer] in Serum |
| 22275-2 | Echovirus 30 Ab [Titer] in Cerebral spinal fluid |
| 22276-0 | Echovirus 4 Ab [Titer] in Cerebral spinal fluid |
| 22277-8 | Echovirus 4 Ab [Titer] in Serum |
| 22278-6 | Echovirus 6 Ab [Titer] in Serum |
| 22279-4 | Echovirus 7 Ab [Titer] in Serum |
| 2228-5 | Enterotoxin [Mass/volume] in Serum |
| 22280-2 | Echovirus 9 Ab [Titer] in Cerebral spinal fluid |
| 22281-0 | Echovirus 9 Ab [Titer] in Serum |
| 22282-8 | Echovirus NOS Ab [Titer] in Serum |
| 22283-6 | Ehrlichia chaffeensis IgG Ab [Presence] in Serum |
| 22284-4 | Ehrlichia chaffeensis IgG Ab [Units/volume] in Serum |
| 22285-1 | Entamoeba histolytica Ab [Presence] in Serum |
| 22286-9 | Entamoeba histolytica Ab [Titer] in Serum |
| 22287-7 | Entamoeba histolytica IgA Ab [Units/volume] in Serum |
| 22288-5 | Entamoeba histolytica IgG Ab [Units/volume] in Serum |
| 22289-3 | Entamoeba histolytica IgM Ab [Units/volume] in Serum |
| 2229-3 | Epiandrosterone [Mass/volume] in Serum or Plasma |
| 22290-1 | Epstein Barr virus capsid IgA Ab [Titer] in Serum |
| 22291-9 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid |
| 22292-7 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid |
| 22293-5 | Epstein Barr virus early Ab [Units/volume] in Serum |
| 22294-3 | Epstein Barr virus early Ab [Titer] in Serum |
| 22295-0 | Epstein Barr virus early IgG Ab [Presence] in Serum |
| 22296-8 | Epstein Barr virus nuclear Ab [Presence] in Serum |
| 22297-6 | Epstein Barr virus nuclear Ab [Titer] in Serum |
| 22298-4 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum |
| 22299-2 | Equine arteritis virus Ab [Titer] in Serum |
| 2230-1 | Epinephrine [Mass/volume] in Plasma |
| 22300-8 | Equine herpesvirus 1 Ab [Titer] in Serum |
| 22301-6 | Equine infectious anemia virus Ab [Presence] in Serum |
| 22302-4 | Equine influenza virus A1 Ab [Titer] in Serum |
| 22303-2 | Equine influenza virus A2 Ab [Titer] in Serum |
| 22304-0 | Giardia lamblia Ab [Titer] in Serum |
| 22305-7 | Giardia lamblia IgA Ab [Titer] in Serum |
| 22306-5 | Giardia lamblia IgG Ab [Titer] in Serum |
| 22307-3 | Giardia lamblia IgM Ab [Titer] in Serum |
| 22308-1 | Hantavirus puumala IgG Ab [Titer] in Serum |
| 22309-9 | Hantavirus puumala IgM Ab [Titer] in Serum |
| 2231-9 | Deprecated Epinephrine [Mass/volume] in Plasma |
| 22310-7 | Helicobacter pylori Ab [Presence] in Serum |
| 22312-3 | Hepatitis A virus Ab [Units/volume] in Serum |
| 22313-1 | Hepatitis A virus IgG Ab [Units/volume] in Serum |
| 22314-9 | Hepatitis A virus IgM Ab [Presence] in Serum |
| 22315-6 | Hepatitis A virus IgM Ab [Units/volume] in Serum |
| 22316-4 | Hepatitis B virus core Ab [Units/volume] in Serum |
| 22317-2 | Hepatitis B virus core Ab [Units/volume] in Serum from donor |
| 22318-0 | Hepatitis B virus core IgG Ab [Units/volume] in Serum |
| 22319-8 | Hepatitis B virus core IgM Ab [Units/volume] in Serum |
| 2232-7 | Epinephrine [Mass/time] in 24 hour Urine |
| 22320-6 | Hepatitis B virus e Ab [Presence] in Serum |
| 22321-4 | Hepatitis B virus e Ab [Units/volume] in Serum |
| 22322-2 | Hepatitis B virus surface Ab [Presence] in Serum |
| 22323-0 | Hepatitis B virus surface Ab [Units/volume] in Serum from donor |
| 22327-1 | Hepatitis C virus Ab [Units/volume] in Serum |
| 22328-9 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum |
| 2233-5 | Epitestosterone [Mass/volume] in Serum or Plasma |
| 22330-5 | Hepatitis D virus Ab [Units/volume] in Serum |
| 22331-3 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid |
| 22333-9 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid |
| 22334-7 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid |
| 22337-0 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid |
| 22338-8 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid |
| 22339-6 | Herpes simplex virus Ab [Presence] in Serum |
| 2234-3 | Epitestosterone [Presence] in Urine |
| 22340-4 | Herpes simplex virus Ab [Titer] in Cerebral spinal fluid |
| 22341-2 | Herpes simplex virus Ab [Titer] in Serum |
| 22343-8 | Herpes simplex virus IgM Ab [Titer] in Serum |
| 22344-6 | Heterophile Ab after absorption [Titer] in Serum |
| 22345-3 | Histoplasma capsulatum Ab [Presence] in Cerebral spinal fluid |
| 22346-1 | Histoplasma capsulatum Ab [Presence] in Serum |
| 22347-9 | Histoplasma capsulatum Ab [Titer] in Serum |
| 22348-7 | Histoplasma capsulatum IgA Ab [Presence] in Serum |
| 22349-5 | Histoplasma capsulatum IgA Ab [Units/volume] in Serum |
| 2235-0 | Epitestosterone [Mass/volume] in Urine |
| 22350-3 | Histoplasma capsulatum IgE Ab [Presence] in Serum |
| 22351-1 | Histoplasma capsulatum IgG Ab [Units/volume] in Serum |
| 22352-9 | Histoplasma capsulatum IgM Ab [Presence] in Serum |
| 22353-7 | Histoplasma capsulatum IgM Ab [Units/volume] in Serum |
| 22354-5 | Histoplasma capsulatum mycelial phase Ab [Units/volume] in Serum |
| 22355-2 | Histoplasma capsulatum yeast phase Ab [Units/volume] in Serum |
| 22356-0 | HIV 1 Ab [Units/volume] in Serum |
| 22357-8 | HIV 1+2 Ab [Units/volume] in Serum |
| 22358-6 | HIV 2 Ab [Units/volume] in Serum |
| 22359-4 | HTLV I Ab [Presence] in Serum |
| 2236-8 | Calciferol (Vit D2) [Mass/volume] in Serum or Plasma |
| 22360-2 | HTLV I IgG Ab [Presence] in Serum |
| 22361-0 | HTLV I+II Ab [Presence] in Cerebral spinal fluid |
| 22362-8 | HTLV I+II Ab [Presence] in Serum |
| 22363-6 | HTLV I+II Ab [Units/volume] in Serum |
| 22364-4 | Infectious bursal disease virus Ab [Presence] in Serum |
| 22365-1 | Influenza virus A Ab [Titer] in Serum |
| 22366-9 | Influenza virus A+B Ab [Titer] in Serum |
| 22367-7 | Influenza virus B Ab [Titer] in Serum |
| 22368-5 | Influenza virus C Ab [Titer] in Serum |
| 22369-3 | Japanese encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 2237-6 | Erythropoietin (EPO) [Mass/volume] in Serum or Plasma |
| 22370-1 | Japanese encephalitis virus Ab [Presence] in Serum |
| 22371-9 | Junin virus Ab [Presence] in Serum |
| 22372-7 | Deprecated La Crosse virus Ab |
| 22373-5 | La Crosse virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22375-0 | La Crosse virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22377-6 | Lassa virus IgG Ab [Presence] in Serum |
| 22378-4 | Lassa virus IgG Ab [Titer] in Serum |
| 22379-2 | Lassa virus IgM Ab [Presence] in Serum |
| 2238-4 | Estradiol (E2) [Mass/volume] in Saliva (oral fluid) |
| 22380-0 | Lassa virus IgM Ab [Titer] in Serum |
| 22381-8 | Legionella pneumophila 1 IgG Ab [Titer] in Serum |
| 22382-6 | Legionella pneumophila 1 IgM Ab [Titer] in Serum |
| 22383-4 | Legionella pneumophila 2 IgG Ab [Titer] in Serum |
| 22384-2 | Legionella pneumophila 2 IgM Ab [Titer] in Serum |
| 22385-9 | Legionella pneumophila 3 IgG Ab [Titer] in Serum |
| 22386-7 | Legionella pneumophila 3 IgM Ab [Titer] in Serum |
| 22387-5 | Legionella pneumophila 4 IgG Ab [Titer] in Serum |
| 22388-3 | Legionella pneumophila 4 IgM Ab [Titer] in Serum |
| 22389-1 | Legionella pneumophila 5 IgG Ab [Titer] in Serum |
| 2239-2 | Estradiol (E2) [Mass/volume] in Semen |
| 22390-9 | Legionella pneumophila 5 IgM Ab [Titer] in Serum |
| 22391-7 | Legionella pneumophila 6 IgG Ab [Titer] in Serum |
| 22392-5 | Legionella pneumophila 6 IgM Ab [Titer] in Serum |
| 22393-3 | Legionella pneumophila 7 Ab [Titer] in Serum |
| 22394-1 | Legionella pneumophila 8 Ab [Titer] in Serum |
| 22395-8 | Legionella pneumophila 9 Ab [Titer] in Serum |
| 22396-6 | Legionella pneumophila Ab [Titer] in Serum |
| 22397-4 | Legionella pneumophila IgG Ab [Titer] in Serum |
| 22398-2 | Legionella pneumophila IgM Ab [Titer] in Serum |
| 22399-0 | Legionella sp Ab [Titer] in Serum |
| 2240-0 | Estradiol (E2) Free [Mass/volume] in Serum or Plasma |
| 22400-6 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum |
| 22401-4 | Leptospira interrogans sv Canicola Ab [Titer] in Serum |
| 22402-2 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum |
| 22403-0 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum |
| 22404-8 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum |
| 22405-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum |
| 22406-3 | Listeria monocytogenes Ab [Titer] in Serum |
| 22408-9 | Lymphocytic choriomeningitis virus Ab [Titer] in Serum |
| 22409-7 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 2241-8 | Estradiol (E2) Free [Moles/mass] in Tissue |
| 22410-5 | Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum |
| 22411-3 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum |
| 22412-1 | Saccharopolyspora rectivirgula Ab [Presence] in Serum |
| 22413-9 | Mumps virus Ab [Titer] in Cerebral spinal fluid |
| 22414-7 | Mumps virus Ab [Titer] in Serum |
| 22415-4 | Mumps virus IgG Ab [Presence] in Serum |
| 22416-2 | Mumps virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22417-0 | Mumps virus IgG Ab [Titer] in Serum |
| 22418-8 | Mumps virus IgM Ab [Presence] in Serum |
| 22419-6 | Mumps virus IgM Ab [Titer] in Cerebral spinal fluid |
| 2242-6 | Deprecated Estradiol Free [Mass/volume] in Serum or Plasma |
| 22420-4 | Mumps virus IgM Ab [Titer] in Serum |
| 22421-2 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum |
| 22422-0 | Mycoplasma gallisepticum Ab [Presence] in Serum |
| 22423-8 | Mycoplasma hominis Ab [Titer] in Serum |
| 22424-6 | Mycoplasma meleagridis Ab [Presence] in Serum |
| 22425-3 | Mycoplasma pneumoniae Ab [Titer] in Serum |
| 22426-1 | Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
| 22427-9 | Mycoplasma pneumoniae IgM Ab [Titer] in Serum |
| 22428-7 | Mycoplasma sp Ab [Presence] in Serum |
| 22429-5 | Mycoplasma synoviae Ab [Presence] in Serum |
| 2243-4 | Estradiol (E2) [Mass/volume] in Serum or Plasma |
| 22430-3 | Neisseria gonorrhoeae Ab [Titer] in Serum |
| 22431-1 | Neisseria meningitidis Y Ab [Titer] in Unspecified specimen |
| 22432-9 | Neospora caninum Ab [Presence] in Serum |
| 22434-5 | Human papilloma virus Ab [Presence] in Tissue |
| 22435-2 | Paracoccidioides brasiliensis Ab [Titer] in Serum |
| 22436-0 | Paragonimus sp Ab [Titer] in Serum |
| 22437-8 | Parainfluenza virus 1 Ab [Titer] in Serum |
| 22438-6 | Parainfluenza virus 2 Ab [Titer] in Serum |
| 22439-4 | Parainfluenza virus 3 Ab [Titer] in Serum |
| 22440-2 | Pasteurella multocida Ab [Presence] in Serum |
| 22441-0 | Plasmodium falciparum Ab [Titer] in Serum |
| 22442-8 | Plasmodium malariae Ab [Titer] in Serum |
| 22443-6 | Plasmodium ovale Ab [Titer] in Serum |
| 22444-4 | Plasmodium vivax Ab [Titer] in Serum |
| 22445-1 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid |
| 22446-9 | Polio virus 1 Ab [Titer] in Serum |
| 22447-7 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid |
| 22448-5 | Polio virus 2 Ab [Titer] in Serum |
| 22449-3 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid |
| 2245-9 | Estradiol (E2) [Moles/mass] in Tissue |
| 22450-1 | Polio virus 3 Ab [Titer] in Serum |
| 22451-9 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum |
| 22452-7 | Pseudorabies virus Ab [Presence] in Serum |
| 22453-5 | Pseudorabies virus Ab [Titer] in Serum |
| 22454-3 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum |
| 22455-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum |
| 22456-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum |
| 22457-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum |
| 22458-4 | Rabies virus Ab [Units/volume] in Tissue |
| 22459-2 | Reagin Ab [Presence] in Cerebral spinal fluid |
| 2246-7 | Estradiol (E2).unconjugated [Mass/time] in 24 hour Urine |
| 22460-0 | Reagin Ab [Units/volume] in Cerebral spinal fluid |
| 22461-8 | Reagin Ab [Presence] in Serum |
| 22462-6 | Reagin Ab [Units/volume] in Serum |
| 22463-4 | Reagin Ab [Presence] in Serum from donor |
| 22464-2 | Reagin Ab [Presence] in Unspecified specimen |
| 22465-9 | Reovirus Ab [Titer] in Serum |
| 22466-7 | Respiratory syncytial virus Ab [Titer] in Serum |
| 22467-5 | Respiratory syncytial virus IgM Ab [Titer] in Serum |
| 22468-3 | Rickettsia (Proteus OX19) Ab [Presence] in Serum |
| 22469-1 | Rickettsia (Proteus OX19) Ab [Titer] in Serum |
| 2247-5 | Estriol (E3).conjugated [Mass/volume] in Serum or Plasma |
| 22470-9 | Rickettsia (Proteus OX2) Ab [Presence] in Serum |
| 22471-7 | Rickettsia (Proteus OX2) Ab [Titer] in Serum |
| 22472-5 | Rickettsia (Proteus OXK) Ab [Presence] in Serum |
| 22473-3 | Rickettsia (Proteus OXK) Ab [Titer] in Serum |
| 22474-1 | Rickettsia spotted fever group Ab [Presence] in Serum |
| 22475-8 | Rickettsia spotted fever group Ab [Titer] in Serum |
| 22476-6 | Rickettsia spotted fever group IgG Ab [Titer] in Cerebral spinal fluid |
| 22477-4 | Rickettsia spotted fever group IgG Ab [Titer] in Serum |
| 22478-2 | Rickettsia spotted fever group IgM Ab [Titer] in Cerebral spinal fluid |
| 22479-0 | Rickettsia spotted fever group IgM Ab [Titer] in Serum |
| 2248-3 | Estriol (E3) [Mass/volume] in Amniotic fluid |
| 22480-8 | Rickettsia typhus group IgG Ab [Titer] in Cerebral spinal fluid |
| 22481-6 | Rickettsia typhus group IgM Ab [Titer] in Cerebral spinal fluid |
| 22482-4 | Rickettsia rickettsii IgG Ab [Titer] in Serum |
| 22483-2 | Rickettsia rickettsii IgM Ab [Titer] in Serum |
| 22484-0 | Rickettsia sp Ab [Titer] in Serum |
| 22485-7 | Orientia tsutsugamushi Ab [Titer] in Serum |
| 22486-5 | Rickettsia typhi Ab [Units/volume] in Serum |
| 22487-3 | Rickettsia typhi IgA Ab [Units/volume] in Serum |
| 22488-1 | Rickettsia typhi IgG Ab [Presence] in Serum |
| 22489-9 | Rickettsia typhi IgG Ab [Titer] in Serum |
| 2249-1 | Estriol (E3).unconjugated [Mass/volume] in Amniotic fluid |
| 22490-7 | Rickettsia typhi IgM Ab [Titer] in Serum |
| 22491-5 | Rickettsia typhus group Ab [Presence] in Serum |
| 22492-3 | Rickettsia typhus group Ab [Titer] in Serum |
| 22493-1 | Rickettsia typhus group IgG Ab [Titer] in Serum |
| 22494-9 | Rickettsia typhus group IgM Ab [Titer] in Serum |
| 22495-6 | Rotavirus Ab [Titer] in Serum |
| 22496-4 | Rubella virus Ab [Presence] in Serum |
| 22497-2 | Rubella virus Ab [Titer] in Serum |
| 22498-0 | Measles virus Ab [Titer] in Cerebral spinal fluid |
| 22499-8 | Measles virus Ab [Titer] in Serum |
| 2250-9 | Estriol (E3).unconjugated [Mass/volume] in Serum or Plasma |
| 22500-3 | Measles virus IgG Ab [Units/volume] in Cerebral spinal fluid |
| 22501-1 | Measles virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22502-9 | Measles virus IgG Ab [Titer] in Serum |
| 22503-7 | Measles virus IgG Ab [Units/volume] in Serum --1st specimen |
| 22504-5 | Measles virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 22505-2 | Measles virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22506-0 | Measles virus IgM Ab [Titer] in Serum |
| 22507-8 | Saint Louis encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 22509-4 | Saint Louis encephalitis virus Ab [Titer] in Cerebral spinal fluid |
| 2251-7 | Estriol (E3) [Mass/volume] in Serum or Plasma |
| 22510-2 | Saint Louis encephalitis virus Ab [Titer] in Serum |
| 22511-0 | Saint Louis encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22512-8 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum |
| 22513-6 | Saint Louis encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22514-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum |
| 22515-1 | Salmonella arizonae Ab [Presence] in Serum |
| 22516-9 | Salmonella paratyphi A Ab [Presence] in Serum |
| 22517-7 | Salmonella paratyphi A H Ab [Presence] in Serum |
| 22518-5 | Salmonella paratyphi A H Ab [Titer] in Serum |
| 22519-3 | Salmonella paratyphi A O Ab [Presence] in Serum |
| 2252-5 | Estriol (E3) [Mass/volume] in Urine |
| 22520-1 | Salmonella paratyphi B Ab [Presence] in Serum |
| 22521-9 | Salmonella paratyphi B H Ab [Presence] in Serum |
| 22522-7 | Salmonella paratyphi B H Ab [Titer] in Serum |
| 22523-5 | Salmonella paratyphi B O Ab [Presence] in Serum |
| 22524-3 | Salmonella paratyphi C H Ab [Presence] in Serum |
| 22525-0 | Salmonella paratyphi C O Ab [Presence] in Serum |
| 22526-8 | Salmonella pullorum Ab [Presence] in Serum |
| 22527-6 | Salmonella sp Ab [Titer] in Serum |
| 22529-2 | Salmonella typhi H Ab [Presence] in Serum |
| 2253-3 | Estriol (E3) [Mass/time] in 24 hour Urine |
| 22531-8 | Salmonella typhimurium Ab [Presence] in Serum |
| 22532-6 | Sarcocystis neurona Ab [Presence] in Blood |
| 22533-4 | Sarcocystis neurona Ab [Presence] in Body fluid |
| 22534-2 | Sarcocystis neurona Ab [Presence] in Serum |
| 22535-9 | Schistosoma japonicum Ab [Titer] in Serum |
| 22536-7 | Schistosoma mansoni Ab [Presence] in Serum |
| 22537-5 | Shigella boydii Ab [Titer] in Serum |
| 22538-3 | Shigella dysenteriae Ab [Titer] in Serum |
| 22539-1 | Shigella flexneri Ab [Titer] in Serum |
| 2254-1 | Estrogen [Mass/volume] in Serum or Plasma |
| 22540-9 | Shigella sonnei Ab [Titer] in Serum |
| 2255-8 | Estrogen [Mass/volume] in Urine |
| 2256-6 | Estrogen [Mass/time] in 24 hour Urine |
| 22562-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
| 22564-9 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
| 22566-4 | Streptococcus pyogenes enzyme Ab [Presence] in Serum |
| 22567-2 | Streptococcus pyogenes enzyme Ab [Titer] in Serum |
| 22568-0 | Streptolysin O Ab [Titer] in Serum |
| 2257-4 | Estrone (E1) [Mass/volume] in Semen |
| 22571-4 | Teichoate Ab [Titer] in Serum |
| 22572-2 | Saccharomonospora viridis Ab [Presence] in Serum |
| 22573-0 | Thermoactinomyces vulgaris Ab [Presence] in Serum |
| 22575-5 | Toxocara canis IgG Ab [Units/volume] in Serum |
| 22577-1 | Toxoplasma gondii Ab [Presence] in Serum |
| 22578-9 | Toxoplasma gondii IgA Ab [Units/volume] in Serum |
| 22579-7 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum |
| 2258-2 | Estrone (E1) [Mass/volume] in Serum or Plasma |
| 22580-5 | Toxoplasma gondii IgG Ab [Presence] in Serum |
| 22581-3 | Toxoplasma gondii IgG Ab [Titer] in Cerebral spinal fluid |
| 22582-1 | Toxoplasma gondii IgG Ab [Titer] in Serum |
| 22583-9 | Toxoplasma gondii IgM Ab [Titer] in Cerebral spinal fluid |
| 22584-7 | Toxoplasma gondii IgM Ab [Titer] in Serum |
| 22585-4 | Treponema pallidum Ab [Units/volume] in Blood |
| 22586-2 | Treponema pallidum Ab [Presence] in Cerebral spinal fluid |
| 22587-0 | Treponema pallidum Ab [Presence] in Serum |
| 2259-0 | Estrone (E1) [Mass/volume] in Urine |
| 22590-4 | Treponema pallidum Ab [Titer] in Serum |
| 22592-0 | Treponema pallidum IgG Ab [Units/volume] in Serum |
| 22594-6 | Treponema pallidum IgM Ab [Units/volume] in Serum |
| 22595-3 | Trichinella spiralis Ab [Presence] in Serum |
| 22596-1 | Trichinella spiralis Ab [Titer] in Serum |
| 22599-5 | Trypanosoma cruzi Ab [Titer] in Serum |
| 2260-8 | Estrone (E1).unconjugated [Mass/volume] in Amniotic fluid |
| 22600-1 | Varicella zoster virus Ab [Presence] in Serum |
| 22601-9 | Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22602-7 | Varicella zoster virus IgG Ab [Titer] in Serum |
| 22603-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum --1st specimen |
| 22604-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 22605-0 | Varicella zoster virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22606-8 | Varicella zoster virus IgM Ab [Titer] in Serum |
| 22607-6 | Venezuelan equine encephalitis virus Ab [Titer] in Serum |
| 22608-4 | Escherichia coli verotoxin 1 Ab [Titer] in Stool |
| 22609-2 | Escherichia coli verotoxin 2 Ab [Titer] in Stool |
| 2261-6 | Estrone (E1).unconjugated [Mass/volume] in Serum or Plasma |
| 22610-0 | Western equine encephalitis virus Ab [Presence] in Cerebral spinal fluid |
| 22611-8 | Western equine encephalitis virus Ab [Presence] in Serum |
| 22613-4 | Western equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid |
| 22614-2 | Western equine encephalitis virus IgG Ab [Titer] in Serum |
| 22615-9 | Western equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid |
| 22616-7 | Western equine encephalitis virus IgM Ab [Titer] in Serum |
| 22617-5 | Wuchereria bancrofti Ab [Presence] in Serum |
| 22618-3 | Yellow fever virus Ab [Titer] in Serum |
| 22619-1 | Yersinia enterocolitica IgA Ab [Units/volume] in Serum |
| 2262-4 | Estrone (E1).unconjugated [Mass/time] in 24 hour Urine |
| 22620-9 | Yersinia enterocolitica IgG Ab [Units/volume] in Serum |
| 22621-7 | Yersinia enterocolitica IgM Ab [Units/volume] in Serum |
| 2265-7 | Ethylmalonate [Mass/volume] in Urine |
| 2266-5 | Etiocholanolone [Presence] in Urine |
| 22663-9 | Estrone (E1) [Moles/volume] in Serum or Plasma |
| 22664-7 | Urea [Moles/volume] in Serum or Plasma |
| 22665-4 | Bilirubin.delta [Moles/volume] in Serum or Plasma |
| 22666-2 | Busulfan [Moles/volume] in Serum or Plasma |
| 22668-8 | Propylene glycol [Moles/volume] in Serum or Plasma |
| 2267-3 | Etiocholanolone [Mass/volume] in Urine |
| 22674-6 | Transferrin [Moles/volume] in Serum or Plasma |
| 22675-3 | Deprecated Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
| 22676-1 | 7-Dehydrocholesterol [Presence] in Serum or Plasma |
| 22678-7 | Ethylene glycol [Moles/volume] in Urine |
| 2268-1 | Etiocholanolone [Mass/time] in 24 hour Urine |
| 22680-3 | Mercury/Creatinine [Molar ratio] in Urine |
| 22687-8 | Cystine/Creatinine [Molar ratio] in Urine |
| 22689-4 | Zinc [Moles/time] in 24 hour Urine |
| 2269-9 | Complement factor B [Mass/volume] in Serum or Plasma |
| 22696-9 | Cadmium/Creatinine [Molar ratio] in Urine |
| 2270-7 | Fat [Presence] in Stool |
| 22700-9 | Urea [Moles/volume] in Urine |
| 22701-7 | Salicylates [Moles/volume] in Urine |
| 22702-5 | Ketones [Moles/volume] in Urine by Test strip |
| 22704-1 | Carnitine free (C0)/Creatinine [Molar ratio] in Urine |
| 22705-8 | Glucose [Moles/volume] in Urine by Test strip |
| 22708-2 | Homovanillate/Creatinine [Molar ratio] in Urine |
| 2271-5 | Fat [Mass/time] in 72 hour Stool |
| 22712-4 | Adenosine monophosphate.cyclic [Moles/volume] in Urine |
| 2272-3 | Fat [Presence] in Urine |
| 22726-4 | Creatinine [Moles/volume] in Unspecified specimen |
| 22731-4 | Triglyceride [Moles/volume] in Unspecified specimen |
| 22732-2 | Salicylates [Moles/volume] in Unspecified specimen |
| 22733-0 | Phosphate [Moles/volume] in Unspecified specimen |
| 22734-8 | Ethylene glycol [Moles/volume] in Unspecified specimen |
| 22735-5 | Bicarbonate [Moles/volume] in Unspecified specimen |
| 22736-3 | Acetaminophen [Moles/volume] in Unspecified specimen |
| 22738-9 | Urea [Moles/volume] in Unspecified specimen |
| 22742-1 | Propylene glycol [Moles/volume] in Unspecified specimen |
| 22744-7 | Copper [Moles/volume] in Unspecified specimen |
| 22745-4 | Ethanol [Moles/volume] in Urine |
| 22746-2 | Gentamicin [Moles/volume] in Serum or Plasma --peak |
| 22747-0 | Gentamicin [Moles/volume] in Serum or Plasma --trough |
| 22748-8 | Cholesterol in LDL [Moles/volume] in Serum or Plasma |
| 22750-4 | Tobramycin [Moles/volume] in Serum or Plasma --random |
| 22751-2 | Tobramycin [Moles/volume] in Serum or Plasma --peak |
| 22752-0 | Tobramycin [Moles/volume] in Serum or Plasma --trough |
| 22753-8 | Iron binding capacity.unsaturated [Moles/volume] in Serum or Plasma |
| 22755-3 | Haemophilus influenzae B Ab [Mass/volume] in Serum |
| 22758-7 | Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
| 22759-5 | Platelet Ab [Titer] in Serum |
| 2276-4 | Ferritin [Mass/volume] in Serum or Plasma |
| 22760-3 | Potassium [Mass/volume] in Serum or Plasma |
| 22763-7 | Ammonia [Mass/volume] in Plasma |
| 22764-5 | Actinobacillus pleuropneumoniae Ab [Presence] in Serum by Complement fixation |
| 22765-2 | Adult fly identified in Unspecified specimen |
| 22766-0 | African horse sickness virus Ab [Presence] in Serum by Immunoassay |
| 22767-8 | African horse sickness virus Ab [Presence] in Serum by Immunoblot (IB) |
| 22768-6 | African horse sickness virus Ab [Presence] in Serum by Complement fixation |
| 22769-4 | African horse sickness virus Ab [Titer] in Serum by Neutralization test |
| 2277-2 | Ferrochelatase [Enzymatic activity/volume] in Serum |
| 22770-2 | African horse sickness virus Ab [Titer] in Serum |
| 22771-0 | African horse sickness virus Ab [Presence] in Serum |
| 22772-8 | African horse sickness virus Ag [Presence] in Tissue by Immunoassay |
| 22773-6 | African horse sickness virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 22774-4 | African horse sickness virus RNA [Presence] in Tissue by Probe and target amplification method |
| 22775-1 | African horse sickness virus serotype [Identifier] in Serum by Neutralization test |
| 22776-9 | African horse sickness virus serotype [Identifier] in Unspecified specimen by Neutralization test |
| 22777-7 | African swine fever virus Ab [Presence] in Body fluid by Immunoassay |
| 22778-5 | African swine fever virus Ab [Presence] in Body fluid |
| 22779-3 | African swine fever virus Ab [Presence] in Serum |
| 2278-0 | Fibrinopeptide B [Mass/volume] in Serum |
| 22780-1 | African swine fever virus Ab [Presence] in Serum by Immunoassay |
| 22781-9 | African swine fever virus Ag [Presence] in Unspecified specimen by Agglutination |
| 22782-7 | African swine fever virus Ag [Presence] in Tissue by Agglutination |
| 22783-5 | African swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 22784-3 | African swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22785-0 | African swine fever virus DNA [Presence] in Tissue by Probe and target amplification method |
| 22786-8 | Alcelaphine herpesvirus 1 Ab [Titer] in Serum |
| 22787-6 | Alcelaphine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 22788-4 | Alcelaphine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
| 22789-2 | Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2279-8 | Fibrinopeptide A [Mass/volume] in Peritoneal fluid |
| 22790-0 | Alcelaphine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
| 22791-8 | Alcelaphine herpesvirus 1 DNA [Presence] in Tissue by Probe and target amplification method |
| 22792-6 | Aleutian disease virus Ab [Presence] in Serum by Counterimmunoelectrophoresis (CIE) |
| 22793-4 | Aleutian disease virus Ab [Presence] in Serum |
| 22794-2 | Anaplasma marginale Ab [Presence] in Serum by Immunofluorescence |
| 22795-9 | Anaplasma marginale Ab [Presence] in Serum by Immunoassay |
| 22796-7 | Anaplasma marginale Ag [Presence] in Tissue by Immunofluorescence |
| 22797-5 | Anaplasma marginale DNA [Presence] in Tissue by Probe and target amplification method |
| 22798-3 | Anaplasma marginale rRNA [Presence] in Tissue by DNA probe |
| 22799-1 | Anaplasma sp identified in Tissue by Modified Giemsa stain |
| 2280-6 | Fibronectin [Mass/volume] in Plasma |
| 22800-7 | Anaplasma sp identified in Blood by Modified Giemsa stain |
| 22801-5 | Infectious bronchitis virus Ab [Titer] in Serum |
| 22802-3 | Infectious bronchitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 22803-1 | Infectious bronchitis virus Ab [Titer] in Serum by Immunoassay |
| 22804-9 | Infectious bronchitis virus Ab [Titer] in Serum by Neutralization test |
| 22805-6 | Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 22806-4 | Infectious bronchitis virus Ag [Presence] in Tissue by Immune stain |
| 22807-2 | Infectious bronchitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22808-0 | Infectious bronchitis virus [Presence] in Unspecified specimen by Electron microscopy |
| 22809-8 | Infectious bronchitis virus RNA [Presence] in Unspecified specimen by DNA probe |
| 2281-4 | Flavin adenine dinucleotide [Mass/volume] in Serum |
| 22810-6 | Infectious bronchitis virus RNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22811-4 | Avian infectious laryngotracheitis virus [Presence] in Unspecified specimen by Electron microscopy |
| 22813-0 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Immunofluorescence |
| 22814-8 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum by Neutralization test |
| 22815-5 | Avian infectious laryngotracheitis virus Ab [Titer] in Serum |
| 22816-3 | Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 22817-1 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immune diffusion (ID) |
| 22818-9 | Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunoassay |
| 22819-7 | Avian infectious laryngotracheitis virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 2282-2 | Folate [Mass/volume] in Blood |
| 22820-5 | Avian orthoreovirus Ag [Presence] in Unspecified specimen |
| 22821-3 | Deprecated Influenza virus A Ab [Titer] in Serum |
| 22822-1 | Influenza virus A Ab [Presence] in Serum by Immunoassay |
| 22823-9 | Influenza virus A Ab [Titer] in Serum by Agglutination |
| 22824-7 | Influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
| 22825-4 | Influenza virus A Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 22826-2 | Influenza virus A identified in Unspecified specimen by Bioassay |
| 22827-0 | Influenza virus A subtype [Identifier] in Unspecified specimen by Probe and target amplification method |
| 22828-8 | Influenza virus A subtype [Identifier] in Unspecified specimen by Immune diffusion (ID) |
| 22829-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Hemagglutination inhibition |
| 2283-0 | Folate [Mass/volume] in Red Blood Cells |
| 22830-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Agglutination |
| 22831-2 | Avian paramyxovirus 1 Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
| 22832-0 | Avian paramyxovirus 1 identified in Unspecified specimen by Bioassay |
| 22833-8 | Avian paramyxovirus 1 [Units/volume] in Unspecified specimen by Bioassay |
| 22834-6 | Avian pneumovirus Ab [Presence] in Serum |
| 22836-1 | Avian pox virus [Presence] in Tissue by Electron microscopy |
| 22837-9 | Avian pox virus Ab [Presence] in Serum by Agglutination |
| 22838-7 | Avian pox virus Ab [Presence] in Serum by Immunofluorescence |
| 22839-5 | Avian pox virus Ab [Presence] in Serum by Neutralization test |
| 2284-8 | Folate [Mass/volume] in Serum or Plasma |
| 22840-3 | Avian pox virus Ab [Presence] in Serum by Immune stain |
| 22841-1 | Avian pox virus Ab [Presence] in Serum by Immunoassay |
| 22842-9 | Avian pox virus DNA [Presence] in Tissue by Probe and target amplification method |
| 22843-7 | Avian pox virus DNA [Presence] in Tissue by DNA probe |
| 22844-5 | Babesia bigemina Ab [Presence] in Serum |
| 22845-2 | Babesia bigemina Ab [Presence] in Serum by Immunofluorescence |
| 22846-0 | Babesia bigemina Ab [Presence] in Serum by Immunoassay |
| 22847-8 | Babesia bovis Ab [Presence] in Serum |
| 22848-6 | Babesia bovis Ab [Presence] in Serum by Immunoassay |
| 22849-4 | Babesia bovis Ab [Presence] in Serum by Immunofluorescence |
| 2285-5 | Follitropin [Moles/volume] in Semen |
| 22850-2 | Babesia caballi Ab [Presence] in Serum by Immunoassay |
| 22851-0 | Babesia caballi Ab [Presence] in Serum by Immunofluorescence |
| 22853-6 | Babesia caballi rRNA [Presence] in Blood by DNA probe |
| 22854-4 | Babesia divergens Ab [Presence] in Serum by Immunofluorescence |
| 22855-1 | Babesia divergens Ab [Presence] in Serum |
| 22856-9 | Babesia sp rRNA [Presence] in Tissue by DNA probe |
| 22857-7 | Babesia sp DNA [Presence] in Tissue by Probe and target amplification method |
| 22858-5 | Babesia sp identified in Tissue by Giemsa stain |
| 22859-3 | Bacillus anthracis Ab [Titer] in Serum |
| 2286-3 | Follitropin [Moles/volume] in Serum or Plasma |
| 22860-1 | Bacillus anthracis Ab [Presence] in Serum |
| 22861-9 | Bacillus anthracis Ab [Presence] in Serum by Immune diffusion (ID) |
| 22862-7 | Bacillus anthracis Ab [Presence] in Serum by Agglutination |
| 22863-5 | Bacillus anthracis Ab [Presence] in Serum by Immunoassay |
| 22864-3 | Bacillus anthracis Ab [Presence] in Serum by Complement fixation |
| 22865-0 | Bacillus anthracis Ab [Titer] in Serum by Immune diffusion (ID) |
| 22866-8 | Bacillus anthracis Ag [Presence] in Tissue by Immunofluorescence |
| 22867-6 | Bacillus anthracis Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22868-4 | Bluetongue virus Ab [Presence] in Serum by Neutralization test |
| 22869-2 | Bluetongue virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2287-1 | Follitropin [Mass/time] in 24 hour Urine |
| 22870-0 | Bluetongue virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 22871-8 | Bluetongue virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 22872-6 | Bluetongue virus Ag [Presence] in Blood |
| 22873-4 | Bluetongue virus Ag [Presence] in Unspecified specimen by Immune stain |
| 22874-2 | Bluetongue virus serotype [Identifier] in Unspecified specimen by Probe and target amplification method |
| 22875-9 | Border disease virus Ab [Units/volume] in Serum by Immunoassay |
| 22876-7 | Border disease virus Ab [Units/volume] in Serum |
| 22877-5 | Border disease virus Ab [Titer] in Serum |
| 22878-3 | Border disease virus Ab [Titer] in Serum by Neutralization test |
| 22879-1 | Border disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2288-9 | Follitropin.alpha subunit [Moles/volume] in Serum or Plasma |
| 22880-9 | Border disease virus Ag [Presence] in Unspecified specimen by Immune stain |
| 22881-7 | Border disease virus Ag [Presence] in Tissue by Immunoassay |
| 22882-5 | Border disease virus Ag [Presence] in Blood by Immunoassay |
| 22883-3 | Border disease virus RNA [Presence] in Tissue from Fetus by Probe and target amplification method |
| 22884-1 | Border disease virus RNA [Presence] in Tissue by Probe and target amplification method |
| 22885-8 | Border disease virus RNA [Presence] in Blood by Probe and target amplification method |
| 22886-6 | Bordetella bronchiseptica Ab [Presence] in Serum |
| 22887-4 | Bordetella bronchiseptica Ab [Presence] in Serum by Agglutination |
| 22888-2 | Bordetella bronchiseptica Ag [Presence] in Unspecified specimen by Agglutination |
| 22889-0 | Bovine diarrhea virus Ab [Presence] in Milk |
| 2289-7 | Follitropin.beta subunit [Moles/volume] in Serum or Plasma |
| 22890-8 | Bovine diarrhea virus Ab [Presence] in Milk by Immunoassay |
| 22891-6 | Bovine diarrhea virus Ab [Titer] in Serum |
| 22892-4 | Bovine diarrhea virus Ab [Titer] in Serum by Neutralization test |
| 22893-2 | Bovine diarrhea virus Ab [Presence] in Serum by Neutralization test |
| 22894-0 | Bovine diarrhea virus Ab [Presence] in Serum by Immunoassay |
| 22895-7 | Bovine diarrhea virus Ab [Presence] in Serum |
| 22896-5 | Bovine diarrhea virus Ag [Presence] in Blood by Immunoassay |
| 22897-3 | Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immune stain |
| 22898-1 | Bovine diarrhea virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22899-9 | Bovine diarrhea virus RNA [Presence] in Tissue by DNA probe |
| 22900-5 | Bovine diarrhea virus RNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22901-3 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immunofluorescence |
| 22902-1 | Bovine herpesvirus 1 Ab [Presence] in Serum by Immune diffusion (ID) |
| 22903-9 | Bovine herpesvirus 1 Ab [Presence] in Milk by Immunoassay |
| 22904-7 | Bovine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
| 22905-4 | Bovine herpesvirus 1 Ab [Presence] in Milk |
| 22906-2 | Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunoassay |
| 22907-0 | Bovine herpesvirus 1 Ag [Presence] in Nose by Immunofluorescence |
| 22908-8 | Bovine herpesvirus 1 Ag [Units/volume] in Unspecified specimen by Neutralization test |
| 22909-6 | Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immune stain |
| 2291-3 | Formate [Mass/volume] in Blood |
| 22910-4 | Bovine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22911-2 | Bovine herpesvirus 1 Ag [Presence] in Genital specimen by Immunofluorescence |
| 22912-0 | Bovine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
| 22913-8 | Bovine herpesvirus 1 DNA [Presence] in Semen by Probe and target amplification method |
| 22914-6 | Bovine herpesvirus 1 DNA [Presence] in Tissue by Probe and target amplification method |
| 22915-3 | Bovine leukemia virus Ab [Presence] in Milk |
| 22916-1 | Bovine leukemia virus Ab [Presence] in Milk by Immunoassay |
| 22917-9 | Bovine leukemia virus Ag [Presence] in Unspecified specimen |
| 22918-7 | Bovine leukemia virus RNA [Presence] in Blood by Probe and target amplification method |
| 22919-5 | Bovine leukemia virus RNA [Presence] in Tissue by Probe and target amplification method |
| 2292-1 | Formate [Mass/volume] in Serum or Plasma |
| 22920-3 | Brucella abortus Ab [Presence] in Serum by Immunofluorescence |
| 22921-1 | Brucella abortus Ab [Units/volume] in Serum by Agglutination |
| 22922-9 | Brucella abortus IgG1 Ab [Presence] in Serum by Immunoassay |
| 22923-7 | Brucella abortus IgG1 Ab [Presence] in Milk by Immunoassay |
| 22924-5 | Brucella abortus IgG1 Ab [Presence] in Serum |
| 22925-2 | Brucella abortus IgG1 Ab [Presence] in Milk |
| 22926-0 | Brucella abortus rRNA [Presence] in Unspecified specimen by DNA probe |
| 22927-8 | Brucella abortus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22928-6 | Brucella canis Ab [Presence] in Serum |
| 22929-4 | Brucella canis Ab [Presence] in Serum by Immune diffusion (ID) |
| 2293-9 | Fructokinase [Enzymatic activity/volume] in Serum |
| 22930-2 | Brucella canis Ab [Presence] in Serum by Agglutination |
| 22931-0 | Brucella melitensis Ab [Presence] in Serum |
| 22932-8 | Brucella melitensis Ab [Presence] in Serum by Immunoassay |
| 22933-6 | Brucella melitensis Ab [Presence] in Serum by Agglutination |
| 22934-4 | Brucella melitensis Ab [Units/volume] in Serum by Complement fixation |
| 22935-1 | Brucella melitensis Ab [Presence] in Serum by Complement fixation |
| 22936-9 | Brucella melitensis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22937-7 | Brucella ovis Ab [Units/volume] in Serum by Complement fixation |
| 22938-5 | Brucella ovis Ab [Presence] in Serum by Agglutination |
| 22939-3 | Brucella ovis Ab [Units/volume] in Serum |
| 2294-7 | Deprecated Fructosamine |
| 22940-1 | Brucella ovis Ab [Presence] in Serum by Immune diffusion (ID) |
| 22943-5 | Brucella sp Ag [Presence] in Placenta by Immunofluorescence |
| 22944-3 | Brucella sp Ag [Presence] in Vaginal fluid by Immune stain |
| 22945-0 | Brucella sp Ag [Presence] in Tissue by Immune stain |
| 22946-8 | Brucella sp Ag [Presence] in Tissue from Fetus by Immunofluorescence |
| 22947-6 | Brucella sp Ag [Presence] in Vaginal fluid by Immunofluorescence |
| 22948-4 | Brucella sp Ag [Presence] in Tissue from Fetus by Immune stain |
| 22949-2 | Brucella sp Ag [Presence] in Placenta by Immune stain |
| 2295-4 | Fructose [Mass/volume] in Semen |
| 22950-0 | Brucella suis Ab [Presence] in Serum by Plate agglutination |
| 22951-8 | Brucella suis Ab [Presence] in Serum |
| 22952-6 | Brucella suis Ab [Presence] in Serum by Immunoassay |
| 22953-4 | Brucella suis Ab [Units/volume] in Serum by Complement fixation |
| 22954-2 | Brucella suis rRNA [Presence] in Unspecified specimen by DNA probe |
| 22955-9 | Brucella suis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22956-7 | Burkholderia mallei Ab [Presence] in Serum |
| 22958-3 | Burkholderia mallei Ab [Presence] in Serum by Immunoassay |
| 22959-1 | Burkholderia mallei Ab [Presence] in Serum by Complement fixation |
| 2296-2 | Fructose [Mass/volume] in Serum |
| 22962-5 | Campylobacter fetus Ab [Presence] in Genital mucus |
| 22963-3 | Campylobacter fetus Ab [Presence] in Genital mucus by Agglutination |
| 22964-1 | Campylobacter fetus Ag [Presence] in Genital fluid by Immunofluorescence |
| 22965-8 | Campylobacter fetus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22966-6 | Campylobacter fetus Ag [Presence] in Tissue by Immunofluorescence |
| 22967-4 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus |
| 22968-2 | Campylobacter fetus ss venerealis Ab [Presence] in Genital mucus by Agglutination |
| 22969-0 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus by Immunoassay |
| 2297-0 | Fructose [Mass/time] in 24 hour Urine |
| 22970-8 | Campylobacter fetus ss venerealis IgA Ab [Presence] in Genital mucus |
| 22971-6 | Caprine arthritis encephalitis virus [Presence] in Unspecified specimen by Electron microscopy |
| 22972-4 | Caprine arthritis encephalitis virus Ab [Presence] in Milk |
| 22973-2 | Caprine arthritis encephalitis virus Ab [Presence] in Milk by Immunoassay |
| 22974-0 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Agglutination |
| 22975-7 | Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immune stain |
| 22976-5 | Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 22977-3 | Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
| 22978-1 | Caprine arthritis encephalitis virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 22979-9 | Caprine herpesvirus 1 Ab [Presence] in Serum |
| 22980-7 | Caprine herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
| 22981-5 | Capripox virus [Presence] in Tissue by Animal inoculation |
| 22982-3 | Capripox virus Ab [Presence] in Serum |
| 22983-1 | Capripox virus Ab [Presence] in Serum by Immunoblot (IB) |
| 22984-9 | Capripox virus Ab [Presence] in Serum by Neutralization test |
| 22986-4 | Capripox virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 22987-2 | Capripox virus Ag [Presence] in Tissue by Immune stain |
| 22988-0 | Capripox virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 22989-8 | Capripox virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2299-6 | Aldolase [Enzymatic activity/volume] in Red Blood Cells |
| 22990-6 | Capripox virus Ag [Presence] in Tissue by Immunoassay |
| 22991-4 | Capripox virus DNA [Presence] in Unspecified specimen by Restriction Fragment Length Polymorphysm (RFLP) |
| 22992-2 | Chlamydophila psittaci [Presence] in Unspecified specimen by Giemsa stain |
| 22993-0 | Chlamydophila psittaci [Presence] in Placenta by Electron microscopy |
| 22994-8 | Chlamydophila psittaci Ab [Presence] in Serum by Agglutination |
| 22995-5 | Chlamydophila psittaci Ab [Presence] in Serum by Immune diffusion (ID) |
| 22996-3 | Chlamydophila psittaci Ab [Presence] in Serum by Immunoassay |
| 22997-1 | Chlamydophila psittaci Ag [Presence] in Unspecified specimen by Immune stain |
| 22998-9 | Chlamydophila psittaci Ag [Presence] in Tissue by Immune stain |
| 22999-7 | Chlamydophila psittaci Ag [Presence] in Stool by Immune stain |
| 23000-3 | Chlamydophila psittaci Ag [Presence] in Exudate by Immune stain |
| 23001-1 | Chlamydophila psittaci DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23002-9 | Classical swine fever virus Ab [Presence] in Serum by Immunoassay |
| 23003-7 | Classical swine fever virus Ab [Presence] in Serum by Neutralization test |
| 23004-5 | Classical swine fever virus Ab [Presence] in Serum |
| 23005-2 | Classical swine fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 23006-0 | Classical swine fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23007-8 | Classical swine fever virus Ag [Presence] in Tissue by Immune stain |
| 23008-6 | Classical swine fever virus RNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23009-4 | Cowdria ruminantium [Presence] in Brain by Giemsa stain |
| 23010-2 | Cowdria ruminantium Ab [Presence] in Serum by Immunofluorescence |
| 23011-0 | Cowdria ruminantium Ab [Presence] in Serum by Immunoassay |
| 23012-8 | Cowdria ruminantium Ab [Presence] in Serum |
| 23013-6 | Cowdria ruminantium Ab [Presence] in Serum by Immunoblot (IB) |
| 23014-4 | Cowdria ruminantium DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23015-1 | Cowdria ruminantium rRNA [Presence] in Unspecified specimen by DNA probe |
| 23016-9 | Coxiella burnetii [Presence] in Placenta by Light microscopy |
| 23017-7 | Coxiella burnetii Ab [Presence] in Serum by Complement fixation |
| 23018-5 | Coxiella burnetii Ab [Presence] in Serum by Immunofluorescence |
| 23019-3 | Coxiella burnetii Ab [Presence] in Serum by Immunoassay |
| 2302-8 | Fumarase [Enzymatic activity/volume] in Serum |
| 23020-1 | Coxiella burnetii Ab [Presence] in Serum |
| 23021-9 | Coxiella burnetii Ag [Presence] in Tissue by Immunoassay |
| 23022-7 | Coxiella burnetii Ag [Presence] in Placenta by Immunofluorescence |
| 23023-5 | Coxiella burnetii Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23024-3 | Coxiella burnetii DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23025-0 | Dermatophilus congolensis [Presence] in Skin by Giemsa stain |
| 23026-8 | Dermatophilus congolensis Ab [Presence] in Serum |
| 23027-6 | Dermatophilus congolensis Ab [Presence] in Serum by Immunoassay |
| 23028-4 | Dermatophilus congolensis Ag [Presence] in Tissue by Immunofluorescence |
| 23029-2 | Dirofilaria immitis Ag [Presence] in Blood |
| 2303-6 | Fumarate [Mass/volume] in Urine |
| 23030-0 | Duck enteritis virus [Presence] in Tissue by Electron microscopy |
| 23031-8 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23032-6 | Duck enteritis virus Ag [Presence] in Unspecified specimen by Agglutination |
| 23033-4 | Duck hepatitis virus 1 Ab [Presence] in Serum by Neutralization test |
| 23034-2 | Duck hepatitis virus 1 Ab [Presence] in Serum |
| 23035-9 | Duck hepatitis virus 1 Ag [Presence] in Unspecified specimen by Neutralization test |
| 23036-7 | Duck hepatitis virus 2 Ab [Presence] in Serum |
| 23037-5 | Duck hepatitis virus 2 Ab [Presence] in Serum by Neutralization test |
| 23038-3 | Duck hepatitis virus 2 Ag [Presence] in Unspecified specimen by Neutralization test |
| 23039-1 | Duck hepatitis virus 3 Ab [Presence] in Serum |
| 2304-4 | Fumarylacetoacetate [Mass/volume] in Serum |
| 23040-9 | Duck hepatitis virus 3 Ab [Presence] in Serum by Neutralization test |
| 23041-7 | Duck hepatitis virus 3 Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23042-5 | Eastern equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23043-3 | Eastern equine encephalitis virus Ab [Presence] in Serum by Agglutination |
| 23044-1 | Eastern equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
| 23045-8 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 23046-6 | Eastern equine encephalitis virus IgM Ab [Presence] in Serum |
| 23047-4 | Eastern equine encephalitis virus Ag [Presence] in Brain by Complement fixation |
| 23048-2 | Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23049-0 | Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
| 2305-1 | Galactokinase [Enzymatic activity/volume] in Red Blood Cells |
| 23050-8 | Eastern equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23051-6 | Eastern equine encephalitis virus RNA [Presence] in Tissue by Probe and target amplification method |
| 23052-4 | Eastern equine encephalitis virus RNA [Presence] in Tissue by DNA probe |
| 23053-2 | Echinococcus sp Ag [Presence] in Stool by Immunoassay |
| 23054-0 | Ehrlichia canis Ab [Presence] in Serum by Immunofluorescence |
| 23055-7 | Ehrlichia risticii Ab [Presence] in Serum by Immunofluorescence |
| 23056-5 | Ehrlichia risticii Ab [Presence] in Serum |
| 23057-3 | Ephemeral fever virus Ab [Presence] in Serum by Neutralization test |
| 23058-1 | Ephemeral fever virus Ab [Presence] in Serum |
| 23059-9 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
| 2306-9 | Galactose [Presence] in Blood |
| 23060-7 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Complement fixation |
| 23061-5 | Epizootic hemorrhagic disease virus Ag [Presence] in Unspecified specimen |
| 23062-3 | Epizootic hemorrhagic disease virus Ag [Presence] in Blood |
| 23063-1 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum |
| 23064-9 | Epizootic hemorrhagic disease virus Alberta Ab [Presence] in Serum by Immune diffusion (ID) |
| 23065-6 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum |
| 23066-4 | Epizootic hemorrhagic disease virus New Jersey Ab [Presence] in Serum by Immune diffusion (ID) |
| 23067-2 | Epizootic hemorrhagic disease virus RNA [Presence] in Blood by Probe and target amplification method |
| 23068-0 | Equine arteritis virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23069-8 | Equine arteritis virus Ab [Titer] in Serum by Complement fixation |
| 2307-7 | Galactose [Mass/volume] in Blood |
| 23070-6 | Equine arteritis virus Ab [Presence] in Serum by Immunoassay |
| 23071-4 | Equine arteritis virus Ab [Presence] in Serum by Neutralization test |
| 23072-2 | Equine arteritis virus Ab [Presence] in Serum by Immunofluorescence |
| 23073-0 | Equine arteritis virus Ab [Presence] in Serum |
| 23074-8 | Equine arteritis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23075-5 | Equine arteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
| 23076-3 | Equine arteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23077-1 | Equine arteritis virus Ag [Presence] in Tissue by Immunofluorescence |
| 23078-9 | Equine arteritis virus Ag [Presence] in Tissue by Immune stain |
| 23079-7 | Equine arteritis virus RNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 2308-5 | Galactose [Mass/volume] in Serum or Plasma |
| 23080-5 | Equine herpesvirus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23081-3 | Equine herpesvirus 1 Ag [Presence] in Tissue by Immune stain |
| 23082-1 | Equine herpesvirus 1 DNA [Presence] in Nose by Probe and target amplification method |
| 23083-9 | Equine herpesvirus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23084-7 | Equine herpesvirus 1 DNA [Presence] in Tissue by Probe and target amplification method |
| 23085-4 | Equine herpesvirus 1+4 Ab [Presence] in Serum by Neutralization test |
| 23086-2 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Immunoassay |
| 23087-0 | Equine herpesvirus 1+4 Ab [Presence] in Serum |
| 23088-8 | Equine herpesvirus 1+4 Ab [Titer] in Serum |
| 23089-6 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Neutralization test |
| 2309-3 | Galactose [Presence] in Urine |
| 23090-4 | Equine herpesvirus 1+4 Ab [Titer] in Serum by Complement fixation |
| 23091-2 | Equine herpesvirus 1+4 Ag [Presence] in Body fluid by Immunofluorescence |
| 23092-0 | Equine herpesvirus 4 Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23093-8 | Equine herpesvirus 4 DNA [Presence] in Nose by Probe and target amplification method |
| 23094-6 | Equine herpesvirus 4 DNA [Presence] in Tissue by Probe and target amplification method |
| 23095-3 | Equine herpesvirus 4 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23096-1 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoblot (IB) |
| 23097-9 | Equine infectious anemia virus Ab [Presence] in Serum by Immunoassay |
| 23098-7 | Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23099-5 | Equine infectious anemia virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 2310-1 | Galactose [Mass/volume] in Urine |
| 23100-1 | Equine influenza virus A1 Ab [Presence] in Serum by Complement fixation |
| 23101-9 | Equine influenza virus A1 Ab [Presence] in Serum |
| 23102-7 | Equine influenza virus A1 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
| 23103-5 | Equine influenza virus A2 Ab [Presence] in Serum by Complement fixation |
| 23104-3 | Equine influenza virus A2 Ag [Titer] in Unspecified specimen by Hemagglutination inhibition |
| 23105-0 | Fly larvae identified in Unspecified specimen |
| 23106-8 | Foot and mouth disease virus Ab [Presence] in Serum |
| 23107-6 | Foot and mouth disease virus Ab [Presence] in Serum by Neutralization test |
| 23108-4 | Foot and mouth disease virus Ab [Presence] in Serum by Immunoassay |
| 23109-2 | Foot and mouth disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 2311-9 | Galactose renal clearance in 24 hour |
| 23110-0 | Foot and mouth disease virus Ag [Presence] in Tissue by Immunoassay |
| 23111-8 | Foot and mouth disease virus Ag [Presence] in Throat by Immunoassay |
| 23112-6 | Foot and mouth disease virus Ag [Presence] in Tissue by Complement fixation |
| 23113-4 | Foot and mouth disease virus Ag [Presence] in Throat by Complement fixation |
| 23114-2 | Foot and mouth disease virus RNA [Presence] in Tissue by DNA probe |
| 23115-9 | Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Complement fixation |
| 23116-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by Immunoassay |
| 23117-5 | Foot and mouth disease virus serotype [Identifier] in Serum by Immunoassay |
| 23118-3 | Foot and mouth disease virus serotype [Identifier] in Serum by Neutralization test |
| 23119-1 | Foot and mouth disease virus serotype [Identifier] in Tissue by Complement fixation |
| 2312-7 | Galactose 1 phosphate [Mass/volume] in Red Blood Cells |
| 23120-9 | Foot and mouth disease virus serotype [Identifier] in Unspecified specimen by Immunoassay |
| 23121-7 | Foot and mouth disease virus serotype [Identifier] in Tissue by Probe and target amplification method |
| 23122-5 | Francisella tularensis A DNA [Presence] in Tissue by Probe and target amplification method |
| 23123-3 | Francisella tularensis A rRNA [Presence] in Tissue by DNA probe |
| 23124-1 | Francisella tularensis Ab [Presence] in Serum by Immunoassay |
| 23125-8 | Francisella tularensis Ab [Titer] in Serum by Agglutination |
| 23126-6 | Francisella tularensis Ag [Presence] in Tissue by Immune stain |
| 23127-4 | Francisella tularensis Ag [Presence] in Tissue by Immunofluorescence |
| 23128-2 | Francisella tularensis B DNA [Presence] in Tissue by Probe and target amplification method |
| 23129-0 | Francisella tularensis B rRNA [Presence] in Tissue by DNA probe |
| 2313-5 | Galactose 1 phosphate uridyl transferase [Presence] in Red Blood Cells |
| 23130-8 | Francisella tularensis DNA [Presence] in Tissue by Probe and target amplification method |
| 23131-6 | Francisella tularensis rRNA [Presence] in Tissue by DNA probe |
| 23132-4 | Histoplasma farciminosum Ab [Presence] in Serum by Immunofluorescence |
| 23133-2 | Histoplasma farciminosum Ab [Presence] in Serum by Immunoassay |
| 23134-0 | Histoplasma farciminosum Ab [Presence] in Serum by Hemagglutination |
| 23135-7 | Histoplasma farciminosum Ab [Presence] in Serum |
| 23139-9 | Infectious bursal disease virus Ab [Titer] in Serum |
| 2314-3 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Red Blood Cells |
| 23140-7 | Infectious bursal disease virus Ab [Titer] in Serum by Immune diffusion (ID) |
| 23141-5 | Infectious bursal disease virus Ab [Titer] in Serum by Neutralization test |
| 23142-3 | Infectious bursal disease virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23143-1 | Infectious bursal disease virus Ag [Presence] in Bursa of Fabricius by Immune diffusion (ID) |
| 23144-9 | Japanese encephalitis virus Ab [Titer] in Serum by Neutralization test |
| 23145-6 | Japanese encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 23146-4 | Japanese encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23147-2 | Japanese encephalitis virus Ab [Titer] in Serum |
| 23148-0 | Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23149-8 | Japanese encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
| 2315-0 | Galactosylceramidase [Enzymatic activity/mass] in Tissue |
| 23150-6 | Leishmania donovani Ag [Presence] in Tissue by Immune stain |
| 23152-2 | Leishmania sp Ab [Titer] in Serum |
| 23153-0 | Leishmania sp Ab [Presence] in Serum by Immunoassay |
| 23154-8 | Leishmania sp Ab [Titer] in Serum by Hemagglutination |
| 23155-5 | Leishmania sp Ab [Presence] in Serum by Immunoelectrophoresis |
| 23156-3 | Leishmania sp Ab [Titer] in Serum by Immunofluorescence |
| 23157-1 | Leishmania sp Ab [Presence] in Serum by Agglutination |
| 23158-9 | Leishmania sp rRNA [Identifier] in Unspecified specimen by DNA probe |
| 23159-7 | Leishmania sp DNA [Identifier] in Unspecified specimen by Probe and target amplification method |
| 2316-8 | Galactosylgalactosylglucosylceramidase [Enzymatic activity/mass] in Tissue |
| 23160-5 | Leishmania sp identified in Tissue by Immunofluorescence |
| 23161-3 | Leishmania sp identified in Tissue by Electrophoresis |
| 23162-1 | Leishmania sp identified in Tissue by Polyacrylamide gel electrophoresis (PAGE) |
| 23163-9 | Leptospira interrogans sv Australis Ab [Presence] in Serum by Agglutination |
| 23164-7 | Leptospira interrogans sv Australis Ab [Presence] in Serum |
| 23165-4 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum by Agglutination |
| 23166-2 | Leptospira interrogans sv Autumnalis Ab [Presence] in Serum |
| 23167-0 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum |
| 23168-8 | Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination |
| 23169-6 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum by Agglutination |
| 23170-4 | Leptospira interrogans sv Bataviae Ab [Presence] in Serum |
| 23171-2 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum by Agglutination |
| 23172-0 | Leptospira interrogans sv Bratislava Ab [Presence] in Serum |
| 23173-8 | Leptospira interrogans sv Canicola Ab [Presence] in Serum |
| 23174-6 | Leptospira interrogans sv Canicola Ab [Presence] in Serum by Agglutination |
| 23175-3 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum |
| 23176-1 | Leptospira interrogans sv Copenhageni Ab [Presence] in Serum by Agglutination |
| 23177-9 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum |
| 23178-7 | Leptospira interrogans sv Grippotyphosa Ab [Presence] in Serum by Agglutination |
| 23179-5 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Immunoassay |
| 23180-3 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum by Agglutination |
| 23181-1 | Leptospira interrogans sv Hardjo Ab [Presence] in Serum |
| 23182-9 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum by Agglutination |
| 23183-7 | Leptospira interrogans sv Hebdomadis Ab [Presence] in Serum |
| 23184-5 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum by Agglutination |
| 23185-2 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Presence] in Serum |
| 23186-0 | Leptospira interrogans Ab [Presence] in Serum by Immunoassay |
| 23187-8 | Leptospira interrogans Ab [Presence] in Serum |
| 23188-6 | Leptospira interrogans Ab [Presence] in Serum by Agglutination |
| 23189-4 | Leptospira interrogans sv Mitis Ab [Presence] in Serum |
| 23190-2 | Leptospira interrogans sv Mitis Ab [Presence] in Serum by Agglutination |
| 23191-0 | Leptospira interrogans sv Pomona Ab [Presence] in Serum |
| 23192-8 | Leptospira interrogans sv Pomona Ab [Presence] in Serum by Agglutination |
| 23193-6 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum |
| 23194-4 | Leptospira borgpetersenii sv Sejroe Ab [Presence] in Serum by Agglutination |
| 23195-1 | Leptospira sp Ab [Presence] in Serum by Immunoassay |
| 23196-9 | Leptospira sp Ab [Presence] in Serum |
| 23197-7 | Leptospira sp Ab [Presence] in Serum by Agglutination |
| 23198-5 | Leptospira sp Ab [Titer] in Serum by Agglutination |
| 23199-3 | Leptospira sp IgG Ab [Presence] in Serum by Immunoassay |
| 2320-0 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Red Blood Cells |
| 23200-9 | Leptospira sp IgG Ab [Presence] in Serum |
| 23201-7 | Leptospira sp IgM Ab [Presence] in Serum by Immunoassay |
| 23202-5 | Leptospira sp IgM Ab [Presence] in Serum |
| 23203-3 | Leptospira sp Ag [Presence] in Tissue by Immunofluorescence |
| 23204-1 | Leptospira sp Ag [Presence] in Tissue by Immune stain |
| 23205-8 | Leptospira sp DNA [Presence] in Body fluid by Probe and target amplification method |
| 23206-6 | Leptospira sp DNA [Presence] in Tissue by Probe and target amplification method |
| 23207-4 | Leptospira subtype [Identifier] in Unspecified specimen |
| 23208-2 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum |
| 23209-0 | Leptospira borgpetersenii sv Tarrasovi Ab [Presence] in Serum by Agglutination |
| 2321-8 | Gamma glutamyl cysteine synthetase [Enzymatic activity/volume] in Serum |
| 23210-8 | Listeria sp Ab [Presence] in Serum |
| 23211-6 | Listeria sp Ab [Presence] in Serum by Agglutination |
| 23212-4 | Lumpy skin disease virus [Presence] in Tissue by Electron microscopy |
| 23213-2 | Lumpy skin disease virus Ab [Titer] in Serum by Immunofluorescence |
| 23214-0 | Lumpy skin disease virus Ab [Presence] in Serum by Immunoblot (IB) |
| 23215-7 | Lumpy skin disease virus Ab [Presence] in Serum by Neutralization test |
| 23216-5 | Lumpy skin disease virus Ab [Presence] in Serum |
| 23217-3 | Lumpy skin disease virus Ab [Titer] in Serum |
| 23218-1 | Lumpy skin disease virus Ag [Presence] in Tissue by Immunoassay |
| 23219-9 | Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 2322-6 | Gamma glutamyl transferase [Enzymatic activity/volume] in Amniotic fluid |
| 23220-7 | Lumpy skin disease virus Ag [Presence] in Unspecified specimen |
| 23221-5 | Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23222-3 | Lumpy skin disease virus Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 23223-1 | Lumpy skin disease virus DNA [Presence] in Unspecified specimen by Restriction Fragment Length Polymorphysm (RFLP) |
| 23224-9 | Mareks disease virus Ab [Presence] in Serum |
| 23225-6 | Mareks disease virus Ab [Presence] in Serum by Immunoassay |
| 23226-4 | Mareks disease virus Ab [Presence] in Serum by Immunofluorescence |
| 23227-2 | Mareks disease virus Ab [Presence] in Serum by Neutralization test |
| 23228-0 | Mareks disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23229-8 | Mareks disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2323-4 | Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
| 23230-6 | Mareks disease virus Ag [Presence] in Feather by Immune diffusion (ID) |
| 23231-4 | Mareks disease virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23232-2 | Mite identified in Skin by Flotation |
| 23233-0 | Mite identified in Skin by Parasite sedimentation |
| 23234-8 | Mycobacterium avium ss avium Ab [Presence] in Blood |
| 23235-5 | Mycobacterium avium ss avium Ab [Presence] in Blood by Agglutination |
| 23236-3 | Mycobacterium avium ss avium rRNA [Presence] in Tissue by DNA probe |
| 23237-1 | Mycobacterium avium ss avium identified in Unspecified specimen by Bioassay |
| 23238-9 | Mycobacterium avium ss avium serotype [Identifier] in Unspecified specimen |
| 23239-7 | Mycobacterium bovis Ab [Presence] in Serum |
| 2324-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma |
| 23240-5 | Mycobacterium bovis Ab [Presence] in Serum by Immunoassay |
| 23241-3 | Mycobacterium bovis Ag [Presence] in Tissue by Immune stain |
| 23242-1 | Mycobacterium bovis Ag [Presence] in Blood |
| 23243-9 | Mycobacterium avium ss paratuberculosis [Presence] in Stool by Acid fast stain.Ziehl-Neelsen |
| 23244-7 | Mycobacterium avium ss paratuberculosis [Presence] in Tissue by Acid fast stain.Ziehl-Neelsen |
| 23245-4 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23246-2 | Mycobacterium avium ss paratuberculosis DNA [Presence] in Stool by Probe and target amplification method |
| 23247-0 | Mycobacterium sp DNA [Presence] in Tissue by Probe and target amplification method |
| 23248-8 | Mycoplasma agalactiae Ab [Presence] in Serum by Neutralization test |
| 23249-6 | Mycoplasma agalactiae Ab [Presence] in Serum by Complement fixation |
| 23250-4 | Mycoplasma agalactiae Ab [Presence] in Serum by Immunoassay |
| 23251-2 | Mycoplasma agalactiae Ab [Presence] in Serum |
| 23252-0 | Mycoplasma agalactiae DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23253-8 | Mycoplasma arginini Ab [Presence] in Serum |
| 23254-6 | Mycoplasma arginini Ab [Presence] in Serum by Complement fixation |
| 23255-3 | Mycoplasma bovis Ab [Presence] in Serum |
| 23256-1 | Mycoplasma bovis Ab [Presence] in Serum by Complement fixation |
| 23257-9 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Immunoassay |
| 23258-7 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum by Complement fixation |
| 23259-5 | Mycoplasma capricolum ss capricolum Ab [Presence] in Serum |
| 2326-7 | Gastric inhibitory polypeptide [Mass/volume] in Plasma |
| 23260-3 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Agglutination |
| 23262-9 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum |
| 23263-7 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Immunoassay |
| 23264-5 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Blood by Agglutination |
| 23265-2 | Mycoplasma capricolum ss capripneumonia Ab [Titer] in Serum by Complement fixation |
| 23266-0 | Mycoplasma capricolum ss capripneumonia Ab [Presence] in Serum by Complement fixation |
| 23267-8 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Neutralization test |
| 23268-6 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23269-4 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Unspecified specimen |
| 2327-5 | Gastrin releasing polypeptide [Mass/volume] in Cerebral spinal fluid |
| 23270-2 | Mycoplasma capricolum ss capripneumonia Ag [Presence] in Tissue |
| 23271-0 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by DNA probe |
| 23272-8 | Mycoplasma capricolum ss capripneumonia rRNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23273-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Hemagglutination |
| 23274-4 | Mycoplasma gallisepticum Ab [Titer] in Serum by Hemagglutination |
| 23275-1 | Mycoplasma gallisepticum Ab [Titer] in Serum |
| 23276-9 | Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23277-7 | Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Immune stain |
| 23278-5 | Mycoplasma gallisepticum Ag [Presence] in Unspecified specimen by Neutralization test |
| 23279-3 | Mycoplasma gallisepticum DNA [Presence] in Nose or Trachea by Probe and target amplification method |
| 2328-3 | Gastrin releasing polypeptide [Moles/volume] in Cerebral spinal fluid |
| 23280-1 | Mycoplasma meleagridis Ab [Presence] in Serum by Hemagglutination |
| 23281-9 | Mycoplasma mycoides ss capri Ab [Presence] in Serum by Complement fixation |
| 23282-7 | Mycoplasma mycoides ss capri Ab [Presence] in Serum |
| 23283-5 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Complement fixation |
| 23284-3 | Mycoplasma mycoides ss mycoides large colony Ab [Presence] in Serum by Immunoassay |
| 23285-0 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum |
| 23286-8 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoblot (IB) |
| 23287-6 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Immunoassay |
| 23288-4 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Complement fixation |
| 23289-2 | Mycoplasma mycoides ss mycoides small colony Ab [Presence] in Serum by Agglutination |
| 2329-1 | Gastrin releasing polypeptide [Mass/volume] in Serum or Plasma |
| 23290-0 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 23291-8 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23292-6 | Mycoplasma mycoides ss mycoides small colony Ag [Presence] in Tissue by Immune stain |
| 23293-4 | Mycoplasma mycoides ss mycoides small colony DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23294-2 | Mycoplasma putrefaciens Ab [Presence] in Serum by Immunoassay |
| 23295-9 | Mycoplasma putrefaciens Ab [Presence] in Serum by Complement fixation |
| 23296-7 | Mycoplasma putrefaciens Ab [Presence] in Serum |
| 23297-5 | Mycoplasma sp Ab [Presence] in Serum by Complement fixation |
| 23298-3 | Mycoplasma sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23299-1 | Mycoplasma sp Ag [Presence] in Unspecified specimen |
| 2330-9 | Gastrin.34 residue fragment [Mass/volume] in Serum or Plasma |
| 23300-7 | Mycoplasma sp rRNA [Presence] in Unspecified specimen by DNA probe |
| 23301-5 | Mycoplasma sp DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23302-3 | Mycoplasma synoviae Ab [Presence] in Serum by Hemagglutination |
| 23303-1 | Myxoma virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23304-9 | Myxoma virus Ab [Presence] in Serum |
| 23305-6 | Myxoma virus Ab [Titer] in Serum |
| 23306-4 | Myxoma virus Ab [Titer] in Serum by Immunofluorescence |
| 23307-2 | Myxoma virus Ab [Presence] in Serum by Complement fixation |
| 23308-0 | Myxoma virus Ab [Presence] in Serum by Neutralization test |
| 23309-8 | Myxoma virus Ab [Presence] in Serum by Immunofluorescence |
| 2331-7 | Gastrin.17 residue fragment [Mass/volume] in Serum or Plasma |
| 23310-6 | Myxoma virus Ag [Presence] in Skin by Immune diffusion (ID) |
| 23311-4 | Myxoma virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23313-0 | Nairobi sheep disease virus Ab [Titer] in Serum |
| 23314-8 | Nairobi sheep disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23315-5 | Nairobi sheep disease virus Ab [Presence] in Serum by Immunofluorescence |
| 23316-3 | Nairobi sheep disease virus Ab [Presence] in Serum |
| 23318-9 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
| 23319-7 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2332-5 | Gastrin.14 residue fragment [Mass/volume] in Serum or Plasma |
| 23320-5 | Nairobi sheep disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 23321-3 | Ovine herpesvirus 2 Ab [Presence] in Serum |
| 23322-1 | Ovine herpesvirus 2 Ab [Presence] in Serum by Complement fixation |
| 23324-7 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunofluorescence |
| 23325-4 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immunoassay |
| 23326-2 | Ovine herpesvirus 2 Ab [Presence] in Serum by Immune stain |
| 23327-0 | Ovine herpesvirus 2 DNA [Presence] in Tissue by Probe and target amplification method |
| 23328-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk |
| 23329-6 | Ovine progressive pneumonia virus Ab [Presence] in Serum |
| 2333-3 | Gastrin [Mass/volume] in Serum or Plasma |
| 23330-4 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immunoassay |
| 23332-0 | Ovine progressive pneumonia virus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23333-8 | Ovine progressive pneumonia virus Ab [Presence] in Milk by Immunoassay |
| 23334-6 | Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23335-3 | Ovine progressive pneumonia virus Ag [Presence] in Unspecified specimen by Immune stain |
| 23336-1 | Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by Polyacrylamide gel electrophoresis (PAGE) |
| 23337-9 | Ovine progressive pneumonia virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23338-7 | Ovine pulmonary adenomatosis retrovirus RNA [Presence] in Lung tissue by Probe and target amplification method |
| 2334-1 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid |
| 23341-1 | Pasteurella multocida Ab [Titer] in Serum by Immunoassay |
| 23342-9 | Pasteurella multocida Ab [Titer] in Serum |
| 23343-7 | Pasteurella multocida Ag [Titer] in Unspecified specimen by Agglutination |
| 23344-5 | Pasteurella multocida rRNA [Presence] in Unspecified specimen by DNA probe |
| 23345-2 | Pasteurella multocida serotype [Identifier] in Unspecified specimen by Agglutination |
| 23346-0 | Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunoelectrophoresis |
| 23347-8 | Pasteurella multocida serotype [Identifier] in Unspecified specimen by Immunofluorescence |
| 23349-4 | Pasteurella multocida toxin [Presence] in Unspecified specimen by Immunoassay |
| 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool |
| 23350-2 | Peste des petits ruminants virus Ab [Titer] in Serum |
| 23351-0 | Peste des petits ruminants virus Ab [Presence] in Serum |
| 23352-8 | Peste des petits ruminants virus Ab [Titer] in Serum by Neutralization test |
| 23354-4 | Peste des petits ruminants virus Ab [Presence] in Serum by Immunoassay |
| 23355-1 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoassay |
| 23356-9 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immunoelectrophoresis |
| 23357-7 | Peste des petits ruminants virus Ag [Presence] in Tissue by Immune diffusion (ID) |
| 23358-5 | Peste des petits ruminants virus RNA [Presence] in Tissue by DNA probe |
| 23359-3 | Peste des petits ruminants virus RNA [Presence] in Tissue by Probe and target amplification method |
| 2336-6 | Globulin [Mass/volume] in Serum |
| 23360-1 | Porcine enterovirus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23361-9 | Porcine enterovirus Ab [Presence] in Serum |
| 23362-7 | Porcine enterovirus Ab [Presence] in Serum by Neutralization test |
| 23363-5 | Porcine enterovirus Ab [Presence] in Serum by Immunoassay |
| 23364-3 | Porcine enterovirus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23365-0 | Porcine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23366-8 | Porcine parvovirus Ab [Presence] in Serum |
| 23367-6 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Complement fixation |
| 23368-4 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Neutralization test |
| 23369-2 | Porcine reproductive and respiratory syndrome virus Ag [Presence] in Unspecified specimen by Immune stain |
| 2337-4 | Glucagon [Mass/volume] in Amniotic fluid |
| 23370-0 | Porcine reproductive and respiratory syndrome virus Ag [Presence] in Tissue by Immune stain |
| 23371-8 | Porcine reproductive and respiratory syndrome virus RNA [Presence] in Semen by Probe and target amplification method |
| 23372-6 | Porcine respiratory coronavirus Ab [Presence] in Serum |
| 23373-4 | Porcine respiratory coronavirus Ab [Presence] in Serum by Neutralization test |
| 23374-2 | Porcine respiratory coronavirus Ab [Presence] in Serum by Immunoassay |
| 23376-7 | Porcine respiratory coronavirus Ag [Presence] in Unspecified specimen by Immune stain |
| 23377-5 | Porcine respiratory coronavirus Ag [Presence] in Small intestine Tissue by Immune stain |
| 23378-3 | Porcine respiratory coronavirus RNA [Presence] in Unspecified specimen by DNA probe |
| 23379-1 | Abnormal Prion Protein [Presence] in Brain by Immunoblot (IB) |
| 2338-2 | Glucagon [Mass/volume] in Serum or Plasma |
| 23380-9 | Abnormal Prion Protein [Presence] in Brain by Immune stain |
| 23381-7 | Abnormal Prion Protein [Presence] in Brain by Electron microscopy |
| 23382-5 | Pseudorabies virus Ab [Presence] in Serum by Neutralization test |
| 23383-3 | Pseudorabies virus Ag [Presence] in Unspecified specimen by Immune stain |
| 23384-1 | Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 23385-8 | Pseudorabies virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23386-6 | Pseudorabies virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23387-4 | Pseudorabies virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23388-2 | Rabies virus [Presence] in Brain by Light microscopy |
| 23389-0 | Rabies virus Ag [Presence] in Brain by Immunoassay |
| 2339-0 | Glucose [Mass/volume] in Blood |
| 23390-8 | Rabies virus Ag [Presence] in Brain by Immune stain |
| 23391-6 | Rabies virus Ag [Presence] in Unspecified specimen by Immune stain |
| 23392-4 | Deprecated Rabies virus DNA by probe |
| 23393-2 | Deprecated Rabies virus DNA by amplified target |
| 23396-5 | Rift valley fever virus Ab [Titer] in Serum by Neutralization test |
| 23397-3 | Rift valley fever virus Ab [Presence] in Serum |
| 23398-1 | Rift valley fever virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23399-9 | Rift valley fever virus Ab [Presence] in Serum by Immunoassay |
| 2340-8 | Glucose [Mass/volume] in Blood by Automated test strip |
| 23400-5 | Rift valley fever virus Ab [Titer] in Serum |
| 23401-3 | Rift valley fever virus Ag [Presence] in Tissue by Neutralization test |
| 23402-1 | Rift valley fever virus Ag [Presence] in Blood by Neutralization test |
| 23403-9 | Rift valley fever virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23404-7 | Rift valley fever virus Ag [Presence] in Tissue by Immunofluorescence |
| 23405-4 | Rift valley fever virus Ag [Presence] in Tissue by Immune diffusion (ID) |
| 23406-2 | Rift valley fever virus Ag [Presence] in Serum by Immune diffusion (ID) |
| 23407-0 | Rinderpest virus Ab [Presence] in Serum by Neutralization test |
| 23408-8 | Rinderpest virus Ab [Titer] in Serum |
| 23409-6 | Rinderpest virus Ab [Titer] in Serum by Neutralization test |
| 2341-6 | Glucose [Mass/volume] in Blood by Test strip manual |
| 23410-4 | Rinderpest virus Ab [Presence] in Serum by Immunoassay |
| 23411-2 | Rinderpest virus Ab [Presence] in Serum |
| 23412-0 | Rinderpest virus Ag [Units/volume] in Tissue by Immunoassay |
| 23413-8 | Rinderpest virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23414-6 | Rinderpest virus Ag [Presence] in Exudate by Immunoelectrophoresis |
| 23415-3 | Rinderpest virus Ag [Presence] in Exudate by Immune diffusion (ID) |
| 23416-1 | Rinderpest virus Ag [Units/volume] in Unspecified specimen by Immunoassay |
| 23417-9 | Rinderpest virus RNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23418-7 | Salmonella abortus equi Ab [Presence] in Serum by Agglutination |
| 23419-5 | Salmonella abortus equi Ab [Presence] in Serum |
| 2342-4 | Glucose [Mass/volume] in Cerebral spinal fluid |
| 23420-3 | Salmonella abortus ovis Ab [Presence] in Serum by Complement fixation |
| 23421-1 | Salmonella abortus ovis Ab [Presence] in Serum |
| 23422-9 | Salmonella enteritidis IgG Ab [Presence] in Serum |
| 23423-7 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk by Immunoassay |
| 23424-5 | Salmonella enteritidis IgG Ab [Presence] in Serum by Immunoassay |
| 23425-2 | Salmonella enteritidis IgG Ab [Presence] in Egg yolk |
| 23426-0 | Salmonella gallinarum Ab [Presence] in Blood by Agglutination |
| 23427-8 | Salmonella gallinarum Ab [Presence] in Serum |
| 23428-6 | Salmonella gallinarum Ab [Presence] in Serum by Immunoassay |
| 23429-4 | Salmonella gallinarum Ab [Presence] in Serum by Agglutination |
| 2343-2 | Glucose [Mass/volume] in Dialysis fluid |
| 23431-0 | Salmonella gallinarum DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23432-8 | Salmonella gallinarum rRNA [Presence] in Unspecified specimen by DNA probe |
| 23433-6 | Salmonella pullorum Ab [Presence] in Serum by Immune diffusion (ID) |
| 23434-4 | Salmonella pullorum Ab [Presence] in Serum by Immunoassay |
| 23435-1 | Salmonella pullorum DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23436-9 | Salmonella pullorum rRNA [Presence] in Unspecified specimen by DNA probe |
| 23437-7 | Swine influenza virus Ab [Presence] in Serum |
| 23438-5 | Swine influenza virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 2344-0 | Glucose [Mass/volume] in Body fluid |
| 23440-1 | Swine vesicular disease virus Ab [Presence] in Serum by Neutralization test |
| 23441-9 | Swine vesicular disease virus Ab [Presence] in Serum |
| 23442-7 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoassay |
| 23443-5 | Swine vesicular disease virus Ab [Presence] in Serum by Immunoelectrophoresis |
| 23444-3 | Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Immunoassay |
| 23445-0 | Swine vesicular disease virus Ag [Presence] in Skin by Complement fixation |
| 23446-8 | Swine vesicular disease virus Ag [Presence] in Unspecified specimen by Complement fixation |
| 23447-6 | Swine vesicular disease virus Ag [Presence] in Skin by Immunoassay |
| 23448-4 | Swine vesicular disease virus RNA [Presence] in Tissue by Probe and target amplification method |
| 23449-2 | Taenia hydatigena Ag [Presence] in Stool by Immunoassay |
| 2345-7 | Glucose [Mass/volume] in Serum or Plasma |
| 23450-0 | Taenia sp Ag [Presence] in Stool by Immunoassay |
| 23451-8 | Taenia sp eggs [Presence] in Stool by DNA probe |
| 23452-6 | Taenia sp eggs [Presence] in Stool by Probe and target amplification method |
| 23453-4 | Taylorella equigenitalis Ab [Presence] in Serum by Complement fixation |
| 23454-2 | Taylorella equigenitalis Ab [Presence] in Serum |
| 23455-9 | Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23456-7 | Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Agglutination |
| 23458-3 | Taylorella equigenitalis DNA [Presence] in Genital specimen by Probe and target amplification method |
| 23459-1 | Theileria annulata Ab [Presence] in Serum |
| 2346-5 | Glucose [Mass/volume] in Pleural fluid |
| 23460-9 | Theileria annulata Ab [Presence] in Serum by Immunofluorescence |
| 23461-7 | Theileria annulata Ab [Titer] in Serum |
| 23462-5 | Theileria annulata Ab [Titer] in Serum by Immunofluorescence |
| 23463-3 | Theileria annulata rRNA [Presence] in Serum by DNA probe |
| 23464-1 | Theileria equi Ab [Presence] in Serum by Immunoassay |
| 23465-8 | Theileria equi rRNA [Presence] in Blood by DNA probe |
| 23466-6 | Theileria equi Ab [Presence] in Serum by Immunofluorescence |
| 23467-4 | Theileria mutans Ab [Titer] in Serum by Immunofluorescence |
| 23468-2 | Theileria mutans Ab [Presence] in Serum by Immunoassay |
| 23469-0 | Theileria mutans Ab [Presence] in Serum by Immunofluorescence |
| 2347-3 | Glucose [Mass/volume] in Peritoneal fluid |
| 23470-8 | Theileria mutans Ab [Presence] in Serum |
| 23471-6 | Theileria mutans Ab [Titer] in Serum |
| 23472-4 | Theileria mutans rRNA [Presence] in Serum by DNA probe |
| 23473-2 | Theileria mutans DNA [Presence] in Serum by Probe and target amplification method |
| 23474-0 | Theileria parva Ab [Presence] in Serum |
| 23475-7 | Theileria parva Ab [Presence] in Serum by Immunofluorescence |
| 23476-5 | Theileria parva Ab [Titer] in Serum by Immunofluorescence |
| 23477-3 | Theileria parva Ab [Presence] in Serum by Immunoassay |
| 23478-1 | Theileria parva Ab [Titer] in Serum |
| 23479-9 | Theileria parva rRNA [Presence] in Serum by DNA probe |
| 2348-1 | Glucose [Mass/volume] in Synovial fluid |
| 23480-7 | Theileria parva DNA [Presence] in Serum by Probe and target amplification method |
| 23481-5 | Deprecated Theileria parva rRNA [Presence] in Serum by DNA probe |
| 23482-3 | Theileria sp [Presence] in Blood by Giemsa stain |
| 23483-1 | Theileria sp [Presence] in Tissue by Giemsa stain |
| 23484-9 | Deprecated Toxoplasma gondii Ab [Presence] in Serum |
| 23485-6 | Toxoplasma gondii Ab [Presence] in Serum by Agglutination |
| 23486-4 | Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination |
| 23487-2 | Transmissible gastroenteritis virus Ab [Presence] in Serum |
| 23488-0 | Transmissible gastroenteritis virus Ab [Presence] in Serum by Neutralization test |
| 23489-8 | Transmissible gastroenteritis virus Ab [Titer] in Serum |
| 2349-9 | Glucose [Presence] in Urine |
| 23491-4 | Transmissible gastroenteritis virus Ab [Presence] in Serum by Immunoassay |
| 23492-2 | Transmissible gastroenteritis virus Ab [Titer] in Serum by Neutralization test |
| 23493-0 | Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23494-8 | Transmissible gastroenteritis virus Ag [Presence] in Stool by Immunoassay |
| 23495-5 | Transmissible gastroenteritis virus Ag [Presence] in Unspecified specimen by Immune stain |
| 23496-3 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immune stain |
| 23497-1 | Transmissible gastroenteritis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
| 23498-9 | Transmissible gastroenteritis virus RNA [Presence] in Unspecified specimen by DNA probe |
| 23499-7 | Trichinella spiralis [Presence] in Tissue by Light microscopy |
| 2350-7 | Glucose [Mass/volume] in Urine |
| 23500-2 | Tritrichomonas foetus Ab [Presence] in Genital mucus |
| 23501-0 | Tritrichomonas foetus Ab [Presence] in Genital mucus by Agglutination |
| 23502-8 | Tritrichomonas foetus Ag [Presence] in Tissue from Fetus by Immune stain |
| 23503-6 | Tritrichomonas foetus Ag [Presence] in Placenta by Immune stain |
| 23504-4 | Tritrichomonas foetus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23505-1 | Tritrichomonas foetus DNA [Presence] in Genital fluid by Probe and target amplification method |
| 23507-7 | Trypanosoma brucei DNA [Presence] in Blood by Probe and target amplification method |
| 23508-5 | Trypanosoma congolense DNA [Presence] in Blood by Probe and target amplification method |
| 23509-3 | Trypanosoma equiperdum [Presence] in Body fluid by Light microscopy |
| 2351-5 | Glucose [Mass/time] in 24 hour Urine |
| 23510-1 | Trypanosoma equiperdum Ab [Titer] in Serum by Complement fixation |
| 23511-9 | Trypanosoma equiperdum Ab [Presence] in Serum by Complement fixation |
| 23512-7 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunoassay |
| 23513-5 | Trypanosoma equiperdum Ab [Presence] in Serum by Immunofluorescence |
| 23514-3 | Trypanosoma equiperdum Ab [Presence] in Serum by Immune diffusion (ID) |
| 23515-0 | Trypanosoma equiperdum Ab [Presence] in Serum |
| 23517-6 | Trypanosoma equiperdum Ab [Titer] in Serum |
| 23518-4 | Trypanosoma evansi [Presence] in Aspirate by Thick film |
| 23519-2 | Trypanosoma evansi [Presence] in Aspirate by Thin film |
| 23520-0 | Trypanosoma evansi [Presence] in Aspirate by Wet preparation |
| 23521-8 | Trypanosoma evansi Ab [Units/volume] in Serum |
| 23522-6 | Trypanosoma evansi Ab [Presence] in Serum |
| 23523-4 | Trypanosoma evansi Ab [Presence] in Serum by Agglutination |
| 23524-2 | Trypanosoma evansi Ab [Units/volume] in Serum by Immunoassay |
| 23526-7 | Trypanosoma evansi Ab [Presence] in Serum by Immunofluorescence |
| 23528-3 | Trypanosoma evansi Ag [Presence] in Blood by Immunoassay |
| 23529-1 | Trypanosoma evansi DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 2353-1 | Glucose phosphate isomerase [Enzymatic activity/volume] in Serum |
| 23530-9 | Trypanosoma evansi rRNA [Presence] in Unspecified specimen by DNA probe |
| 23531-7 | Trypanosoma sp Ab [Presence] in Serum by Immunoassay |
| 23532-5 | Trypanosoma sp Ab [Presence] in Serum by Agglutination |
| 23533-3 | Trypanosoma sp Ab [Presence] in Serum |
| 23534-1 | Trypanosoma sp Ab [Presence] in Serum by Immunofluorescence |
| 23535-8 | Trypanosoma sp Ag [Presence] in Blood by Immunoassay |
| 23536-6 | Trypanosoma sp identified in Blood by Concentration |
| 2354-9 | Glucose-6-Phosphatase [Enzymatic activity/volume] in Serum |
| 23540-8 | Turkey enteritis coronavirus [Presence] in Serum by Immunofluorescence |
| 23541-6 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Complement fixation |
| 23542-4 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23543-2 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23544-0 | Venezuelan equine encephalitis virus Ab [Presence] in Serum |
| 23545-7 | Venezuelan equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
| 23546-5 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum |
| 23547-3 | Venezuelan equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 23548-1 | Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 23549-9 | Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 2355-6 | Glucose-6-Phosphatase [Enzymatic activity/mass] in Tissue |
| 23550-7 | Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Hemagglutination inhibition |
| 23551-5 | Venezuelan equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
| 23552-3 | Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Neutralization test |
| 23553-1 | Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Probe and target amplification method |
| 23554-9 | Venezuelan equine encephalitis virus subtype [Identifier] in Unspecified specimen by Immunofluorescence |
| 23555-6 | Vesicular stomatitis virus Ab [Presence] in Serum |
| 23557-2 | Vesicular stomatitis virus Ag [Presence] in Skin by Immunoassay |
| 23558-0 | Vesicular stomatitis virus Ag [Presence] in Throat by Immunoassay |
| 23559-8 | Vesicular stomatitis virus Ag [Presence] in Skin by Complement fixation |
| 2356-4 | Glucose-6-Phosphate dehydrogenase [Presence] in Red Blood Cells |
| 23560-6 | Vesicular stomatitis virus Ag [Presence] in Throat by Complement fixation |
| 23561-4 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum |
| 23562-2 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Neutralization test |
| 23563-0 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Immunoassay |
| 23564-8 | Vesicular stomatitis Indiana virus Ab [Presence] in Serum by Complement fixation |
| 23565-5 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum |
| 23566-3 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Immunoassay |
| 23567-1 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Neutralization test |
| 23568-9 | Vesicular stomatitis New Jersey virus Ab [Presence] in Serum by Complement fixation |
| 23569-7 | Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Complement fixation |
| 2357-2 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 23570-5 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Complement fixation |
| 23571-3 | Vesicular stomatitis virus serotype [Identifier] in Tissue by Immunoassay |
| 23572-1 | Vesicular stomatitis virus serotype [Identifier] in Unspecified specimen by Immunoassay |
| 23573-9 | Viral hemorrhagic disease virus [Presence] in Tissue by Electron microscopy |
| 23574-7 | Viral hemorrhagic disease virus Ab [Presence] in Serum |
| 23575-4 | Viral hemorrhagic disease virus Ab [Titer] in Serum |
| 23576-2 | Viral hemorrhagic disease virus Ab [Titer] in Serum by Immunoassay |
| 23577-0 | Viral hemorrhagic disease virus Ab [Presence] in Serum by Immunoassay |
| 23578-8 | Viral hemorrhagic disease virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23579-6 | Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunofluorescence |
| 2358-0 | Glucose-6-Phosphate dehydrogenase [Presence] in Serum |
| 23580-4 | Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immunoassay |
| 23581-2 | Viral hemorrhagic disease virus Ag [Presence] in Tissue by Agglutination |
| 23582-0 | Viral hemorrhagic disease virus Ag [Presence] in Tissue by Immune stain |
| 23583-8 | Western equine encephalitis virus Ab [Presence] in Serum by Agglutination |
| 23584-6 | Western equine encephalitis virus Ab [Titer] in Serum by Hemagglutination inhibition |
| 23585-3 | Western equine encephalitis virus Ab [Presence] in Serum by Neutralization test |
| 23586-1 | Western equine encephalitis virus Ab [Presence] in Serum by Hemagglutination inhibition |
| 23587-9 | Western equine encephalitis virus IgM Ab [Presence] in Serum |
| 23588-7 | Western equine encephalitis virus IgM Ab [Presence] in Serum by Immunoassay |
| 23589-5 | Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Neutralization test |
| 2359-8 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
| 23590-3 | Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23591-1 | Western equine encephalitis virus Ag [Presence] in Unspecified specimen by Complement fixation |
| 23592-9 | African swine fever virus Ab [Presence] in Serum by Immune stain |
| 23593-7 | Bovine leukemia virus [Presence] in Blood by Organism specific culture |
| 23594-5 | Brucella sp identified in Semen by Organism specific culture |
| 23595-2 | Dermatophilus congolensis [Presence] in Exudate by Giemsa stain |
| 23596-0 | Dermatophilus congolensis [Presence] in Exudate by Carbol-fuchsin stain |
| 23597-8 | Dermatophilus congolensis [Presence] in Exudate by Methylene blue stain |
| 23598-6 | Dermatophilus congolensis Ag [Presence] in Exudate by Immunofluorescence |
| 23599-4 | Leptospira sp identified in Tissue by Organism specific culture |
| 2360-6 | Glucose-6-Phosphate dehydrogenase [Enzymatic activity/volume] in Leukocytes |
| 23600-0 | Leptospira sp identified in Milk by Organism specific culture |
| 23601-8 | Mareks disease virus serotype [Identifier] in Tissue by Organism specific culture |
| 23602-6 | Salmonella enteritidis [Presence] in Stool by Organism specific culture |
| 23603-4 | Taylorella equigenitalis [Presence] in Genital specimen by Organism specific culture |
| 23604-2 | Tritrichomonas foetus [Presence] in Body fluid by Organism specific culture |
| 23605-9 | Tritrichomonas foetus [Presence] in Placenta by Organism specific culture |
| 23606-7 | Tritrichomonas foetus [Presence] in Genital fluid by Organism specific culture |
| 2361-4 | Glucosylceramidase [Enzymatic activity/mass] in Tissue |
| 23644-8 | Actinobacillus pleuropneumoniae 1 Ab [Presence] in Serum by Immunoassay |
| 23645-5 | Actinobacillus pleuropneumoniae 3 Ab [Presence] in Serum by Immunoassay |
| 23646-3 | Actinobacillus pleuropneumoniae 5 Ab [Presence] in Serum by Immunoassay |
| 23647-1 | Actinobacillus pleuropneumoniae 7 Ab [Presence] in Serum by Immunoassay |
| 23648-9 | Actinobacillus pleuropneumoniae Ab [Titer] in Serum |
| 23649-7 | Actinobacillus pleuropneumoniae biovar 2 serotype [Identifier] in Unspecified specimen by Agglutination |
| 23650-5 | Actinobacillus pleuropneumoniae serotype [Identifier] in Unspecified specimen by Agglutination |
| 23651-3 | Actinobacillus suis serotype [Identifier] in Isolate by Agglutination |
| 23652-1 | Aeromonas salmonicida DNA [Presence] in Tissue by Probe and target amplification method |
| 23653-9 | Aflatoxin [Mass/volume] in Unspecified specimen |
| 23654-7 | Aflatoxin [Mass/mass] in Feed |
| 23655-4 | Aflatoxin [Mass/mass] in Tissue |
| 23656-2 | Ammonia [Mass/volume] in Unspecified specimen |
| 23657-0 | Anaplasma marginale Ab [Titer] in Serum by Complement fixation |
| 23660-4 | Aspergillus sp Ab [Titer] in Serum by Immunoassay |
| 23661-2 | Avian paramyxovirus 1 Ab [Titer] in Serum by Immunoassay |
| 23662-0 | Babesia bigemina Ab [Presence] in Serum by Complement fixation |
| 23663-8 | Babesia bovis Ab [Presence] in Serum by Complement fixation |
| 23664-6 | Babesia canis Ab [Titer] in Serum by Immunofluorescence |
| 23665-3 | Babesia divergens Ab [Presence] in Serum by Complement fixation |
| 23666-1 | Babesia sp Ab [Titer] in Serum by Complement fixation |
| 23667-9 | Bacteria identified in Unspecified specimen |
| 23668-7 | Bartonella henselae Ab [Titer] in Serum |
| 23669-5 | Biochanin A [Mass/volume] in Serum or Plasma |
| 2367-1 | Glutamate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 23670-3 | Deprecated Blastomyces dermatitidis Ab [Presence] in Serum |
| 23671-1 | Bluetongue virus 10 Ab [Titer] in Serum by Neutralization test |
| 23672-9 | Bluetongue virus 11 Ab [Titer] in Serum by Neutralization test |
| 23673-7 | Bluetongue virus 13 Ab [Titer] in Serum by Neutralization test |
| 23674-5 | Bluetongue virus 17 Ab [Titer] in Serum by Neutralization test |
| 23675-2 | Bluetongue virus 2 Ab [Titer] in Serum by Neutralization test |
| 23676-0 | Borrelia burgdorferi Ab [Presence] in Serum by Immunofluorescence |
| 23677-8 | Bovine leukemia virus Ab [Titer] in Serum by Complement fixation |
| 23678-6 | Bovine parainfluenza virus 3 Ag [Presence] in Tissue by Immunofluorescence |
| 23679-4 | Bovine respiratory syncytial virus Ag [Presence] in Unspecified specimen |
| 2368-9 | Glutamate dehydrogenase.NAD [Enzymatic activity/volume] in Serum or Plasma |
| 23680-2 | Bromide [Mass/volume] in Unspecified specimen |
| 23681-0 | Brucella canis Ab [Presence] in Serum by Immunofluorescence |
| 23682-8 | Brucella canis Ab [Titer] in Serum by Agglutination |
| 23683-6 | Brucella canis Ab [Titer] in Serum by Immunofluorescence |
| 23684-4 | Brucella ovis Ab [Titer] in Serum |
| 23685-1 | Canine adenovirus 1 Ab [Presence] in Serum by Neutralization test |
| 23686-9 | Canine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23687-7 | Canine coronavirus Ab [Presence] in Serum by Immunofluorescence |
| 23688-5 | Canine coronavirus Ag [Presence] in Tissue by Immunofluorescence |
| 23689-3 | Canine distemper virus Ab [Presence] in Serum by Immunofluorescence |
| 2369-7 | Glutamate dehydrogenase.NADP [Enzymatic activity/volume] in Serum or Plasma |
| 23690-1 | Canine distemper virus Ab [Titer] in Serum |
| 23691-9 | Canine distemper virus IgG Ab [Titer] in Serum by Immunofluorescence |
| 23692-7 | Canine distemper virus IgG Ab [Titer] in Serum |
| 23693-5 | Canine distemper virus IgM Ab [Titer] in Serum by Immunofluorescence |
| 23694-3 | Canine distemper virus IgM Ab [Titer] in Serum |
| 23695-0 | Canine distemper virus Ag [Presence] in Tissue by Immunofluorescence |
| 23696-8 | Canine distemper virus Ag [Presence] in Conjunctival specimen |
| 23697-6 | Canine herpesvirus Ab [Presence] in Serum by Neutralization test |
| 23698-4 | Canine herpesvirus Ag [Presence] in Tissue by Immunofluorescence |
| 23699-2 | Canine parainfluenza virus 2 Ag [Presence] in Tissue by Immunofluorescence |
| 23700-8 | Canine parvovirus Ab [Presence] in Serum by Immunofluorescence |
| 23701-6 | Canine parvovirus Ab [Presence] in Serum |
| 23702-4 | Canine parvovirus Ab [Titer] in Serum |
| 23703-2 | Canine parvovirus IgG Ab [Titer] in Serum |
| 23704-0 | Canine parvovirus IgM Ab [Titer] in Serum |
| 23705-7 | Canine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23706-5 | Canine parvovirus Ag [Presence] in Stool by Immunofluorescence |
| 23707-3 | Canine parvovirus DNA [Presence] in Stool by DNA probe |
| 23708-1 | Caprine arthritis encephalitis virus Ag [Presence] in Unspecified specimen |
| 23710-7 | Dirofilaria immitis Ag [Presence] in Serum by Immunoassay |
| 23711-5 | Ehrlichia canis Ab [Titer] in Serum |
| 23713-1 | Ethylene glycol [Presence] in Serum or Plasma |
| 23714-9 | Fat [Mass/volume] in Milk |
| 23715-6 | Feline calicivirus Ab [Titer] in Serum |
| 23716-4 | Feline coronavirus Ab [Presence] in Serum by Immunoassay |
| 23717-2 | Feline coronavirus Ab [Presence] in Serum |
| 23718-0 | Feline coronavirus Ab [Titer] in Serum |
| 23719-8 | Feline herpesvirus 1 Ab [Presence] in Serum by Neutralization test |
| 23720-6 | Feline herpesvirus 1 Ag [Presence] in Tissue by Immunofluorescence |
| 23721-4 | Feline herpesvirus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23722-2 | Feline herpesvirus Ab [Titer] in Serum by Neutralization test |
| 23723-0 | Feline immunodeficiency virus Ab [Presence] in Serum by Immunoassay |
| 23724-8 | Feline immunodeficiency virus Ab [Presence] in Serum |
| 23725-5 | Feline immunodeficiency virus Ab [Titer] in Serum by Immunofluorescence |
| 23726-3 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunoassay |
| 23727-1 | Feline infectious peritonitis virus Ab [Presence] in Serum by Immunofluorescence |
| 23728-9 | Feline infectious peritonitis virus Ab [Presence] in Serum |
| 23729-7 | Feline infectious peritonitis virus Ag [Presence] in Tissue by Immunofluorescence |
| 23730-5 | Feline infectious peritonitis virus Ag [Presence] in Small intestine Tissue by Immunofluorescence |
| 23731-3 | Feline leukemia provirus [Presence] in Unspecified specimen |
| 23732-1 | Feline leukemia virus Ab [Presence] in Serum by Immunoassay |
| 23733-9 | Feline leukemia virus Ab [Presence] in Serum by Immunofluorescence |
| 23734-7 | Feline leukemia virus Ab [Presence] in Serum |
| 23735-4 | Feline leukemia virus Ab [Titer] in Serum by Neutralization test |
| 23736-2 | Feline leukemia virus Ag [Presence] in Tissue by Immunofluorescence |
| 23737-0 | Feline panleukopenia virus Ab [Titer] in Serum |
| 23738-8 | Feline herpesvirus 1 Ab [Titer] in Serum |
| 23739-6 | Feline syncytial virus Ab [Titer] in Serum |
| 23741-2 | Francisella tularensis Ab [Titer] in Serum by Complement fixation |
| 23742-0 | Fumonisin [Mass/volume] in Unspecified specimen |
| 23743-8 | Genistein [Units/volume] in Serum or Plasma |
| 23744-6 | Giardia lamblia Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23745-3 | Gossypol [Mass/volume] in Unspecified specimen |
| 23746-1 | Gossypol Free [Mass/volume] in Unspecified specimen |
| 23747-9 | Heavy metals [Presence] in Unspecified specimen |
| 23748-7 | Deprecated Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) |
| 23749-5 | Lead [Mass/volume] in Unspecified specimen |
| 2375-4 | Glutaryl CoA dehydrogenase [Enzymatic activity/mass] in Tissue |
| 23750-3 | Leptospira sp Ag [Presence] in Urine by Immunofluorescence |
| 23751-1 | Metaldehyde [Mass/volume] in Unspecified specimen |
| 23752-9 | Mite identified in Skin |
| 23753-7 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunofluorescence |
| 23754-5 | Mycoplasma sp Ab [Titer] in Serum |
| 23755-2 | Mycoplasma synoviae Ab [Titer] in Serum by Hemagglutination |
| 23756-0 | Neospora caninum Ab [Units/volume] in Serum by Immunoassay |
| 23757-8 | Neospora caninum Ab [Titer] in Serum by Immunofluorescence |
| 23758-6 | Neospora caninum Ab [Titer] in Serum |
| 23759-4 | Neospora caninum Ag [Presence] in Tissue by Immune stain |
| 2376-2 | Glutathione peroxidase [Enzymatic activity/volume] in Serum or Plasma |
| 23760-2 | Neospora caninum Ag [Presence] in Fixed tissue by Immune stain |
| 23762-8 | Nitrate+Nitrite [Mass/volume] in Unspecified specimen |
| 23763-6 | Pasteurella multocida serotype [Identifier] in Isolate |
| 23764-4 | Pesticides [Identifier] in Unspecified specimen |
| 23765-1 | Porcine adenovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23766-9 | Porcine circovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23767-7 | Porcine circovirus Ag [Presence] in Tissue by Immune stain |
| 23768-5 | Porcine influenza virus A Ab [Titer] in Serum by Hemagglutination inhibition |
| 23769-3 | Porcine influenza virus A Ag [Presence] in Tissue by Immune stain |
| 2377-0 | Glutathione peroxidase [Enzymatic activity/volume] in Red Blood Cells |
| 23770-1 | Porcine parvovirus Ab [Titer] in Serum |
| 23771-9 | Porcine parvovirus Ag [Presence] in Tissue by Immunofluorescence |
| 23772-7 | Porcine reproductive and respiratory syndrome virus Ab [Titer] in Serum by Immunofluorescence |
| 23773-5 | Porcine rotavirus Ag [Presence] in Tissue by Immunofluorescence |
| 23774-3 | Pseudorabies virus Ag [Presence] in Tissue by Immunofluorescence |
| 23775-0 | Rhodococcus equi Ab [Titer] in Serum |
| 23776-8 | Rickettsia spotted fever group Ab [Presence] in Serum by Immunofluorescence |
| 23777-6 | Salmonella pullorum Ab [Titer] in Serum by Agglutination |
| 23778-4 | Salmonella typhimurium Ab [Titer] in Serum by Agglutination |
| 23779-2 | Selenium [Mass/volume] in Unspecified specimen |
| 2378-8 | Glutathione reductase [Enzymatic activity/volume] in Red Blood Cells |
| 23780-0 | Strychnine [Mass/volume] in Unspecified specimen |
| 23781-8 | Swine influenza virus Ag [Presence] in Tissue by Immunofluorescence |
| 23782-6 | Swine influenza virus Ag [Presence] in Tissue by Immune stain |
| 23783-4 | Taylorella equigenitalis Ab [Titer] in Serum by Complement fixation |
| 23784-2 | Toxoplasma gondii Ab [Titer] in Serum by Hemagglutination |
| 23785-9 | Trypanosoma cruzi Ab [Presence] in Serum |
| 23786-7 | Urea [Mass/volume] in Unspecified specimen |
| 23787-5 | Venezuelan equine encephalitis virus Ab [Titer] in Serum by Complement fixation |
| 23788-3 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Complement fixation |
| 23789-1 | Vesicular stomatitis Indiana virus Ab [Titer] in Serum by Neutralization test |
| 2379-6 | Glutathione S-transferase [Enzymatic activity/volume] in Red Blood Cells |
| 23790-9 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Complement fixation |
| 23791-7 | Vesicular stomatitis New Jersey virus Ab [Titer] in Serum by Neutralization test |
| 23792-5 | Western equine encephalitis virus Ab [Presence] in Unspecified specimen |
| 23793-3 | Canine parvovirus Ag [Presence] in Stool by Immunoassay |
| 23794-1 | Food Allergen Mix C (Oat+Barley+Rice+Rye+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
| 23795-8 | Dust Allergen Mix 2 (Cockroach+American house dust mite+European house dust mite+House dust Hollister Stier) IgE Ab [Presence] in Serum by Multidisk |
| 23796-6 | Deprecated Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multiple allergens |
| 23797-4 | Tree Allergen Mix 2 (Boxelder+White oak+White elm+Cottonwood+Pecan/Hickory) IgE Ab [Presence] in Serum by Multidisk |
| 23798-2 | Epidermal Allergen Mix 1 (Cat dander+Cow dander+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
| 23799-0 | Epidermal Allergen Mix 73 (Chicken feather+Duck feather+Goose feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
| 2380-4 | Glutathione synthase [Enzymatic activity/volume] in Red Blood Cells |
| 23800-6 | Mold Allergen Mix 1 (Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
| 23801-4 | Food Allergen Mix 5 (Peanut+Cow milk+Egg white+Cod+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
| 23802-2 | Grass Allergen Mix D (Bermuda grass+Perennial rye grass+Timothy+Kentucky blue grass+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
| 23803-0 | Grass Allergen Mix 1 (Orchard grass+Meadow Fescue+Perennial rye grass+Timothy+Kentucky blue grass) IgE Ab [Presence] in Serum by Multidisk |
| 23804-8 | Deprecated Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multiple allergens |
| 23805-5 | 5-Fluorocytosine [Mass/volume] in Unspecified specimen |
| 23808-9 | Aldosterone free [Mass/time] in 24 hour Urine |
| 2381-2 | Glutathione.oxidized [Mass/volume] in Red Blood Cells |
| 23810-5 | Alpha fucosidase [Units/volume] in Leukocytes |
| 23814-7 | Amantadine [Mass/volume] in Urine |
| 23815-4 | Androstanediol [Mass/time] in 24 hour Urine |
| 23816-2 | Other Antibiotic [Mass/volume] in Serum or Plasma |
| 23819-6 | Antibody coated bacteria [Presence] in Urine by Immunofluorescence |
| 2382-0 | Glutathione.reduced [Mass/volume] in Red Blood Cells |
| 23820-4 | Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23821-2 | Aspergillus fumigatus Ab [Presence] in Serum by Immune diffusion (ID) |
| 23822-0 | Azinphos-methyl [Mass/volume] in Blood |
| 23826-1 | Bordetella pertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 23827-9 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum |
| 23828-7 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum |
| 23829-5 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum |
| 2383-8 | Glutathione [Mass/volume] in Red Blood Cells |
| 23830-3 | Bordetella pertussis toxin IgA Ab [Units/volume] in Serum |
| 23831-1 | Bordetella pertussis toxin IgG Ab [Units/volume] in Serum |
| 23832-9 | Bordetella pertussis toxin IgM Ab [Units/volume] in Serum |
| 23833-7 | Borrelia burgdorferi Ab index [Presence] in Serum and CSF |
| 23835-2 | Carbon disulfide [Mass/volume] in Urine |
| 23836-0 | Carbon disulfide [Mass/volume] in Serum or Plasma |
| 23838-6 | Chlamydia trachomatis rRNA [Presence] in Genital fluid by DNA probe |
| 23839-4 | Deprecated Cholinesterase [Enzymatic activity/volume] in Red Blood Cells |
| 2384-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Serum |
| 23842-8 | Cobalt [Mass/volume] in Synovial fluid |
| 23843-6 | Cockatiel droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 23844-4 | Complement C3 Nephritic [Units/volume] in Serum or Plasma |
| 23847-7 | Deprecated Cotton fibers IgE Ab [Units/volume] in Serum |
| 23848-5 | Creosol [Mass/volume] in Unspecified specimen |
| 23849-3 | Creosol [Mass/volume] in Serum or Plasma |
| 2385-3 | Glycerate [Mass/volume] in Serum |
| 23850-1 | Creosol [Mass/volume] in Urine |
| 23851-9 | Cyclohexanone [Mass/volume] in Serum or Plasma |
| 23853-5 | Dimethylformamide/Creatinine [Mass Ratio] in Urine |
| 23854-3 | Dioxin [Mass/volume] in Serum or Plasma |
| 23855-0 | Echinococcus granulosus IgE Ab [Units/volume] in Serum |
| 23856-8 | Endrin [Mass/volume] in Serum or Plasma |
| 23858-4 | Epstein Barr virus DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
| 2386-1 | Glycerate [Mass/volume] in Urine |
| 23861-8 | Ethanol [Mass/mass] in Tissue |
| 23862-6 | Famotidine [Mass/volume] in Serum or Plasma |
| 23864-2 | Flunitrazepam [Mass/volume] in Serum or Plasma |
| 23865-9 | Fluoxetine+Norfluoxetine [Presence] in Urine |
| 23866-7 | Glutaraldehyde [Presence] in Urine |
| 23867-5 | Hantavirus sin nombre IgG Ab [Titer] in Serum |
| 23868-3 | Hantavirus sin nombre IgM Ab [Titer] in Serum |
| 23869-1 | Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by DNA probe |
| 23876-6 | HIV 1 RNA [Units/volume] (viral load) in Plasma by Probe and signal amplification method |
| 23877-4 | Anaplasma phagocytophilum IgG Ab [Titer] in Serum by Immunofluorescence |
| 23878-2 | Anaplasma phagocytophilum IgM Ab [Titer] in Serum by Immunofluorescence |
| 23879-0 | Immune complex [Units/volume] in Body fluid by C1q binding assay |
| 23880-8 | Immune complex [Units/volume] in Body fluid by Raji cell assay |
| 23881-6 | Immune complex [Mass/volume] in Body fluid by Polyethylene glycol (PEG) assay |
| 23882-4 | Immune complex [Units/volume] in Body fluid by Conglutinin assay |
| 23883-2 | Inhibin A [Mass/volume] in Serum or Plasma |
| 23884-0 | Interleukin 2 receptor [Presence] in Tissue by Immunocytochemical assay |
| 23888-1 | Isopropanol [Mass/volume] in Gastric fluid |
| 23889-9 | Kanamycin [Mass/volume] in Unspecified specimen |
| 23890-7 | Lead [Mass/mass] in Unspecified specimen |
| 23891-5 | Magnesium [Moles/volume] in 24 hour Stool |
| 23892-3 | Magnesium [Moles/time] in 24 hour Stool |
| 23893-1 | Malaoxon [Mass/volume] in Blood |
| 23896-4 | Mercury [Mass/mass] in Unspecified specimen |
| 23899-8 | Methanol [Mass/volume] in Gastric fluid |
| 23900-4 | Methanol [Mass/mass] in Tissue |
| 23901-2 | Microscopic observation [Identifier] in Body fluid by Wet preparation |
| 23905-3 | Mycophenolate [Mass/volume] in Serum or Plasma |
| 23906-1 | Mycophenolate glucuronide [Mass/volume] in Serum or Plasma |
| 23907-9 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Units/volume] in Serum |
| 23908-7 | Deprecated Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by DNA probe |
| 23929-3 | Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum |
| 23930-1 | Salmonella typhi O D Ab [Titer] in Serum by Agglutination |
| 23931-9 | Salmonella typhi O D [Titer] in Serum by Immunofluorescence |
| 23933-5 | Staphylococcus aureus enterotoxin B [Presence] in Unspecified specimen |
| 23934-3 | Staphylococcus aureus enterotoxin B Ab [Presence] in Serum |
| 23935-0 | Staphylococcus aureus toxin 1 [Presence] in Unspecified specimen |
| 23936-8 | Staphylococcus aureus toxin 1 Ab [Presence] in Serum |
| 23937-6 | Trans nonachlor [Mass/volume] in Serum or Plasma |
| 2394-5 | Glycogen synthase [Enzymatic activity/volume] in Serum |
| 2395-2 | Glycolate [Mass/volume] in Serum or Plasma |
| 23950-9 | Adenovirus Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 23953-3 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 23954-1 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23955-8 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23956-6 | Aspergillus sp Ab [Titer] in Cerebral spinal fluid |
| 23957-4 | Bartonella henselae IgG Ab [Titer] in Cerebral spinal fluid |
| 23958-2 | Dengue virus IgG Ab [Units/volume] in Serum |
| 23959-0 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid |
| 2396-0 | Glycolate [Mass/volume] in Urine |
| 23960-8 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid |
| 23961-6 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid |
| 23962-4 | Bartonella henselae IgM Ab [Titer] in Cerebral spinal fluid |
| 23963-2 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid |
| 23964-0 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid |
| 23965-7 | Burkholderia pseudomallei IgG Ab [Titer] in Serum |
| 23966-5 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid |
| 23967-3 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid |
| 23968-1 | Dengue virus IgM Ab [Units/volume] in Serum |
| 23969-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid |
| 2397-8 | Glycoproteins [Presence] in Urine |
| 23970-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid |
| 23971-5 | Epstein Barr virus early IgG Ab [Titer] in Serum |
| 23972-3 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid |
| 23973-1 | Burkholderia pseudomallei IgM Ab [Titer] in Serum |
| 23974-9 | Bartonella quintana IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23975-6 | Bartonella quintana IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23976-4 | Blastomyces dermatitidis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 23977-2 | Borrelia burgdorferi Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 23978-0 | Borrelia burgdorferi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2398-6 | Glycosaminoglycans [Presence] in Urine |
| 23980-6 | Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot (IB) |
| 23982-2 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot (IB) |
| 23984-8 | Borrelia burgdorferi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23986-3 | Brucella abortus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23987-1 | Brucella abortus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23988-9 | Burkholderia pseudomallei IgG Ab [Titer] in Serum by Immunofluorescence |
| 23989-7 | Burkholderia pseudomallei IgM Ab [Titer] in Serum by Immunofluorescence |
| 2399-4 | Glycosaminoglycans [Mass/volume] in Urine |
| 23990-5 | Chlamydia sp Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 23991-3 | Dengue virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 23992-1 | Dengue virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 23993-9 | Echovirus 7 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
| 23994-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 23995-4 | Epstein Barr virus early IgG Ab [Titer] in Serum by Immunofluorescence |
| 23996-2 | Epstein Barr virus early IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 2400-0 | Guanine deaminase [Enzymatic activity/volume] in Blood |
| 24002-8 | Microscopic observation [Identifier] in Bronchial specimen by Acid fast stain |
| 24003-6 | Brucella sp identified in Bone marrow by Organism specific culture |
| 24004-4 | Chlamydophila pneumoniae IgM Ab [Presence] in Serum |
| 24005-1 | Chlamydia sp identified in Bronchial specimen by Organism specific culture |
| 24007-7 | Epstein Barr virus early IgG Ab [Units/volume] in Serum |
| 24008-5 | Echovirus 14 Ab [Titer] in Serum by Complement fixation |
| 24009-3 | Fungus identified in Bronchial specimen by Culture |
| 2401-8 | Guanine deaminase [Enzymatic activity/volume] in Serum |
| 24010-1 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid |
| 24012-7 | HIV 1 Ag [Presence] in Serum |
| 24014-3 | Herpes simplex virus 2 IgG Ab [Titer] in Serum |
| 24015-0 | Influenza virus A+B Ag [Presence] in Unspecified specimen |
| 24017-6 | Neisseria meningitidis B Ag [Presence] in Cerebral spinal fluid |
| 24018-4 | Neisseria meningitidis B Ag [Presence] in Urine |
| 2402-6 | Guanosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
| 24020-0 | Streptococcus agalactiae Ag [Presence] in Urine |
| 24027-5 | Streptococcus pneumoniae Ag [Presence] in Urine |
| 24028-3 | Toxocara canis IgA Ab [Presence] in Serum |
| 24029-1 | Toxocara canis IgG Ab [Presence] in Serum |
| 2403-4 | Hemopexin [Mass/volume] in Serum |
| 24030-9 | Toxocara canis IgM Ab [Presence] in Serum |
| 24031-7 | 14-3-3 Ag [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
| 24032-5 | Rifabutin [Mass/volume] in Serum or Plasma |
| 24033-3 | Bordetella pertussis filamentous hemagglutinin IgG Ab [Units/volume] in Serum by Immunoassay |
| 24034-1 | Bordetella pertussis filamentous hemagglutinin IgA Ab [Units/volume] in Serum by Immunoassay |
| 24035-8 | Bordetella pertussis filamentous hemagglutinin IgM Ab [Units/volume] in Serum by Immunoassay |
| 24036-6 | Borrelia sp Ag [Presence] in Unspecified specimen by Immunofluorescence |
| 24037-4 | Deprecated Coccidioides immitis rRNA [Presence] in Unspecified specimen by DNA probe |
| 2404-2 | Hemopexin [Mass/volume] in Urine |
| 24041-6 | Cytomegalovirus DNA [Units/volume] (viral load) in Unspecified specimen by Probe and signal amplification method |
| 24042-4 | Ehrlichia chaffeensis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 24043-2 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Fibroblast |
| 24044-0 | Acetyl-CoA:glucosamine acetyltransferase [Enzymatic activity/mass] in Leukocytes |
| 24045-7 | Alpha fucosidase [Enzymatic activity/volume] in Serum or Plasma |
| 24046-5 | Alpha fucosidase [Enzymatic activity/mass] in Fibroblast |
| 24047-3 | Alpha fucosidase [Enzymatic activity/mass] in Leukocytes |
| 24048-1 | Alpha galactosidase A [Enzymatic activity/mass] in Fibroblast |
| 24049-9 | Alpha galactosidase A [Enzymatic activity/mass] in Leukocytes |
| 2405-9 | Heparan sulfate [Presence] in Urine |
| 24050-7 | Acid alpha glucosidase [Enzymatic activity/mass] in Fibroblast |
| 24051-5 | Acid alpha glucosidase [Enzymatic activity/mass] in Leukocytes |
| 24052-3 | Alpha mannosidase [Enzymatic activity/mass] in Fibroblast |
| 24053-1 | Alpha mannosidase [Enzymatic activity/mass] in Leukocytes |
| 24054-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Fibroblast |
| 24055-6 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/mass] in Leukocytes |
| 24056-4 | Alpha-L-iduronidase [Enzymatic activity/mass] in Fibroblast |
| 24057-2 | Alpha-L-iduronidase [Enzymatic activity/mass] in Leukocytes |
| 24058-0 | Aspartylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
| 24059-8 | Aspartylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
| 2406-7 | Heparan sulfate [Mass/volume] in Urine |
| 24060-6 | Beta galactosidase [Enzymatic activity/mass] in Fibroblast |
| 24061-4 | Beta galactosidase [Enzymatic activity/mass] in Leukocytes |
| 24064-8 | Beta glucuronidase [Enzymatic activity/mass] in Fibroblast |
| 24065-5 | Beta glucuronidase [Enzymatic activity/mass] in Leukocytes |
| 24066-3 | Beta mannosidase [Enzymatic activity/volume] in Serum or Plasma |
| 24067-1 | Beta mannosidase [Enzymatic activity/mass] in Fibroblast |
| 24068-9 | Beta mannosidase [Enzymatic activity/mass] in Leukocytes |
| 24072-1 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Fibroblast |
| 24073-9 | Beta-N-acetylhexosaminidase.B [Enzymatic activity/mass] in Leukocytes |
| 24074-7 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Fibroblast |
| 24075-4 | Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Leukocytes |
| 24076-2 | Cerebroside sulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 24077-0 | Cerebroside sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24078-8 | Cerebroside sulfatase [Enzymatic activity/mass] in Leukocytes |
| 24079-6 | Cholesterol esterase [Enzymatic activity/mass] in Fibroblast |
| 2408-3 | Hexachlorophene [Mass/volume] in Blood |
| 24080-4 | Cholesterol esterase [Enzymatic activity/mass] in Leukocytes |
| 24081-2 | Dihydroxyacetone phosphate acylcoa acyl transferase [Enzymatic activity/mass] in Fibroblast |
| 24082-0 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/mass] in Red Blood Cells |
| 24083-8 | Galactosylceramidase [Enzymatic activity/mass] in Fibroblast |
| 24084-6 | Galactosylceramidase [Enzymatic activity/mass] in Leukocytes |
| 24085-3 | Heparan-N-sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24086-1 | Heparan-N-sulfatase [Enzymatic activity/mass] in Leukocytes |
| 24087-9 | Iduronate-2-Sulfatase [Enzymatic activity/volume] in Serum or Plasma |
| 24088-7 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24089-5 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 2409-1 | Hexokinase [Enzymatic activity/volume] in Plasma |
| 24091-1 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Fibroblast |
| 24092-9 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Leukocytes |
| 24093-7 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24094-5 | N-Acetylgalactosamine-4-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 24095-2 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24096-0 | N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 24097-8 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Fibroblast |
| 24098-6 | N-Acetylglucosamine-6-Sulfatase [Enzymatic activity/mass] in Leukocytes |
| 24099-4 | Sialidase [Enzymatic activity/mass] in Fibroblast |
| 2410-9 | Hexokinase [Enzymatic activity/volume] in Red Blood Cells |
| 24100-0 | Acid sphingomyelinase [Enzymatic activity/mass] in Fibroblast |
| 24101-8 | Acid sphingomyelinase [Enzymatic activity/mass] in Leukocytes |
| 24102-6 | Corynebacterium toxin [Presence] in Unspecified specimen by Immune diffusion (ID) |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
| 24109-1 | Progesterone [Moles/volume] in Saliva (oral fluid) |
| 24110-9 | Treponema pallidum Ab [Presence] in Serum by Immunoassay |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and target amplification method |
| 24112-5 | Deprecated Trichomonas vaginalis rRNA [Presence] in Genital specimen by DNA probe |
| 24113-3 | Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 24114-1 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay |
| 24115-8 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay |
| 24116-6 | Rubella virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 24117-4 | Ross river virus IgG Ab [Presence] in Serum by Immunoassay |
| 24118-2 | Barmah forest virus IgM Ab [Presence] in Serum by Immunoassay |
| 24119-0 | Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 24120-8 | Ross river virus IgM Ab [Presence] in Serum by Immunoassay |
| 24121-6 | Barmah forest virus IgG Ab [Presence] in Serum by Immunoassay |
| 24126-5 | Adenovirus type [Identifier] in Unspecified specimen by Neutralization test |
| 24127-3 | Bordetella pertussis toxin IgG Ab [Units/volume] in Serum by Immunoassay |
| 24128-1 | Bordetella pertussis toxin IgA Ab [Units/volume] in Serum by Immunoassay |
| 24129-9 | Bordetella pertussis toxin IgM Ab [Units/volume] in Serum by Immunoassay |
| 2413-3 | Hippuran renal clearance in 24 hour |
| 24130-7 | Bordetella pertussis secretory IgA Ab [Presence] in Unspecified specimen by Immunoassay |
| 24131-5 | Deprecated Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multiple allergens |
| 24132-3 | Grass Allergen Mix B (Sweet vernal grass+Perennial rye grass+Common reed+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
| 24133-1 | Deprecated Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multiple allergens |
| 24134-9 | Deprecated Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multiple allergens |
| 24135-6 | Deprecated Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multiple allergens |
| 24136-4 | Black Walnut IgG Ab [Units/volume] in Serum |
| 24137-2 | White Hickory IgG Ab [Units/volume] in Serum |
| 24138-0 | Johnson grass IgG Ab [Units/volume] in Serum |
| 24139-8 | Cockroach IgG Ab [Units/volume] in Serum |
| 2414-1 | Hippurate [Mass/time] in 24 hour Urine |
| 24140-6 | White Ash IgG Ab [Units/volume] in Serum |
| 24141-4 | Marsh Elder IgG Ab [Units/volume] in Serum |
| 24142-2 | Red mulberry IgG Ab [Units/volume] in Serum |
| 24143-0 | Sheep Sorrel IgG Ab [Units/volume] in Serum |
| 24144-8 | Brome IgG Ab [Units/volume] in Serum |
| 24145-5 | American Sycamore IgG Ab [Units/volume] in Serum |
| 24146-3 | Western Water Hemp IgG Ab [Units/volume] in Serum |
| 24147-1 | Epidermal Allergen Mix A (Chicken feather+Duck feather+Goose feather) IgE Ab [Units/volume] in Serum by Multidisk |
| 24148-9 | Kentucky blue grass IgG Ab [Units/volume] in Serum |
| 24149-7 | Food Allergen Mix D (Cauliflower+Cabbage+Brussel sprouts+Broccoli) IgG Ab [Units/volume] in Serum by Multidisk |
| 2415-8 | Histamine [Mass/volume] in Blood |
| 24150-5 | Red Maple IgG Ab [Units/volume] in Serum |
| 24151-3 | Giant Ragweed IgG Ab [Units/volume] in Serum |
| 24152-1 | Deprecated ALTERNARIA ALTERNATA+ALTERNARIA TENUIS IgG Ab [Units/volume] in Serum |
| 24153-9 | Kamut flour IgG Ab [Units/volume] in Serum |
| 24154-7 | Goosefoot IgG Ab [Units/volume] in Serum |
| 24155-4 | Mango IgG Ab [Units/volume] in Serum |
| 24156-2 | Maple syrup IgG Ab [Units/volume] in Serum |
| 24157-0 | Deprecated Virginia Live Oak IgE Ab [Units/volume] in Serum |
| 24158-8 | White+Black Pepper IgG Ab [Units/volume] in Serum |
| 24159-6 | White+Black Pepper IgE Ab [Units/volume] in Serum |
| 2416-6 | Histamine [Mass/volume] in Serum or Plasma |
| 24160-4 | Deprecated Wax Bean IgE Ab [Units/volume] in Serum |
| 24161-2 | Deprecated Melon IgE Ab [Units/volume] in Serum |
| 24163-8 | Food Allergen Mix 73 (Beef+Chicken+Pork) IgE Ab [Presence] in Serum by Multidisk |
| 24164-6 | Deprecated Mandarin IgE Ab [Units/volume] in Serum |
| 24165-3 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab [Units/volume] in Serum |
| 24166-1 | Deprecated Monterey Pine IgE Ab [Units/volume] in Serum |
| 24167-9 | Deprecated Rat epithelium, serum proteins & urine proteins IgE Ab [Units/volume] in Serum |
| 24168-7 | Deprecated Cat hair + Cat dander IgG Ab [Units/volume] in Serum |
| 24169-5 | Polio virus 1 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 2417-4 | Histamine [Mass/volume] in Urine |
| 24170-3 | Polio virus 1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24171-1 | Polio virus 2 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24172-9 | Polio virus 2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24173-7 | Polio virus 3 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24174-5 | Polio virus 3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24175-2 | Adenovirus Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24176-0 | Adenovirus Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24177-8 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24178-6 | Coxsackievirus B1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24179-4 | Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24180-2 | Coxsackievirus B1 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24181-0 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24182-8 | Coxsackievirus B2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24183-6 | Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24184-4 | Coxsackievirus B2 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24185-1 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24186-9 | Coxsackievirus B3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24187-7 | Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24188-5 | Coxsackievirus B3 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24189-3 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24190-1 | Coxsackievirus B4 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24191-9 | Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24192-7 | Coxsackievirus B4 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24193-5 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24194-3 | Coxsackievirus B5 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24195-0 | Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24196-8 | Coxsackievirus B5 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24197-6 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24198-4 | Coxsackievirus B6 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24199-2 | Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --1st specimen |
| 24200-8 | Coxsackievirus B6 Ab [Titer] in Serum by Neutralization test --2nd specimen |
| 24201-6 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24202-4 | Saint Louis encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24203-2 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24204-0 | Legionella pneumophila Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24205-7 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24206-5 | Rickettsia typhi IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24207-3 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24208-1 | Rickettsia spotted fever group IgG Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24209-9 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24210-7 | La Crosse virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24211-5 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24212-3 | Western equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24213-1 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --1st specimen |
| 24214-9 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence --2nd specimen |
| 24215-6 | Influenza virus A Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24216-4 | Influenza virus A Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24217-2 | Influenza virus B Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24218-0 | Influenza virus B Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24219-8 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24220-6 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24221-4 | Parainfluenza virus 2 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24222-2 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24223-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24224-8 | Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24225-5 | Respiratory syncytial virus Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24226-3 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24227-1 | Coxsackievirus A10 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24228-9 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24229-7 | Coxsackievirus A16 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24230-5 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24231-3 | Coxsackievirus A7 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24232-1 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24233-9 | Coxsackievirus A9 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24234-7 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --1st specimen |
| 24235-4 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum --2nd specimen |
| 24236-2 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --1st specimen |
| 24237-0 | Mycoplasma pneumoniae Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 24238-8 | Chlamydia sp IgG Ab [Units/volume] in Serum --1st specimen |
| 24239-6 | Chlamydia sp IgG Ab [Units/volume] in Serum --2nd specimen |
| 24240-4 | Mumps virus IgG Ab [Units/volume] in Serum --1st specimen |
| 24241-2 | Mumps virus IgG Ab [Units/volume] in Serum --2nd specimen |
| 24242-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --1st specimen |
| 24243-8 | Polio virus 1 Ab [Titer] in Serum --1st specimen |
| 24244-6 | Polio virus 1 Ab [Titer] in Serum --2nd specimen |
| 24245-3 | Polio virus 2 Ab [Titer] in Serum --1st specimen |
| 24246-1 | Polio virus 2 Ab [Titer] in Serum --2nd specimen |
| 24247-9 | Polio virus 3 Ab [Titer] in Serum --1st specimen |
| 24248-7 | Polio virus 3 Ab [Titer] in Serum --2nd specimen |
| 24249-5 | Adenovirus Ab [Titer] in Serum --1st specimen |
| 2425-7 | Histidine ammonia lyase [Enzymatic activity/volume] in Serum |
| 24250-3 | Adenovirus Ab [Titer] in Serum --2nd specimen |
| 24251-1 | Coxsackievirus B1 Ab [Titer] in Serum --1st specimen |
| 24252-9 | Coxsackievirus B1 Ab [Titer] in Serum --2nd specimen |
| 24255-2 | Coxsackievirus B2 Ab [Titer] in Serum --1st specimen |
| 24256-0 | Coxsackievirus B2 Ab [Titer] in Serum --2nd specimen |
| 24259-4 | Coxsackievirus B3 Ab [Titer] in Serum --1st specimen |
| 24260-2 | Coxsackievirus B3 Ab [Titer] in Serum --2nd specimen |
| 24263-6 | Coxsackievirus B4 Ab [Titer] in Serum --1st specimen |
| 24264-4 | Coxsackievirus B4 Ab [Titer] in Serum --2nd specimen |
| 24267-7 | Coxsackievirus B5 Ab [Titer] in Serum --1st specimen |
| 24268-5 | Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen |
| 24271-9 | Coxsackievirus B6 Ab [Titer] in Serum --1st specimen |
| 24272-7 | Coxsackievirus B6 Ab [Titer] in Serum --2nd specimen |
| 24275-0 | Saint Louis encephalitis virus Ab [Titer] in Serum --1st specimen |
| 24276-8 | Saint Louis encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 24277-6 | Legionella pneumophila Ab [Titer] in Serum --1st specimen |
| 24278-4 | Legionella pneumophila Ab [Titer] in Serum --2nd specimen |
| 24279-2 | Rickettsia typhi IgG Ab [Titer] in Serum --1st specimen |
| 2428-1 | Homocysteine [Mass/volume] in Serum or Plasma |
| 24280-0 | Rickettsia typhi IgG Ab [Titer] in Serum --2nd specimen |
| 24281-8 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --1st specimen |
| 24282-6 | Rickettsia spotted fever group IgG Ab [Titer] in Serum --2nd specimen |
| 24283-4 | La Crosse virus Ab [Titer] in Serum --1st specimen |
| 24284-2 | La Crosse virus Ab [Titer] in Serum --2nd specimen |
| 24285-9 | Western equine encephalitis virus Ab [Titer] in Serum --1st specimen |
| 24286-7 | Western equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 24287-5 | Eastern equine encephalitis virus Ab [Titer] in Serum --1st specimen |
| 24288-3 | Eastern equine encephalitis virus Ab [Titer] in Serum --2nd specimen |
| 24289-1 | Influenza virus A Ab [Titer] in Serum --1st specimen |
| 24290-9 | Influenza virus A Ab [Titer] in Serum --2nd specimen |
| 24291-7 | Influenza virus B Ab [Titer] in Serum --1st specimen |
| 24292-5 | Influenza virus B Ab [Titer] in Serum --2nd specimen |
| 24293-3 | Parainfluenza virus 1 Ab [Titer] in Serum --1st specimen |
| 24294-1 | Parainfluenza virus 2 Ab [Titer] in Serum --1st specimen |
| 24295-8 | Parainfluenza virus 2 Ab [Titer] in Serum --2nd specimen |
| 24296-6 | Parainfluenza virus 3 Ab [Titer] in Serum --1st specimen |
| 24297-4 | Parainfluenza virus 3 Ab [Titer] in Serum --2nd specimen |
| 24298-2 | Respiratory syncytial virus Ab [Titer] in Serum --1st specimen |
| 24299-0 | Respiratory syncytial virus Ab [Titer] in Serum --2nd specimen |
| 24300-6 | Coxsackievirus A10 Ab [Titer] in Serum --1st specimen |
| 24301-4 | Coxsackievirus A10 Ab [Titer] in Serum --2nd specimen |
| 24302-2 | Coxsackievirus A16 Ab [Titer] in Serum --1st specimen |
| 24303-0 | Coxsackievirus A16 Ab [Titer] in Serum --2nd specimen |
| 24304-8 | Coxsackievirus A7 Ab [Titer] in Serum --1st specimen |
| 24305-5 | Coxsackievirus A7 Ab [Titer] in Serum --2nd specimen |
| 24306-3 | Coxsackievirus A9 Ab [Titer] in Serum --1st specimen |
| 24307-1 | Coxsackievirus A9 Ab [Titer] in Serum --2nd specimen |
| 24310-5 | Mycoplasma pneumoniae Ab [Titer] in Serum --1st specimen |
| 24311-3 | Mycoplasma pneumoniae Ab [Titer] in Serum --2nd specimen |
| 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination |
| 2432-3 | Homogentisate [Presence] in Urine |
| 2433-1 | Homogentisate [Mass/volume] in Urine |
| 2434-9 | Homovanillate [Mass/volume] in Cerebral spinal fluid |
| 2435-6 | Homovanillate [Mass/volume] in Serum |
| 2436-4 | Homovanillate [Mass/time] in 24 hour Urine |
| 24373-3 | Ferritin [Mass/volume] in Blood |
| 24374-1 | Platelet associated Ab [Presence] in Blood |
| 24375-8 | Platelet Ab [Presence] in Serum |
| 24376-6 | von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoassay |
| 24382-4 | Neutrophil associated Ab [Identifier] in Serum |
| 24383-2 | Intrinsic factor Ab [Presence] in Serum by Immunoassay |
| 24385-7 | Cardiolipin IgG Ab [Presence] in Serum by Immunoassay |
| 24386-5 | Cardiolipin IgM Ab [Presence] in Serum by Immunoassay |
| 24387-3 | Brucella sp IgG Ab [Presence] in Serum by Immunoassay |
| 24388-1 | Brucella sp IgM Ab [Presence] in Serum by Immunoassay |
| 2439-8 | Hydroxycalcidiol [Mass/volume] in Serum |
| 24396-4 | Brucella sp IgG Ab [Presence] in Serum |
| 24397-2 | Brucella sp IgM Ab [Presence] in Serum |
| 24398-0 | Deprecated Toxoplasma gondii IgM Ab [Units/volume] in Serum by Immunoassay |
| 24399-8 | Deprecated Toxoplasma gondii IgM Ab [Units/volume] in Serum |
| 2440-6 | Hydroxocobalamin [Mass/volume] in Serum or Plasma |
| 24400-4 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 24401-2 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
| 24402-0 | Chlamydophila pneumoniae+Chlamydophila psittaci DNA [Presence] in Unspecified specimen by Probe with amplification |
| 24403-8 | Neuronal nuclear type 1 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) |
| 24404-6 | Neuronal nuclear type 2 Ab [Titer] in Cerebral spinal fluid by Immunoblot (IB) |
| 24405-3 | Aeromonas salmonicida [Presence] in Unspecified specimen |
| 24406-1 | Aeromonas salmonicida serotype [Identifier] in Isolate |
| 24408-7 | Babesia canis [Presence] in Blood by Giemsa stain |
| 24409-5 | Brachyspira sp identified in Unspecified specimen by Organism specific culture |
| 24410-3 | Brucella canis Ab [Presence] in Serum by Plate agglutination |
| 24411-1 | Canine parvovirus Ab [Presence] in Serum by Hemagglutination inhibition |
| 24412-9 | Coccidia identified in Small intestine Tissue by Giemsa stain |
| 24413-7 | Eperythrozoon sp [Presence] in Blood by Giemsa stain |
| 24415-2 | Feline panleukopenia virus Ag [Presence] in Tissue by Immunofluorescence |
| 24416-0 | Filovirus Ab [Titer] in Serum |
| 24418-6 | Formononetin [Mass/volume] in Serum or Plasma |
| 24420-2 | Haemophilus somnus Ab [Titer] in Serum |
| 24421-0 | Haemobartonella felis [Presence] in Blood by Light microscopy |
| 24422-8 | Hydrocarbons.chlorinated [Identifier] in Unspecified specimen |
| 24427-7 | Mycobacterium avium ss paratuberculosis [Presence] in Unspecified specimen by Organism specific culture |
| 24428-5 | Mycoplasma hyopneumoniae Ab [Presence] in Serum by Immunoassay |
| 24429-3 | Parasite identified in Blood |
| 24430-1 | Streptococcus suis serotype [Identifier] in Isolate by Agglutination |
| 24431-9 | IgA.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 24432-7 | IgG.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 24433-5 | IgG.equine [Mass/volume] in Serum |
| 24434-3 | IgM.canine [Mass/volume] in Serum by Immune diffusion (ID) |
| 24438-4 | Hexanoylglycine/Creatinine [Molar ratio] in Urine |
| 2444-8 | Hydroxymethylglutaryl CoA lyase [Enzymatic activity/volume] in Serum |
| 24441-8 | Phenylpropionylglycine/Creatinine [Molar ratio] in Urine |
| 24442-6 | Propionylglycine/Creatinine [Molar ratio] in Urine |
| 24444-2 | Tiglylglycine/Creatinine [Molar ratio] in Urine |
| 24446-7 | Porphobilinogen [Mass/volume] in Urine |
| 24447-5 | Magnesium [Mass/time] in 24 hour Urine |
| 24448-3 | Carnitine [Moles/time] in 24 hour Urine |
| 24449-1 | Carnitine esters [Moles/volume] in Urine |
| 2445-5 | Hydroxyproline [Presence] in Serum or Plasma |
| 24450-9 | Carnitine esters [Moles/mass] in Tissue |
| 24451-7 | Carnitine [Moles/mass] in Tissue |
| 24452-5 | Carnitine free (C0) [Moles/mass] in Tissue |
| 24456-6 | Deoxypyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
| 24458-2 | Interleukin 2 receptor [Mass/volume] in Serum or Plasma |
| 2446-3 | Hydroxyproline [Mass/volume] in Serum or Plasma |
| 24463-2 | Keratan sulfate [Presence] in Urine |
| 24464-0 | Chondroitin sulfate [Presence] in Urine |
| 24465-7 | Urea nitrogen [Mass/time] in 12 hour Urine |
| 2447-1 | Hydroxyproline [Mass/time] in 24 hour Urine |
| 24474-9 | Cancer associated serum Ag [Units/volume] in Serum |
| 24475-6 | F2 gene c.20210G>A [Presence] in Blood or Tissue by Molecular genetics method |
| 24476-4 | F2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 2448-9 | Hydroxyproline Free [Mass/volume] in Serum or Plasma |
| 24480-6 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Units/volume] in Serum by Multidisk |
| 2449-7 | Hydroxyproline Free [Mass/volume] in Urine |
| 24491-3 | Tree Allergen Mix 4 (White oak+White elm+London plane or Maple leaf sycamore+Willow+Cottonwood) IgE Ab [Units/volume] in Serum by Multidisk |
| 24493-9 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Units/volume] in Serum by Multidisk |
| 24497-0 | Canary serum proteins Ab [Presence] in Serum by Immune diffusion (ID) |
| 24498-8 | Chicken serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 24499-6 | Cryptostroma corticale Ab [Presence] in Serum by Immune diffusion (ID) |
| 2450-5 | Hydroxyproline Free [Mass/time] in 24 hour Urine |
| 24500-1 | Parrot serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 24501-9 | Parrot droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 24502-7 | Parakeet serum Ab [Presence] in Serum by Immune diffusion (ID) |
| 24503-5 | Parakeet droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 24504-3 | Pullularia sp Ab [Presence] in Serum by Immune diffusion (ID) |
| 24505-0 | Pigeon droppings Ab [Presence] in Serum by Immune diffusion (ID) |
| 24507-6 | Aspergillus clavatus Ab [Presence] in Serum by Immune diffusion (ID) |
| 24508-4 | Aspergillus nidulans Ab [Presence] in Serum by Immune diffusion (ID) |
| 24509-2 | Aspergillus terreus Ab [Presence] in Serum by Immune diffusion (ID) |
| 2451-3 | Hydroxyproline [Mass/volume] in Urine |
| 24511-8 | Western wheatgrass IgE Ab [Units/volume] in Serum |
| 24512-6 | Tree Allergen Mix C (Berry juniper+Oneseed juniper+Rocky mountain juniper) IgE Ab [Units/volume] in Serum by Multidisk |
| 24515-9 | Grass Allergen Mix A (Sweet vernal grass+Bermuda grass+Perennial rye grass+Timothy+Johnson grass) IgE Ab [Units/volume] in Serum by Multidisk |
| 24517-5 | Phoma sp IgG Ab [Units/volume] in Serum |
| 24518-3 | Calcium/Creatinine [Molar ratio] in Urine |
| 24519-1 | Phosphate [Moles/volume] in Blood |
| 2452-1 | Hypoxanthine [Mass/volume] in Body fluid |
| 24520-9 | Phosphate [Moles/volume] in Red Blood Cells |
| 24521-7 | Epinephrine [Moles/volume] in Urine |
| 24522-5 | Epinephrine/Creatinine [Molar ratio] in Urine |
| 24523-3 | Norepinephrine/Creatinine [Molar ratio] in Urine |
| 24524-1 | Dopamine/Creatinine [Molar ratio] in Urine |
| 2453-9 | Hypoxanthine [Mass/volume] in Serum |
| 24531-6 | Abdomen retroperitoneum US |
| 24532-4 | Abdomen RUQ US |
| 24533-2 | Abdominal vessels MRI angiogram W contrast IV |
| 24534-0 | Abdominal vessels US.doppler |
| 24535-7 | Acetabulum X-ray |
| 24536-5 | Acromioclavicular Joint X-ray |
| 24537-3 | US Guidance for removal of amniotic fluid from Uterus |
| 24538-1 | Ankle MRI |
| 24539-9 | Ankle MRI WO and W contrast IV |
| 2454-7 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
| 24540-7 | Ankle X-ray 2 views |
| 24541-5 | Ankle X-ray |
| 24542-3 | Anus US |
| 24543-1 | Aorta Fluoroscopic angiogram Angioplasty W contrast IA |
| 24544-9 | Thoracic Aorta CT |
| 24545-6 | Thoracic Aorta CT W contrast IV |
| 24546-4 | Aorta arch and Neck Fluoroscopic angiogram W contrast IA |
| 24547-2 | Aorta US |
| 24548-0 | Appendix US |
| 24549-8 | Upper extremity vessels MRI angiogram W contrast IV |
| 2455-4 | Hypoxanthine phosphoribosyltransferase [Enzymatic activity/mass] in Tissue |
| 24550-6 | Upper extremity veins Fluoroscopic angiogram W contrast IV |
| 24551-4 | AV fistula Fluoroscopic angiogram W contrast IA |
| 24552-2 | Stent Fluoroscopy W contrast intra stent |
| 24553-0 | Vessel intracranial Fluoroscopic angiogram Embolectomy W contrast IV |
| 24554-8 | Artery Fluoroscopic angiogram Embolization W contrast IA |
| 24555-5 | Fluoroscopic angiogram Guidance for placement of stent in Artery |
| 24556-3 | Abdomen MRI |
| 24557-1 | Abdomen MRI WO and W contrast IV |
| 24558-9 | Abdomen US |
| 24559-7 | US Guidance for drainage of Abdomen |
| 2456-2 | Iduronate-2-Sulfatase [Enzymatic activity/mass] in Tissue |
| 24560-5 | Abdomen X-ray AP left lateral-decubitus portable |
| 24561-3 | Abdomen X-ray AP left lateral-decubitus |
| 24562-1 | Abdomen X-ray AP (left lateral-decubitus and right lateral-decubitus) |
| 24563-9 | Abdomen X-ray AP right lateral-decubitus |
| 24564-7 | Abdomen X-ray AP upright portable |
| 24565-4 | Deprecated Chest and Abdomen Narrative X-ray |
| 24566-2 | Retroperitoneum CT |
| 24567-0 | Deprecated Abdomen>Retroperitoneum CT W contrast |
| 24568-8 | AV fistula Fluoroscopic angiogram Atherectomy W contrast IV |
| 24569-6 | AV shunt Fluoroscopic angiogram W contrast IV |
| 2457-0 | IgA [Mass/volume] in Cerebral spinal fluid |
| 24570-4 | Fluoroscopy Guidance for stone removal of Biliary duct common-- W contrast intra biliary duct |
| 24571-2 | Biliary ducts and Gallbladder Scan for patency of biliary structures and ejection fraction W sincalide and W radionuclide IV |
| 24572-0 | Biliary ducts and Gallbladder Scan for patency of biliary structures W Tc-99m IV |
| 24573-8 | Biliary ducts and Gallbladder X-ray W contrast IV |
| 24574-6 | Biliary ducts and Gallbladder Fluoroscopy during surgery W contrast biliary duct |
| 24575-3 | Biliary ducts and Gallbladder Fluoroscopy W contrast percutaneous transhepatic |
| 24576-1 | Urinary bladder arteries Fluoroscopic angiogram W contrast IA |
| 24577-9 | Bone X-ray during surgery |
| 24578-7 | Bones SPECT |
| 24579-5 | Bones long X-ray survey |
| 2458-8 | IgA [Mass/volume] in Serum or Plasma |
| 24580-3 | Brachiocephalic artery Fluoroscopic angiogram Angioplasty W contrast IA |
| 24581-1 | Brachial artery and Subclavian artery Fluoroscopic angiogram W contrast IA |
| 24582-9 | Thoracic outlet MRI |
| 24583-7 | Thoracic outlet MRI WO and W contrast IV |
| 24584-5 | Thoracic outlet vessels MRI angiogram W contrast IV |
| 24585-2 | CT Guidance for stereotactic biopsy of Head-- W contrast IV |
| 24586-0 | Brain MRI W anesthesia |
| 24587-8 | Brain MRI WO and W contrast IV |
| 24588-6 | Brain MRI WO and W contrast IV and W anesthesia |
| 24589-4 | Brain MRI W contrast IV |
| 2459-6 | IgA.monoclonal [Mass/volume] in Serum |
| 24590-2 | Brain MRI |
| 24591-0 | Brain Scan brain death protocol W Tc-99m HMPAO IV |
| 24593-6 | Head vessels MRI angiogram W contrast IV |
| 24594-4 | Mammogram Guidance for aspiration of cyst of Breast |
| 24595-1 | Mammogram Guidance for needle localization of mass of Breast |
| 24596-9 | Breast specimen US |
| 24597-7 | Breast specimen Mammogram |
| 24598-5 | Mammogram Guidance for aspiration of Breast |
| 24599-3 | Breast US limited |
| 2460-4 | IgD [Mass/volume] in Serum |
| 24600-9 | US Guidance for needle localization of Breast |
| 24601-7 | Breast US |
| 24602-5 | Mammogram Guidance for biopsy of Breast |
| 24603-3 | Mammogram Guidance for stereotactic biopsy of Breast |
| 24604-1 | Breast Mammogram diagnostic limited |
| 24605-8 | Breast Mammogram diagnostic |
| 24606-6 | Breast Mammogram screening |
| 24609-0 | Mammogram Guidance for core needle percutaneous biopsy of Breast |
| 2461-2 | IgD.monoclonal [Mass/volume] in Serum |
| 24610-8 | Breast Mammogram limited |
| 24611-6 | Outpatient Consultation 2nd opinion |
| 24612-4 | Deprecated Calcaneus X-ray |
| 24613-2 | Fluoroscopic angiogram Guidance for placement of catheter in artery in Central cardiovascular artery |
| 24614-0 | Carotid artery extracranial Fluoroscopic angiogram Angioplasty W contrast IA |
| 24615-7 | Carotid artery intracranial Fluoroscopic angiogram Angioplasty W contrast IA |
| 24616-5 | Carotid artery US |
| 24617-3 | Carotid artery Fluoroscopic angiogram W contrast IA |
| 24619-9 | Wrist X-ray |
| 2462-0 | IgE [Mass/volume] in Serum |
| 24620-7 | Catheter Fluoroscopy Patency check W contrast via catheter |
| 24621-5 | Fluoroscopy Guidance for percutaneous drainage of Unspecified body region |
| 24622-3 | Celiac artery Fluoroscopic angiogram W contrast IA |
| 24623-1 | CT Guidance for nerve block of Celiac plexus |
| 24624-9 | Fluoroscopic angiogram Guidance for change of central catheter in Central vein-- W contrast IV |
| 24625-6 | Fluoroscopic angiogram Guidance for placement of catheter in Central vein-- W contrast IV |
| 24626-4 | Fluoroscopic angiogram Guidance for reposition of catheter in Central vein-- W contrast IV |
| 24627-2 | Chest CT |
| 24628-0 | Chest CT W contrast IV |
| 24629-8 | Chest MRI |
| 2463-8 | IgE.monoclonal [Mass/volume] in Serum |
| 24630-6 | Chest US |
| 24631-4 | Unspecified body region Fluoroscopy Central vein catheter placement check |
| 24632-2 | Chest X-ray AP portable |
| 24634-8 | Chest X-ray portable W inspiration and expiration |
| 24635-5 | Chest X-ray PA upright W inspiration and expiration |
| 24636-3 | Chest X-ray AP left lateral-decubitus portable |
| 24637-1 | Chest X-ray AP left lateral-decubitus |
| 24638-9 | Chest X-ray left lateral upright portable |
| 24639-7 | Chest X-ray left lateral upright |
| 2464-6 | IgG [Mass/volume] in Cerebral spinal fluid |
| 24640-5 | Chest X-ray lordotic |
| 24641-3 | Chest X-ray left oblique portable |
| 24642-1 | Chest X-ray AP and PA upright |
| 24643-9 | Chest X-ray PA and lateral and right or-left oblique upright |
| 24644-7 | Chest X-ray PA and lateral upright portable |
| 24645-4 | Chest X-ray PA and right lateral and right oblique and left oblique upright portable |
| 24646-2 | Chest X-ray PA and right lateral and right oblique and left oblique upright |
| 24647-0 | Chest X-ray PA and lateral upright |
| 24648-8 | Chest X-ray PA upright |
| 24649-6 | Chest X-ray AP (right lateral-decubitus and left lateral-decubitus) portable |
| 2465-3 | IgG [Mass/volume] in Serum or Plasma |
| 24650-4 | Chest X-ray AP (right lateral-decubitus and left lateral-decubitus) |
| 24651-2 | Chest X-ray right oblique and left oblique upright |
| 24652-0 | Chest X-ray AP right lateral-decubitus portable |
| 24653-8 | Chest X-ray AP and AP right lateral-decubitus |
| 24654-6 | Chest X-ray AP and AP right lateral-decubitus portable |
| 24655-3 | Chest Fluoroscopy Image intensifier during surgery |
| 24656-1 | Chest Fluoroscopy during surgery |
| 24657-9 | Chest X-ray tomograph |
| 24658-7 | Aorta Fluoroscopic angiogram W contrast IA |
| 24659-5 | Chest vessels MRI angiogram W contrast IV |
| 2466-1 | IgG subclass 1 [Mass/volume] in Serum |
| 24660-3 | Aorta thoracic MRI angiogram |
| 24661-1 | Pleural space Fluoroscopy W contrast intra pleural space |
| 24662-9 | US Guidance for aspiration of Pleural space |
| 24663-7 | Head Cistern Scan W radionuclide IT |
| 24664-5 | Clavicle X-ray |
| 24665-2 | Sacrum and Coccyx X-ray |
| 24666-0 | Colon Fluoroscopy W air and barium contrast PR |
| 24667-8 | Colon Fluoroscopy W contrast PR |
| 24668-6 | Colon Fluoroscopy transit Post solid contrast |
| 24669-4 | Colon Fluoroscopy W water soluble contrast PR |
| 2467-9 | IgG subclass 2 [Mass/volume] in Serum |
| 24670-2 | US Guidance for biopsy of cyst of Unspecified body region |
| 24671-0 | Fluoroscopy Guidance for aspiration of cyst of Unspecified body region |
| 24672-8 | Diaphragm US Motion |
| 24673-6 | Duodenum Fluoroscopy W contrast PO and hypotonic agent per ng |
| 24674-4 | Elbow MRI |
| 24675-1 | Elbow MRI WO and W contrast IV |
| 24676-9 | Elbow X-ray |
| 24677-7 | Pelvis US transvaginal |
| 24678-5 | Esophagus Fluoroscopy W contrast PO |
| 24679-3 | Esophagus Fluoroscopy W gastrografin PO |
| 2468-7 | IgG subclass 3 [Mass/volume] in Serum |
| 24680-1 | Fluoroscopy Guidance for dilation of Esophagus |
| 24681-9 | Esophagus and Hypopharynx Fluoroscopy video W contrast PO during swallowing |
| 24682-7 | Esophagus and Hypopharynx Fluoroscopy video W liquid and paste contrast PO during swallowing |
| 24683-5 | Esophagus and Stomach Scan W Tc-99m SC PO |
| 24684-3 | Extracranial vessels Fluoroscopic angiogram Embolectomy W contrast IA |
| 24685-0 | Peripheral veins Fluoroscopic angiogram W contrast IV |
| 24686-8 | Lower extremity X-ray |
| 24687-6 | Lower Extremity Joint MRI |
| 24688-4 | Upper extremity MRI |
| 24689-2 | Upper extremity X-ray |
| 2469-5 | IgG subclass 4 [Mass/volume] in Serum |
| 24690-0 | Extremity CT |
| 24691-8 | Extremity CT W contrast IV |
| 24692-6 | US Guidance for drainage of Extremity |
| 24693-4 | Extremity US |
| 24694-2 | Face MRI WO and W contrast IV |
| 24695-9 | Facial bones X-ray |
| 24696-7 | Facial bones CT |
| 24697-5 | Facial bones CT W contrast IV |
| 24698-3 | Femoral artery Fluoroscopic angiogram Angioplasty W contrast IA |
| 24699-1 | Femoral artery Fluoroscopic angiogram runoff W contrast IA |
| 24700-7 | Femur and Tibia X-ray for leg length |
| 24702-3 | Thigh MRI |
| 24703-1 | Thigh MRI WO and W contrast IV |
| 24704-9 | Femur X-ray |
| 24705-6 | Finger MRI |
| 24706-4 | Finger X-ray |
| 24707-2 | Foot MRI |
| 24708-0 | Foot X-ray standing |
| 24709-8 | Foot X-ray |
| 2471-1 | IgM [Mass/volume] in Cerebral spinal fluid |
| 24710-6 | Forearm MRI |
| 24711-4 | Gallbladder US |
| 24712-2 | Gallbladder X-ray W contrast PO |
| 24713-0 | Gallbladder X-ray 48 hours post contrast PO |
| 24714-8 | Gastrointestine Scan W Tc-99m tagged RBC IV |
| 24715-5 | Gastrointestine upper Fluoroscopy Single view W contrast PO |
| 24716-3 | Fluoroscopy Guidance for placement of decompression tube in Gastrointestine |
| 24717-1 | Ileal conduit X-ray Loopogram |
| 24718-9 | Fluoroscopy Guidance for transjugular biopsy of Liver-- W contrast IV |
| 24719-7 | Groin US |
| 2472-9 | IgM [Mass/volume] in Serum or Plasma |
| 24720-5 | Hand MRI |
| 24721-3 | Hand X-ray 2 views |
| 24722-1 | Hand X-ray 3 views |
| 24723-9 | Hand X-ray arthritis |
| 24724-7 | Wrist and Hand X-ray bone age |
| 24725-4 | Head CT |
| 24726-2 | Head CT WO and W contrast IV |
| 24727-0 | Head CT W contrast IV |
| 24728-8 | Head CT perfusion |
| 24729-6 | Head CT perfusion WO and W contrast IV |
| 2473-7 | IgM.monoclonal [Mass/volume] in Serum |
| 24730-4 | Brain Scan |
| 24731-2 | Head US |
| 24732-0 | Head US during surgery |
| 24733-8 | Head vessels US.doppler |
| 24734-6 | Cerebral cisterns CT W contrast IT |
| 24735-3 | Internal auditory canal and Posterior fossa MRI |
| 2474-5 | Indicans [Presence] in Urine |
| 24740-3 | Internal auditory canal and Posterior fossa MRI WO and W contrast IV |
| 24745-2 | Petrous bone X-ray |
| 24746-0 | Head Sagittal Sinus MRI |
| 24747-8 | Head Sagittal Sinus MRI angiogram W contrast IV |
| 24748-6 | Heart MRI |
| 2475-2 | Indicans [Mass/volume] in Urine |
| 24750-2 | Heart Scan at rest and W Tl-201 IV |
| 24751-0 | Parathyroid Scan W TI-201 subtraction Tc-99m IV |
| 24752-8 | Heart Fluoroscopy video |
| 24753-6 | Unspecified body region CT W contrast IV |
| 24754-4 | Administration of vasodilator into catheter of Vein |
| 24755-1 | Fluoroscopic angiogram Guidance for atherectomy of Vein-- W contrast IV |
| 24756-9 | Fluoroscopic angiogram Guidance for placement of stent in Vein |
| 24757-7 | Deprecated Coronary arteries CT fast |
| 2476-0 | Indolamine [Mass/volume] in Serum |
| 24760-1 | Hip US |
| 24761-9 | Hip X-ray Single view |
| 24762-7 | Hip X-ray |
| 24764-3 | Hip Fluoroscopy W contrast IS |
| 24765-0 | Humerus X-ray 2 views |
| 24766-8 | Iliac artery Fluoroscopic angiogram Angioplasty W contrast IA |
| 24767-6 | Internal auditory canal X-ray tomograph |
| 24769-2 | CT Guidance for injection of Joint space |
| 2477-8 | Indole [Mass/volume] in Serum |
| 24770-0 | Joint Scan W In-111 intrajoint |
| 24771-8 | Fluoroscopy Guidance for aspiration of Joint space |
| 24772-6 | US Guidance for biopsy of Kidney |
| 24773-4 | Kidney - bilateral Scan W radionuclide transplant scan |
| 24774-2 | Deprecated Kidney - bilateral and Collecting system CT |
| 24775-9 | Deprecated Kidney - bilateral and Collecting system CT W contrast IV |
| 24776-7 | Kidney - bilateral Scan |
| 24777-5 | Deprecated Kidney - bilateral and Collecting system US |
| 24778-3 | Kidney - bilateral X-ray 3 views serial WO and W contrast IV |
| 24779-1 | Fluoroscopy Guidance for placement of percutaneous nephrostomy in Kidney - bilateral-- W contrast via tube |
| 2478-6 | Inhibin [Mass/volume] in Serum or Plasma |
| 24780-9 | Kidney - bilateral Fluoroscopy W contrast via nephrostomy tube |
| 24781-7 | Fluoroscopy Guidance for exchange of percutaneous nephrostomy tube of Kidney - bilateral-- W contrast |
| 24782-5 | Fluoroscopy Guidance for placement of percutaneous nephroureteral stent in Kidney - bilateral-- W contrast via stent |
| 24783-3 | Kidney - bilateral Fluoroscopy Urodynamics |
| 24784-1 | Kidney - bilateral X-ray tomograph WO and W contrast IV |
| 24785-8 | deprecated Kidney - bilateral & Collecting system X-ray tomograph Single view |
| 24786-6 | Deprecated Kidney Bilateral & Collecting system X-ray tomograph Multisection W & WO contrast IV |
| 24787-4 | Kidney - bilateral X-ray tomograph WO contrast and 10M post contrast IV |
| 24788-2 | Kidney - bilateral X-ray W contrast IV |
| 24789-0 | Kidney - bilateral X-ray tomograph |
| 2479-4 | Inosine [Mass/volume] in Serum |
| 24790-8 | Kidney - bilateral X-ray tomograph W contrast IV |
| 24791-6 | Deprecated Kidney Bilateral & Collecting system X-ray tomograph Multisection |
| 24792-4 | Abdomen X-ray AP and AP left lateral-decubitus portable |
| 24793-2 | Abdomen X-ray AP and lateral portable |
| 24794-0 | Abdomen X-ray AP and lateral |
| 24795-7 | Abdomen X-ray AP (supine and upright) portable |
| 24796-5 | Abdomen X-ray AP and AP left lateral-decubitus |
| 24797-3 | Abdomen X-ray AP and oblique prone |
| 24798-1 | Abdomen X-ray AP (supine and upright) |
| 24799-9 | Abdomen X-ray AP single view |
| 2480-2 | Inositol Free [Mass/volume] in Serum |
| 24800-5 | Knee Fluoroscopy W contrast IS |
| 24801-3 | Knee X-ray Merchants |
| 24802-1 | Knee MRI |
| 24803-9 | Knee MRI WO and W contrast IV |
| 24804-7 | Knee Scan |
| 24805-4 | Knee X-ray AP and lateral standing |
| 24806-2 | Knee X-ray 2 views |
| 24807-0 | Knee X-ray AP single view standing |
| 24808-8 | Knee X-ray AP and PA standing |
| 24809-6 | Knee X-ray standing |
| 2481-0 | Insulin Ab [Presence] in Serum |
| 24811-2 | CT Guidance for aspiration of Liver |
| 24812-0 | CT Guidance for biopsy of Liver |
| 24813-8 | CT Guidance for core needle biopsy of Liver |
| 24814-6 | Liver CT |
| 24815-3 | Liver CT W contrast IV |
| 24816-1 | US Guidance for biopsy of Liver |
| 24817-9 | Liver SPECT W Tc-99m IV |
| 24818-7 | Liver and Diaphragm US |
| 24819-5 | Liver and Spleen Scan W Tc-99m calcium colloid IV |
| 2482-8 | Insulin Ab [Mass/volume] in Serum |
| 24820-3 | Lower leg vessels MRI angiogram W contrast IV |
| 24821-1 | Lower leg MRI |
| 24822-9 | CT Guidance for aspiration of Lung |
| 24823-7 | CT Guidance for biopsy of Lung |
| 24824-5 | Lung Scan portable |
| 24825-2 | Lung X-ray W contrast intrabronchial |
| 24826-0 | Lymphatics Scan W radionuclide intra lymphatic |
| 24827-8 | Lymphatics Fluoroscopy W contrast intra lymphatic |
| 24828-6 | Mandible X-ray panorex |
| 24829-4 | Mandible X-ray |
| 2483-6 | Insulin-like growth factor binding protein 3 [Mass/volume] in Serum or Plasma |
| 24830-2 | Mastoid X-ray |
| 24831-0 | Meckels diverticulum Scan W Tc-99m M04 IV |
| 24832-8 | Mesenteric artery Fluoroscopic angiogram Angioplasty W contrast IA |
| 24833-6 | Mesenteric artery Fluoroscopic angiogram W contrast IA |
| 24834-4 | Nasal bones X-ray |
| 24835-1 | Nasopharynx and Neck CT |
| 24836-9 | Nasopharynx and Neck CT W contrast IV |
| 24837-7 | CT Guidance for aspiration of Neck |
| 24838-5 | CT Guidance for biopsy of Neck |
| 24839-3 | Neck MRI |
| 2484-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma |
| 24840-1 | Neck MRI WO and W contrast IV |
| 24841-9 | Neck MRI W contrast IV |
| 24842-7 | Neck US |
| 24843-5 | Neck X-ray lateral |
| 24844-3 | Neck vessels MRI angiogram W contrast IV |
| 24845-0 | Neck Fluoroscopy W contrast intra larynx |
| 24846-8 | Optic foramen X-ray |
| 24848-4 | Orbit - bilateral CT |
| 24849-2 | Orbit - bilateral CT WO and W contrast IV |
| 2485-1 | Insulin-like growth factor-II [Mass/volume] in Serum or Plasma |
| 24850-0 | Orbit - bilateral CT W contrast IV |
| 24851-8 | Orbit - bilateral MRI WO and W contrast IV |
| 24852-6 | Orbit - bilateral MRI W contrast IV |
| 24853-4 | Eye+Orbit - bilateral US |
| 24854-2 | Orbit - bilateral X-ray |
| 24855-9 | Oropharynx Fluoroscopy video |
| 24856-7 | CT Guidance for aspiration of Pancreas |
| 24857-5 | Pancreas CT |
| 24858-3 | Pancreas CT W contrast IV |
| 24859-1 | Pancreas US |
| 2486-9 | Somatomedins [Mass/volume] in Serum or Plasma |
| 24860-9 | Pancreatic artery Fluoroscopic angiogram W contrast IA |
| 24861-7 | Patella X-ray 2 views |
| 24862-5 | Iliac artery Internal Fluoroscopic angiogram W contrast IA |
| 24863-3 | CT Guidance for aspiration of Pelvis |
| 24864-1 | CT Guidance for biopsy of Pelvis |
| 24865-8 | Pelvis CT |
| 24866-6 | Pelvis CT W contrast IV |
| 24867-4 | Pelvis MRI |
| 24868-2 | US Guidance for drainage of Pelvis |
| 24869-0 | Pelvis US |
| 2487-7 | Inter alpha trypsin inhibitor [Mass/volume] in Serum |
| 24870-8 | Pelvis vessels US.doppler |
| 24871-6 | Pelvis X-ray pelvimetry |
| 24872-4 | Pelvis and Hip MRI |
| 24873-2 | Pelvis vessels MRI angiogram W contrast IV |
| 24874-0 | Peripheral arteries Fluoroscopic angiogram W contrast IA |
| 24875-7 | Peripheral vessel US.doppler Peripheral plane |
| 24876-5 | Peritoneovenous shunt Scan for patency W Tc-99m DTPA IT |
| 24877-3 | Petrous part of temporal bone CT |
| 24878-1 | Petrous part of temporal bone CT W contrast IV |
| 24879-9 | Pituitary and Sella turcica MRI WO and W contrast IV |
| 2488-5 | Intrinsic factor [Mass/volume] in Serum |
| 24880-7 | Pituitary and Sella turcica MRI |
| 24881-5 | Popliteal space US |
| 24882-3 | Popliteal artery Fluoroscopic angiogram Percutaneous transluminal angioplasty of vessel W contrast IA |
| 24883-1 | US Guidance for biopsy of Prostate |
| 24884-9 | Prostate US |
| 24885-6 | US Guidance for repair of Pseudoaneurysm/AV fistula |
| 24886-4 | Deprecated Pulmonary artery Bilateral X-ray fluoroscopy angio W contrast IA |
| 24887-2 | Pulmonary artery Fluoroscopic angiogram Embolectomy W contrast IA |
| 24888-0 | Pulmonary system Scan ventilation and perfusion W Xe-133 IH and W Tc-99m MAA IV |
| 24889-8 | Pylorus US for Pyloric Stenosis |
| 2489-3 | Intrinsic factor blocking Ab [Titer] in Serum |
| 24891-4 | Radius and Ulna X-ray |
| 24892-2 | Rectum US |
| 24893-0 | Rectum Fluoroscopy post contrast PR during defecation |
| 24894-8 | Rectum and Urinary bladder Fluoroscopy W contrast PR and intra bladder during defecation and voiding |
| 24896-3 | US Guidance for drainage of Kidney |
| 24899-7 | Ribs X-ray |
| 2490-1 | Inulin [Mass/volume] in Serum or Plasma |
| 24900-3 | Sacroiliac Joint X-ray |
| 24901-1 | CT Guidance for injection of Sacroiliac Joint |
| 24902-9 | Salivary gland Fluoroscopy W contrast intra salivary duct |
| 24903-7 | Scapula X-ray |
| 24904-5 | Pituitary and Sella turcica CT WO and W contrast IV |
| 24905-2 | Shoulder MRI |
| 24906-0 | Shoulder MRI WO and W contrast IV |
| 24907-8 | Shoulder US |
| 24908-6 | Shoulder X-ray 3 views |
| 24909-4 | Shoulder X-ray |
| 2491-9 | Inulin renal clearance in 24 hour |
| 24910-2 | Shoulder Fluoroscopy W contrast IS |
| 24911-0 | Shunt Fluoroscopy |
| 24912-8 | Sinus tract Fluoroscopy W contrast intra sinus tract |
| 24913-6 | Sinuses CT limited |
| 24914-4 | Sinuses MRI |
| 24915-1 | Sinuses MRI W contrast IV |
| 24916-9 | Sinuses X-ray |
| 24917-7 | Skull X-ray Single view |
| 24918-5 | Skull X-ray 3 views |
| 24919-3 | Skull X-ray AP and lateral |
| 2492-7 | Iodine [Mass/time] in 24 hour Urine |
| 24920-1 | Skull X-ray lateral |
| 24921-9 | Skull X-ray Waters |
| 24922-7 | Skull X-ray 5 views |
| 24923-5 | Small bowel Fluoroscopy W positive contrast via enteroclysis tube |
| 24924-3 | Small bowel Fluoroscopy W contrast PO |
| 24925-0 | Spinal artery Fluoroscopic angiogram W contrast IA |
| 24926-8 | Spine US |
| 24927-6 | Spine Fluoroscopy W contrast intradisc |
| 24928-4 | Spine X-ray AP and lateral |
| 24929-2 | Spine Thoracic and Lumbar X-ray scoliosis W flexion and W extension |
| 2493-5 | Iodine Free [Mass/volume] in Urine |
| 24930-0 | Spine Thoracic and Lumbar X-ray scoliosis |
| 24931-8 | Fluoroscopy Guidance for injection of Spine facet joint |
| 24932-6 | Cervical spine CT |
| 24933-4 | Cervical spine CT W contrast IV |
| 24934-2 | Cervical spine CT W contrast IT |
| 24935-9 | Cervical spine MRI |
| 24936-7 | Cervical spine MRI W anesthesia |
| 24937-5 | Cervical spine MRI WO and W contrast IV |
| 24938-3 | Cervical spine MRI W contrast IV |
| 24939-1 | Cervical spine X-ray 5 views |
| 2494-3 | Iodine [Mass/volume] in Serum or Plasma |
| 24940-9 | Cervical spine X-ray Single view |
| 24941-7 | Cervical spine X-ray 3 views |
| 24942-5 | Cervical spine X-ray AP and lateral |
| 24943-3 | Cervical spine X-ray lateral |
| 24944-1 | Cervical spine X-ray Swimmers |
| 24945-8 | Cervical spine X-ray W flexion and W extension |
| 24946-6 | Cervical spine X-ray |
| 24947-4 | Cervical spine Fluoroscopy W contrast IT |
| 24948-2 | Spine Cervical Odontoid and Cervical axis X-ray AP single view |
| 2495-0 | Iodine [Mass/volume] in Urine |
| 2496-8 | Iodohippuran renal clearance in 24 hour |
| 24963-1 | Lumbar spine CT |
| 24964-9 | Lumbar spine CT W contrast IV |
| 24965-6 | Lumbar spine CT W contrast IT |
| 24967-2 | Lumbar spine MRI WO and W contrast IV |
| 24968-0 | Lumbar spine MRI |
| 24969-8 | Lumbar spine X-ray lateral |
| 2497-6 | Iron [Mass/mass] in Hair |
| 24970-6 | Lumbar spine X-ray AP and lateral |
| 24971-4 | Lumbar spine X-ray W flexion and W extension |
| 24972-2 | Lumbar spine X-ray |
| 24973-0 | Fluoroscopy Guidance for aspiration of Spine Lumbar Space |
| 24974-8 | Lumbar spine Fluoroscopy W contrast IT |
| 24975-5 | Spine.lumbar and Sacroiliac joint - bilateral X-ray |
| 24977-1 | Lumbar spine MRI W anesthesia |
| 24978-9 | Thoracic spine CT |
| 24979-7 | Thoracic spine CT W contrast IV |
| 2498-4 | Iron [Mass/volume] in Serum or Plasma |
| 24980-5 | Thoracic spine MRI |
| 24981-3 | Thoracic spine MRI WO and W contrast IV |
| 24982-1 | Thoracic spine MRI W contrast IV |
| 24983-9 | Thoracic spine X-ray |
| 24984-7 | Spine Thoracic and Lumbar X-ray 2 views |
| 24985-4 | Thoracic spine Fluoroscopy W contrast IT |
| 24986-2 | CT Guidance for biopsy of Spine |
| 24987-0 | Spine CT W contrast IV |
| 24988-8 | Spleen CT |
| 24989-6 | Spleen CT WO and W contrast IV |
| 2499-2 | Iron [Mass/time] in 24 hour Urine |
| 24990-4 | Spleen US |
| 24991-2 | Splenic vein and Portal vein Fluoroscopic angiogram W contrast IA |
| 24992-0 | Splenic artery Fluoroscopic angiogram W contrast IA |
| 24993-8 | Sternoclavicular Joints X-ray |
| 24994-6 | Sternum X-ray |
| 24995-3 | Fluoroscopy Guidance for placement of tube in Stomach |
| 24996-1 | Fluoroscopy Guidance for replacement of percutaneous gastrostomy in Stomach |
| 24997-9 | Stomach Scan for gastric emptying solid phase W Tc-99m SC PO |
| 24998-7 | Placement check of gastrostomy tube W contrast via GI tube |
| 24999-5 | Temporomandibular joint MRI |
| 2500-7 | Iron binding capacity [Mass/volume] in Serum or Plasma |
| 25000-1 | Temporomandibular joint X-ray |
| 25001-9 | Scrotum and Testicle Scan W Tc-99m pertechnetate IV |
| 25002-7 | Scrotum and Testicle US |
| 25003-5 | Thigh vessels MRI angiogram W contrast IV |
| 25004-3 | Deprecated Thigh MRI Multisection |
| 25005-0 | Three vessels Fluoroscopic angiogram W contrast |
| 25006-8 | Thumb X-ray |
| 25007-6 | Thyroid Scan W I-131 IV |
| 25008-4 | Thyroid Scan and uptake W I-131 IV |
| 25009-2 | US Guidance for biopsy of Thyroid |
| 2501-5 | Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma |
| 25010-0 | Thyroid US |
| 25011-8 | Tibia and Fibula X-ray |
| 25012-6 | Tibial artery Fluoroscopic angiogram Angioplasty W contrast IA |
| 25013-4 | Toes X-ray |
| 25014-2 | Two vessels Fluoroscopic angiogram W contrast |
| 25015-9 | Upper GI tract Replacement of percutaneous gastrojejunostomy |
| 25016-7 | Urethra Fluoroscopy W contrast intra urethra |
| 25017-5 | Urinary Bladder and Urethra Fluoroscopy W contrast intra bladder |
| 25018-3 | Urinary bladder Scan |
| 25019-1 | Urinary bladder US |
| 2502-3 | Iron saturation [Mass Fraction] in Serum or Plasma |
| 25020-9 | Urinary Bladder and Urethra Fluoroscopy W contrast retrograde via urethra |
| 25021-7 | Deprecated Urinary Bladder & Urethra Fluoroscopy W voiding |
| 25022-5 | Uterus and Fallopian tubes Fluoroscopy W contrast IU |
| 25023-3 | Vein Fluoroscopic angiogram W contrast IV |
| 25024-1 | Fluoroscopic angiogram Guidance for placement of longterm peripheral catheter in Central vein |
| 25025-8 | Vena cava Fluoroscopic angiogram W contrast IV |
| 25026-6 | Fluoroscopic angiogram Guidance for placement of IVC filter in Inferior vena cava-- W contrast IV |
| 25027-4 | Guidance for placement of large bore catheter into vessel in Central vein |
| 25028-2 | Fluoroscopic angiogram Guidance for placement of catheter for adminstration of thrombolytic in Vessel-- W contrast intravascular |
| 25029-0 | Fluoroscopic angiogram Guidance for placement of catheter for vasoconstrictor infusion in Vessels |
| 2503-1 | Iron.chelated [Mass/volume] in Urine |
| 25030-8 | Abdominal Arteries Fluoroscopic angiogram W contrast IA |
| 25031-6 | Bone Scan |
| 25032-4 | Bone Scan W In-111 tagged WBC IV |
| 25033-2 | Wrist MRI |
| 25034-0 | Wrist Fluoroscopy W contrast IS |
| 25035-7 | Wrist MRI WO and W contrast IV |
| 25036-5 | Wrist US |
| 25037-3 | Deprecated Wrist X-ray |
| 25039-9 | Unspecified body region CT limited |
| 2504-9 | Iron [Mass/volume] in Urine |
| 25040-7 | Deprecated Unspecified body region CT 3D |
| 25041-5 | CT Guidance for aspiration or biopsy of Unspecified body region-- W contrast IV |
| 25042-3 | CT Guidance for aspiration or biopsy of Unspecified body region |
| 25043-1 | CT Guidance for aspiration of Unspecified body region |
| 25044-9 | CT Guidance for biopsy of Unspecified body region |
| 25045-6 | Unspecified body region CT |
| 25046-4 | Unspecified body region CT W anesthesia |
| 25047-2 | Unspecified body region CT W conscious sedation |
| 25049-8 | Deprecated Unspecified body region CT 3D multiple sagittal & coronal |
| 25050-6 | Deprecated Unspecified body region CT 3D sagittal and coronal disarticulation |
| 25051-4 | Deprecated Unspecified body region CT Multisectional sagittal |
| 25052-2 | Deprecated Unspecified body region CT sagittal and coronal |
| 25053-0 | CT Guidance for radiosurgery of Unspecified body region |
| 25054-8 | CT Guidance for radiosurgery of Unspecified body region-- W contrast IV |
| 25055-5 | Unspecified body region MRI additional sequence |
| 25056-3 | Unspecified body region MRI |
| 25057-1 | Unspecified body region MRI W conscious sedation |
| 25058-9 | Unspecified body region MRI angiogram W contrast IV |
| 25059-7 | US Guidance for biopsy of Unspecified body region |
| 2506-4 | Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 25060-5 | Unspecified body region US No charge |
| 25061-3 | Unspecified body region US |
| 25062-1 | Unspecified body region X-ray Comparison view |
| 25063-9 | Vessel Fluoroscopic angiogram Single view W contrast IA |
| 25064-7 | Vessel Fluoroscopic angiogram Angioplasty W contrast IA |
| 25069-6 | Fluoroscopy Guidance for biopsy of Unspecified body region |
| 25070-4 | Unspecified body region Fluoroscopy during surgery |
| 25071-2 | Unspecified body region X-ray tomograph |
| 25072-0 | Guidance for placement of infusion port in Unspecified body region |
| 25073-8 | Vessel Fluoroscopic angiogram Removal of foreign body from vascular space |
| 25074-6 | Zygomatic arch X-ray |
| 25076-1 | Hepatic artery Fluoroscopic angiogram W contrast IA |
| 25077-9 | Fluoroscopic angiogram Guidance for placement of catheter in Hepatic artery-- W contrast IA |
| 25078-7 | Fluoroscopy Guidance for placement of stent in Intrahepatic portal system |
| 25079-5 | Kidney arteries Fluoroscopic angiogram W contrast IA |
| 25080-3 | Renal vein - bilateral Fluoroscopic angiogram W contrast IV and W renin sampling |
| 25081-1 | Renal vessel Fluoroscopic angiogram Angioplasty W contrast IA |
| 25083-7 | 2-Oxo,3-Methylvalerate/Creatinine [Molar ratio] in Urine |
| 25088-6 | 4-Hydroxyphenylacetate/Creatinine [Molar ratio] in Urine |
| 25090-2 | Benzoate/Creatinine [Molar ratio] in Urine |
| 25091-0 | C peptide/Creatinine [Molar ratio] in Urine |
| 25095-1 | Deoxypyridinoline/Creatinine [Molar ratio] in Urine |
| 25096-9 | Deoxypyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
| 25099-3 | Ethylmalonate/Creatinine [Molar ratio] in Urine |
| 25100-9 | Formate/Creatinine [Molar ratio] in Urine |
| 25101-7 | Fumarate/Creatinine [Molar ratio] in Urine |
| 25102-5 | Galactose/Creatinine [Molar ratio] in Urine |
| 25103-3 | Glutaconate/Creatinine [Molar ratio] in Urine |
| 25104-1 | Glutarate/Creatinine [Molar ratio] in Urine |
| 25105-8 | Glycerate/Creatinine [Molar ratio] in Urine |
| 25106-6 | Glycolate/Creatinine [Molar ratio] in Urine |
| 25107-4 | Glyoxylate/Creatinine [Molar ratio] in Urine |
| 2511-4 | Keratan sulfate [Mass/volume] in Blood |
| 25110-8 | Hydroxyproline/Creatinine [Molar ratio] in Urine |
| 25111-6 | Isocitrate/Creatinine [Molar ratio] in Urine |
| 25112-4 | Lactate/Creatinine [Molar ratio] in Urine |
| 25113-2 | Malate/Creatinine [Molar ratio] in Urine |
| 25115-7 | Methylmalonate/Creatinine [Molar ratio] in 24 hour Urine |
| 25116-5 | Methylmalonate/Creatinine [Molar ratio] in Urine |
| 25117-3 | Methylsuccinate/Creatinine [Molar ratio] in Urine |
| 25118-1 | Mevalonate/Creatinine [Molar ratio] in Urine |
| 25119-9 | N-acetyltyrosine/Creatinine [Molar ratio] in Urine |
| 2512-2 | Keratan sulfate [Mass/volume] in Urine |
| 25123-1 | Para nitrophenol/Creatinine [Molar ratio] in Urine |
| 25124-9 | Phenylacetate/Creatinine [Molar ratio] in Urine |
| 25125-6 | Phenyllactate/Creatinine [Molar ratio] in Urine |
| 25126-4 | Phenylpyruvate/Creatinine [Molar ratio] in Urine |
| 25129-8 | Pyridinoline/Creatinine [Molar ratio] in Urine |
| 2513-0 | Ketones [Presence] in Serum or Plasma |
| 25130-6 | Pyridinoline/Creatinine [Molar ratio] in 24 hour Urine |
| 25131-4 | Pyridinoline/Creatinine [Molar ratio] in 2 hour Urine |
| 25132-2 | Pyruvate/Creatinine [Molar ratio] in Urine |
| 25135-5 | Suberate/Creatinine [Molar ratio] in Urine |
| 25136-3 | Succinate/Creatinine [Molar ratio] in Urine |
| 2514-8 | Ketones [Presence] in Urine by Test strip |
| 25140-5 | Uracil/Creatinine [Molar ratio] in Urine |
| 25141-3 | Carnitine esters/Creatinine [Molar ratio] in Urine |
| 25142-1 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --peak |
| 25143-9 | 5-Fluorocytosine [Mass/volume] in Serum or Plasma --trough |
| 2515-5 | Kynurenate [Mass/volume] in Urine |
| 2516-3 | L-iditol dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
| 25168-6 | Perhexiline [Mass/volume] in Serum or Plasma |
| 25169-4 | Nickel [Moles/volume] in Blood |
| 2517-1 | L-iditol dehydrogenase [Enzymatic activity/volume] in Serum |
| 25170-2 | Mercury [Moles/volume] in Blood |
| 25171-0 | Bromide [Moles/volume] in Blood |
| 25172-8 | Fluoride [Moles/volume] in Blood |
| 25173-6 | Thallium [Moles/volume] in Blood |
| 2518-9 | Lactate [Moles/volume] in Arterial blood |
| 2519-7 | Lactate [Moles/volume] in Venous blood |
| 2520-5 | Lactate [Moles/volume] in Cerebral spinal fluid |
| 2521-3 | Lactate [Presence] in Gastric fluid |
| 2522-1 | Lactate [Moles/volume] in Pleural fluid |
| 2523-9 | Lactate [Moles/volume] in Peritoneal fluid |
| 25232-0 | Nafcillin [Mass/volume] in Unspecified specimen |
| 25233-8 | Azithromycin [Mass/volume] in Unspecified specimen |
| 25234-6 | Aztreonam [Mass/volume] in Unspecified specimen |
| 25235-3 | Cefazolin [Mass/volume] in Unspecified specimen |
| 25236-1 | Cefixime [Mass/volume] in Unspecified specimen |
| 25237-9 | Cefonicid [Mass/volume] in Unspecified specimen |
| 25238-7 | Cefotaxime [Mass/volume] in Unspecified specimen |
| 25239-5 | Cefotetan [Mass/volume] in Unspecified specimen |
| 2524-7 | Lactate [Moles/volume] in Serum or Plasma |
| 25240-3 | Cefoxitin [Mass/volume] in Unspecified specimen |
| 25241-1 | Cefpodoxime [Mass/volume] in Unspecified specimen |
| 25242-9 | Cefsulodin [Mass/volume] in Unspecified specimen |
| 25243-7 | Ceftizoxime [Mass/volume] in Unspecified specimen |
| 25244-5 | Ceftriaxone [Mass/volume] in Unspecified specimen |
| 25245-2 | Cefuroxime Parenteral [Mass/volume] in Unspecified specimen |
| 25246-0 | Cephalothin [Mass/volume] in Unspecified specimen |
| 25247-8 | Chloramphenicol [Mass/volume] in Unspecified specimen |
| 25248-6 | Ciprofloxacin [Mass/volume] in Unspecified specimen |
| 25249-4 | Clindamycin [Mass/volume] in Unspecified specimen |
| 2525-4 | Lactate [Moles/volume] in Synovial fluid |
| 25250-2 | Cloxacillin [Mass/volume] in Unspecified specimen |
| 25251-0 | Cycloserine [Mass/volume] in Unspecified specimen |
| 25252-8 | Dicloxacillin [Mass/volume] in Unspecified specimen |
| 25253-6 | Clarithromycin [Mass/volume] in Unspecified specimen |
| 25254-4 | Ticarcillin [Mass/volume] in Unspecified specimen |
| 25255-1 | Fluconazole [Mass/volume] in Unspecified specimen |
| 25256-9 | Ganciclovir [Mass/volume] in Unspecified specimen |
| 25257-7 | Imipenem [Mass/volume] in Unspecified specimen |
| 25258-5 | Itraconazole [Mass/volume] in Unspecified specimen |
| 25259-3 | Ketoconazole [Mass/volume] in Unspecified specimen |
| 2526-2 | Lactate [Mass/time] in 24 hour Urine |
| 25261-9 | Nalidixate [Mass/volume] in Unspecified specimen |
| 25262-7 | Neomycin [Mass/volume] in Unspecified specimen |
| 25263-5 | Netilmicin [Mass/volume] in Unspecified specimen |
| 25264-3 | Ofloxacin [Mass/volume] in Unspecified specimen |
| 25265-0 | Oxacillin [Mass/volume] in Unspecified specimen |
| 25266-8 | Oxytetracycline [Mass/volume] in Unspecified specimen |
| 25267-6 | Penicillin [Mass/volume] in Unspecified specimen |
| 25268-4 | Piperacillin [Mass/volume] in Unspecified specimen |
| 25269-2 | Polymyxin B [Mass/volume] in Unspecified specimen |
| 2527-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
| 25270-0 | Pyrazinamide [Mass/volume] in Unspecified specimen |
| 25271-8 | Sulfamethoxazole [Mass/volume] in Unspecified specimen |
| 25272-6 | Tetracycline [Mass/volume] in Unspecified specimen |
| 25273-4 | Trimethoprim+Sulfamethoxazole [Mass/volume] in Unspecified specimen |
| 25274-2 | Amoxicillin [Mass/volume] in Unspecified specimen |
| 25275-9 | Erythromycin [Mass/volume] in Unspecified specimen |
| 2528-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 2529-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid |
| 25297-3 | Parainfluenza virus 1 Ab [Titer] in Serum by Complement fixation --2nd specimen |
| 2530-4 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid |
| 25302-1 | Alanine aminotransferase [Enzymatic activity/volume] in Body fluid |
| 25303-9 | Alpha 1 antitrypsin [Mass/mass] in Stool |
| 25308-8 | Ammonia [Moles/time] in 24 hour Urine |
| 25309-6 | Amobarbital [Moles/volume] in Serum or Plasma |
| 2531-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid |
| 25311-2 | Amylase [Enzymatic activity/volume] in 24 hour Urine |
| 25314-6 | Androstenediol [Moles/time] in 24 hour Urine |
| 25315-3 | 11-Deoxycortisol [Moles/time] in 24 hour Urine |
| 25316-1 | 17-Hydroxypregnenolone [Moles/volume] in Serum or Plasma |
| 25317-9 | 17-Ketosteroids [Moles/volume] in 24 hour Urine |
| 2532-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 25321-1 | Antimony [Moles/volume] in Serum or Plasma |
| 25323-7 | Arsenic [Moles/volume] in Serum or Plasma |
| 25324-5 | Arsenic/Creatinine [Molar ratio] in Urine |
| 25325-2 | Ascaris sp IgE Ab [Units/volume] in Serum by Immunoassay |
| 2533-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid |
| 25331-0 | Bordetella pertussis IgG Ab [Titer] in Serum |
| 25332-8 | Bordetella pertussis IgM Ab [Titer] in Serum |
| 25333-6 | Campylobacter fetus Ab [Titer] in Serum |
| 25335-1 | Coxiella burnetii IgG Ab [Titer] in Serum |
| 25336-9 | Coxiella burnetii IgM Ab [Titer] in Serum |
| 25337-7 | Taenia solium larva IgG Ab [Units/volume] in Serum |
| 25338-5 | Dengue virus IgM Ab [Presence] in Serum |
| 25339-3 | Echinococcus sp Ab [Presence] in Serum |
| 2534-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Urine |
| 25342-7 | Fasciola sp Ab [Titer] in Serum |
| 25343-5 | Fasciola sp IgG Ab [Units/volume] in Serum |
| 25344-3 | Filaria Ab [Titer] in Serum |
| 25349-2 | Silver Birch IgG Ab [Units/volume] in Serum |
| 25351-8 | Bismuth [Moles/volume] in Serum or Plasma |
| 25352-6 | Bordetella pertussis IgG Ab [Titer] in Serum by Immunofluorescence |
| 25353-4 | Bordetella pertussis IgM Ab [Titer] in Serum by Immunofluorescence |
| 25354-2 | Wheat Bran IgG Ab [Units/volume] in Serum |
| 25357-5 | Butabarbital [Moles/volume] in Serum or Plasma |
| 25358-3 | C peptide [Moles/time] in 24 hour Urine |
| 25359-1 | Cadmium [Moles/volume] in Serum or Plasma |
| 25360-9 | Cadmium [Moles/volume] in Urine |
| 25361-7 | Caffeine [Moles/volume] in Serum or Plasma |
| 25362-5 | Calcium [Moles/volume] in 24 hour Urine |
| 25363-3 | Campylobacter fetus Ab [Titer] in Serum by Complement fixation |
| 25364-1 | Campylobacter jejuni Ab [Titer] in Serum by Complement fixation |
| 25369-0 | Chlamydia sp IgA Ab [Units/volume] in Serum |
| 25372-4 | Choriogonadotropin [Units/volume] in Urine |
| 25373-2 | Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma |
| 25374-0 | Chromium [Moles/volume] in Serum or Plasma |
| 25375-7 | Chymotrypsin [Enzymatic activity/mass] in Stool |
| 25378-1 | Cobalt [Moles/volume] in Serum or Plasma |
| 25379-9 | Cobalt [Moles/time] in 24 hour Urine |
| 25381-5 | Corticosterone [Moles/volume] in Serum or Plasma |
| 25382-3 | Cortisone [Moles/volume] in Serum or Plasma |
| 25384-9 | Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence |
| 25385-6 | Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25386-4 | Creatinine [Moles/volume] in Body fluid |
| 25387-2 | Cyanide [Moles/volume] in Serum or Plasma |
| 25389-8 | Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay |
| 25390-6 | Cytokeratin 19 [Mass/volume] in Serum or Plasma |
| 25391-4 | Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine |
| 25392-2 | Dengue virus IgM Ab [Presence] in Serum by Immunoblot (IB) |
| 25393-0 | Desethylamiodarone [Moles/volume] in Serum or Plasma |
| 25394-8 | Nortrimipramine [Moles/volume] in Serum or Plasma |
| 25397-1 | Echinococcus sp Ab [Presence] in Serum by Immunoassay |
| 25398-9 | Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
| 25399-7 | Endomysium Ab [Titer] in Serum by Immunofluorescence |
| 25400-3 | Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence |
| 25401-1 | Estradiol (E2) [Moles/time] in 24 hour Urine |
| 25402-9 | Estrogen [Moles/time] in 24 hour Urine |
| 25403-7 | Estrone (E1) [Moles/volume] in Urine |
| 25404-5 | Ethambutol [Presence] in Serum or Plasma |
| 25406-0 | Fasciola sp Ab [Titer] in Serum by Immunofluorescence |
| 25407-8 | Fasciola sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 25409-4 | Filaria Ab [Titer] in Serum by Immunofluorescence |
| 25410-2 | Filaria IgG Ab [Units/volume] in Serum by Immunoassay |
| 25412-8 | Flunitrazepam [Moles/volume] in Serum or Plasma |
| 25413-6 | Fluoride [Moles/time] in 24 hour Urine |
| 25415-1 | Folate [Moles/volume] in Blood |
| 25416-9 | Herpes virus 6 IgG Ab [Titer] in Serum by Immunofluorescence |
| 25417-7 | Herpes virus 6 IgM Ab [Titer] in Serum by Immunofluorescence |
| 25418-5 | Mumps virus IgG Ab [Units/volume] in Serum by Immunoassay |
| 25419-3 | Mumps virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 25420-1 | Rubella virus IgM Ab [Presence] in Serum by Latex agglutination |
| 25421-9 | Measles virus IgM Ab [Units/volume] in Serum by Immunoassay |
| 25422-7 | Schistosoma sp Ab [Titer] in Serum by Immunofluorescence |
| 25423-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay |
| 25424-3 | Trypanosoma sp Ab [Units/volume] in Serum by Immunofluorescence |
| 25425-0 | Gabapentin [Moles/volume] in Serum or Plasma |
| 25426-8 | Galactose [Moles/volume] in Serum or Plasma |
| 25428-4 | Glucose [Presence] in Urine by Test strip |
| 25432-6 | Haemophilus influenzae Ab [Mass/volume] in Serum |
| 25433-4 | Free Hemoglobin [Moles/volume] in Plasma |
| 25435-9 | Herpes simplex virus IgM Ab [Presence] in Serum |
| 25439-1 | Histamine [Moles/time] in 24 hour Urine |
| 25447-4 | Insulin Free [Moles/volume] in Serum or Plasma |
| 25448-2 | Iodine [Moles/volume] in Serum or Plasma |
| 25449-0 | Iodine [Moles/time] in 24 hour Urine |
| 25451-6 | Isoniazid [Moles/volume] in Serum or Plasma |
| 25453-2 | Lactalbumin alpha IgA Ab [Units/volume] in Serum |
| 25455-7 | Lactoglobulin IgA Ab [Units/volume] in Serum |
| 25458-1 | Lamotrigine [Moles/volume] in Serum or Plasma |
| 25459-9 | Lead [Moles/volume] in Serum or Plasma |
| 25461-5 | Lithium [Moles/volume] in Blood |
| 25462-3 | Lithium [Moles/volume] in Red Blood Cells |
| 25463-1 | Lithium [Moles/volume] in Urine |
| 25466-4 | Manganese [Moles/volume] in Blood |
| 25467-2 | Manganese [Moles/volume] in Serum or Plasma |
| 25468-0 | Mephenytoin [Moles/volume] in Serum or Plasma |
| 25469-8 | Meprobamate [Moles/volume] in Serum or Plasma |
| 25470-6 | Mercury [Moles/volume] in Saliva (oral fluid) |
| 25471-4 | Mercury [Moles/time] in 24 hour Urine |
| 25472-2 | Mesoridazine [Moles/volume] in Serum or Plasma |
| 25473-0 | Metanephrine [Moles/volume] in Serum or Plasma |
| 25474-8 | Metanephrines [Moles/volume] in Serum or Plasma |
| 25475-5 | Methaqualone [Moles/volume] in Serum or Plasma |
| 25477-1 | Methionine sulfoxide [Moles/time] in 24 hour Urine |
| 25478-9 | Methyprylon [Moles/volume] in Serum or Plasma |
| 25479-7 | Saccharopolyspora rectivirgula IgG Ab [Units/volume] in Serum |
| 25481-3 | Molybdenum [Moles/volume] in Serum or Plasma |
| 25484-7 | Nefazodone [Moles/volume] in Serum or Plasma |
| 25486-2 | Nickel [Moles/volume] in Serum or Plasma |
| 25487-0 | Nickel [Moles/time] in 24 hour Urine |
| 25488-8 | Nicotinamide [Moles/volume] in Serum or Plasma |
| 25489-6 | Normetanephrine [Moles/volume] in Serum or Plasma |
| 25492-0 | Oxipurinol [Moles/volume] in Serum or Plasma |
| 25498-7 | Adenosine monophosphate.cyclic [Moles/volume] in Serum or Plasma |
| 25499-5 | Adrenal cortex Ab [Titer] in Serum by Immunofluorescence |
| 25500-0 | Phenylbutazone [Moles/volume] in Serum or Plasma |
| 25501-8 | Phosphate [Moles/volume] in Body fluid |
| 25505-9 | Pituitary glucoprotein hormone.alpha subunit [Units/volume] in Serum |
| 25506-7 | Potassium [Moles/mass] in Stool |
| 25507-5 | Pregnenolone [Moles/volume] in Serum or Plasma |
| 2551-0 | Lactoferrin [Mass/volume] in Serum |
| 25511-7 | Propafenone [Moles/volume] in Serum or Plasma |
| 25514-1 | Rubella virus IgG Ab [Presence] in Serum |
| 2552-8 | Lactose [Mass/volume] in Serum or Plasma |
| 25520-8 | Secobarbital [Moles/volume] in Serum or Plasma |
| 25521-6 | Selenium [Moles/volume] in Serum or Plasma |
| 25524-0 | Serotonin [Moles/volume] in Blood |
| 25526-5 | Silicon [Moles/volume] in Serum or Plasma |
| 25527-3 | Silver [Moles/volume] in Serum or Plasma |
| 25528-1 | Insulin-like growth factor [Moles/volume] in Serum or Plasma |
| 25529-9 | Somatotropin [Moles/volume] in Serum or Plasma |
| 2553-6 | Lactose [Presence] in Urine |
| 25531-5 | Streptococcus pneumoniae Ab [Mass/volume] in Serum |
| 25534-9 | Teicoplanin [Moles/volume] in Serum or Plasma --peak |
| 25535-6 | Teicoplanin [Moles/volume] in Serum or Plasma --trough |
| 25537-2 | Thallium [Moles/volume] in Serum or Plasma |
| 25538-0 | Thermoactinomyces vulgaris IgG Ab [Units/volume] in Serum |
| 2554-4 | Lactose [Mass/time] in 24 hour Urine |
| 25541-4 | Topiramate [Moles/volume] in Serum or Plasma |
| 25542-2 | Toxoplasma gondii IgM Ab [Presence] in Serum |
| 25543-0 | Lipase [Enzymatic activity/time] in 24 hour Urine |
| 25548-9 | Urate [Moles/volume] in Body fluid |
| 25549-7 | Urea [Moles/volume] in Body fluid |
| 2555-1 | Lecithin cholesterol acyltransferase [Enzymatic activity/volume] in Serum or Plasma |
| 25550-5 | Urea [Moles/time] in 24 hour Urine |
| 25551-3 | Urobilinogen [Presence] in Body fluid |
| 25555-4 | Wuchereria bancrofti Ag [Presence] in Serum |
| 25556-2 | Xylose [Moles/volume] in Urine |
| 25557-0 | Zinc [Moles/volume] in Red Blood Cells |
| 25559-6 | Zolpidem [Moles/volume] in Serum or Plasma |
| 2556-9 | Lecithin phosphorus [Mass/volume] in Amniotic fluid |
| 25560-4 | Allobarbital [Moles/volume] in Serum or Plasma |
| 25561-2 | 11-Deoxycorticosterone [Moles/volume] in Serum or Plasma |
| 25562-0 | Angiotensin II [Moles/volume] in Plasma --supine |
| 25563-8 | Angiotensin II [Moles/volume] in Plasma --upright |
| 25564-6 | Bilirubin.direct [Moles/volume] in Body fluid |
| 25565-3 | Bougainvillea IgE Ab [Units/volume] in Serum |
| 2557-7 | Lecithin/Sphingomyelin [Mass Ratio] in Amniotic fluid |
| 25583-6 | Calcium [Moles/volume] in Red Blood Cells |
| 25587-7 | Chromogranin A [Moles/volume] in Serum or Plasma |
| 25589-3 | Citalopram [Moles/volume] in Serum or Plasma |
| 25593-5 | Rotavirus IgG Ab [Presence] in Serum |
| 25598-4 | Cladosporium cladosporioides IgG Ab [Units/volume] in Serum |
| 25599-2 | Rotavirus IgG Ab [Units/volume] in Serum |
| 25600-8 | Rotavirus IgM Ab [Units/volume] in Serum |
| 25601-6 | Rotavirus IgM Ab [Presence] in Serum |
| 25603-2 | Rickettsia prowazekii IgG Ab [Titer] in Serum |
| 25604-0 | Rickettsia prowazekii IgM Ab [Titer] in Serum |
| 25609-9 | Cochineal extract IgE Ab [Units/volume] in Serum |
| 25611-5 | Oriental Cockroach IgE Ab [Units/volume] in Serum |
| 25613-1 | Smoky Brown Cockroach IgE Ab [Units/volume] in Serum |
| 25615-6 | Conalbumin IgE Ab [Units/volume] in Serum |
| 2563-5 | Leukocyte esterase [Enzymatic activity/volume] in Leukocytes |
| 25630-5 | Parvovirus B19 IgG Ab [Titer] in Serum |
| 25631-3 | Parvovirus B19 IgM Ab [Titer] in Serum |
| 25632-1 | Plasmodium sp Ab [Titer] in Serum |
| 25633-9 | Leishmania donovani Ab [Titer] in Serum |
| 25638-8 | Eosinophil cationic protein (ECP) [Mass/volume] in Serum |
| 25639-6 | Follitropin [Units/volume] in Urine by 2nd IRP |
| 25664-4 | Glucose [Mass/volume] in Urine --1 hour post dose glucose |
| 25665-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post XXX challenge |
| 25667-7 | Glucose [Mass/volume] in Urine --2 hours post dose glucose |
| 25668-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post XXX challenge |
| 2567-6 | Phospholipid phosphorus [Mass/volume] in Serum |
| 2568-4 | Phospholipid [Mass/volume] in Serum or Plasma |
| 25681-8 | Immunoglobulin light chains.kappa [Presence] in Serum by Immunoelectrophoresis |
| 25682-6 | Immunoglobulin light chains.kappa [Mass/time] in 24 hour Urine |
| 25683-4 | Immunoglobulin light chains.lambda [Presence] in Serum by Immunoelectrophoresis |
| 25684-2 | Immunoglobulin light chains.lambda [Mass/time] in 24 hour Urine |
| 2569-2 | Lipids [Mass/volume] in Serum |
| 2570-0 | Fat [Mass/volume] in Stool |
| 25703-0 | Jujube IgE Ab [Units/volume] in Serum |
| 25708-9 | Leishmania donovani Ab [Titer] in Serum by Immunofluorescence |
| 25709-7 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Complement fixation |
| 2571-8 | Triglyceride [Mass/volume] in Serum or Plasma |
| 25710-5 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Complement fixation |
| 25711-3 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Complement fixation |
| 25712-1 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Complement fixation |
| 25714-7 | Litchi IgE Ab [Units/volume] in Serum |
| 25716-2 | Lutropin [Units/volume] in Urine by 1st IRP |
| 2572-6 | Lipoprotein lipase [Enzymatic activity/volume] in Serum or Plasma |
| 25721-2 | Mianserin [Moles/volume] in Serum or Plasma |
| 25725-3 | Ovary Ab [Titer] in Serum by Immunofluorescence |
| 25726-1 | Oxcarbazepine [Moles/volume] in Serum or Plasma |
| 25729-5 | Parvovirus B19 IgG Ab [Titer] in Serum by Immunofluorescence |
| 25730-3 | Parvovirus B19 IgM Ab [Titer] in Serum by Immunofluorescence |
| 25731-1 | Plasmodium sp Ab [Titer] in Serum by Immunofluorescence |
| 25732-9 | Pregnanetriolone [Moles/time] in 24 hour Urine |
| 25733-7 | Procollagen type III [Units/volume] in Serum |
| 25742-8 | Prothrombin Fragment 1.2 [Moles/volume] in Serum or Plasma |
| 25743-6 | Quinoa IgE Ab [Units/volume] in Serum |
| 25745-1 | Rheumatoid factor [Presence] in Body fluid by Sheep Cell Agglutination |
| 25746-9 | Rheumatoid factor [Titer] in Body fluid by Sheep Cell Agglutination |
| 25747-7 | Ribosomal Ab [Presence] in Serum by Immunoassay |
| 25748-5 | Ribosomal Ab [Titer] in Serum by Immunofluorescence |
| 25749-3 | Rickettsia conorii IgG Ab [Titer] in Serum by Immunofluorescence |
| 25750-1 | Rickettsia conorii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25751-9 | Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunofluorescence |
| 25752-7 | Rickettsia prowazekii IgM Ab [Titer] in Serum by Immunofluorescence |
| 25753-5 | Rotavirus IgG Ab [Presence] in Serum by Immunoassay |
| 25754-3 | Rotavirus IgG Ab [Units/volume] in Serum by Immunoassay |
| 25755-0 | Rotavirus IgM Ab [Presence] in Serum by Immunoassay |
| 25756-8 | Rotavirus IgM Ab [Units/volume] in Serum by Immunoassay |
| 25757-6 | Schistosoma sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 2577-5 | Lithocholate [Mass/volume] in Serum |
| 25779-0 | Stachybotrys chartarum IgG Ab [Units/volume] in Serum |
| 2578-3 | Lutropin [Moles/volume] in Semen |
| 25788-1 | Streptolysin O Ab [Units/volume] in Serum by Latex agglutination |
|
Propose a change